Citrus Sinensis ID: 020072
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | 2.2.26 [Sep-21-2011] | |||||||
| Q0V7T5 | 427 | Probable receptor-like pr | no | no | 0.833 | 0.646 | 0.496 | 5e-66 | |
| O65530 | 731 | Proline-rich receptor-lik | no | no | 0.564 | 0.255 | 0.489 | 1e-47 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.583 | 0.271 | 0.466 | 4e-47 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.806 | 0.520 | 0.352 | 3e-46 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.583 | 0.268 | 0.456 | 1e-45 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.558 | 0.258 | 0.465 | 2e-45 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.583 | 0.296 | 0.456 | 8e-45 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.845 | 0.395 | 0.363 | 8e-45 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.570 | 0.277 | 0.450 | 2e-44 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.761 | 0.311 | 0.378 | 3e-44 |
| >sp|Q0V7T5|Y1864_ARATH Probable receptor-like protein kinase At1g80640 OS=Arabidopsis thaliana GN=At1g80640 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 251 bits (641), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 148/298 (49%), Positives = 186/298 (62%), Gaps = 22/298 (7%)
Query: 38 ISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILAL--LCLWLY- 94
IS S M A SPG + D + K+LIALI++ S LC+ ++ L L LW Y
Sbjct: 42 ISQASPRMGAQSPGPPIVKV---VLRQDLNKKILIALIVSSSLLCVTVMFLVYLLLWRYR 98
Query: 95 HLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFH 154
++K SF + + DS V + K SVR KG+ I EY+LLE AT+ F
Sbjct: 99 NMKNSFTGIKRKS---DSVKSVTTKPTVHKIDSVR----KGT-IPVYEYQLLESATNKFS 150
Query: 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLL 213
+SN+L GG GC+Y+A LD+ V VKKLD + D ++FE EVD L+ I H N+V LL
Sbjct: 151 DSNVLSRGGRGCLYRACLDEKSSVTVKKLDGGGETDIEKQFETEVDWLAKIRHQNIVSLL 210
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G+ + T IVYELM+N SL+ QLHGPS GS LTW +RMKIA+D ARGLEYLHEHC+P
Sbjct: 211 GFCVYRQTSCIVYELMQNGSLESQLHGPSQGSGLTWQLRMKIAVDIARGLEYLHEHCHPP 270
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331
V+HRDLKSS+ILLDS FNAK+SDFG A +QNKN L + A E LLDG V
Sbjct: 271 VVHRDLKSSSILLDSDFNAKISDFGFATVLTTQNKN-------LIHKASEDLLDGKVT 321
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65530|PEK14_ARATH Proline-rich receptor-like protein kinase PERK14 OS=Arabidopsis thaliana GN=PERK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 94/192 (48%), Positives = 127/192 (66%), Gaps = 5/192 (2%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLS 202
Y+ L KAT F E N+LGEGGFG V+K L + VAVK+L + REF+ EVD +S
Sbjct: 379 YEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDTIS 438
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+HH ++V L+GY + D R +VYE + +L+ LH + GS L W MR++IA+ A+G
Sbjct: 439 RVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHE-NRGSVLEWEMRLRIAVGAAKG 497
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNNLKLSGTLG 318
L YLHE C+P +IHRD+K++NILLDSKF AK+SDFGLA T+ S + ++ GT G
Sbjct: 498 LAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGTFG 557
Query: 319 YVAPEYLLDGMV 330
Y+APEY G V
Sbjct: 558 YMAPEYASSGKV 569
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 91/195 (46%), Positives = 131/195 (67%), Gaps = 2/195 (1%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L T+ F + NILGEGGFGCVYK KL+D VAVK+L + REF
Sbjct: 335 GSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREF 394
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 395 KAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGR-PVLEWARRVR 453
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD +F A+++DFGLA + D +Q + ++
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRV 513
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 514 MGTFGYLAPEYAQSG 528
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 185 bits (470), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 106/301 (35%), Positives = 159/301 (52%), Gaps = 34/301 (11%)
Query: 29 PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILAL 88
P P P + +M +PG + P A ++ + I L ++
Sbjct: 91 PPPPASPSGQEPTTPTM---TPGFSLSPPSPSRLSTGA----VVGISIGGGVFVLTLIFF 143
Query: 89 LCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEK 148
LC K ++ K+ + G+VL FT Y L +
Sbjct: 144 LCK---------KKRPRDDKALPAPIGLVLGIHQSTFT----------------YGELAR 178
Query: 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
AT+ F E+N+LGEGGFG VYK L++ VAVK+L + +EF+ EV+++S IHH N
Sbjct: 179 ATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V L+GY R +VYE + N +L+ LHG + W +R+KIA+ +++GL YLHE
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSLRLKIAVSSSKGLSYLHE 297
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+CNP +IHRD+K++NIL+D KF AK++DFGLA I + + ++ GT GY+APEY
Sbjct: 298 NCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAAS 357
Query: 328 G 328
G
Sbjct: 358 G 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 89/195 (45%), Positives = 128/195 (65%), Gaps = 2/195 (1%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L + T F NILGEGGFGCVYK L D VAVK+L + REF
Sbjct: 353 GSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREF 412
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 413 KAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGL-PVLEWSKRVR 471
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD ++ A+++DFGLA + D +Q + ++
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 532 MGTFGYLAPEYASSG 546
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 182 bits (463), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 87/187 (46%), Positives = 125/187 (66%), Gaps = 2/187 (1%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLS 202
Y+ L +AT+ F E+N+LG+GGFG V+K L + VAVK+L + REF+ EV ++S
Sbjct: 344 YEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGIIS 403
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+HH ++V L+GY D R +VYE + N +L+ LHG + W R+KIA+ +A+G
Sbjct: 404 RVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSSRLKIAVGSAKG 462
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVA 321
L YLHE+CNP +IHRD+K+SNIL+D KF AK++DFGLA I + + ++ GT GY+A
Sbjct: 463 LSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLA 522
Query: 322 PEYLLDG 328
PEY G
Sbjct: 523 PEYASSG 529
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 8e-45, Method: Compositional matrix adjust.
Identities = 89/195 (45%), Positives = 126/195 (64%), Gaps = 2/195 (1%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + S Y+ L +AT+ F E+N+LG+GGFG V+K L VAVK+L + REF
Sbjct: 262 GFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREF 321
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY R +VYE + N +L+ LHG + W R+K
Sbjct: 322 QAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGR-PTMEWSTRLK 380
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IAL +A+GL YLHE CNP +IHRD+K+SNIL+D KF AK++DFGLA I + + ++
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 440
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 441 MGTFGYLAPEYAASG 455
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 8e-45, Method: Compositional matrix adjust.
Identities = 113/311 (36%), Positives = 159/311 (51%), Gaps = 31/311 (9%)
Query: 31 PLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLC 90
P + PL +P ST+ + G +G I++ +A L + + C
Sbjct: 259 PTLRPPLDAPNSTNNSGIGTGAVVG----------------ISVAVALVVFTLFGIFVWC 302
Query: 91 LWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK------------GSAI 138
L + S S S S S+F +S + + K G++
Sbjct: 303 LRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSK 362
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEV 198
+ Y+ L KAT+ F + N+LGEGGFGCVYK L D VAVK+L REF+ EV
Sbjct: 363 ALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEV 422
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+ LS IHH ++V ++G+ D R ++Y+ + N L LHG S L W R+KIA
Sbjct: 423 ETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHG--EKSVLDWATRVKIAAG 480
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-NLKLSGTL 317
ARGL YLHE C+P +IHRD+KSSNILL+ F+A++SDFGLA N + ++ GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTF 540
Query: 318 GYVAPEYLLDG 328
GY+APEY G
Sbjct: 541 GYMAPEYASSG 551
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 87/193 (45%), Positives = 120/193 (62%), Gaps = 4/193 (2%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEV 198
S+ Y L + T F E N+LGEGGFGCVYK L D VAVK+L REF+ EV
Sbjct: 325 SWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEV 384
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+++S +HH ++V L+GY + R +VY+ + N +L LH P +TW R+++A
Sbjct: 385 EIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGR-PVMTWETRVRVAAG 443
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN---NLKLSG 315
ARG+ YLHE C+P +IHRD+KSSNILLD+ F A ++DFGLA + N + ++ G
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 316 TLGYVAPEYLLDG 328
T GY+APEY G
Sbjct: 504 TFGYMAPEYATSG 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 101/267 (37%), Positives = 147/267 (55%), Gaps = 15/267 (5%)
Query: 65 DAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGK 124
+ +K+++A I++ S ++ A C Y +K++ + SK++ N
Sbjct: 421 NKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWNN--------- 471
Query: 125 FTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLD 184
+ + S + F E ++ ATD+F SN LG+GGFG VYK KL D +AVK+L
Sbjct: 472 ----DLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLS 527
Query: 185 CATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHG 244
++ EF NE+ L+S + H N+V +LG + R +VYE + N+SLD L
Sbjct: 528 SSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKR 587
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITD 303
+ W R I ARGL YLH VIHRDLK SNILLD K N K+SDFGLA +
Sbjct: 588 LEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQ 647
Query: 304 GSQNKNNL-KLSGTLGYVAPEYLLDGM 329
G++ ++N +++GTLGY+APEY GM
Sbjct: 648 GTEYQDNTRRVAGTLGYMAPEYAWTGM 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| 356552492 | 440 | PREDICTED: probable receptor-like protei | 0.927 | 0.697 | 0.671 | 1e-117 | |
| 356563914 | 452 | PREDICTED: probable receptor-like protei | 0.927 | 0.679 | 0.665 | 1e-115 | |
| 357468623 | 458 | Wall-associated receptor kinase-like pro | 0.957 | 0.692 | 0.666 | 1e-114 | |
| 359475853 | 455 | PREDICTED: probable receptor-like protei | 0.954 | 0.694 | 0.624 | 1e-113 | |
| 255637266 | 322 | unknown [Glycine max] | 0.897 | 0.922 | 0.654 | 1e-108 | |
| 255641950 | 391 | unknown [Glycine max] | 0.797 | 0.675 | 0.694 | 1e-104 | |
| 356518228 | 412 | PREDICTED: probable receptor-like protei | 0.821 | 0.660 | 0.657 | 1e-103 | |
| 356509894 | 414 | PREDICTED: probable receptor-like protei | 0.830 | 0.664 | 0.636 | 5e-98 | |
| 255548800 | 446 | Serine/threonine-protein kinase PBS1, pu | 0.969 | 0.719 | 0.598 | 7e-98 | |
| 449442156 | 400 | PREDICTED: probable receptor-like protei | 0.845 | 0.7 | 0.610 | 2e-95 |
| >gi|356552492|ref|XP_003544601.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 211/314 (67%), Positives = 247/314 (78%), Gaps = 7/314 (2%)
Query: 16 HQSFWIHASIEPL-PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIAL 74
H+ WI AS PL P P V P SP TSM+A SPGI MG+E HMD+H K++IA+
Sbjct: 17 HKPTWILASAYPLAPSPQV--PPFSPFPTSMSASSPGIVMGAE---QQHMDSHKKMVIAV 71
Query: 75 IIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK 134
+A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL KF+S+++V KK
Sbjct: 72 AVASTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKK 131
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + I+YK +EK T +F E NILGEGGFGCVYKA LDDNL VAVKKL C Q A +EF
Sbjct: 132 G-CVPIIDYKQIEKTTGNFEEINILGEGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEF 190
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
ENEVDLLS I HPNV+ LLG S++DDTR IVYELM N SL+ QLHGPSHGSALTWH+RMK
Sbjct: 191 ENEVDLLSKIQHPNVISLLGCSSNDDTRIIVYELMHNGSLETQLHGPSHGSALTWHLRMK 250
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
IALDTARGL+YLHEHC P VIHRDLKSSN+LLD+KFNAKLSDFGLAIT+GSQNKNNLKLS
Sbjct: 251 IALDTARGLKYLHEHCYPPVIHRDLKSSNVLLDTKFNAKLSDFGLAITNGSQNKNNLKLS 310
Query: 315 GTLGYVAPEYLLDG 328
GTLGYVAPEYLLDG
Sbjct: 311 GTLGYVAPEYLLDG 324
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563914|ref|XP_003550202.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1084), Expect = e-115, Method: Compositional matrix adjust.
Identities = 209/314 (66%), Positives = 247/314 (78%), Gaps = 7/314 (2%)
Query: 16 HQSFWIHASIEPL-PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIAL 74
H+ W AS PL P P V P SP TSM+A SPGI MG+E HMD+H K++IA+
Sbjct: 18 HKPTWFLASAYPLAPSPQV--PPFSPFPTSMSASSPGIVMGAE---QQHMDSHKKMVIAV 72
Query: 75 IIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK 134
+A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL KF+S+++V KK
Sbjct: 73 AVASTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKK 132
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + I+YK +EKAT +F E NILG+GGFGCVYKA LDDNL VAVKKL C Q A +EF
Sbjct: 133 G-CVPIIDYKQIEKATGNFKEINILGKGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEF 191
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
ENEVDLLS I HPNV+ LLG S+++DTR IVYELM N SL+ QLHGPSHGSALTWH+R+K
Sbjct: 192 ENEVDLLSKIQHPNVISLLGCSSNEDTRIIVYELMHNGSLETQLHGPSHGSALTWHLRIK 251
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
IALDTARGL+YLHEHC P VIHRDLKSSNILLD+KFNAKLSDFGLAIT+GSQNKNNLKLS
Sbjct: 252 IALDTARGLKYLHEHCYPPVIHRDLKSSNILLDTKFNAKLSDFGLAITNGSQNKNNLKLS 311
Query: 315 GTLGYVAPEYLLDG 328
GTLGYVAPEYLLDG
Sbjct: 312 GTLGYVAPEYLLDG 325
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357468623|ref|XP_003604596.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355505651|gb|AES86793.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-114, Method: Compositional matrix adjust.
Identities = 220/330 (66%), Positives = 259/330 (78%), Gaps = 13/330 (3%)
Query: 1 MKLLLILFVVLFVFLHQSFWIHASIEPLPGPLVFSPLISPVSTSMA--AFSPGIQMGSED 58
MKLL + F++ H+ WI ASI PLV SP ISP+ TS+A A SP I +G E
Sbjct: 20 MKLLFMFFLIP----HKPIWILASIV---DPLVPSPQISPILTSIAVSASSPDIHVGDE- 71
Query: 59 PHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVL 118
H +MD+H K ++A + A + L IIL LL W++++KYS KS KN ++ D E G+ L
Sbjct: 72 --HQNMDSHMKKVMAFVAASTGLGAIILCLLSFWIFYIKYSSKSKKKNLQNSDGEKGLRL 129
Query: 119 SSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHV 178
FL KF+SVR+V KKG + I+YK LEKAT +F ESNI+GEGGFGCVYKA+LDDNL V
Sbjct: 130 VPFLSKFSSVRLVGKKG-CVPIIDYKQLEKATGNFKESNIIGEGGFGCVYKARLDDNLDV 188
Query: 179 AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL 238
A+KKL+C Q A REFENEVDLLS I HPNV+ LLG S+++D+RFIVYELM+N SL+ QL
Sbjct: 189 AIKKLNCECQYAEREFENEVDLLSKIQHPNVISLLGCSSNEDSRFIVYELMQNGSLETQL 248
Query: 239 HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
HGPSHGSALTWHMRMKIALDTARGL+YLHEHC PAVIHRDLKSSNILLD+ FNAKLSDFG
Sbjct: 249 HGPSHGSALTWHMRMKIALDTARGLKYLHEHCYPAVIHRDLKSSNILLDANFNAKLSDFG 308
Query: 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
LAITDGSQNKNN+KLSGTLGYVAPEYLLDG
Sbjct: 309 LAITDGSQNKNNIKLSGTLGYVAPEYLLDG 338
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475853|ref|XP_002285386.2| PREDICTED: probable receptor-like protein kinase At1g80640-like [Vitis vinifera] gi|296082091|emb|CBI21096.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1062), Expect = e-113, Method: Compositional matrix adjust.
Identities = 208/333 (62%), Positives = 255/333 (76%), Gaps = 17/333 (5%)
Query: 8 FVVLFVFLHQSFW------IHASIEP----LPGPLVFSPL--ISPVSTSMAAFSPGIQMG 55
F +L + L QS W + A +P + PL P+ SP+S+SMAAFSP IQ G
Sbjct: 3 FFLLILPLLQSIWSFHFSIVEAISDPPLSSISAPLSSPPIGATSPISSSMAAFSPAIQEG 62
Query: 56 SEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENG 115
SE+ + D+H K IAL +A +AL + IL LL LW+ H K S KS NA+S D+E
Sbjct: 63 SEE---NQKDSHKKTFIALTVASAALGVTILILLSLWI-HKKCSQKSHKSNAQSSDAEKA 118
Query: 116 VVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDN 175
+ L L KF +++++ +KGS +S I+YK+LE AT++F ESNILGEGGFGCVYKA+LDDN
Sbjct: 119 LTLGPLLAKFNTMKVIGRKGS-VSCIDYKVLETATNNFQESNILGEGGFGCVYKARLDDN 177
Query: 176 LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235
HVAVKK+D QDA REFENEVDLL+ I HPN++ LLGYS+H++++F+VYELM+N SL+
Sbjct: 178 SHVAVKKIDGRGQDAEREFENEVDLLTKIQHPNIISLLGYSSHEESKFLVYELMQNGSLE 237
Query: 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295
+LHGPSHGS+LTWH+RMKIALD ARGLEYLHEHCNP VIHRDLKSSNILLDS FNAKLS
Sbjct: 238 TELHGPSHGSSLTWHIRMKIALDAARGLEYLHEHCNPPVIHRDLKSSNILLDSNFNAKLS 297
Query: 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
DFGLA+ DG QNKNNLKLSGTLGY+APEYLLDG
Sbjct: 298 DFGLAVIDGPQNKNNLKLSGTLGYLAPEYLLDG 330
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255637266|gb|ACU18963.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 199/304 (65%), Positives = 236/304 (77%), Gaps = 7/304 (2%)
Query: 16 HQSFWIHASIEPL-PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIAL 74
H+ W AS PL P P V P SP TSM+A SPGI MG+E HMD+H K++IA+
Sbjct: 18 HKPTWFLASAYPLAPSPQV--PPFSPFPTSMSASSPGIVMGAE---QQHMDSHKKMVIAV 72
Query: 75 IIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK 134
+ ++L +IL LLC+W+Y+ KY KS KN + D+E G+ S FL KF+S+++V KK
Sbjct: 73 AVVSTSLGAVILCLLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKK 132
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + I+YK +EKAT +F E NILG+GGFGCVYKA LDDNL VAVKKL C Q A +EF
Sbjct: 133 G-CVPIIDYKQIEKATGNFKEINILGKGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEF 191
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
ENEVDLLS I HPNV+ LLG S+++DTR IVYELM N SL+ QLHGPSHGSALTWH+R+K
Sbjct: 192 ENEVDLLSKIQHPNVISLLGCSSNEDTRIIVYELMHNGSLETQLHGPSHGSALTWHLRIK 251
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
IALDTARGL+YLHEHC P VIHRDLKSSNILLD+KFNAKLSDFGLAIT+GSQNKNNLKLS
Sbjct: 252 IALDTARGLKYLHEHCYPPVIHRDLKSSNILLDTKFNAKLSDFGLAITNGSQNKNNLKLS 311
Query: 315 GTLG 318
GTLG
Sbjct: 312 GTLG 315
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255641950|gb|ACU21242.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 385 bits (988), Expect = e-104, Method: Compositional matrix adjust.
Identities = 184/265 (69%), Positives = 220/265 (83%), Gaps = 1/265 (0%)
Query: 64 MDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLG 123
MD+H K++IA+ +A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL
Sbjct: 1 MDSHKKMVIAVAVAGTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLS 60
Query: 124 KFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL 183
KF+S+++V KKG + I+YK +EKAT +F E NILG+GGFGCVYKA LDDNL VAVKKL
Sbjct: 61 KFSSIKLVGKKG-CVPIIDYKQIEKATGNFKEINILGKGGFGCVYKAHLDDNLDVAVKKL 119
Query: 184 DCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSH 243
C Q A +EFENEVDLLS I HPNV+ LLG S+++DT+ IVYELM N SL+ QLHGPSH
Sbjct: 120 HCENQYAEQEFENEVDLLSKIQHPNVISLLGCSSNEDTKIIVYELMHNGSLETQLHGPSH 179
Query: 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303
GSALTWH+R+KIALDTARGL+YLHEHC P VIHRDLKSSNILLD+KFNAKLSDFGLAIT+
Sbjct: 180 GSALTWHLRIKIALDTARGLKYLHEHCYPPVIHRDLKSSNILLDTKFNAKLSDFGLAITN 239
Query: 304 GSQNKNNLKLSGTLGYVAPEYLLDG 328
GSQNKNNLKLSGTLGYVAPEYLLDG
Sbjct: 240 GSQNKNNLKLSGTLGYVAPEYLLDG 264
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518228|ref|XP_003527781.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 380 bits (977), Expect = e-103, Method: Compositional matrix adjust.
Identities = 186/283 (65%), Positives = 224/283 (79%), Gaps = 11/283 (3%)
Query: 47 AFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYH-LKYSFKSSNK 105
AFSPG + HHM+ K++IA+++A +AL +I LC W+YH KY KS +K
Sbjct: 27 AFSPGEE-------QHHMNK--KVVIAIVVATTALAALIFTFLCFWIYHHTKYPTKSKSK 77
Query: 106 NAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFG 165
N +S D+E G+ L+ FL KF+S+++V GS + I+YK +EK T++F ESNILGEGGFG
Sbjct: 78 NVQSPDAEKGITLAPFLNKFSSIKIVGMNGS-VPIIDYKQIEKTTNNFQESNILGEGGFG 136
Query: 166 CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225
VY+A+LD N VAVKKL C TQ A REFENEV+LLS I HPN++ LLG S +RFIV
Sbjct: 137 RVYRARLDHNFDVAVKKLHCETQHAEREFENEVNLLSKIQHPNIISLLGCSIDGYSRFIV 196
Query: 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285
YELM+N SL+ QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC+PAVIHRD+KSSNIL
Sbjct: 197 YELMQNGSLETQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCHPAVIHRDMKSSNIL 256
Query: 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
LD+ FNAKLSDFGLA+TDGSQ+K N+KLSGTLGYVAPEYLLDG
Sbjct: 257 LDANFNAKLSDFGLALTDGSQSKKNIKLSGTLGYVAPEYLLDG 299
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509894|ref|XP_003523677.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 363 bits (933), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 182/286 (63%), Positives = 220/286 (76%), Gaps = 11/286 (3%)
Query: 44 SMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYH-LKYSFKS 102
S A SPG E+ HH + +K++IA+++A +AL +I + LC W+YH KY KS
Sbjct: 26 SSPALSPG-----EEQHHRN----NKVVIAIVVATTALAALIFSFLCFWVYHHTKYPTKS 76
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEG 162
K+ + E G+ L+ F+ KF+S+++V G + I+YK +EK T++F ESNILGEG
Sbjct: 77 KFKSKNFRSPEKGITLAPFVSKFSSIKIVGMDG-YVPIIDYKQIEKTTNNFQESNILGEG 135
Query: 163 GFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222
GFG VYKA LD NL VAVKKL C TQ A REFENEV++LS I HPN++ LLG S TR
Sbjct: 136 GFGRVYKACLDHNLDVAVKKLHCETQHAEREFENEVNMLSKIQHPNIISLLGCSMDGYTR 195
Query: 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSS 282
F+VYELM N SL+ QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC+PAVIHRD+KSS
Sbjct: 196 FVVYELMHNGSLEAQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCHPAVIHRDMKSS 255
Query: 283 NILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
NILLD+ FNAKLSDFGLA+TDGSQ+K N+KLSGTLGYVAPEYLLDG
Sbjct: 256 NILLDANFNAKLSDFGLALTDGSQSKKNIKLSGTLGYVAPEYLLDG 301
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548800|ref|XP_002515456.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545400|gb|EEF46905.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 363 bits (932), Expect = 7e-98, Method: Compositional matrix adjust.
Identities = 200/334 (59%), Positives = 246/334 (73%), Gaps = 13/334 (3%)
Query: 1 MKLLLILFVVLFVFLHQSFWIHASIEPLPGPLVFSPL---ISPVSTSMAAFSPGIQM--G 55
M+L +I + + + Q +H+ E P V+SP ISP+STSMAAFSPG+Q+ G
Sbjct: 1 MELPVIFLLCIPTLIFQFSLVHSLQE---HPFVYSPAPSPISPISTSMAAFSPGVQLQLG 57
Query: 56 SEDPHHHHMDAHHKLLIALIIACSALCLIILAL-LCLWLYHLKYSFKSSNKNAKSKDSEN 114
ED HH M K+ + LI+AC L LI+LA +Y+ K+S + K+A D+E
Sbjct: 58 MED-DHHKMKLDKKVAMLLIVACGILALILLACLFGCGVYYWKFSQR--KKSAHCSDAEK 114
Query: 115 GVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDD 174
GV + FLGKF S+RMVS +GS +S I+YKLLEKAT +F + +LG GGFG VYKA L+D
Sbjct: 115 GVSSTPFLGKFNSLRMVSNRGS-VSLIDYKLLEKATKNFGDDCLLGIGGFGHVYKAVLED 173
Query: 175 NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234
+ HVAVKKLDC+ DA REFENEVDLLS +HHPN++ L+GYS H++ FIVYELM N SL
Sbjct: 174 DKHVAVKKLDCSGDDAHREFENEVDLLSKMHHPNIISLVGYSVHEEMGFIVYELMRNGSL 233
Query: 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294
+ LHGPS GS+L+WHMR+KIALD ARGLEYLHE C PAVIHRDLKSSNILLDS +NAKL
Sbjct: 234 EDLLHGPSRGSSLSWHMRLKIALDIARGLEYLHEFCKPAVIHRDLKSSNILLDSNYNAKL 293
Query: 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
SDFGLA+ D S NKN LKLSGT+GYVAPEY+LDG
Sbjct: 294 SDFGLAVADSSHNKNKLKLSGTVGYVAPEYMLDG 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442156|ref|XP_004138848.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus] gi|449499334|ref|XP_004160788.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 354 bits (909), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 174/285 (61%), Positives = 221/285 (77%), Gaps = 5/285 (1%)
Query: 45 MAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSN 104
M A SPGI +G E + D H K+LIALI+ C++ +++ L LW+Y+ + S
Sbjct: 1 MTASSPGIPIGMETLSN---DTHKKMLIALIV-CASFGAVLVVSLFLWIYYRRNSPNFHK 56
Query: 105 KNAKSKDSENGVV-LSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGG 163
+N +S D+E GVV L+ L KF+S +M+ ++ I+Y++LEKAT+ F ESNILGEGG
Sbjct: 57 RNGQSSDAEKGVVGLAPILRKFSSNKMMGSNKVSVPLIDYEVLEKATNIFEESNILGEGG 116
Query: 164 FGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223
FG VYKA+L++NL VAVKKL+C +D+ +EFENEVDLLS IHH N++ LLGY+ H ++R
Sbjct: 117 FGRVYKARLEENLCVAVKKLECTDKDSEKEFENEVDLLSKIHHSNIIRLLGYTIHGESRL 176
Query: 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283
+VYELMEN SL+ LHGPSHG ALTWHMRMKIALD AR LEYLHEHC P+VIHRDLKSSN
Sbjct: 177 LVYELMENGSLETLLHGPSHGEALTWHMRMKIALDAARALEYLHEHCKPSVIHRDLKSSN 236
Query: 284 ILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
ILLD+ FNAKLSDFGL++ G+QNKN++KLSGT+GYVAPEYLLDG
Sbjct: 237 ILLDANFNAKLSDFGLSVIVGAQNKNDIKLSGTMGYVAPEYLLDG 281
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.634 | 0.484 | 0.640 | 2.5e-75 | |
| TAIR|locus:2198998 | 427 | AT1G80640 [Arabidopsis thalian | 0.574 | 0.444 | 0.577 | 3.8e-53 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.601 | 0.272 | 0.478 | 1.4e-46 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.580 | 0.172 | 0.502 | 1.3e-45 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.583 | 0.271 | 0.466 | 1.8e-45 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.570 | 0.260 | 0.505 | 4.9e-45 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.583 | 0.268 | 0.456 | 4.8e-44 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.583 | 0.298 | 0.456 | 1.3e-43 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.583 | 0.296 | 0.456 | 1.7e-43 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.577 | 0.266 | 0.458 | 2.2e-43 |
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 2.5e-75, Sum P(2) = 2.5e-75
Identities = 137/214 (64%), Positives = 171/214 (79%)
Query: 120 SFLGKFTSVRMVSK---KGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNL 176
+FL +F+ + + K K +S I+Y +LE+ T F ESNILG+GGFGCVY A L++N+
Sbjct: 105 TFLNRFSRSKTLDKRTTKQGTVSLIDYNILEEGTSGFKESNILGQGGFGCVYSATLENNI 164
Query: 177 HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236
AVKKLDCA +DA +EF++EV++LS + HPN++ LLGYS +D RFIVYELM N SL+
Sbjct: 165 SAAVKKLDCANEDAAKEFKSEVEILSKLQHPNIISLLGYSTNDTARFIVYELMPNVSLES 224
Query: 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296
LHG S GSA+TW MRMKIALD RGLEYLHEHC+PA+IHRDLKSSNILLDS FNAK+SD
Sbjct: 225 HLHGSSQGSAITWPMRMKIALDVTRGLEYLHEHCHPAIIHRDLKSSNILLDSNFNAKISD 284
Query: 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330
FGLA+ DG +NKN+ KLSGT+GYVAPEYLL+G +
Sbjct: 285 FGLAVVDGPKNKNH-KLSGTVGYVAPEYLLNGQL 317
|
|
| TAIR|locus:2198998 AT1G80640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
Identities = 115/199 (57%), Positives = 141/199 (70%)
Query: 133 KKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAG 191
+KG+ I EY+LLE AT+ F +SN+L GG GC+Y+A LD+ V VKKLD + D
Sbjct: 130 RKGT-IPVYEYQLLESATNKFSDSNVLSRGGRGCLYRACLDEKSSVTVKKLDGGGETDIE 188
Query: 192 REFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251
++FE EVD L+ I H N+V LLG+ + T IVYELM+N SL+ QLHGPS GS LTW +
Sbjct: 189 KQFETEVDWLAKIRHQNIVSLLGFCVYRQTSCIVYELMQNGSLESQLHGPSQGSGLTWQL 248
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311
RMKIA+D ARGLEYLHEHC+P V+HRDLKSS+ILLDS FNAK+SDFG A +QNKN
Sbjct: 249 RMKIAVDIARGLEYLHEHCHPPVVHRDLKSSSILLDSDFNAKISDFGFATVLTTQNKN-- 306
Query: 312 KLSGTLGYVAPEYLLDGMV 330
L + A E LLDG V
Sbjct: 307 -----LIHKASEDLLDGKV 320
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 1.4e-46, Sum P(2) = 1.4e-46
Identities = 98/205 (47%), Positives = 132/205 (64%)
Query: 131 VSKKGSAIS-FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD 189
V+K S S Y+ L KAT F E N+LGEGGFG V+K L + VAVK+L +
Sbjct: 366 VAKNISMPSGMFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQ 425
Query: 190 AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTW 249
REF+ EVD +S +HH ++V L+GY + D R +VYE + +L+ LH + GS L W
Sbjct: 426 GEREFQAEVDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLH-ENRGSVLEW 484
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGS 305
MR++IA+ A+GL YLHE C+P +IHRD+K++NILLDSKF AK+SDFGLA T+ S
Sbjct: 485 EMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSS 544
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330
+ ++ GT GY+APEY G V
Sbjct: 545 FTHISTRVVGTFGYMAPEYASSGKV 569
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 1.3e-45, Sum P(2) = 1.3e-45
Identities = 99/197 (50%), Positives = 128/197 (64%)
Query: 136 SAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE 195
SA +F +++ KAT++F ES +LGEGGFG VY+ DD VAVK L Q REF
Sbjct: 707 SAKTFTASEIM-KATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFL 765
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMK 254
EV++LS +HH N+V L+G D R +VYEL+ N S++ LHG S+ L W R+K
Sbjct: 766 AEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLK 825
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKN-NL 311
IAL ARGL YLHE +P VIHRD KSSNILL++ F K+SDFGLA D N++ +
Sbjct: 826 IALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHIST 885
Query: 312 KLSGTLGYVAPEYLLDG 328
++ GT GYVAPEY + G
Sbjct: 886 RVMGTFGYVAPEYAMTG 902
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.8e-45, P = 1.8e-45
Identities = 91/195 (46%), Positives = 131/195 (67%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L T+ F + NILGEGGFGCVYK KL+D VAVK+L + REF
Sbjct: 335 GSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREF 394
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 395 KAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGR-PVLEWARRVR 453
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD +F A+++DFGLA + D +Q + ++
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRV 513
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 514 MGTFGYLAPEYAQSG 528
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 4.9e-45, P = 4.9e-45
Identities = 98/194 (50%), Positives = 132/194 (68%)
Query: 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVD 199
F+ Y+ L++AT +F ++ILGEGGFG VY+ L D VA+KKL +EF+ E+D
Sbjct: 367 FLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEID 426
Query: 200 LLSNIHHPNVVCLLGY-SAHDDTRFIV-YELMENRSLDIQLHGP-SHGSALTWHMRMKIA 256
+LS +HH N+V L+GY S+ D ++ ++ YEL+ N SL+ LHGP L W RMKIA
Sbjct: 427 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIA 486
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS 314
LD ARGL YLHE P+VIHRD K+SNILL++ FNAK++DFGLA +G N + ++
Sbjct: 487 LDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVM 546
Query: 315 GTLGYVAPEYLLDG 328
GT GYVAPEY + G
Sbjct: 547 GTFGYVAPEYAMTG 560
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 4.8e-44, P = 4.8e-44
Identities = 89/195 (45%), Positives = 128/195 (65%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L + T F NILGEGGFGCVYK L D VAVK+L + REF
Sbjct: 353 GSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREF 412
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 413 KAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGL-PVLEWSKRVR 471
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD ++ A+++DFGLA + D +Q + ++
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 532 MGTFGYLAPEYASSG 546
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 460 (167.0 bits), Expect = 1.3e-43, P = 1.3e-43
Identities = 89/195 (45%), Positives = 128/195 (65%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + S Y+ L +AT+ F E+N+LG+GGFG V+K L VAVK+L + REF
Sbjct: 257 GFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREF 316
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY R +VYE + N +L++ LHG + + W R+K
Sbjct: 317 QAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPT-MEWSTRLK 375
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IAL +A+GL YLHE CNP +IHRD+K+SNIL+D KF AK++DFGLA I + + ++
Sbjct: 376 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 435
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 436 MGTFGYLAPEYAASG 450
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 1.7e-43, P = 1.7e-43
Identities = 89/195 (45%), Positives = 127/195 (65%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + S Y+ L +AT+ F E+N+LG+GGFG V+K L VAVK+L + REF
Sbjct: 262 GFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREF 321
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY R +VYE + N +L+ LHG + + W R+K
Sbjct: 322 QAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT-MEWSTRLK 380
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IAL +A+GL YLHE CNP +IHRD+K+SNIL+D KF AK++DFGLA I + + ++
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 440
Query: 314 SGTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 441 MGTFGYLAPEYAASG 455
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 2.2e-43, P = 2.2e-43
Identities = 89/194 (45%), Positives = 132/194 (68%)
Query: 136 SAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE 195
S I F Y+ L + T+ F +S ++GEGGFGCVYK L + VA+K+L + + REF+
Sbjct: 354 SKIHFT-YEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFK 412
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
EV+++S +HH ++V L+GY + RF++YE + N +LD LHG + L W R++I
Sbjct: 413 AEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-PVLEWSRRVRI 471
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS 314
A+ A+GL YLHE C+P +IHRD+KSSNILLD +F A+++DFGLA + D +Q+ + ++
Sbjct: 472 AIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVM 531
Query: 315 GTLGYVAPEYLLDG 328
GT GY+APEY G
Sbjct: 532 GTFGYLAPEYASSG 545
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT2G25220 | ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; FUNCTIONS IN- protein serine/threonine kinase activity, protein tyrosine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; EXPRESSED IN- 8 plant structures; EXPRESSED DURING- LP.06 six leaves visible, 4 anthesis, petal differentiation and expansion stage, LP.08 eight leaves visible; CONTAINS InterPro DOMAIN/s- Protein kinase, A [...] (414 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 331 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 64/174 (36%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVCLLGYS 216
LGEGGFG VY A+ VA+K + + E E+++L ++HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++ ++V E E SL L L+ ++I L GLEYLH + +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
RDLK NILLDS KL+DFGL+ S + GT Y+APE LL
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG 169
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 7e-42
Identities = 64/180 (35%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 159 LGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG VYK L VAVK L + A+++ EF E ++ + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
LG + +IV E M L L HG LT +++AL A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAIT----DGSQNKNNLKLSGTLGYVAPEYLLDG 328
+HRDL + N L+ K+SDFGL+ D + + KL + ++APE L DG
Sbjct: 123 -FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP--IKWMAPESLKDG 179
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 9e-41
Identities = 66/180 (36%), Positives = 86/180 (47%), Gaps = 14/180 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK KL VAVK L + A++ EF E ++ + HPNVV
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ +IV E ME L L + L+ + AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY--VAPEYLLDGM 329
IHRDL + N L+ K+SDFGL+ D + K G L +APE L +G
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 54/149 (36%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 158 ILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK L VAVK L + A++ EF E ++ + HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ IV E M L L L+ + AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL + N L+ K+SDFGL+
Sbjct: 124 --FIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 1e-39
Identities = 58/169 (34%), Positives = 74/169 (43%), Gaps = 9/169 (5%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVCLLG 214
LGEG FG VY A+ VA+K + RE E+ +L + HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+D ++V E E L L G L+ LEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK--KRGR-LSEDEARFYLRQILSALEYLHSKG---I 118
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+HRDLK NILLD + KL+DFGLA K GT Y+APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 67/181 (37%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNV 209
+ LG G FG VYKAK VAVK L ++ + + E+ +L + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V L+ D ++V E E L + GP L+ KIAL RGLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-----LSEDEAKKIALQILRGLEYLH 115
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+ +IHRDLK NILLD K++DFGLA + + GT Y+APE LL
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 328 G 328
G
Sbjct: 173 G 173
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 61/186 (32%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK KL VAVK L + A+++ ++F E ++ + HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLD------IQLHGPSHGSALTWHMRMKIALDTARGLEY 265
LLG ++ ++V E ME L + S L+ + A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT---LGYVAP 322
L +HRDL + N L+ K+SDFGL+ D + K +G + ++AP
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 323 EYLLDG 328
E L DG
Sbjct: 177 ESLKDG 182
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-31
Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDN-LHVAVKK--LDCATQDAGREFENEVDLLSNIHHPN 208
+ +LG G FG VY A D +AVK L +++ E E+ +LS++ HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 209 VVCLLGYSAHDDTRF--IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V G ++ I E + SL L L + K GL YL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYL 117
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
H + ++HRD+K +NIL+DS KL+DFG A + D + + GT ++APE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-31
Identities = 59/166 (35%), Positives = 84/166 (50%), Gaps = 7/166 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+GGFG VYKA+ VA+K + +++ + NE+ +L HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
D +IV E SL L S LT + + +GLEYLH + +IHR
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHSN---GIIHR 122
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
D+K++NILL S KL DFGL+ S K + GT ++APE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 13/176 (7%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNV 209
+ +++G G FG VYK L+ VA+K++ ++A + E+DLL N+ HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V +G D+ +I+ E EN SL I+ GP S + ++ +GL YLH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY-----QVLQGLAYLH 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
E VIHRD+K++NIL KL+DFG+A +K++ + GT ++APE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 11/171 (6%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG VY + D +K++D ++ + NEV +L ++HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 216 SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
IV E + L I+ + + L+YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-FPEEQILDWFVQLCLALKYLHSR---K 123
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
++HRD+K NI L S KL DFG++ + + + + GT Y++PE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 60/176 (34%), Positives = 87/176 (49%), Gaps = 27/176 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+GEG G VYKA VA+KK+ Q+ NE+ ++ + HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVDYYDSYL 85
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWH-MRMK------IALDTARGLEYLHEH 269
D ++V E M+ SL DI +T + +RM + + +GLEYLH
Sbjct: 86 VGDELWVVMEYMDGGSLTDI----------ITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
VIHRD+KS NILL + KL+DFG A +T +N+ + GT ++APE
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-24
Identities = 60/176 (34%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSNIHHPNVV 210
LGEG +G VYKA+ VA+KK+ ++ G RE + LL + HPN+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNIV 61
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LL + ++V+E + L L L+ ++ I RGL Y H H
Sbjct: 62 KLLDVIHTERKLYLVFEYCD-MDLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
++HRDLK NIL++ KL+DFGLA G + TL Y APE LL
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 60/179 (33%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 154 HESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD----AGREFENEVDLLSNIHHPN 208
N +G G FG VY A LD +AVK++ QD +E +E+ +L + HPN
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V G H + +I E +L+ L HG L H+ L GL YLH
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPE 323
H ++HRD+K +NI LD KL DFG A + + + + L+GT Y+APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.9 bits (242), Expect = 6e-23
Identities = 62/187 (33%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHP 207
S+ LGEG FG VY A+ D VA+K L F E+ +L+++ H P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V L + + + ++V E ++ SL+ L L+ + I LEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 268 EHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLA------ITDGSQNKNNLKLSGTLGYV 320
+IHRD+K NILLD KL DFGLA + S GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 321 APEYLLD 327
APE LL
Sbjct: 176 APEVLLG 182
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-23
Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLL 213
+GEG +G VYKA+ VA+KK+ + G E+ LL + HPN+V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 214 G--YSAHDDTRFIVYELMENRSLDIQ--LHGPSHGSALTWHMRMKIALDTAR-------- 261
S + ++V+E M++ D+ L P +K +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH---DLTGLLDSPE----------VKFTESQIKCYMKQLLE 111
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--IT-DGSQNKNNLKLSGTLG 318
GL+YLH + ++HRD+K SNIL+++ KL+DFGLA T S + N + TL
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLW 166
Query: 319 YVAPEYLL 326
Y PE LL
Sbjct: 167 YRPPELLL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-23
Identities = 53/145 (36%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG VYK L N VAVK C D R+F E ++L HPN+V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKT--CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+IV EL+ SL L + LT ++++LD A G+EYL I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N L+ K+SDFG++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 9e-23
Identities = 65/187 (34%), Positives = 91/187 (48%), Gaps = 38/187 (20%)
Query: 159 LGEGGFGCVYKA--KLDDNLHVAVKKL---------DCATQDAGREFENEVDLLSNIHHP 207
LGEG + VYKA K + VA+KK+ D A RE + LL + HP
Sbjct: 8 LGEGTYAVVYKARDKETGRI-VAIKKIKLGERKEAKDGINFTALRE----IKLLQELKHP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELME--------NRSLDIQLHGPSHGSALTWHMRMKIALDT 259
N++ LL H +V+E ME ++S+ + P+ + +M M T
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT---PADIKS---YMLM-----T 111
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
RGLEYLH + ++HRDLK +N+L+ S KL+DFGLA + GS N+ T Y
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 320 VAPEYLL 326
APE L
Sbjct: 169 RAPELLF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 156 SNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNV 209
LGEG FG V + D VAVK L+ + ++ R +FE E+++L + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 210 VCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V G + ++ E + + SL L H + + + +G++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL + NIL++S+ K+SDFGLA
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-22
Identities = 55/169 (32%), Positives = 83/169 (49%), Gaps = 23/169 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSN 203
D+ LGEG FG V+ + +D VAVK L + A+ DA ++FE E +LL+N
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSA---------LTWHMR 252
H N+V G D +V+E ME+ L+ ++ HGP LT
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 253 MKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++IA+ A G+ YL +H +HRDL + N L+ K+ DFG++
Sbjct: 125 LQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 61/168 (36%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G+G FG V VAVK L A + F E +++ + HPN+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQ-KVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+ +IV E M SL L S G A +T ++ ALD G+EYL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
DL + N+L+ AK+SDFGLA + SQ +++ KL + + APE L
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLA-KEASQGQDSGKLP--VKWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-22
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNVVCLLGY 215
+GEG +G VYKA+ VA+KK+ + G E+ LL ++HPN++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
H ++V+E M+ + L + +GL + H H ++
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
HRDLK N+L++++ KL+DFGLA + GS + T Y APE LL
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-22
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
E+ + F LG G FG V++ + + VA+K L ++F+ EV L + H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+++ L + + +I+ ELME SL L P G L + +A A G+ YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYL 120
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
E IHRDL + NIL+ K++DFGLA
Sbjct: 121 EEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-21
Identities = 60/183 (32%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPNVVCLLG 214
LG+G FG V K D A+K L +E E E ++LS I+HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 215 YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--DTAR--------GL 263
Y+ + + ++V E G L H+ + + AR L
Sbjct: 60 YAFQTEEKLYLVLEYAP-------------GGELFSHLSKEGRFSEERARFYAAEIVLAL 106
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
EYLH +I+RDLK NILLD+ + KL+DFGLA S+ GT Y+APE
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
Query: 324 YLL 326
LL
Sbjct: 164 VLL 166
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 67/182 (36%), Positives = 91/182 (50%), Gaps = 17/182 (9%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNV 209
F + N +GEG +G VY+A+ VA+KK+ + G + E+ LL N+ HPN+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 210 VCLLGYSA--HDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
V L H D+ F+V E E LD + + + + L RGL+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLD------NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLHE+ +IHRDLK SN+LL K K++DFGLA T G K TL Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 325 LL 326
LL
Sbjct: 180 LL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 64/193 (33%), Positives = 95/193 (49%), Gaps = 30/193 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFE 195
Y+ +EK +GEG +G VYKA+ VA+KK+ T+D G RE
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE-- 48
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGS-ALTWHMRM 253
+ LL ++HPN+V LL H + + ++V+E ++ LD++ + S L +
Sbjct: 49 --ISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIK 102
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+G+ Y H H V+HRDLK N+L+D + KL+DFGLA G +
Sbjct: 103 SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159
Query: 314 SGTLGYVAPEYLL 326
TL Y APE LL
Sbjct: 160 VVTLWYRAPEILL 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 48/142 (33%), Positives = 71/142 (50%), Gaps = 5/142 (3%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V++ ++ VAVK L T D ++F E ++ + HP ++ L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +IV ELM+ SL L G G AL + +A A G+ YL IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L + N+L+ K++DFGLA
Sbjct: 129 LAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-20
Identities = 61/179 (34%), Positives = 90/179 (50%), Gaps = 29/179 (16%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKL-----DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LG G FG VY+ LDD AVK++ Q+A ++ E E+ LLS + HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQL--HGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LG +D +I EL+ SL L +G + + R + GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH--- 119
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS------GTLGYVAPE 323
+ +HRD+K +NIL+D+ KL+DFG+A K ++ S G+ ++APE
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 10/148 (6%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG V + +L + VA+K L ++ +F E ++ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G I+ E MEN SLD L + T + + A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+HRDL + NIL++S K+SDFGL
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGL 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 54/162 (33%), Positives = 79/162 (48%), Gaps = 23/162 (14%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK +L VA+K L + A +EF E +L+S++ HPN+VC
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQL--HGPSHG-----------SALTWHMRMKIALD 258
LLG + +++E + + L L + P S+L + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+EYL H +HRDL + N L+ K+SDFGL+
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 157 NILGEGGFGCVYKAKLDDNLHV-AVK---KLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
++G+G FG V + D + A+K K C + + R NE +L ++HP +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP-FLVN 64
Query: 213 LGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L YS D+ ++V +L+ G L +H+ K+ +
Sbjct: 65 LWYSFQDEENMYLVVDLLL-------------GGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
LEYLH +IHRD+K NILLD + + ++DF +A T + + SGT GY+A
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA-TKVTPDTLTTSTSGTPGYMA 167
Query: 322 PE 323
PE
Sbjct: 168 PE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 63/196 (32%), Positives = 91/196 (46%), Gaps = 39/196 (19%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI- 204
+ E +GEG +G VYKA+ L+ VA+KK+ + G RE + LL +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQLE 56
Query: 205 --HHPNVVCLLGYSA-HDDTR----FIVYELMENRSLDIQL-HGPSHG---SALTWHMRM 253
HPN+V LL R +V+E ++ + L L P G + MR
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ RG+++LH H ++HRDLK NIL+ S K++DFGLA + L
Sbjct: 116 LL-----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEMAL 163
Query: 314 SG---TLGYVAPEYLL 326
+ TL Y APE LL
Sbjct: 164 TSVVVTLWYRAPEVLL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 58/200 (29%), Positives = 79/200 (39%), Gaps = 50/200 (25%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD---------LLSNIHH 206
+G G +G V A VA+KK+ F++ +D LL ++ H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 207 PNVVCLLGYSAHDDTR-----FIVYELME---------NRSLDIQLHGPSHGSALTWHMR 252
N++ LL +IV ELME + L H + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD-----HIQYFLYQI- 112
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
RGL+YLH N VIHRDLK SNIL++S + K+ DFGLA
Sbjct: 113 -------LRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 313 LSG---TLGYVAPEYLLDGM 329
L+ T Y APE LL
Sbjct: 163 LTEYVVTRWYRAPELLLSSS 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 40/186 (21%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G VYKA + VA+K + ++ +E E+ +L P +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 217 AHDDTRFIVYE---------LME--NRSLD---IQLHGPSHGSALTWHMRMKIALDTARG 262
+ +IV E +M+ N++L I I T +G
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA----------------ILYQTLKG 111
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
LEYLH + IHRD+K+ NILL+ + AKL+DFG++ +TD +N + GT ++
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWM 166
Query: 321 APEYLL 326
APE +
Sbjct: 167 APEVIQ 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 60/175 (34%), Positives = 89/175 (50%), Gaps = 15/175 (8%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG VY +D +AVK++ D + + +E E E+ LL N+ H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
G D+T I E M S+ QL ++G ALT + K G+EYLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLK--AYG-ALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI---TDGSQNKNNLKLSGTLGYVAPE 323
++HRD+K +NIL DS N KL DFG + T S ++GT +++PE
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 45/142 (31%), Positives = 62/142 (43%), Gaps = 5/142 (3%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ + VAVK L T F E ++ + H +V L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +IV E M SL L G L + +A A G+ YL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L + NIL+ K++DFGLA
Sbjct: 129 LAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 69/196 (35%), Positives = 91/196 (46%), Gaps = 26/196 (13%)
Query: 157 NILGEGGFGCVYKAKLDDNL-------HVAVKKL-DCATQDAGREFENEVDLLSNIHHPN 208
N LG G FG VY+ D L VAVK L AT +EF E L+SN +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGP----SHGSALTWHMRMKIALDTARGLE 264
+V LLG ++ ++I+ ELME L L LT + I LD A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNA-----KLSDFGLA----ITDGSQNKNNLKLSG 315
YL + IHRDL + N L+ K K+ DFGLA +D + + L
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP- 176
Query: 316 TLGYVAPEYLLDGMVN 331
+ ++APE LLDG
Sbjct: 177 -VRWMAPESLLDGKFT 191
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 69/200 (34%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKL----DDN--LHVAVKKL--DCATQDAGREFENEV 198
E DS LG G FG VY+ D L VAVK L C+ QD +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEA 60
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH----GPSHGSALTWHMRMK 254
++S +H N+V L+G S RFI+ ELM L L P S+LT +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLA--ITDGSQNKN 309
A D A+G +YL E+ IHRD+ + N LL K AK++DFG+A I S +
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 310 NLKLSGTLGYVAPEYLLDGM 329
+ + ++ PE LDG+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGI 197
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKA+ + L A K + +++ +F E+D+LS HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+++ +I+ E + +LD + G LT + L +LH H VIHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
DLK+ NILL + KL+DFG++ + S + GT ++APE
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH----VAVKKLDCATQDAGREFENEVDLLSNIHH 206
+ + +G G +G VYKA+ ++ VA+K + D + E+ +L H
Sbjct: 3 EDYELIQRIGSGTYGDVYKAR---DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-DI--QLHGPSHGSALTWHMRMKIALDTARGL 263
PN+V G D +IV E SL DI GP L+ + +T +GL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVA 321
YLHE IHRD+K +NILL + KL+DFG++ +T + + GT ++A
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMA 169
Query: 322 PE 323
PE
Sbjct: 170 PE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 60/177 (33%), Positives = 80/177 (45%), Gaps = 30/177 (16%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+GEG G V A VAVKK+D Q NEV ++ + HPN+V + YS+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM--YSS 84
Query: 218 H--DDTRFIVYELMENRSLDIQLHGPSHGSALT---WHMRMK------IALDTARGLEYL 266
+ D ++V E +E G ALT H RM + L + L +L
Sbjct: 85 YLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
H VIHRD+KS +ILL S KLSDFG + L GT ++APE
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 52/162 (32%), Positives = 88/162 (54%), Gaps = 21/162 (12%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQLH---GPSHGSALTWHMRMKIALD 258
LLG H ++ E L ++R L+ S S L+ + A D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
ARG++YL + IHRDL + NIL+ + AK++DFGL+
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 54/178 (30%), Positives = 78/178 (43%), Gaps = 10/178 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDA-GREFENEVDLLSNIHHPN 208
+ E + LGEG G V K +L + + A+K + ++ E+++ + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 209 VVCLLG--YSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTARGLEY 265
+V G + I E E SLD I G + + KIA +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
LH +IHRD+K SNILL K KL DFG ++ N +GT Y+APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG--VSGELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKK--LDCATQDAGREFENEVDLLSNIHHPN 208
+F + +GEG +G VYKA+ VA+KK LD T+ E+ LL ++HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
+V LL ++ ++V+E + + +D S S + + +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-----SPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H H V+HRDLK N+L++++ KL+DFGLA G + TL Y APE L
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 326 L 326
L
Sbjct: 173 L 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 51/166 (30%), Positives = 74/166 (44%), Gaps = 29/166 (17%)
Query: 159 LGEGGFGCVYKAKLDDNLH-----------------VAVKKLDCATQDAGR-EFENEVDL 200
LGEG FG V+ + D VAVK L D R +F EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLH-----GPSHGS-ALTWHMR 252
LS + PN+ LLG D ++ E MEN L+ +Q H G + S +L++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
+ +A A G+ YL +HRDL + N L+ + K++DFG
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G VYK + VA+KK+ +++ G E+ LL + HPN+VCL
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH-MRMKIAL-DTARGLEYLHEHCNPA 273
+ ++++E + S+D++ + S +K L +G+ + H
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
V+HRDLK N+L+D+K KL+DFGLA G + TL Y APE LL
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 15/171 (8%)
Query: 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLLGYS 216
LG+G G VYK + A+KK+ + R + E+ L + P VV G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ IV E M+ SL ++ G L IA +GL+YLH + +
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTKRH--I 121
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
IHRD+K SN+L++SK K++DFG++ + + N GT+ Y++PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 58/187 (31%), Positives = 89/187 (47%), Gaps = 25/187 (13%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDC-ATQDAGREFENEVD 199
+ LLE +G+G FG VYKA N VA+K +D +D + + E+
Sbjct: 2 LFTLLEC----------IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ 51
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALD 258
LS P + G +I+ E S LD+ G + + + +R +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----E 106
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
GLEYLHE IHRD+K++NILL + + KL+DFG++ +T + +K N GT
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRN-TFVGT 161
Query: 317 LGYVAPE 323
++APE
Sbjct: 162 PFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 46/142 (32%), Positives = 62/142 (43%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ K + VA+K + + +F E ++ + HPN+V L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
FIV E M N L L W + M D +EYL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIHRD 125
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L + N L+ K+SDFGLA
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 69/182 (37%), Positives = 94/182 (51%), Gaps = 25/182 (13%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKLDCATQ---DAGREFENEVDLLSNI-HHPNVVCL 212
LG+G +G V+KA +D VA+KK+ A + DA R F E+ L + HPN+V L
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 213 LG-YSAHDDTR-FIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEH 269
L A +D ++V+E ME LH H R I + L+Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEYMET-----DLHAVIRANILEDVHKRY-IMYQLLKALKYIH-- 124
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS---GTLGYVAPEY 324
+ VIHRDLK SNILL+S KL+DFGLA +++ +N N L+ T Y APE
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 325 LL 326
LL
Sbjct: 184 LL 185
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 53/172 (30%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKA+ + + A K +D +++ ++ E+D+L++ HPN+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 218 HDDTRFIVYELMENRSLD---IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+++ +I+ E ++D ++L P LT + T L YLHE+ +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP-----LTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRDLK+ NIL + KL+DFG++ + + GT ++APE ++
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 62/181 (34%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHP 207
D + + +GEG +G VYKA+ N +A+KK+ +D G E+ LL + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYL 266
N+V L + ++V+E ++ LD++ H S +K L RG+ Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H H V+HRDLK N+L+D + NA KL+DFGLA G + TL Y APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 326 L 326
L
Sbjct: 176 L 176
|
Length = 294 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-17
Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVC 211
++G+G FGCVY L D+ +H AVK L+ T + +F E ++ + HPNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 212 LLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG + + +V M++ L + +H T + L A+G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQVAKGMEYL---A 115
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ +HRDL + N +LD F K++DFGLA
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 63/190 (33%), Positives = 100/190 (52%), Gaps = 29/190 (15%)
Query: 151 DSFHESNILGEGGFGCVYKA--KLDDNLHVAVKKLDCATQDAG------REFENEVDLLS 202
D + + N + EG +G VY+A K + VA+KKL + G RE +++L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEI-VALKKLKMEKEKEGFPITSLRE----INILL 59
Query: 203 NIHHPNVVCL----LGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIA 256
+ HPN+V + +G ++ D ++V E +E+ +SL + P S + M
Sbjct: 60 KLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM----- 112
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
L G+ +LH++ ++HRDLK+SN+LL+++ K+ DFGLA GS K +L T
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169
Query: 317 LGYVAPEYLL 326
L Y APE LL
Sbjct: 170 LWYRAPELLL 179
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 31/195 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDL 200
Y+L+E +G G VY A L +N VA+K++D E EV
Sbjct: 3 YELIEV----------IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA 52
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHG-----SALTWHMRMK 254
+S +HPNVV D ++V + S LDI G T
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------ 106
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
+ + +GLEYLH + IHRD+K+ NILL + K++DFG++ + DG ++
Sbjct: 107 VLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 313 --LSGTLGYVAPEYL 325
GT ++APE +
Sbjct: 164 KTFVGTPCWMAPEVM 178
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G+G F VYKA L D VA+KK+ + A ++ E+DLL + HPNV+ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
++ IV EL + L + H + K + LE++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++HRD+K +N+ + + KL D GL S+ L GT Y++PE
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 7/174 (4%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE--NEVDLLSNIHHPNV 209
F N +G+G FG V+K + V A+K++D + + E +E +L+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ IV E EN L L G L + + GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++HRD+KS N+ LD+ N K+ D G+A + GT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 55/204 (26%), Positives = 75/204 (36%), Gaps = 47/204 (23%)
Query: 158 ILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREF---ENEVD--------LLSNIH 205
I+GEG F V AK + N A+K LD + E +V L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 206 HPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HP ++ L Y+ D+ + V E N L + +L A + LE
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---------- 314
YLH +IHRDLK NILLD + K++DFG A +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 315 ----------GTLGYVAPEYLLDG 328
GT YV+PE L +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEK 197
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 63/169 (37%), Positives = 92/169 (54%), Gaps = 13/169 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
I+GEG FG V + + VAVK + C + F E +++ +HH N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQ-KVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM-KIALDTARGLEYLHEHCNPAVIH 276
H+ +IV ELM +L L + G AL +++ + +LD A G+EYL + ++H
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
RDL + NIL+ AK+SDFGLA GS +N KL + + APE L
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDNSKLP--VKWTAPEAL 169
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 54/161 (33%), Positives = 75/161 (46%), Gaps = 24/161 (14%)
Query: 158 ILGEGGFGCVYKAKL--DDN--LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
ILGEG FG V + +L DD L VAVK KLD T EF +E + + HPNV+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 212 LLG--YSAHDDTRF----IVYELMENRSLDIQL------HGPSHGSALTWHMRMKIALDT 259
L+G + A + ++ M++ L L P L +K +D
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---LPLQTLLKFMVDI 122
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+EYL N IHRDL + N +L ++DFGL+
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 159 LGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE----NEVDLLSNIHHPNVVCLL 213
LG+GGFG V ++ + A KKLD + R+ E NE +L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLD-KKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYLHEHCN 271
Y+ +V LM D++ H + G R A GLE+LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+++RDLK N+LLD N ++SD GLA+ + K +GT GY+APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAV-ELKGGKKIKGRAGTPGYMAPEVLQGE 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 49/145 (33%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 159 LGEGGFGCVYKAKLD-DNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ +L DN VAVK + D +F E +L HPN+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVI 275
+IV EL++ D + G L +++ + A G+EYL +HC I
Sbjct: 63 TQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N L+ K K+SDFG++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 24/196 (12%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEVDLLSN 203
++ D F +GEG +G VYKA+ D VA+KK+ + G E+ +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 204 IHHPNVVCL----------LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
++H N+V L L + ++V+E M++ + + G H S M
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNN 310
K L+ GL Y H +HRD+K SNILL++K KL+DFGLA ++ S+ N
Sbjct: 123 KQLLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 311 LKLSGTLGYVAPEYLL 326
+ TL Y PE LL
Sbjct: 177 KVI--TLWYRPPELLL 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 56/194 (28%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEV 198
YK+L + +GEG G V+KAK + VA+KK+ + G + E+
Sbjct: 1 RYKILGR----------IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI 50
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-----WHMRM 253
L HP VV LL H +V E M L L L +MRM
Sbjct: 51 KALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRM 107
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLK 312
+ +G+ Y+H + ++HRDLK +N+L+ + K++DFGLA + + +
Sbjct: 108 LL-----KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
Query: 313 LSGTLGYVAPEYLL 326
T Y APE L
Sbjct: 160 QVATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 62/182 (34%), Positives = 76/182 (41%), Gaps = 31/182 (17%)
Query: 159 LGEGGFGCVY--KAKLDDNLHV--AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG GGFG V K K + VKK +E ++L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD--TAR--------GLE 264
Y D ++I Y LME G L +R + D TAR E
Sbjct: 59 YRTFKDKKYI-YMLME----------YCLGGELWTILRDRGLFDEYTARFYIACVVLAFE 107
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLH +I+RDLK N+LLDS KL DFG A S K GT YVAPE
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK-TWTFCGTPEYVAPEI 163
Query: 325 LL 326
+L
Sbjct: 164 IL 165
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFE----------NEVDLLSNIHH 206
++G+G +G VY A + +AVK+++ AGR +E++ L ++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL------DTA 260
N+V LG+ ++ I E + G S GS L + R + L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVP---------GGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
GL YLH + ++HRDLK+ N+L+D+ K+SDFG++ D N N+ + G++
Sbjct: 119 EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 319 YVAPE 323
++APE
Sbjct: 176 WMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 59/170 (34%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ K VAVKK+D Q NEV ++ + HH NVV +
Sbjct: 30 IGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D ++V E +E +L DI H + + + L R L YLH N VI
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH---NQGVI 140
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
HRD+KS +ILL S KLSDFG + L GT ++APE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 54/178 (30%), Positives = 78/178 (43%), Gaps = 20/178 (11%)
Query: 162 GGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLGYS- 216
G +G V+ AK A+K + A + + E D+LS P VV L YS
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++V E + L L + +L + + LEYLH + +IH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSN---GIIH 116
Query: 277 RDLKSSNILLDSKFNAKLSDFGL--------AITDGSQNKNNLKLSGTLGYVAPEYLL 326
RDLK NIL+DS + KL+DFGL I K + ++ GT Y+APE +L
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 64/188 (34%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI 204
L T F ++GEG +G VYKA+ VA+K +D +D E + E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKY 59
Query: 205 -HHPNVVCLLG------YSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIA 256
+HPN+ G +DD ++V EL S+ D+ G L I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSG 315
+T RGL YLHE+ VIHRD+K NILL KL DFG+ A D + + N + G
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-G 175
Query: 316 TLGYVAPE 323
T ++APE
Sbjct: 176 TPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 51/162 (31%), Positives = 90/162 (55%), Gaps = 21/162 (12%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQ-LHGPSHGSALTWHMR--MKIALD 258
LLG H ++ E L ++R L+ ++ +A T + + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
ARG++YL + IHRDL + NIL+ + AK++DFGL+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 56/214 (26%)
Query: 149 ATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAG------REFENEVDLL 201
+ LGEG FG VYKA ++ VA+KK+ + G RE + +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKIL 61
Query: 202 SNIHHPNVVCLLG--YSAHDDTRF---IVYE-----------LMENRSLDIQLHGPSHGS 245
+ HPNVV L+ D ++ VY L+EN S+ + S
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT---ESQIK 118
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDG 304
M L+ G+ YLHE+ ++HRD+K++NIL+D++ K++DFGLA DG
Sbjct: 119 CY-----MLQLLE---GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 305 SQNKNNLKLSGTLG------------YVAPEYLL 326
N K G G Y PE LL
Sbjct: 168 --PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 53/162 (32%), Positives = 88/162 (54%), Gaps = 21/162 (12%)
Query: 157 NILGEGGFGCVYKA--KLDDN-LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V +A K D ++ A+K L + A+++ R+F E+++L + HHPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQ-LHGPSHGSA--LTWHMRMKIALD 258
LLG + +I E L ++R L+ HG+A LT ++ A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G++YL E IHRDL + N+L+ +K++DFGL+
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 19/158 (12%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L A+ +A ++F E +LL+N+ H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP-----SHG---SALTWHMRMKIALDTARG 262
G D +V+E M++ L+ ++ HGP + G + LT + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ YL + +HRDL + N L+ K+ DFG++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQ-DAGREFE-NEVDLLSNIHHPNVVCLLGY 215
LG+G +G VYK K L DN A+K++D + RE NE+ +L++++HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 216 SAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ IV E L + +I + RGL+ LHE +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPE 323
+HRDLKS+NILL + K+ D G++ K N+ + GT Y+APE
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGIS----KVLKKNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 159 LGEGGFGCVYKAKL-----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGE FG +YK L D VA+K L D EF+ E L++ +HHPN+VCL
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 213 LGYSAHDDTRFIVYE-----------LMENRSLDIQLHGPSHG---SALTWHMRMKIALD 258
LG + +++E +M + D+ G S+L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+EYL H +H+DL + NIL+ + + K+SD GL+
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 29/168 (17%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+G+G FG V++A+ + VAVK L + A+ D +F+ E L++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LLGYSAHDDTRFIVYELMENRSLD--------IQLHGPSHGSA-----------LTWHMR 252
LLG A +++E M L+ SH ++ L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ IA A G+ YL E +HRDL + N L+ K++DFGL+
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NE 197
+Y++LE +G+G FG V K + D + K++D +E + +E
Sbjct: 1 DYEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSE 49
Query: 198 VDLLSNIHHPNVVCLLGY--SAHDDTRFIVYELME-----NRSLDIQLHGPSHGSALTWH 250
V++L + HPN+V Y D + +Y +ME + + IQ +
Sbjct: 50 VNILRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEE 105
Query: 251 MRMKIALDTARGLEYLH--EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ 306
+I L H V+HRDLK +NI LD+ N KL DFGLA + S
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165
Query: 307 NKNNLKLSGTLGYVAPEYLLD 327
GT Y++PE L
Sbjct: 166 FAKT--YVGTPYYMSPEQLNH 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGRE---------FENEVDLLSNIHHP 207
++G G FG VY +AVK+++ + A + E+ LL + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LG S D I E + S+ L+ ++G A + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA------ITDGSQNKNNLKLSGTLGYVA 321
N +IHRD+K +NIL+D+K K+SDFG++ N L G++ ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 322 PE 323
PE
Sbjct: 181 PE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 10/172 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G V K + VA+KK + +D + EV +L + H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
++V+E +E L++ P L + + Y H H +I
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NII 122
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL-KLSGTLGYVAPEYLL 326
HRD+K NIL+ KL DFG A ++ + L T Y APE L+
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKK--LDCATQDAG----REFENEVDLLSNIHHPNVV 210
+LG+G +G VY + +AVK+ LD + A + + EVDLL ++ H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
LG D+T I E + S+ + GP + + + G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFG----LAITDGSQNKNNL--KLSGTLGYVAP 322
+C V+HRD+K +N++L KL DFG LA +N+ + GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 323 E 323
E
Sbjct: 178 E 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 7e-15
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 32/168 (19%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH-VAVKKLDCATQDAGREFEN----- 196
YK++++ LG+G FG VY A+ + VA+KK+ ++F +
Sbjct: 1 YKVIKQ----------LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECM 43
Query: 197 ---EVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR 252
EV L + HPN+V L +D + V+E ME +L QL G + +
Sbjct: 44 NLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NL-YQLMKDRKGKPFSESVI 101
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
I +GL ++H+H HRDLK N+L+ K++DFGLA
Sbjct: 102 RSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 60/173 (34%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+LG+G FG V+K L D VAVK K D Q+ +F +E +L HPN+V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAV 274
+IV EL+ L L +K ALD A G+ YL ++C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAIT--DGSQNKNNLKLSGTLGYVAPEYL 325
IHRDL + N L+ K+SDFG++ DG + + LK + + APE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-QIPIKWTAPEAL 166
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-15
Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ + + VA+K L + F E +L+ + HP +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +I+ E MEN SL L P G LT + + +A A G+ ++ IHRD
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L+++NIL+ K++DFGLA
Sbjct: 128 LRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-15
Identities = 53/169 (31%), Positives = 78/169 (46%), Gaps = 12/169 (7%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGYS 216
LG G G V K + K + ++ E+D+L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++ I E M+ SLD L + + KIA+ +GL YLHE +IH
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPE 323
RD+K SNIL++S+ KL DFG++ Q N+L + GT Y+APE
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 34/160 (21%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V + +L + VA+K L T+ R+F +E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 213 LGYSAHDDTRFIVYELMENRSLD------------IQLHGPSHGSALTWHMRMKIALDTA 260
G I+ E MEN +LD IQL G G A
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG--------------IA 116
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
G++YL E +HRDL + NIL++S K+SDFGL+
Sbjct: 117 AGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 159 LGEGGFGCVYKAKLD---DNLH--VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
LG+G FG V + D DN VAVKKL +T + R+FE E+++L ++ H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 214 G--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
G YSA +V E + SL L H L + A +G+EYL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + NIL++S+ K+ DFGL
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE------NEVDLLSNIHHPNVV 210
LG G F Y+A+ + +AVK++ + + E E+ L++ ++HP+++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHE 268
+LG + D + E M S+ L G + + + RGL YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121
Query: 269 HCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQ----NKNNLKLSGTLGYVAPE 323
+ +IHRD+K +N+L+DS +++DFG A ++ + +L GT+ ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 324 YL 325
L
Sbjct: 179 VL 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 51/178 (28%), Positives = 74/178 (41%), Gaps = 19/178 (10%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLL 213
LG+G FG V + + VAVK L D +F E ++ ++ H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNP 272
G +V EL SL +L A+ A G+ YL +
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRF-- 118
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQN---KNNLKLSGTLGYVAPEYL 325
IHRDL + NILL S K+ DFGL A+ + + +LK+ + APE L
Sbjct: 119 --IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESL 172
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 9/172 (5%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKK-LDCATQDAGREFE-NEVDLLSNIHHPNVVCLLG 214
++GEG +G V K K + VA+KK L+ ++ E+ +L + H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
++V+E +++ LD P +G L K RG+E+ H H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYP-NG--LDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K NIL+ KL DFG A T + + T Y APE L+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 6/169 (3%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKAK + A K ++ +++ ++ E+++L+ +HP +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
D +I+ E ++D + G LT I L+YLH + +IHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
DLK+ N+LL + KL+DFG++ + + GT ++APE ++
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 10/171 (5%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + V+K +KL +NL VA+K++ ++ A EV LL ++ H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + +V+E ++ D++ + G+ ++ H RGL Y H V+
Sbjct: 73 VHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
HRDLK N+L++ + KL+DFGLA K TL Y P+ LL
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V +L + VA+K L T+ R+F +E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G IV E MEN SLD L H T + + A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSDM--- 125
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + NIL++S K+SDFGL+
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L A++ A ++F+ E +LL+ + H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP-------SHGSA---LTWHMRMKIALDTA 260
G +V+E M + L+ ++ HGP A LT + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
G+ YL + +HRDL + N L+ K+ DFG++
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 24/162 (14%)
Query: 159 LGEGGFGCVYKAK------LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L T A ++F+ E +LL+N+ H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP------------SHGSALTWHMRMKIALD 258
G D +V+E M++ L+ ++ HGP + G L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHIASQ 131
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+ YL + +HRDL + N L+ + K+ DFG++
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 25/186 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFEN-----EVDLLSNI 204
+ +G G G VYK + HV AVK++ + G + EN ++D++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM----RRTGNKEENKRILMDLDVVLKS 70
Query: 205 HH-PNVVCLLGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
H P +V GY D FI ELM L ++ GP + + K+ + +
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-----IPEDILGKMTVAIVK 125
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
L YL E VIHRD+K SNILLD+ N KL DFG++ + D +K + +G Y
Sbjct: 126 ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAY 180
Query: 320 VAPEYL 325
+APE +
Sbjct: 181 MAPERI 186
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 29/162 (17%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LG+G FG VY+ K + VA+K + + A+ EF NE ++ + +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 212 LLGYSAHDDTRFIVYELM----------ENRSLDIQLHG---PSHGSALTWHMRMKIALD 258
LLG + +V ELM R G P+ + A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM------AAE 127
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+ YL +HRDL + N ++ K+ DFG+
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 47/146 (32%), Positives = 68/146 (46%), Gaps = 12/146 (8%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHHPNVVCLL 213
LG G FG V Y K + VAVK L AG +EF E +++ + HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G + +V EL L L ++A A G+ YL E +
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYL-ESKH-- 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGL 299
+HRDL + N+LL ++ AK+SDFG+
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGM 141
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 35/183 (19%)
Query: 159 LGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPNVVCLLG 214
LG G FG V + + + A+K L A ++ E NE +L +I HP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM-KIALDTAR--------GLEY 265
S DD+ +Y +ME + G G + + + AR LEY
Sbjct: 69 -SFQDDSN--LYLVME----YVP--G---GELFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
LH + +++RDLK N+LLDS K++DFG A + + L GT Y+APE
Sbjct: 117 LH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLAPE 168
Query: 324 YLL 326
+L
Sbjct: 169 IIL 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + V+K +KL +NL VA+K++ ++ A EV LL N+ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +V+E +++ D++ + + G+ ++ H RGL Y H+ ++
Sbjct: 72 IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
HRDLK N+L++ K KL+DFGLA K TL Y P+ LL
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-14
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD 199
+EY E D E +LG+G +G VY A+ L + +A+K++ + E+
Sbjct: 1 LEY---EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIA 57
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH---GPSHGSALTWHMRMKIA 256
L S + H N+V LG + + I E + SL L GP + T K
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLKLSG 315
L+ GL+YLH++ ++HRD+K N+L+++ K+SDFG + N +G
Sbjct: 118 LE---GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG 171
Query: 316 TLGYVAPEYLLDG 328
TL Y+APE + G
Sbjct: 172 TLQYMAPEVIDKG 184
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 159 LGEGGFGCVYKA--KLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPNVVCLLG 214
LGEG + VYK KL L VA+K++ + G F E LL ++ H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRL-EHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYLHEHCNPA 273
T +V+E ++ D++ + G L+ H +++ L RGL Y H+
Sbjct: 71 IIHTKKTLTLVFEYLDT---DLKQYMDDCGGGLSMH-NVRLFLFQLLRGLAYCHQR---R 123
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA 300
V+HRDLK N+L+ + KL+DFGLA
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 58/167 (34%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG VY D +AVK++ D + + +E E E+ LL N+ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 212 LLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
G + T I E M S+ QL S+G ALT ++ K G+ YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYG-ALTENVTRKYTRQILEGVSYLHSN 125
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
++HRD+K +NIL DS N KL DFG S+ + LSGT
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGT 164
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 46/144 (31%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V K VA+K K ++D EF E ++ + H +V L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV E M N L L HG +++ D G+ YL IH
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA 300
RDL + N L+D + K+SDFGL+
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPN 208
+ +GEG FG +Y AK D+ H +K++D T+ +E E EV LL+ + HPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQL---HGP--SHGSALTWHMRMKIALDTARGL 263
+V + FIV E + L ++ G S L+W +++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
+++H+ ++HRD+KS NI L AKL DFG+A + GT Y++P
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 323 E 323
E
Sbjct: 172 E 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVV- 210
+LG G FG VY D +AVK++ D +Q+ +E E E+ LL N+ H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 211 ---CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
CL + F+ E M S+ QL ++G ALT ++ + +G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFV--EYMPGGSIKDQLK--AYG-ALTENVTRRYTRQILQGVSYLH 123
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
+ ++HRD+K +NIL DS N KL DFG S+ + +SGT
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFG-----ASKRIQTICMSGT 164
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 55/170 (32%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ K L VAVKK+D Q NEV ++ + H NVV +
Sbjct: 28 IGEGSTGIVCIATVKSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D ++V E +E +L DI H + + + L + L LH VI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
HRD+KS +ILL KLSDFG + L GT ++APE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 13/172 (7%)
Query: 158 ILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLL 213
+LG+G FG +Y+ DD+L V K+++ R+ NE+ +LS + HPN++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--DTARGLEYLHEHCN 271
+ D+T I E +L ++ + M + + Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++HRD+K+ NI L KL DFG++ GS+ + GT Y++PE
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCAT---QDAGREFEN 196
YK +E +G G +G V A +D VA+KK+ A A R
Sbjct: 6 RYKPIEN----------IGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLR- 53
Query: 197 EVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSA--LTWH 250
E+ +L + H N++ + A ++V +LME+ LH H H
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-----DLHHIIHSDQPLTEEH 108
Query: 251 MR--MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQN 307
+R + L RGL+Y+H VIHRDLK SN+L++ ++ DFG+A S
Sbjct: 109 IRYFLYQLL---RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 308 KNNLKLS---GTLGYVAPEYLL 326
++ ++ T Y APE LL
Sbjct: 163 EHKYFMTEYVATRWYRAPELLL 184
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 57/178 (32%), Positives = 80/178 (44%), Gaps = 17/178 (9%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPN 208
HE +G G FG VY A N VAVKK+ + + ++++ EV L + HPN
Sbjct: 26 LHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+ G + T ++V E + D+ H L I +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +IHRD+K+ NILL KL+DFG A N GT ++APE +L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----SFVGTPYWMAPEVIL 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 60/180 (33%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 159 LGEGGFGCVYKAKLDDN--LHVAVKKLDCATQDAGREFEN--EVDLLSNIH---HPNVV- 210
+GEG +G V+KA+ N VA+K++ T + G EV +L ++ HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 211 ----CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
C + + + +V+E ++ P G M L RGL++L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDFL 126
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H H V+HRDLK NIL+ S KL+DFGLA Q + TL Y APE LL
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 56/171 (32%), Positives = 85/171 (49%), Gaps = 10/171 (5%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + VYK +KL DNL VA+K++ ++ A EV LL ++ H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ + +V+E ++ D++ + G+++ H RGL Y H V+
Sbjct: 73 IHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
HRDLK N+L++ + KL+DFGLA K TL Y P+ LL
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 62/183 (33%), Positives = 88/183 (48%), Gaps = 25/183 (13%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIH---HPNVVCL 212
+G G +G VYKA+ VA+K + T + G EV LL + HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 213 LGY--SAHDDTRFIVYELMENRSLDIQLH---GPSHGSAL-TWHMRMKIALDTARGLEYL 266
+ ++ D V + E+ D++ + P G T M+ L RGL++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDFL 124
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPE 323
H +C ++HRDLK NIL+ S KL+DFGLA Q + L+ TL Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVVTLWYRAPE 177
Query: 324 YLL 326
LL
Sbjct: 178 VLL 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
S E N++ G G YK K N + VK+ D +E+ + + HPN+V
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKE----INDVNSIPSSEIADMGKLQHPNIV 746
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L+G + ++++E +E ++L L L+W R KIA+ A+ L +LH C
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 271 NPAVIHRDLKSSNILLDSKFNAKL--SDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+PAV+ +L I++D K L S GL TD K + YVAPE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD-------TKCFISSAYVAPE 848
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 66/180 (36%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFE-NE---VDLLSNIHHPNVV 210
I+G GGFG VY K D A+K LD G NE + L+S P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 211 CL-LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
C+ + D FI+ +LM D+ H HG MR A + GLE++H
Sbjct: 61 CMSYAFHTPDKLSFIL-DLMNGG--DLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMH-- 114
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
N V++RDLK +NILLD + ++SD GLA D S+ K + + GT GY+APE L G+
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASV-GTHGYMAPEVLQKGV 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 46/208 (22%)
Query: 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVD--- 199
K + + D + + +G G +G V A VA+KKL R F++ +
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKR 60
Query: 200 ------LLSNIHHPNVVCLLGYSAHDDTR------FIVYELME---NRSLDIQLHGPSHG 244
LL ++ H NV+ LL + ++V LM N + Q H
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
L + + RGL+Y+H + +IHRDLK SNI ++ K+ DFGLA
Sbjct: 121 QFLVYQI--------LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA---- 165
Query: 305 SQNKNNLKLSG---TLGYVAPEYLLDGM 329
+ +++G T Y APE +L+ M
Sbjct: 166 --RHTDDEMTGYVATRWYRAPEIMLNWM 191
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 63/179 (35%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCL-- 212
+G G +G V AK + N VA+KK+ A DA R E+ LL ++ H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 213 ----LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS-ALTWHMRMKIALDTARGLEYLH 267
A +D +IVYELM D LH S L+ RGL+Y+H
Sbjct: 72 IMPPPHREAFNDV-YIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
+ V+HRDLK SN+LL++ + K+ DFGLA T + + T Y APE LL
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 158 ILGEGGFGCVYKA----KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG VY+ ++ + VAVK +C + +F E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +IV EL L L + +L + + + L YL +
Sbjct: 73 IGVIT-ENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRD+ + N+L+ S KL DFGL+
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 6/145 (4%)
Query: 157 NILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L + + + + + +A + +EYL + I
Sbjct: 71 CTREPPFYIITEFMTYGNL-LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N L+ K++DFGL+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 37/176 (21%)
Query: 159 LGEGGFGCVYKAKLDD-----------------NLHVAVKKLDC-ATQDAGREFENEVDL 200
LGEG FG V+ ++ + L VAVK L A ++A +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH---------------GPSH-G 244
LS + PN++ LLG +D ++ E MEN L+ L P+H
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A+++ + +AL A G++YL + +HRDL + N L+ K++DFG++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 51/168 (30%), Positives = 74/168 (44%), Gaps = 32/168 (19%)
Query: 158 ILGEGGFGCVYKA------KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNV 209
LGEG FG V KA ++ VAVK L D AT+ + +E++++ I H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 210 VCLLGYSAHDDTRFIVYEL----------------MENRSLDIQLHGPSHGSALTWHMRM 253
+ LLG + ++V E E S D LT +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR---PPEETLTQKDLV 135
Query: 254 KIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A ARG+E+L + C IHRDL + N+L+ K++DFGLA
Sbjct: 136 SFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 59/193 (30%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDL 200
I+ L F ++G G +G VYK + +A K+ T+D E + E+++
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 201 LSNI-HHPNVVCLLGY------SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
L HH N+ G HDD ++V E S+ L + G+AL
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIA 124
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLK 312
I + RGL +LH H VIHRD+K N+LL KL DFG+ A D + + N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-T 180
Query: 313 LSGTLGYVAPEYL 325
GT ++APE +
Sbjct: 181 FIGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 66/179 (36%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFE-NE---VDLLSNIHHPNVV 210
I+G GGFG VY K D A+K LD G NE + L+S P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 211 CLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
C+ Y+ H D + +LM D+ H HG MR A + GLE++H
Sbjct: 61 CMT-YAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH-- 114
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
N V++RDLK +NILLD + ++SD GLA D S+ K + + GT GY+APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASV-GTHGYMAPEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 43/202 (21%)
Query: 153 FHESNILGEGGFGCVYKAKL---DDNLHVAVKKLDCA-------TQDAGREFENEVDLLS 202
+ +G G +G VYKAK D A+KK +Q A RE + LL
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 203 NIHHPNVVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSA---------LTWHM 251
+ H NVV L+ + +++++ E+ I L W +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQN 307
L+ G+ YLH + V+HRDLK +NIL+ + K+ D GLA +
Sbjct: 118 -----LN---GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 308 KNNLKLSG---TLGYVAPEYLL 326
K L T+ Y APE LL
Sbjct: 167 KPLADLDPVVVTIWYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 14/172 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
+G G FG VY A+ + N VA+KK+ + + + ++++ EV L + HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ T ++V E + DI H L I +GL YLH H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K+ NILL KL+DFG A N GT ++APE +L
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPYWMAPEVIL 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-13
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
+G G FG VY A+ + ++ VA+KK+ + + + ++++ EV L + HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ T ++V E + D+ H L + +GL YLH H +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K+ NILL KL DFG A N GT ++APE +L
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----XFVGTPYWMAPEVIL 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNI 204
D S++L EG FG ++ L D V VK + D A++ E LL +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 205 HHPNVVCLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGS-----ALTWHMRMKIALD 258
H N++ +L D + F++Y M +L + L G AL+ + +A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+ YLH+ VIH+D+ + N ++D + K++D L+
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 152 SFHESNILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIH 205
++ +LG+G FG VY +D +A K++ D + + +E E E+ LL N+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 206 HPNVV----CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
H +V CL + T F+ Y M S+ QL ++G ALT + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEY--MPGGSVKDQLK--AYG-ALTESVTRKYTRQILE 117
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
G+ YLH + ++HRD+K +NIL DS N KL DFG S+ + +SGT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICMSGT 164
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 28/167 (16%)
Query: 159 LGEGGFGCVYKAKLDDNLH---------------VAVKKLDC-ATQDAGREFENEVDLLS 202
LGEG FG V+ + + VAVK L T+ A +F E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMEN---------RSLDIQLHGPSHGSALTWHMRM 253
+ +PN++ LLG DD ++ E MEN R ++ ++ +++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+A+ A G++YL + +HRDL + N L+ + + K++DFG++
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 56/178 (31%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPN 208
F + +G G FG VY A+ + N VA+KK+ + + + ++++ EV L I HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+ G + T ++V E + D+ H L I +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +IHRD+K+ NILL KL+DFG A N GT ++APE +L
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPYWMAPEVIL 194
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 20/185 (10%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHH---P 207
+ ++G G +G VY+ K + VA+K ++ T D + + EV LLS + P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-GPSHGSALTWHMRMKIALDTARGLEYL 266
N+ G +I+ E E S+ + GP ++ +R + L+Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYI 117
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTLGYVAPE 323
H+ VIHRD+K++NIL+ + N KL DFG+A N+N+ K S GT ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSKRSTFVGTPYWMAPE 171
Query: 324 YLLDG 328
+ +G
Sbjct: 172 VITEG 176
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 17/179 (9%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNV 209
F + +G+G FG VYK +D+ VA+K +D +D + + E+ +LS P +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 210 VCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
G +I+ E + S LD+ GP + + +R + +GL+YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS 119
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRD+K++N+LL + + KL+DFG+A +TD +N GT ++APE +
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 158 ILGEGGFGCVYKA--KLDDN--LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG+G FG V +A K +D VAVK K D + EF E + HPNV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 212 LLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGS---ALTWHMRMKIALDTARG 262
L+G S + ++ M++ L L G L ++ +D A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+EYL + IHRDL + N +L+ ++DFGL+
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG V+K +D+ VA+K +D +D + + E+ +LS P V G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 216 SAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
D +I+ E + S LD+ GP + + +R + +GL+YLH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE---KK 122
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRD+K++N+LL KL+DFG+A +TD +N GT ++APE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 53/165 (32%), Positives = 75/165 (45%), Gaps = 31/165 (18%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVC 211
LGE FG VYK L + VA+K L + RE F++E + S + HPN+VC
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 212 LLG-------------YSAHDDTRFIVYELMENRSLDIQLHGPSHG----SALTWHMRMK 254
LLG Y +H D ++E + RS + S L +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSD----LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
I A G+E+L H V+H+DL + N+L+ K N K+SD GL
Sbjct: 129 IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G G FG V+ + VA+K + + +F E ++ + HP +V L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+V+E ME+ L L + + + + LD G+ YL VIHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L + N L+ K+SDFG+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 158 ILGEGGFGCVYKA-----KLDDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK + VA+K L T A +E +E +++++ HP+VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ +LM L + +H + + + A+G+ YL E
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++HRDL + N+L+ + + K++DFGLA
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 152 SFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI 204
+ E LG G FG V+ AK V VK L ++ EF E+D+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 205 HHPNVVCLLGYSAHDDTRFIVYE----------LMENRSLDIQLHGPSHGSALTWHMRMK 254
H NVV LLG + +++ E L +S D +L P L+ ++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP----LSTKQKVA 121
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+ A G+++L N +HRDL + N L+ S+ K+S L
Sbjct: 122 LCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSL 163
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 23/185 (12%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHH 206
T+ + + +G G FG V A+ +VA+KK+ +T + E+ LL ++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 207 PNVVCL--LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
N++ L + S +D F V EL+ LH L RGL+
Sbjct: 69 ENIISLSDIFISPLEDIYF-VTELLGT-----DLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVA 321
Y+H + V+HRDLK SNIL++ + K+ DFGLA Q ++G T Y A
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ------MTGYVSTRYYRA 173
Query: 322 PEYLL 326
PE +L
Sbjct: 174 PEIML 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 57/189 (30%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVD 199
+K LEK LGEG + VYK + VA+K LD A + E+
Sbjct: 2 FKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLD-AEEGTPSTAIREIS 50
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS--ALTWHMRMKIAL 257
L+ + H N+V L ++ +V+E M+ D++ + +HG AL +
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+G+ + HE+ V+HRDLK N+L++ + KL+DFGLA G TL
Sbjct: 108 QLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL 164
Query: 318 GYVAPEYLL 326
Y AP+ LL
Sbjct: 165 WYRAPDVLL 173
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVC 211
F ++G G +G VYK + +A K+ T D E + E+++L HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 212 LLGY------SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
G DD ++V E S+ L + G+ L I + RGL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSGTLGYVAPEY 324
LH+H VIHRD+K N+LL KL DFG+ A D + + N GT ++APE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEV 182
Query: 325 L 325
+
Sbjct: 183 I 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 39/189 (20%)
Query: 159 LGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G FG VY+ + D + A+K L + +E + ++ I N+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNI---LVRTL 51
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSH---------GSALTWHMRM--KIALDTAR----- 261
D++ FIV L S G L WH++ + + D A+
Sbjct: 52 LDESPFIV-------GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAE 104
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
LE+LH++ +++RDLK NILLD+ + L DFGL+ + + NK GT
Sbjct: 105 LVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTE 161
Query: 319 YVAPEYLLD 327
Y+APE LLD
Sbjct: 162 YLAPEVLLD 170
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 9/171 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G V+KAK + + VA+K++ D G E+ LL + H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D +V+E + D++ + S + + +GL + H H V+
Sbjct: 68 LHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
HRDLK N+L++ KL+DFGLA G + TL Y P+ L
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF---ENEVDLLSNIHHPNVVCLLGY 215
+G G +G VYKA+ + +A K+ + G +F + E+ ++ + H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKV--IKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 216 SAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D +I E SL H GP S + + R +T +GL YLH +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH---SKG 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+HRD+K +NILL + KL+DFG++ + GT ++APE
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 58/171 (33%), Positives = 82/171 (47%), Gaps = 15/171 (8%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA-GREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V N VAVK C DA + F E +++ + H N+V LLG
Sbjct: 13 TIGKGEFGDVMLGDYRGN-KVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 217 AHDD-TRFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +IV E M SL L S G S L +K +LD +EYL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
+HRDL + N+L+ AK+SDFGL + S ++ KL + + APE L
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT-KEASSTQDTGKLP--VKWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 32/179 (17%)
Query: 157 NILGEGGFGCVYKAKLDDNLH------VAVKKLDCATQDAGR-EFENEVDLLSNIHHPNV 209
N +G G G VYK +H A+K + +D R + E+++L +++HPNV
Sbjct: 80 NRIGSGAGGTVYKV-----IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----GLEY 265
V H+ ++ E M+ SL+ + D AR G+ Y
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQF--LADVARQILSGIAY 183
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
LH ++HRD+K SN+L++S N K++DFG++ I + + N + GT+ Y++PE
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 47/144 (32%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE--FENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V+ K + VA+K ++ + A E F E ++ + HP +V L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV E MEN L L L+ M + + D G+EYL + + IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA 300
RDL + N L+ S K+SDFG+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 57/177 (32%), Positives = 82/177 (46%), Gaps = 25/177 (14%)
Query: 159 LGEGGFGCVYKAKLDDNLH-VAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
+G+GG+G V+ AK D VA+K++ + + R E D+L+ +V LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 215 YSAHDDTRFIVYELMEN------RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
Y+ DD +Y ME R+L L S A + M A+D L Y
Sbjct: 68 YAFQDDEY--LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY--- 122
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRDLK N L+D+ + KL+DFGL+ G N + G+ Y+APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYAN-SVVGSPDYMAPEVL 170
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 35/201 (17%)
Query: 158 ILGEGGFGCVYKAK------LDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
LGEG FG V KA VAVK L + A+ R+ +E +LL ++HP+V+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLH-----GPSH-GS---------------ALTW 249
L G + D ++ E + SL L GPS+ GS ALT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ A +RG++YL E ++HRDL + N+L+ K+SDFGL+ D + +
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLS-RDVYEEDS 182
Query: 310 NLKLSG---TLGYVAPEYLLD 327
+K S + ++A E L D
Sbjct: 183 YVKRSKGRIPVKWMAIESLFD 203
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 42/192 (21%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---------EVDLLSNIHH 206
+ +GEG +G V A + VA+KK+ FE+ E+ +L H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQTFCQRTLREIKILRRFKH 62
Query: 207 PNVVCLL------GYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIAL 257
N++ +L + + +D +IV ELME + + Q H +
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--- 314
RGL+Y+H N V+HRDLK SN+LL++ + K+ DFGLA ++ + L+
Sbjct: 115 -ILRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 315 GTLGYVAPEYLL 326
T Y APE +L
Sbjct: 171 ATRWYRAPEIML 182
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 56/187 (29%), Positives = 87/187 (46%), Gaps = 27/187 (14%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGEAMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-----GPSHGSALTWHMRMKIALDTA 260
VV L D +V LM L ++ G A+ + A +
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEIT 112
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
GLE LH +++RDLK NILLD + ++SD GLA I +G + + GT+G
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVG 166
Query: 319 YVAPEYL 325
Y+APE +
Sbjct: 167 YMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYK-AKLDDNLHVAVKKLDCATQDAGREFENE 197
S + + L TD++ +G+G +G VYK D AVK LD D E E E
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAE 68
Query: 198 VDLLSNI-HHPNVVCLLGYSAHDD-----TRFIVYELMENRSLDIQLHGP-SHGSALTWH 250
++L ++ +HPNVV G D ++V EL S+ + G G L
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310
M I GL++LH N +IHRD+K +NILL ++ KL DFG++ S
Sbjct: 129 MISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 311 LKLSGTLGYVAPEYL 325
GT ++APE +
Sbjct: 186 NTSVGTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLH-VAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVC 211
+GEG +G V+K + + VA+KK + D A RE + +L + HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L+ +V+E ++ L+ +L G + H+ KI T + + + H+H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKH-- 119
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRD+K NIL+ + KL DFG A + T Y APE L
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V++ L + VA+K L T+ ++F +E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G I+ E MEN +LD L H + + + + A G++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLSDM--- 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + NIL++S K+SDFGL+
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCAT-QDAGREFENEVD-LLSNIHHPNVVCLLGY 215
+G G FG V K +AVK++ + + ++D ++ + P +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 216 SAHDDTRFIVYELMENRSLD-----IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
+ +I ELM+ SLD + S + + KIA+ T + L YL E
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSV---IPEEILGKIAVATVKALNYLKEEL 127
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+IHRD+K SNILLD N KL DFG++
Sbjct: 128 K--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 158 ILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK + VA+K L+ T A EF +E +++++ HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG + +V +LM + L +H H + + + + A+G+ YL E
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEER-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNN 310
++HRDL + N+L+ S + K++DFGLA + +G + + N
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 39/200 (19%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFE--NEVDLLSNIHHP 207
+ + +G+G FG V+KA+ VA+KK+ + G E+ +L + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 208 NVVCLL--------GYSAHDDTRFIVYE--------LMENRSLDIQLHGPSHGSALTWHM 251
NVV L+ Y+ + + ++V+E L+ N+++ L S +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL---SEIKKV---- 124
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----ITDGSQ 306
MK+ L+ GL Y+H + ++HRD+K++NIL+ KL+DFGLA +
Sbjct: 125 -MKMLLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 307 NKNNLKLSGTLGYVAPEYLL 326
N+ ++ TL Y PE LL
Sbjct: 178 NRYTNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
++G G FG V+ + D V +K++ T+D +NE +L + HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 215 YSAHDDTRFIVYELMENRSLD--IQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEH 269
D IV E +L IQ S + L + +++ +AL H H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVH 118
Query: 270 CNPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++HRDLK+ NILLD K+ DFG++ S++K + GT Y++PE
Sbjct: 119 -TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY-TVVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 31/186 (16%)
Query: 159 LGEGGFGCVYKAKLDDN--LHVAVKKLDC-------ATQDAGREFENEVDLLSNI----H 205
LG G FGCVYK + +N +A+K+++ ++ + + V ++ I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSL-----DIQLHGPSHGSALTWHMRMKIALDTA 260
HPN+V +D +IV +L+E L ++ W++ +++ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTL 317
L YLH+ ++HRDL +NI+L ++DFGLA Q + KL+ GT+
Sbjct: 125 -ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA----KQKQPESKLTSVVGTI 177
Query: 318 GYVAPE 323
Y PE
Sbjct: 178 LYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
E +S LG G FG V+ + N VAVK L T + F E ++ + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L + + +IV E M SL L G AL + +A A G+ Y+
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
E N IHRDL+S+NIL+ K++DFGLA
Sbjct: 119 -ERMN--YIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 5/142 (3%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ +++ VAVK L T + F E +L+ + H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +I+ E M SL + G + + + A G+ Y+ IHRD
Sbjct: 73 EEPIYIITEYMAKGSL-LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L+++N+L+ K++DFGLA
Sbjct: 129 LRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 23/189 (12%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGR-EFENEVDLLS--NIHHPNV 209
LG+G FG VY+ K + VA+K ++ A R EF NE ++ N HH V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--V 71
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + ++ ELM RSL ++ + + +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+ YL+ + +HRDL + N ++ F K+ DFG+ I + + K + ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 321 APEYLLDGM 329
+PE L DG+
Sbjct: 189 SPESLKDGV 197
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 44/203 (21%)
Query: 157 NILGEGGFGCVYKAKLDDNLH--VAVKKLDCATQDAGREFEN--------------EVDL 200
LGEG +G V KA D VA+KK+ + E+ +
Sbjct: 15 AHLGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIAL 257
++ I H N++ L+ D +V ++M + + +D ++ LT I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-------LTESQVKCILL 126
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----------ITDGSQ 306
GL LH +HRDL +NI ++SK K++DFGLA ++
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 307 NKNNLKLSG---TLGYVAPEYLL 326
+ +++ TL Y APE L+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLM 206
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 8/168 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHHPNVVCLLGYS 216
LG+G +G VYK + +A+K++ ++ + E+D+L P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+ ++ E M+ SLD G + + +I +GL++L E N +IH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAIT-DGSQNKNNLKLSGTLGYVAPE 323
RD+K +N+L++ KL DFG++ S K N+ G Y+APE
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 39/167 (23%)
Query: 159 LGEGGFGCVYKAKLDDN---LHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLL 213
LGEG FG V + +L+ + L VAVK + A T+ +F +E + HPNV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 214 G-------------------YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
G + H D F++Y +R D + P+ M +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY----SRLGDCPQYLPTQ-------MLV 115
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
K D A G+EYL + + IHRDL + N +L+ N ++DFGL+
Sbjct: 116 KFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV------AVKKLDCA--TQDAGREFENEVDL-L 201
D LG G +G V K + HV AVK++ +Q+ R ++D+ +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMR-----HVPTGTIMAVKRIRATVNSQEQKRLL-MDLDISM 54
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTA 260
++ P V G + +I E+M+ SLD G + + KIA+
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ LEYLH + VIHRD+K SN+L++ KL DFG++
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 58/181 (32%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F + +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGESMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLE 264
VV L D +V LM D++ H G A R A + GLE
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGG--DLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
LH+ +++RDLK NILLD + ++SD GLA + +G K + GT+GY+AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 170
Query: 323 E 323
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 159 LGEGGFGCVYKAKLDDNL--HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G G V+ A D VA+K+++ Q NE+ ++ + +PN+V L
Sbjct: 27 IGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D F+V E + SL D+ + + + + + LE+LH + VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
HRD+KS N+LL + KL+DFG + + GT ++APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+K+++ Q NE+ ++ HPN+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + LE+LH + VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
RD+KS NILL + KL+DFG + + GT ++APE
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 8/178 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPN 208
DS+ + LGEG + VYK K N + K+ ++ G F E LL + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V L +T +V+E + D+ + H L RGL Y+H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
++HRDLK N+L+ KL+DFGLA + TL Y P+ LL
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNV 209
F + +G+G FG V+K +D+ VA+K +D +D + + E+ +LS P V
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 210 VCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
G +I+ E + S LD+ GP + ++ + +GL+YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHS 119
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRD+K++N+LL + + KL+DFG+A +TD +N GT ++APE +
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 8/170 (4%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL- 213
++G+G +G V + D +KKL+ A++ + E E LLS + HPN+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
+ D +IV E L +L G L + ++ + A L+YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++HRDLK+ N+ L K+ D G+A +Q L GT Y++PE
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 59/219 (26%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V+ + D V A+K L D ++ E D+L++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR---- 261
P +V L Y + D + Y +ME + G G + +R + +TAR
Sbjct: 61 PWIVKL--YYSFQDEEHL-YLVME------YMPG---GDLMNLLIRKDVFPEETARFYIA 108
Query: 262 ----GLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-- 314
L+ +H+ IHRD+K NIL+D+ + KL+DFGL L+
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 315 ---------------------------GTLGYVAPEYLL 326
GT Y+APE L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 178 VAVKKL-DCATQDAGR--EFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVYELMENRS 233
VA+K L A ++ + F E L + ++HPN+V LL A F V+E + R+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKF 290
L L A M LD L H N ++HRDLK NI++ +
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLD---ALACAH---NQGIVHRDLKPQNIMVSQTGVRP 119
Query: 291 NAKLSDFGL-AITDGSQNKNNLKLS------GTLGYVAPEYL 325
+AK+ DFG+ + G ++ + L+ GT Y APE L
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 18/165 (10%)
Query: 153 FHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCATQ-DAGREFENEVDLLSNIHH 206
F + +LG G FG VYK + VA+K+L AT A +E +E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSA--LTWHMRMKIALDTARGL 263
P+V LLG + I + LD ++ H + GS L W +++ A+G+
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 122
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
YL E ++HRDL + N+L+ + + K++DFGLA G+ K
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F + +LG+GGFG C + + ++ A K+L+ + R+ E NE +L ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMY-ACKRLE-KKRIKKRKGESMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLE 264
VV L D +V +M D++ H + G+ R A + GLE
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
LH ++RDLK NILLD + ++SD GLA I +G + + GT+GY+AP
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAP 170
Query: 323 EYL 325
E L
Sbjct: 171 EVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLL 213
LG+GGFG + + L+ A KKL+ + +E E +L+ +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLY-ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y+ T +V +M L ++ GLE+LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQNKNNLKLSGTLGYVAPEYLLD 327
+I+RDLK N+LLD+ N ++SD GLA+ DG Q+K +GT G++APE L
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTK-GYAGTPGFMAPELLQG 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 31/175 (17%)
Query: 152 SFHESNILGEGGFG-----------------CVYKAKLDDNLHVAVKKLDC-ATQDAGRE 193
+F E LGEG FG + + VAVK L A ++A +
Sbjct: 8 TFKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 194 FENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL--HGP------SHGS 245
F E+ ++S + PN++ LL D ++ E MEN L+ L H P +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+++ + +A A G++YL + +HRDL + N L+ + K++DFG++
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 34/197 (17%)
Query: 159 LGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V +A+ D + VAVK L D AT + +E++L+ I H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL------------DIQLHGP-SHGSALTWHMRMKI 255
++ LLG + +++ E +L D L++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 256 ALDTARGLEYLH-EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNN 310
A ARG+EYL C IHRDL + N+L+ K++DFGLA D + +N
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 311 LKLSGTLGYVAPEYLLD 327
+L + ++APE L D
Sbjct: 196 GRLP--VKWMAPEALFD 210
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HP 207
+D++ +G+G +G V+K + AVK LD D E E E ++L + HP
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHP 75
Query: 208 NVVCLLG-YSAHD----DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTAR 261
NVV G Y D D ++V EL S+ + G G + + I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH + IHRD+K +NILL ++ KL DFG++ S GT ++A
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 322 PEYL 325
PE +
Sbjct: 193 PEVI 196
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 45/142 (31%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG+G FG V+ + VA+K L T + F E ++ + H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +IV E M SL L G G L + +A A G+ Y+ E N +HRD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L+++NIL+ K++DFGLA
Sbjct: 128 LRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 50/170 (29%), Positives = 70/170 (41%), Gaps = 8/170 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPNVVCLLGYS 216
LGEG + VYK N + K+ + G F E LL + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+T V+E M D+ + H L + RGL Y+H ++H
Sbjct: 73 HTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
RDLK N+L+ KL+DFGLA ++ TL Y P+ LL
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+++++ Q NE+ ++ +PN+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + LE+LH + VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
RD+KS NILL + KL+DFG + + GT ++APE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 158 ILGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNI-HHPNV 209
LG G FG V +A K D + VAVK L + RE +E+ ++S++ +H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HE 268
V LLG ++ E L L + + + A+G+ +L +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLASK 160
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPEY 324
+C IHRDL + N+LL K+ DFGLA I + S K N +L + ++APE
Sbjct: 161 NC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPES 214
Query: 325 LLDGM 329
+ + +
Sbjct: 215 IFNCV 219
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 57/183 (31%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 158 ILGEGGFGCVYKAKL--DDNLH-VAVKKLDCATQDAGREFE-NEVDLLSNIH-HPNVVCL 212
+LG+G FG V A+L L+ V V K D QD E E +LS HP + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG---------- 262
D F V E + +G L +H++ D AR
Sbjct: 62 YCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
L +LH+ +I+RDLK N+LLD + + KL+DFG+ K GT Y+AP
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165
Query: 323 EYL 325
E L
Sbjct: 166 EIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 157 NILGEGGFGCVYKA-KLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
ILG G G VYKA L +AVK LD T + ++ +E+++L P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G ++ I E M+ SLD+ P H + +IA+ +GL YL +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEH-------VLGRIAVAVVKGLTYL---WSLK 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPEYLL 326
++HRD+K SN+L++++ KL DFG++ +Q N++ + GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERIS 166
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 23/190 (12%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGR-EFENEVDLLS--NIHHPNV 209
LG+G FG VY+ K + VAVK ++ + R EF NE ++ HH V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + +V ELM + RSL + T +++A + A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+ YL+ +HRDL + N ++ F K+ DFG+ I + + K + ++
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 321 APEYLLDGMV 330
APE L DG+
Sbjct: 189 APESLKDGVF 198
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G +G VYKA+ NLH AVK + D + E+ ++ H N+V G
Sbjct: 17 VGSGTYGDVYKAR---NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 215 YSAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+ +I E SL H GP + + R +T +GL YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSK--- 125
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+HRD+K +NILL + KL+DFG+A + GT ++APE
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+K+++ Q NE+ ++ +PN+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + L++LH + VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
RD+KS NILL + KL+DFG + + GT ++APE
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ A + + VAVK + + F E +++ + H +V L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +I+ E M SL + GS + + A G+ ++ + IHRD
Sbjct: 73 EPI-YIITEFMAKGSL-LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L+++NIL+ + K++DFGLA
Sbjct: 128 LRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VY+A L D + VA+KK+ D A + E+DLL ++HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D+ IV EL + L + H + K + LE++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
V+HRD+K +N+ + + KL D GL S+ L GT Y++PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL-DCATQDAGR-EFENEVDLLSNI 204
E D F + LG G G V K + + + +KL + A R + E+ +L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ P +V G D I E M+ SLD L + + K+++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLA 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
YL E ++HRD+K SNIL++S+ KL DFG++ + D N GT Y++P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSP 171
Query: 323 EYL 325
E L
Sbjct: 172 ERL 174
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 54/175 (30%), Positives = 75/175 (42%), Gaps = 15/175 (8%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVKKLDCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L D+ + V K D QD + E + L+ HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYLHEHC 270
L D F V E + L Q+ R + A + L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE----PRSRFYAAEVTLALMFLHRH- 115
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
VI+RDLK NILLD++ + KL+DFG+ GT Y+APE L
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 48/194 (24%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y N VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80
Query: 213 LGYSAHDDTR------FIVYELME-------NRSLDIQLHGPSHGSALTWHMRMKIAL-D 258
L + ++V ELM+ LD H RM L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD--------------HERMSYLLYQ 126
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
G+++LH + +IHRDLK SNI++ S K+ DFGLA T G + ++
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVV 179
Query: 316 TLGYVAPEYLLDGM 329
T Y APE +L GM
Sbjct: 180 TRYYRAPEVIL-GM 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 37/187 (19%)
Query: 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVK---KLDCATQDAGREFENEVDLLSNIHHPN 208
F LG G FG V AK + A+K K + + E +L + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR----- 261
+V ++ S D+ R VY L+E G L H+R + D A+
Sbjct: 80 IVNMM-CSFQDENR--VYFLLEFVV----------GGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
EYLH + +I+RDLK N+LLD+K + K++DFG A + D L GT
Sbjct: 127 LVLAFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGT 178
Query: 317 LGYVAPE 323
Y+APE
Sbjct: 179 PEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VY+A L D VA+KK+ + A ++ E+DLL ++HPNV+ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D+ IV EL + L + + + K + +E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
V+HRD+K +N+ + + KL D GL S+ L GT Y++PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 59/188 (31%), Positives = 81/188 (43%), Gaps = 39/188 (20%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVKKLDCATQDAGREF---ENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L D+ V V K D QD E E V L+ HP +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L D F V E + +G L +H++ D R
Sbjct: 61 LHSCFQTKDRLFFVMEYV-------------NGGDLMFHIQRSGRFDEPRARFYAAEIVL 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLG 318
GL++LHE +I+RDLK N+LLDS+ + K++DFG+ I G GT
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST---FCGTPD 161
Query: 319 YVAPEYLL 326
Y+APE L
Sbjct: 162 YIAPEILS 169
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 31/189 (16%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGEAMALNEKRILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
VV L D +V +M D++ H + G+ D R + Y
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNP---------GFDEQRAIFY 107
Query: 266 LHEHC-------NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
E C +++RDLK NILLD + + ++SD GLA I +G + + GT
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GT 164
Query: 317 LGYVAPEYL 325
+GY+APE +
Sbjct: 165 VGYMAPEVI 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 53/163 (32%), Positives = 77/163 (47%), Gaps = 30/163 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V + D H+ A+KKL + ++ E D+L+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM----------RMKIA 256
P VV L YS D+ +Y +ME L G G +T M R IA
Sbjct: 61 PWVVKLY-YSFQDENY--LYLIME------YLPG---GDMMTLLMKKDTFTEEETRFYIA 108
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+T ++ +H+ IHRD+K N+LLD+K + KLSDFGL
Sbjct: 109 -ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL-DCATQDAGR-EFENEVDLLSNI 204
E D F + + LG G G V+K + + +KL + A R + E+ +L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ P +V G D I E M+ SLD L + + K+++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
YL E ++HRD+K SNIL++S+ KL DFG++ + D N GT Y++P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSP 171
Query: 323 EYL 325
E L
Sbjct: 172 ERL 174
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 18/175 (10%)
Query: 158 ILGEGGFGCVY---KAKLDDNLHV-AVKKLDCAT---QDAGREFENEVDLLSNIHHPNVV 210
+LG+G FG V+ K D + A+K L AT +D R + E D+L+ ++HP +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 211 CLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYLHE 268
L Y+ + + +++ + + L +L S T +K L + A L++LH
Sbjct: 62 -KLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFT-EEDVKFYLAELALALDHLH- 115
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ +I+RDLK NILLD + + KL+DFGL+ K GT+ Y+APE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLD---DNL--HVAVKKLDCAT-QDAGREFE 195
E + L++ D LGEG FG V + D DN VAVK L + + + +
Sbjct: 2 EKRFLKRIRD-------LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK 54
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSLDIQLHGPSHGSALTWHMRM 253
E+++L N++H N+V G D I + E + + SL L P + + + ++
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQL 112
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL--AI-TDGSQNKNN 310
K A+ +G++YL +HRDL + N+L++S+ K+ DFGL AI TD
Sbjct: 113 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 311 LKLSGTLGYVAPEYLL 326
L + + APE L+
Sbjct: 170 DDLDSPVFWYAPECLI 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNV 209
+LG+GG+G V++ + D A+K L AT Q + E ++L + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM-RMKIAL-DTAR------ 261
V L+ Y+ + +Y ++E S G L H+ R I + DTA
Sbjct: 63 VDLI-YAFQTGGK--LYLILEYLS----------GGELFMHLEREGIFMEDTACFYLSEI 109
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
LE+LH+ +I+RDLK NILLD++ + KL+DFGL + GT+ Y
Sbjct: 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166
Query: 320 VAPEYL 325
+APE L
Sbjct: 167 MAPEIL 172
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 37/191 (19%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
D +G G FG V+ + + A+K + ++ + NE +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P ++ L + D RF+ Y LME G L ++R + + T
Sbjct: 61 PFIIRL--FWTEHDQRFL-YMLMEYVP----------GGELFSYLRNSGRFSNSTGLFYA 107
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS 314
LEYLH +++RDLK NILLD + + KL+DFG A + D L
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLC 159
Query: 315 GTLGYVAPEYL 325
GT Y+APE +
Sbjct: 160 GTPEYLAPEVI 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 56/180 (31%), Positives = 75/180 (41%), Gaps = 23/180 (12%)
Query: 158 ILGEGGFGCVY--KAKLDDNLHVAVKKLDCATQDAGREFENEVD--------LLSNIHHP 207
++G+G FG V K K D + AVK L Q + E LL N+ HP
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFY-AVKVL----QKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYL 266
+V L D + V + + L L R + A + A L YL
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYL 112
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +I+RDLK NILLDS+ + L+DFGL +K GT Y+APE L
Sbjct: 113 HSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 142 EYKLLEKATDSFHESNI-----LGEGGFGCVY--------KAKLDDNLHVAVKKL-DCAT 187
EY+L E F + LGEG FG V K K + + VAVK L D AT
Sbjct: 1 EYELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 188 QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS---- 242
+ + +E++++ I H N++ LLG D +++ E +L L
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 243 ---------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+T+ + ARG+EYL + IHRDL + N+L+ K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 177
Query: 294 LSDFGLAI----TDGSQNKNNLKLSGTLGYVAPEYLLD 327
++DFGLA D + N +L + ++APE L D
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLP--VKWMAPEALFD 213
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG+G FG V+ + VA+K L T F E ++ + H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +IV E M SL + G L + +A A G+ Y+ E N IHRD
Sbjct: 73 EPI-YIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN--YIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA 300
L+++NIL+ K++DFGLA
Sbjct: 128 LRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 51/178 (28%), Positives = 75/178 (42%), Gaps = 49/178 (27%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNL---HVAVKKLDCA---TQDAGREFEN 196
YK+ E ++G+G +G V A D VA+KK++ DA R
Sbjct: 2 YKIQE----------VIGKGSYGVVCSAI--DTHTGEKVAIKKINDVFEHVSDATRILR- 48
Query: 197 EVDLLSNIHHPNVVCLLGYSAHDDTR-----FIVYELMENRSLDIQLH---------GPS 242
E+ LL + HP++V + R ++V+ELME+ LH P
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPE 103
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
H + + R L+Y+H V HRDLK NIL ++ K+ DFGLA
Sbjct: 104 HHQFFLYQL--------LRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCA--TQDAGREFEN-EVDLLSNIHHPNVVCLL 213
LG+GGFG C + K ++ A KKLD + +G + E ++L ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMY-ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGS-ALTWHMRMKIALDTARGLEYLHEHCN 271
Y+ T +V LM D++ H + G L + + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGG--DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-- 114
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+++RD+K N+LLD + N +LSD GLA+ + K + +GT GY+APE L +
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAV-ELKDGKTITQRAGTNGYMAPEILKE 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 19/172 (11%)
Query: 162 GGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFEN----EVDLLSNIHHPNVVCLLGYS 216
G FG VY A K + A+K L + A + N ++ P V L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
D ++V E + I+ G L + + G+E LH+ +
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDLHQR---GI 118
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K N+L+D + KL+DFGL+ +G +NK K GT Y+APE +L
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS-RNGLENK---KFVGTPDYLAPETIL 166
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y A LD N VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYSAHDDTR------FIVYELME-NRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLE 264
L + ++V ELM+ N IQ+ H RM L G++
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIK 133
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+LH + +IHRDLK SNI++ S K+ DFGLA T G+ + T Y APE
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 189
Query: 325 LL 326
+L
Sbjct: 190 IL 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 12/168 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ + K VAVK +D Q NEV ++ + H NVV +
Sbjct: 29 IGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +++ E ++ +L DI + L + + L YLH VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
HRD+KS +ILL KLSDFG L GT ++APE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 159 LGEGGFGCVY--------KAKLDDNLHVAVKKLDC-ATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V K K + VAVK L AT+ + +E++++ I H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQL-----------HGPSHG--SALTWHMRMKI 255
++ LLG D +++ E +L L + P+ L++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNNL 311
A ARG+EYL + IHRDL + N+L+ K++DFGLA D + N
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 312 KLSGTLGYVAPEYLLD 327
+L + ++APE L D
Sbjct: 203 RLP--VKWMAPEALFD 216
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 31/187 (16%)
Query: 159 LGEGGFGCVYKAK---LDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIH-HPNVVC 211
LG+G +G V A+ + VA+KK+ A R E+ LL + H N+ C
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 212 LLG-----YSAHDDTRFIVYELMENRSLDIQLHGPSH-GSALT-WHMRMKIALDTARGLE 264
L ++ ++ ELME LH G LT H + I GL+
Sbjct: 67 LYDMDIVFPGNFNEL-YLYEELME-----ADLHQIIRSGQPLTDAHFQSFI-YQILCGLK 119
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSG---TLGY 319
Y+H + V+HRDLK N+L+++ K+ DFGLA ++ +N ++ T Y
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN-PGENAGFMTEYVATRWY 175
Query: 320 VAPEYLL 326
APE +L
Sbjct: 176 RAPEIML 182
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 159 LGEGGFGCVY-----KAKLDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNVVC 211
LG+G FG VY KA ++ L V +K++ + + E LLS + HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSH-GSALTWHMRMKIALDTARGLEYLHEHC 270
D I+ E E R LD +L H G L+ + + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
++HRDLK+ NI L + K+ DFG++ +GT Y++PE L
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLLGYS 216
LG G G V K K + +A K + + + R + E+ ++ P +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPA 273
+++ + E M+ SLD + GP + + KIA+ GL YL+ H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVH---R 124
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGL------AITDGSQNKNNLKLSGTLGYVAPE 323
++HRD+K SNIL++S+ KL DFG+ +I D GT Y++PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--------TFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
D++ + +GEG +G VYKA+ + VA+KK + G E+ LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 208 NVVCLLGYSAHDDTR------FIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTA 260
+ L H + + ++V+E +++ + +G G L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+G+ + H+H V+HRDLK N+L+D K K++D GL K+ TL Y
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 320 VAPEYLL 326
APE LL
Sbjct: 178 RAPEVLL 184
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 32/203 (15%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-EV 198
I+ + S+ NI+G G FG VY+A +D + VA+KK+ QD +++N E+
Sbjct: 56 IDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDP--QYKNREL 110
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTR--------FIVYELMENRSLDIQLHGPSHGSALTWH 250
++ N++H N++ L Y + + +V E + H + AL
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKN 309
+ + R L Y+H + + HRDLK N+L+D + KL DFG A KN
Sbjct: 171 LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA-------KN 220
Query: 310 NLKLSGTLGYV------APEYLL 326
L ++ Y+ APE +L
Sbjct: 221 LLAGQRSVSYICSRFYRAPELML 243
|
Length = 440 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 30/161 (18%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL---LG 214
LG G G V+ A D + VAVKK+ + + E+ ++ + H N+V + LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 215 YSAHDDTR-----------FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTA 260
S D T +IV E ME ++ GP H + +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--------L 124
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLA 300
RGL+Y+H + V+HRDLK +N+ ++++ K+ DFGLA
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 17/151 (11%)
Query: 159 LGEGGFGCV----YKAKLDDNLH-VAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG V Y D VAVK L +C Q+ ++ E+++L ++H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT-SGWKKEINILKTLYHENIVK 70
Query: 212 LLGYSAH--DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
G + ++ E + SL L P H L + A G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA--QLLLFAQQICEGMAYLHSQ 126
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL + N+LLD+ K+ DFGLA
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 60/191 (31%), Positives = 86/191 (45%), Gaps = 44/191 (23%)
Query: 158 ILGEGGFGCVY--KAKLDDNLHVAVKKLDCATQDAGREF-----ENEVDLLSNIHHPNVV 210
+LG+G FG V + K + A+K L A E E+ V L N HP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYY-AMKILKKEVIIAKDEVAHTLTESRV--LQNTRHPFLT 58
Query: 211 CL-LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK--IALDTAR------ 261
L + HD F+ ME ++G L +H+ + + D AR
Sbjct: 59 ALKYSFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGT 316
L YLH C+ V++RDLK N++LD + K++DFGL I+DG+ K GT
Sbjct: 105 VSALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGT 158
Query: 317 LGYVAPEYLLD 327
Y+APE L D
Sbjct: 159 PEYLAPEVLED 169
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 11/173 (6%)
Query: 158 ILGEGGFGCVY--KAKLDDNLH---VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
++G+G FG V K KLD + V KK+ ++ LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+ + V + + L L S R A + A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ--RERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
+++RDLK NILLDS+ + L+DFGL +Q+ GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 159 LGEGGFGCVY--------KAKLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V K K + + VAVK L D AT + +E++++ I H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHG---PSHGSA----------LTWHMRMKI 255
++ LLG D +++ E +L L P + LT+ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNNL 311
A ARG+EYL + IHRDL + N+L+ K++DFGLA D + N
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 312 KLSGTLGYVAPEYLLD 327
+L + ++APE L D
Sbjct: 197 RLP--VKWMAPEALFD 210
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 158 ILGEGGFGCVYKA---KLDDNLH--VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG V+K D++ VA+K + D + + +E + + + ++ H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG + + LD H H +L + + A+G+ YL EH
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLD---HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++HR+L + NILL S +++DFG+A
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 36/188 (19%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQDA--GREFENEVDLLSNIHHPNVVCLL 213
+G G +G V Y +L VAVKKL Q R E+ LL ++ H NV+ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 214 -----GYSAHD-DTRFIVYELME---NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
S + + ++V LM N + Q H L + + RGL+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LRGLK 132
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVA 321
Y+H + +IHRDLK SN+ ++ ++ DFGLA + + +++G T Y A
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA------RQADDEMTGYVATRWYRA 183
Query: 322 PEYLLDGM 329
PE +L+ M
Sbjct: 184 PEIMLNWM 191
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 36/196 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCATQD---AGREFENEVDLLSNIH 205
D + + +G G +G V A LD VA+KKL Q A R + E+ LL ++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMK 72
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK---------IA 256
H NV+ LL D + +R D L P G+ L M+ + +
Sbjct: 73 HENVIGLLDVFTPDLSL--------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
+GL+Y+H +IHRDLK N+ ++ K+ DFGLA S+ ++G
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTGY 175
Query: 316 --TLGYVAPEYLLDGM 329
T Y APE +L+ M
Sbjct: 176 VVTRWYRAPEVILNWM 191
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 23/176 (13%)
Query: 159 LGEGGFGCVYKAKL----DDNLHVAVKKLD-CATQDAGR-EFENEVDLLSNIHHPNVVCL 212
+GEG FG KA L +D +K+++ R E EV +LSN+ HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGP-----SHGSALTWHMRMKIALDTARGLEYLH 267
+ +IV + E L +++ L W +++ +AL H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------H 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
H + ++HRD+KS NI L KL DFG+A S + GT Y++PE
Sbjct: 117 VH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPN 208
D F + LG G G V K L +A K + + A R + E+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V G D I E M+ SLD L + ++ KI++ RGL YL E
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
++HRD+K SNIL++S+ KL DFG++ + D N GT Y++PE L
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 170
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 62/185 (33%), Positives = 89/185 (48%), Gaps = 30/185 (16%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y A L+ +VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYSAHDDTR------FIVYELME-NRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLE 264
L + +IV ELM+ N IQ+ H RM L G++
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIK 140
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+LH + +IHRDLK SNI++ S K+ DFGLA T G+ + T Y APE
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 196
Query: 325 LLDGM 329
+L GM
Sbjct: 197 IL-GM 200
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 20/153 (13%)
Query: 158 ILGEGGFGCVYK---AKLDDNLH--VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK +N+ VA+K L + + A +E +E +++ + P V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSA--LTWHMRMKIALDTARGLEYLH 267
LLG T +V +LM L ++ + GS L W +++ A+G+ YL
Sbjct: 74 LLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
E ++HRDL + N+L+ S + K++DFGLA
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 25/66 (37%), Positives = 38/66 (57%), Gaps = 3/66 (4%)
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL+YLHE+ +++RDLK N+LLD++ K++DFGL GT ++A
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169
Query: 322 PEYLLD 327
PE L +
Sbjct: 170 PEVLTE 175
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCL 212
LG G FG V YK K + VAVK L D E E +++ + +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +V EL E L+ L H +T ++ + G++YL E
Sbjct: 62 IGI-CEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEET--- 114
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT----LGYVAPE 323
+HRDL + N+LL ++ AK+SDFGL+ G+ ++N K + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 33/184 (17%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD----LLSNIHHPNVVCL 212
++G+G FG V A+ + AVK L +E ++ + LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 213 -LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK----------IALDTAR 261
+ D F++ + +G L +H++ + A + A
Sbjct: 62 HFSFQTADKLYFVLDYI--------------NGGELFYHLQRERCFLEPRARFYAAEIAS 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
L YLH + +++RDLK NILLDS+ + L+DFGL + N GT Y+A
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164
Query: 322 PEYL 325
PE L
Sbjct: 165 PEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 33/185 (17%)
Query: 158 ILGEGGFGCVYKAKLDD-NLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L N A+K L D +D E E V L+ HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L + F V E + +G L +H++ D AR
Sbjct: 61 LFCTFQTKEHLFFVMEYL-------------NGGDLMFHIQSSGRFDEARARFYAAEIIC 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH+ +I+RDLK N+LLD + K++DFG+ + + GT Y+A
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164
Query: 322 PEYLL 326
PE L
Sbjct: 165 PEILK 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 158 ILGEGGFG--CVYKAKLDDNLHVA----VKKLDCATQDAGREFENEVDLLSNIHHPNVVC 211
++GEG FG + + D + + K A +D+ +E LL+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE----AVLLAKMKHPNIVA 62
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
D +IV E + L +Q G ++ + G++++HE
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-- 119
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
V+HRD+KS NI L KL DFG A S GT YV PE
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 57/188 (30%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 158 ILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL- 212
+LG+G FG V K +KK +D E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK--IALDTAR--------G 262
+ HD F+ ME ++G L +H+ + + D AR
Sbjct: 62 YSFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFSEDRARFYGAEIVSA 107
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGY 319
L+YLH N V++RDLK N++LD + K++DFGL I DG+ K GT Y
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEY 162
Query: 320 VAPEYLLD 327
+APE L D
Sbjct: 163 LAPEVLED 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 144 KLLEKATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD---AGREFENEVD 199
K + + + + + +G G +G V A L VAVKKL Q A R + E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELR 68
Query: 200 LLSNIHHPNVVCLL-------GYSAHDDTRFIVYELME---NRSLDIQLHGPSHGSALTW 249
LL ++ H NV+ LL +D ++V LM N + Q H L +
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ RGL+Y+H + +IHRDLK SN+ ++ K+ DFGLA +
Sbjct: 128 QI--------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176
Query: 310 NLKLSGTLGYVAPEYLLDGM 329
+ T Y APE +L+ M
Sbjct: 177 YV---ATRWYRAPEIMLNWM 193
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 38/188 (20%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCL- 212
+LG+G FG V + + A+K L A E + E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM-RMKI-ALDTAR--------G 262
+ HD F+ ME ++G L +H+ R ++ + AR
Sbjct: 62 YAFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFTEERARFYGAEIVSA 107
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGY 319
LEYLH V++RD+K N++LD + K++DFGL I+DG+ K GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEY 161
Query: 320 VAPEYLLD 327
+APE L D
Sbjct: 162 LAPEVLED 169
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 28/173 (16%)
Query: 151 DSFHESNILGEGGFGCV-YKAKLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHH 206
+ FH ++G+G FG V K D A+K L + +D + E D+L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR---- 261
P VV L Y + D +++ Y +ME L G G +T ++ + D R
Sbjct: 61 PWVVSL--YYSFQDAQYL-YLIMEF------LPG---GDLMTMLIKYDTFSEDVTRFYMA 108
Query: 262 ----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310
+E +H+ IHRD+K NIL+D + KLSDFGL+ Q+ +
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 44/146 (30%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
ILG G FG + + L L VA+ L + R F E L H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G +T IV E M N +LD L H L M + A G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSEM--- 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFG 298
+H+ L + +L++S K+S F
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 54/185 (29%), Positives = 81/185 (43%), Gaps = 33/185 (17%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V+ A+L N A+K L D D E E V L+ HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L + F V E + +G L +H++ D R
Sbjct: 61 LYCTFQTKENLFFVMEYL-------------NGGDLMFHIQSCHKFDLPRATFYAAEIIC 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH + +++RDLK NILLD+ + K++DFG+ + + GT Y+A
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIA 164
Query: 322 PEYLL 326
PE LL
Sbjct: 165 PEILL 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 38/139 (27%), Positives = 53/139 (38%), Gaps = 27/139 (19%)
Query: 197 EVDLLSNIHHPNVVCLLGYSAHDDTRFIV----------YELMENRSLDIQLHGPSHGSA 246
E LL N++HP+V+ + +V Y +R L I A
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPID-------QA 159
Query: 247 LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306
L I GL YLH +IHRD+K+ NI ++ + D G A
Sbjct: 160 LI------IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 307 NKNNLKLSGTLGYVAPEYL 325
L L+GT+ APE L
Sbjct: 211 -PAFLGLAGTVETNAPEVL 228
|
Length = 357 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLL 213
LG G FGCV YK + + VA+K L + + R E E +++ + +P +V ++
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G + +V E+ L+ L G +T +++ + G++YL
Sbjct: 62 GV-CEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N+LL ++ AK+SDFGL+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 13/94 (13%)
Query: 243 HGSALTWHMRMKIALDTAR----------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
+G L H++ + D +R LE LH+ VI+RDLK NILLD + +
Sbjct: 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHI 132
Query: 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
L DFGL + + GT Y+APE LL
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 31/183 (16%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVD----LLSNIHHPNVVCL 212
++G+G FG V AK D AVK L T +E + + LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK----------IALDTARG 262
+ + V + + +G L +H++ + A + A
Sbjct: 62 HYSFQTAEKLYFVLDYV-------------NGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
+ YLH +I+RDLK NILLDS+ + L+DFGL + GT Y+AP
Sbjct: 109 IGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 323 EYL 325
E L
Sbjct: 166 EVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+HP +V L + F V E + D+ H H R A + + L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLHE +I+RDLK N+LLDS+ + KL+D+G+ GT Y+APE
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 325 L 325
L
Sbjct: 168 L 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 32/148 (21%), Positives = 52/148 (35%), Gaps = 21/148 (14%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-----PNVVCL 212
+L G VY + +K +++ G + E EV +L + P V+
Sbjct: 5 LLKGGLTNRVYLLG-TKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA- 60
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
D +++ E +E +LD IA A L LH+
Sbjct: 61 --SGESDGWSYLLMEWIEGETLD-----EVSEEEKE-----DIAEQLAELLAKLHQLPLL 108
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ H DL NIL+D + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 12/181 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKL-DCATQDAGREFE-NEVDLLSNIHHP 207
+ F ++GEG +G V K + + VA+KK D + +E E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V L ++V+E +E L++ P+ +R I + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYI-YQLIKAIHWCH 117
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
++ ++HRD+K N+L+ KL DFG A +++GS N N + T Y +PE L
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELL 173
Query: 326 L 326
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCLL- 213
+G G +G V A VA+KKL Q A R + E+ LL ++ H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 214 ----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
S + F Y +M D+Q G L+ + GL+Y+H
Sbjct: 82 VFTSAVSGDEFQDF--YLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHS- 135
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLL 326
+IHRDLK N+ ++ K+ DFGLA + +++G T Y APE +L
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVIL 187
Query: 327 DGM 329
+ M
Sbjct: 188 NWM 190
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 61/189 (32%), Positives = 87/189 (46%), Gaps = 26/189 (13%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNL--HVAVKKLDCATQD---AGREFENEVDLLSNIHHP 207
+ + +G G G V A D L +VAVKKL Q+ A R + E+ LL ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 208 NVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTA 260
N++ LL + ++V ELM+ + +H H RM L
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-IHMELD------HERMSYLLYQML 133
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
G+++LH + +IHRDLK SNI++ S K+ DFGLA T N T Y
Sbjct: 134 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 189
Query: 321 APEYLLDGM 329
APE +L GM
Sbjct: 190 APEVIL-GM 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 19/90 (21%)
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----------I 301
RM A +T LEYLH N ++HRDLK N+L+ S + KL+DFGL+ +
Sbjct: 104 RMYFA-ETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 302 TDGSQNKN-----NLKLSGTLGYVAPEYLL 326
+G K+ + ++ GT Y+APE +L
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 25/71 (35%), Positives = 41/71 (57%), Gaps = 3/71 (4%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
A + A GL +LH + +I+RDLK N++LD++ + K++DFG+ + K G
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 316 TLGYVAPEYLL 326
T Y+APE +
Sbjct: 164 TPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 52/206 (25%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
YK+L K +GEG F V KA+ + A+K + + +V+ L
Sbjct: 1 YKILGK----------IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-----EQVNNL 45
Query: 202 SNI-------HHPNVVCLLGYSAHDDTR----FI-------VYELMENRSLDIQLHGPSH 243
I HPN++ L+ D + +YEL++ R P
Sbjct: 46 REIQALRRLSPHPNILRLIEV-LFDRKTGRLALVFELMDMNLYELIKGR------KRPLP 98
Query: 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303
+ +M + + L+++H + + HRD+K NIL+ KL+DFG
Sbjct: 99 EKRVKSYMYQLL-----KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGI 149
Query: 304 GSQNKNNLKLSGTLGYVAPEYLL-DG 328
S+ +S T Y APE LL DG
Sbjct: 150 YSKPPYTEYIS-TRWYRAPECLLTDG 174
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 162 GGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
G FG VY + +N + VKK D ++ + + E D L+ P +V L YS
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWH------MRMKIALDTARGLEYLHEHCN 271
VY +ME L G S L + M +K + A L+YLH H
Sbjct: 74 QSANN--VYLVME------YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH-- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+IHRDLK N+L+ ++ + KL+DFGL+
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 28/183 (15%)
Query: 159 LGEGGFGCVYKAKLD--DNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCLL 213
+G G FG V+ D D VA+KK+ Q+ R F E+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVT-DPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 214 G--YSAHDD---TRFIVYELMENRSLDIQLH----GPSHGSALTWHMRMKIALDTARGLE 264
H D ++V ELM++ LH P S+ H+++ RGL+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-----DLHKIIVSPQPLSSD--HVKV-FLYQILRGLK 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
YLH + ++HRD+K N+L++S K+ DFGLA + + ++K+ + T Y APE
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 324 YLL 326
L+
Sbjct: 175 ILM 177
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 44/153 (28%), Positives = 59/153 (38%), Gaps = 36/153 (23%)
Query: 191 GREFENEVDLLSNIHH------------PNVVCL-LGYSAHDDTRFIVYELMENRSLDIQ 237
G+ E+D+L I H + VC+ + D F + L+
Sbjct: 130 GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLE-- 185
Query: 238 LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
A+T R+ A L YLH +IHRD+K+ NI LD NA L DF
Sbjct: 186 -------QAITIQRRLLEA------LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229
Query: 298 GLA--ITDGSQNKNNLKLSGTLGYVAPEYL-LD 327
G A + SGTL +PE L LD
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALD 262
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 13/92 (14%)
Query: 244 GSALTWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
G L +HM+ K+ + AR L +LHE +I+RDLK N+LLD++ + K
Sbjct: 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIK 136
Query: 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
L+D+G+ GT Y+APE L
Sbjct: 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
L++LH+ +I+RD+K NILLDS+ + L+DFGL+ + + GT+ Y+
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY-SFCGTIEYM 173
Query: 321 APE 323
APE
Sbjct: 174 APE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 146 LEKATDSFHESNILGEGGF--GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN 203
+EKA S E+ G GF C+ + HV +K A Q G E +L
Sbjct: 89 IEKAGFSILETFTPGAEGFAFACIDNKTCE---HVVIK----AGQRGGTA--TEAHILRA 139
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
I+HP+++ L G ++ ++ + D+ + + + + + I R +
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIERSVLRAI 195
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQNKNNLKLSGTLGYVA 321
+YLHE+ +IHRD+K+ NI ++ + L DFG A D + NK +GT+ A
Sbjct: 196 QYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIATNA 251
Query: 322 PEYL 325
PE L
Sbjct: 252 PELL 255
|
Length = 391 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 154 HESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPN 208
+E +G G +G VYKAK D A+K+++ + A RE + LL + HPN
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPN 59
Query: 209 VVCLLG-YSAHDDTR-FIVYELMENRSLDI-QLHGPSHGSA----LTWHMRMKIALDTAR 261
V+ L + +H D + +++++ E+ I + H S + L M +
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAITDGSQNKNNLKLSG-- 315
G+ YLH + V+HRDLK +NIL+ + K++D G A S K L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 316 -TLGYVAPEYLL 326
T Y APE LL
Sbjct: 177 VTFWYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 3/68 (4%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
A + + GL +LH +I+RDLK N++LDS+ + K++DFG+ G
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
Query: 316 TLGYVAPE 323
T Y+APE
Sbjct: 164 TPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 53/178 (29%), Positives = 74/178 (41%), Gaps = 18/178 (10%)
Query: 158 ILGEGGFGCVY----KAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
+LG+G FG V KA +KK +D E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
YS R V E + L L S + + L+YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLH---SG 114
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+++RDLK N++LD + K++DFGL ITD + K GT Y+APE L D
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAPEVLED 169
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 25/156 (16%)
Query: 159 LGEGGFGCVYKAKLDDNLHVA---VKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V + + A VK+L AT D F EV ++HPNV+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 215 YSAHDDTRFIVYE----------LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+V E L NR + Q+ + ++A + A GL
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--------VLQRMACEVASGLL 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+LH+ IH DL N L + + K+ D+GLA
Sbjct: 115 WLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 19/148 (12%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKK--LDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ + K K + L VAVKK LD +++ + + E+ + HPN++ +
Sbjct: 9 CFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 216 SAHDDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIAL---DTARGLEYLH-EH 269
D ++V LM + ++ H P L IA D L+Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA------IAFILKDVLNALDYIHSKG 121
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDF 297
IHR +K+S+ILL LS
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 28/71 (39%), Positives = 42/71 (59%), Gaps = 9/71 (12%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLK 312
A + A GL +LH + +I+RDLK N++LDS+ + K++DFG+ + DG K
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--- 160
Query: 313 LSGTLGYVAPE 323
GT Y+APE
Sbjct: 161 FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 13/93 (13%)
Query: 243 HGSALTWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
+G L +HM+ K+ + AR L +LHE +I+RDLK N+LLD+ +
Sbjct: 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHI 135
Query: 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
KL+D+G+ GT Y+APE L
Sbjct: 136 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 26/192 (13%)
Query: 154 HESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPN 208
+E +G G +G VYKAK D + A+K+++ + A RE + LL + HPN
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPN 59
Query: 209 VVCLLG-YSAHDDTR-FIVYELMENRSLDI-QLHGPSHGSA----LTWHMRMKIALDTAR 261
V+ L + +H D + +++++ E+ I + H S + L M +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAITDGSQNKNNLKLSG-- 315
G+ YLH + V+HRDLK +NIL+ + K++D G A S K L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 316 -TLGYVAPEYLL 326
T Y APE LL
Sbjct: 177 VTFWYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 53/187 (28%), Positives = 78/187 (41%), Gaps = 37/187 (19%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKL--DCATQDAGRE---FENEVDLLS--NIHHPNV 209
+LG+G FG V A+L + AVK L D D E E V L+ N ++
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR-------- 261
C H F V E + +G L +H++ K D R
Sbjct: 62 YCTFQTKEH---LFFVMEFL-------------NGGDLMFHIQDKGRFDLYRATFYAAEI 105
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
GL++LH +I+RDLK N++LD + K++DFG+ + + GT Y
Sbjct: 106 VCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDY 162
Query: 320 VAPEYLL 326
+APE L
Sbjct: 163 IAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 127 SVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKA--KLDDNLHVAVKKLD 184
++++ KK S + + + + F+ LG G FG V A K +D VA+K+ +
Sbjct: 6 NLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 185 CATQDAGREFE---NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGP 241
+ ++ + +E +L+ I+HP V L G + ++V E +
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG---------- 115
Query: 242 SHGSALTWHMRMK---------IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
G T+ R K A EYL + +++RDLK N+LLD
Sbjct: 116 --GEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI 170
Query: 293 KLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
K++DFG A + D L GT Y+APE LL+
Sbjct: 171 KMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLN 202
|
Length = 340 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 28/154 (18%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V K+D N A+K L D ++ + E D+L+ + VV L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR--------GLEY 265
YS D +Y +M+ + P G ++ +R+ I D AR +E
Sbjct: 68 YSFQDKDN--LYFVMD--------YIPG-GDMMSLLIRLGIFEEDLARFYIAELTCAIES 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+H IHRD+K NIL+D + KL+DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 50/221 (22%), Positives = 79/221 (35%), Gaps = 67/221 (30%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLD--CATQDAG-REFENEVDLLSNIHH 206
F + +LG+G G V+ +L + A+K LD + + E ++L+ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELME-------NRSLDIQLHGPSHGSALTWHMRMKIALDT 259
P + L A T + +M+ R L Q ++ +
Sbjct: 61 PFLPTLY---ASFQTETYLCLVMDYCPGGELFRLLQRQPGK-------------CLSEEV 104
Query: 260 AR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--------- 302
AR LEYLH +++RDLK NILL + LSDF L+
Sbjct: 105 ARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 303 ----DGSQNKNNLKLS----------------GTLGYVAPE 323
GS+ + + GT Y+APE
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 26/62 (41%), Positives = 39/62 (62%), Gaps = 4/62 (6%)
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-NLKLSGTLGYVA 321
LE+LH+ +++RD+K NILLDS+ + L+DFGL+ S+ K GT+ Y+A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 322 PE 323
PE
Sbjct: 175 PE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 30/163 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V + D H+ ++K D ++ E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--------- 257
VV + Y + R+L + + G +T M+ K L
Sbjct: 61 AWVVKMF------------YSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYI 107
Query: 258 -DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+T ++ +H+ IHRD+K N+LLD+K + KLSDFGL
Sbjct: 108 AETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 12/154 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHH 206
+ F ++G G FG V + D HV ++K D ++ E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
VV + YS D +++ E + + L LT +T ++
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDS 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+H+ IHRD+K N+LLDSK + KLSDFGL
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 26/70 (37%), Positives = 40/70 (57%), Gaps = 8/70 (11%)
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLG 318
LE+LH+ +I+RD+K NILLDS + L+DFGL+ D + + GT+
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVERAYSFCGTIE 171
Query: 319 YVAPEYLLDG 328
Y+AP+ + G
Sbjct: 172 YMAPDIVRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 159 LGEGGFGCVYKAKLDD-----NLH---VAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LG+G F ++K + LH V +K LD + ++ F ++S + H ++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
G D +V E ++ SLD L + ++W ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 271 NPAVIHRDLKSSNILL----DSKFNA----KLSDFGLAIT 302
+ H ++ + N+LL D K KLSD G++IT
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 159 LGEGGFGCVYKAKL----DDN---------LHVAVKKLDCATQDAGREFENEVDLLSNIH 205
LG G +Y L DD + V +K LD + +D F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
H ++V L G D +V E +E LD+ +H S LT + K+A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 266 LHEHCNPAVIHRDLKSSNILL-----DSKFNA--KLSDFGLAIT 302
L + ++H ++ + NILL D + KLSD G+ IT
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 48/199 (24%)
Query: 151 DSFHESNILGEGGFGCV-----------YKAKLDDNLHVAVKKLDCATQDAGREFENEVD 199
+ F ++G G FG V Y KL + +K+ D A F E D
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF------FWEERD 95
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL-------DIQLHGPSHGSALTWHM 251
++++ + +V L Y+ DD ++V E M L DI A +
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-----PEKWARFYTA 149
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311
+ +ALD + + IHRD+K N+LLD + KL+DFG + + N +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGM 197
Query: 312 KLS----GTLGYVAPEYLL 326
GT Y++PE L
Sbjct: 198 VRCDTAVGTPDYISPEVLK 216
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/147 (25%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 186 ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS 245
A A + ENE+ L ++H N++ + R M + D L+ +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENIL-----KIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 246 ALTWHMR------MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
A W R I +EY+H+ +IHRD+K NI L+ L DFG
Sbjct: 257 AFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 300 AIT-DGSQNKNNLKLSGTLGYVAPEYL 325
A+ + + + GT+ +PE L
Sbjct: 314 AMPFEKEREAFDYGWVGTVATNSPEIL 340
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 24/187 (12%)
Query: 151 DSFHESNILGEGGFGCVY----KAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
F +++G G FG V KA D +KK Q+ FE E D+LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENR------SLDIQLHGPSHGSALTWHM-RMKIALDT 259
P + L Y+ D +Y +ME + SL + +++ + +A+ +
Sbjct: 61 PWIPQLQ-YAFQDKDN--LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-GTLG 318
+ Y +HRD+K N+L+D + KL+DFG A + N KL GT
Sbjct: 118 VHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 319 YVAPEYL 325
Y+APE L
Sbjct: 169 YIAPEVL 175
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 38/148 (25%), Positives = 61/148 (41%), Gaps = 9/148 (6%)
Query: 159 LGEGGFGCVYKAKLDDNL---HVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V +++ V VK+L A+ +F E ++ H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTARGLEYLHEHCNP 272
+V E L L +T ++A + A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IH DL N LL + K+ D+GL+
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 23/52 (44%), Positives = 31/52 (59%), Gaps = 2/52 (3%)
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLGYVAPE 323
+IHRD+KS+NILL S KL DFG + + +++ GT YVAPE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 14/96 (14%)
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL----DIQLHGPSHGSALTWHMRMKIALDTARG 262
PN+VCL Y +D+ F+V + E L L+ P W M +ALD
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-EECVKRWAAEMVVALDA--- 100
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
LH ++ RDL +NILLD + + +L+ F
Sbjct: 101 ---LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 5/46 (10%)
Query: 256 ALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ ARG+E+L C IHRDL + NILL K+ DFGLA
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLA 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 14/76 (18%)
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI---TDGSQNKN 309
M +A+D+ L Y +HRD+K N+LLD + +L+DFG + DG+ N
Sbjct: 111 MVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161
Query: 310 NLKLSGTLGYVAPEYL 325
GT Y++PE L
Sbjct: 162 --VAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 27/80 (33%), Positives = 46/80 (57%), Gaps = 11/80 (13%)
Query: 253 MKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQN-- 307
++ + A+G+++L ++C IHRD+ + N+LL AK+ DFGLA I + S
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 308 KNNLKLSGTLGYVAPEYLLD 327
K N +L + ++APE + D
Sbjct: 271 KGNARLP--VKWMAPESIFD 288
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 11/77 (14%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-----KNN 310
+ ARG+E+L + IHRDL + NILL K+ DFGLA D ++ K +
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPDYVRKGS 235
Query: 311 LKLSGTLGYVAPEYLLD 327
+L L ++APE + D
Sbjct: 236 ARLP--LKWMAPESIFD 250
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENEVDLLSNIHH 206
+ F ++G G FG V KL + V K+ + R F E D+L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTAR 261
+ L Y+ D+ ++V + L L A + M IA+D+
Sbjct: 61 -QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG--LAITDGSQNKNNLKLSGTLGY 319
L Y +HRD+K NIL+D + +L+DFG L + + ++++ + GT Y
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 169
Query: 320 VAPEYL 325
++PE L
Sbjct: 170 ISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 176 LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235
L V +K LD + +D F L+S + H ++ + G +V E +E+ LD
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--- 292
+ L + W ++ +A A L YL + ++H ++ + NILL A
Sbjct: 105 VCLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGT 159
Query: 293 ----KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
KLSD G++ T S+ + ++ ++APE + G
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIP----WIAPECVPGG 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 51/192 (26%), Positives = 79/192 (41%), Gaps = 26/192 (13%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENEVDLL 201
L + + ++G G FG V + V KL + R F E D++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 202 SNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQL---HGPSHGSALTWHMRMKIAL 257
+ + P VV L Y+ DD ++V E M L + L + A + + +AL
Sbjct: 98 AFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL----KL 313
D + + IHRD+K N+LLD + KL+DFG + NK +
Sbjct: 156 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTA 203
Query: 314 SGTLGYVAPEYL 325
GT Y++PE L
Sbjct: 204 VGTPDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 20/155 (12%)
Query: 159 LGEGGFGCVYKAKLDDNLHVA---VKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V +++ + VA VK+L A+ EF + D + HPN++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR-------MKIALDTARGLEYLH 267
+V+E E L S+ S WH R ++A + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLK------SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302
+H +H DL N L S K+ D+G+ +
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 18/192 (9%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENE 197
+ + L+ + + ++G G FG V + + V KL + R F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL---HGPSHGSALTWHMRMK 254
D+++ + P VV L D ++V E M L + L + A + +
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVV 152
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI-TDGSQNKNNLKL 313
+ALD + +IHRD+K N+LLD + KL+DFG + D +
Sbjct: 153 LALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 314 SGTLGYVAPEYL 325
GT Y++PE L
Sbjct: 204 VGTPDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 15/82 (18%)
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG--LAITDGSQNKNN 310
M +A+ + L Y +HRD+K N+LLD + +L+DFG L + +++
Sbjct: 111 MVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161
Query: 311 LKLSGTLGYVAPEYLL---DGM 329
+ + GT Y++PE L DGM
Sbjct: 162 VAV-GTPDYISPEILQAMEDGM 182
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 7/75 (9%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
+ A+G+E+L + IHRDL + NILL K+ DFGLA D ++ + ++
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPDYVRKGD 240
Query: 316 T---LGYVAPEYLLD 327
L ++APE + D
Sbjct: 241 ARLPLKWMAPETIFD 255
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
L G GCV+++ D V K +E LL + HP V+ LL
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASSV-----HEARLLRRLSHPAVLALLDVRVV 231
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+V L + RS D+ + + L +A ++Y+H +IHRD
Sbjct: 232 GGLTCLV--LPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRD 285
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKN-NLKLSGTLGYVAPEYL 325
+K+ N+L++ + L DFG A GS + + ++GT+ APE L
Sbjct: 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334
|
Length = 461 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 48/197 (24%), Positives = 74/197 (37%), Gaps = 51/197 (25%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFEN--------EVDLLSNIHHPNV 209
++G GGFGCVY+ + + C A + EN E + +NI+ +
Sbjct: 19 LIGCGGFGCVYETQCASD--------HCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70
Query: 210 VCL-----------------LGYSAHDDT--RFIVYELMENRSLDIQLHGPSHGSALTWH 250
+ L G RFI+ E + + +I L
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI-- 128
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDG--- 304
I D LEY+HEH + H D+K NI++D + D+G+A I G
Sbjct: 129 --KNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 305 --SQNKNNLKLSGTLGY 319
S+ + +L GTL Y
Sbjct: 184 EYSKEQKDLH-RGTLYY 199
|
Length = 294 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPN 208
F + LG G FG V A K+D A+K L D ++ + E D+L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 209 VVCLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR----- 261
VV L YS D D + V + + G ++ +RM I D AR
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPG------------GDMMSLLIRMGIFPEDLARFYIAE 109
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+E +H+ IHRD+K NIL+D + KL+DFGL
Sbjct: 110 LTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 11/69 (15%)
Query: 260 ARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQN--KNNLKLS 314
A+G+ +L ++C IHRDL + NILL K+ DFGLA I + S K N +L
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 315 GTLGYVAPE 323
+ ++APE
Sbjct: 280 --VKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.86 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.55 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.44 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.43 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.29 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.28 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.67 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.11 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.88 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.87 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.8 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.56 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.41 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.31 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.87 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 95.79 | |
| PF06679 | 163 | DUF1180: Protein of unknown function (DUF1180); In | 95.74 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.47 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.38 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.32 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=339.83 Aligned_cols=194 Identities=52% Similarity=0.847 Sum_probs=171.3
Q ss_pred ccccccHHHHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeE
Q 020072 137 AISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216 (331)
Q Consensus 137 ~~~~~~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 216 (331)
....++++++..+|++|...++||+|+||.||+|.+++|..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678899999999999999999999999999999999999999988765443156699999999999999999999999
Q ss_pred EcCC-eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEE
Q 020072 217 AHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (331)
Q Consensus 217 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 295 (331)
.+.+ ..+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.++|+|||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999975443 89999999999999999999999999999999999999999999999999
Q ss_pred eccCceeCCCCCccccee-ccccCCccccccccCCCC
Q 020072 296 DFGLAITDGSQNKNNLKL-SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 296 Dfgla~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~t 331 (331)
|||+|+............ .||.+|+|||++..|.+|
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt 256 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLT 256 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcC
Confidence 999996654311111122 799999999999888764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=301.03 Aligned_cols=175 Identities=29% Similarity=0.431 Sum_probs=155.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..+|...+.||+|+||+||+|+.+ ++..||||.+... .+...+.+..|+.+|+.++|||||+|+++++.++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356777888999999999999875 5799999999766 4556677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC------CcEEEEeccCc
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK------FNAKLSDFGLA 300 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~------~~~kl~Dfgla 300 (331)
|||++|+|.+|++.. +.+++.....++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999753 4699999999999999999999999 99999999999999864 46899999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+...... ...+.+|++.|||||+++.++||
T Consensus 163 R~L~~~~-~a~tlcGSplYMAPEV~~~~~Yd 192 (429)
T KOG0595|consen 163 RFLQPGS-MAETLCGSPLYMAPEVIMSQQYD 192 (429)
T ss_pred hhCCchh-HHHHhhCCccccCHHHHHhcccc
Confidence 9876433 33467999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=292.46 Aligned_cols=174 Identities=39% Similarity=0.582 Sum_probs=149.8
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-eEEEEEEecC
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYELME 230 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 230 (331)
...+.+|+|+||+||+|.++....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 335569999999999999986656999999754322 2568999999999999999999999999988 7999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc-eEecCCCCCCEEECCCC-cEEEEeccCceeCCCCCc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA-VIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 308 (331)
+|+|..++++. ....+++..+++++.|||+||.|||++ + |||||||++|||++.++ .+||+|||+++.......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 99999999863 456899999999999999999999998 6 99999999999999998 999999999977654322
Q ss_pred ccceeccccCCccccccc--cCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLL--DGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~--~~~~t 331 (331)
......||+.|||||++. ...||
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~ 224 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYT 224 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCC
Confidence 223357999999999999 44654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=290.72 Aligned_cols=173 Identities=32% Similarity=0.485 Sum_probs=157.8
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..|...++||+|||+.||+++. ++|..||+|++... .....+.+.+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999987 88999999999653 3445567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
|+|++|+|..++. ..+++++.++..+++||+.||.|||++ +|+|||||..|++|++++++||+|||||.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999885 456899999999999999999999999 9999999999999999999999999999888777
Q ss_pred CcccceeccccCCccccccccCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.....+.|||+.|+|||++...-
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~g 194 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSG 194 (592)
T ss_pred ccccceecCCCcccChhHhccCC
Confidence 66677889999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.48 Aligned_cols=175 Identities=31% Similarity=0.463 Sum_probs=151.0
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCc-------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQ-------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
..+.|...+.||+|+||.|-+|.. ++|+.||||.+..... ......++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456778889999999999999964 5799999999964321 12344689999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEEEec
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDF 297 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Df 297 (331)
..||||||+++|+|.+.+-. .+.+.+.....++.|++.|+.|||++ +|+||||||+|||++.+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998853 45688888899999999999999999 99999999999999866 77999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|+|+..+.. ....+.|||+.|.|||++.++-+
T Consensus 324 GlAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~ 355 (475)
T KOG0615|consen 324 GLAKVSGEG-SFMKTLCGTPSYVAPEVLASKGV 355 (475)
T ss_pred chhhccccc-eehhhhcCCccccChhheecCCe
Confidence 999888743 33456899999999999987643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.18 Aligned_cols=176 Identities=30% Similarity=0.436 Sum_probs=157.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..++||+|+||+||.++. ++++.+|+|++++. .....+...+|..+|.+++||+||+++..+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46888999999999999999975 46889999999654 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||+.||.|..+|++ ...+++..+..++.+|+.||.|||++ +||||||||+|||||++|.++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999963 45689999999999999999999999 999999999999999999999999999986655
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+++||+.|||||++.+..|+
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~ 203 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYD 203 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCC
Confidence 55555568999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=300.31 Aligned_cols=182 Identities=34% Similarity=0.508 Sum_probs=156.2
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
+..+.+....+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++++.++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344555666788999999999999753 4578999999877665 778999999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCC-------CCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPS-------HGS----ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~ 288 (331)
+..|||+|||..|||.++|.... .+. +|+..+.+.||.|||.||+||-++ .+|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999986421 122 389999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeccCceeCCCCCcccce--eccccCCccccccccCCCC
Q 020072 289 KFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 289 ~~~~kl~Dfgla~~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~t 331 (331)
+..+||+||||++..-..+++... ..-..+||+||.|+-|+||
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT 683 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT 683 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence 999999999999876655554321 2346799999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=273.03 Aligned_cols=171 Identities=29% Similarity=0.391 Sum_probs=150.9
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-eEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~ 229 (331)
++..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||.++|.|..+. ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 334778999999999999886 5788999999544 4456688999999999999999999999999998 599999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++|+|++.+.. .+.+++...-+|+.+|++||.|||+ + +||||||||+|+|++..|++||||||.+......
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999998853 3569999999999999999999996 6 9999999999999999999999999999766544
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...+++||..|||||.+.++.|+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys 255 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYS 255 (364)
T ss_pred hcccccccccccChhhhcCCcCC
Confidence 23356899999999999999885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.46 Aligned_cols=167 Identities=35% Similarity=0.565 Sum_probs=140.7
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCcceeeeeeEEcCC----eEEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHDD----TRFIVYE 227 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e 227 (331)
...++||+|+||.||||++. ++.||||++.. +..+.|++|-++.+. ++|+||++++++.+..+ +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34678999999999999996 48999999963 345667777766654 58999999999988766 8999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
|.++|+|.++|.. ..++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999953 4699999999999999999999964 46789999999999999999999999999996
Q ss_pred eCCCCC--cccceeccccCCccccccccC
Q 020072 302 TDGSQN--KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.+.... ......+||.+|||||++.+.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 654322 222335799999999999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=281.08 Aligned_cols=173 Identities=31% Similarity=0.429 Sum_probs=151.4
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
...+.||+|.||.||.|+++....||+|.++.... ..++|.+|+++|++|+|+|||+++|+|..++.+|||||||++|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34678999999999999999888999999976533 44678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc-e
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL-K 312 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~ 312 (331)
|.++|+. ..+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||||+..+++..... .
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 9999986 3567799999999999999999999999 999999999999999999999999999995544433221 1
Q ss_pred eccccCCccccccccCCCC
Q 020072 313 LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~t 331 (331)
..-+..|.|||.+..++||
T Consensus 364 ~kfPIkWtAPEa~~~~~FS 382 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFS 382 (468)
T ss_pred CCCCceecCHHHHhhCCcc
Confidence 2236789999999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=265.50 Aligned_cols=181 Identities=29% Similarity=0.396 Sum_probs=155.4
Q ss_pred cCCcccceeeecCceEEEEEE-ECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeee-EEcCCe-EEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGY-SAHDDT-RFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~-~~~~~~-~~lv 225 (331)
.+|++.+.||+|.||+||++. ..+|..||.|.+.-. +....++...|+.+|++|+|||||++++. +.++++ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456678899999999999996 568999999988633 44566789999999999999999999984 444444 8999
Q ss_pred EEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC-ceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 226 YELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNP-AVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
||||+.|+|...++. +.....++++.+|++..|+++||..+|+.... .++||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988865 23445689999999999999999999994221 3999999999999999999999999999998
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........+.+|||.||+||.+.+..|+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~ 206 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYN 206 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCC
Confidence 8777777778999999999999999885
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=253.39 Aligned_cols=173 Identities=29% Similarity=0.379 Sum_probs=154.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||.|+||+|.+++.+ +|.-+|+|+++... ....+...+|..+|+.+.||+++++++.+.+.+..|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357778999999999999999875 57889999997553 23445678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|.|..+|++ ...+++..+..+|.||+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999964 45699999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ..+.|||+.|+|||.++...|+
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~yn 219 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYN 219 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCC
Confidence 3 4578999999999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=266.19 Aligned_cols=185 Identities=30% Similarity=0.441 Sum_probs=147.0
Q ss_pred ecCCCccccccHHHHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHh--cCCCCcc
Q 020072 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLS--NIHHPNV 209 (331)
Q Consensus 132 ~~~~~~~~~~~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~H~ni 209 (331)
++.|++.+..-... ...+....+.||+|.||.||+|+++ |+.||||++...+ .+.+.+|.++.+ .|+|+||
T Consensus 195 SGSGSGlplLVQRT---iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRT---IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred CCCCCCchhHhHHh---hhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchh
Confidence 44455555443332 3446677899999999999999996 7799999996443 344556666655 4699999
Q ss_pred eeeeeeEEcCC----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCceEecCCC
Q 020072 210 VCLLGYSAHDD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-----HCNPAVIHRDLK 280 (331)
Q Consensus 210 v~l~g~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivHrdlk 280 (331)
+.+++.-..++ .+|||+||.++|||+|||.+ ..++.+..++++..+|+||++||. +.+|.|.|||||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 99998866543 68999999999999999964 569999999999999999999994 457899999999
Q ss_pred CCCEEECCCCcEEEEeccCceeCCCCC----cccceeccccCCcccccccc
Q 020072 281 SSNILLDSKFNAKLSDFGLAITDGSQN----KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 281 ~~Nill~~~~~~kl~Dfgla~~~~~~~----~~~~~~~gt~~y~aPE~l~~ 327 (331)
+.|||+.+++.+.|+|+|||....... ......+||.+|||||++-+
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 999999999999999999996543321 12234579999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.65 Aligned_cols=181 Identities=30% Similarity=0.439 Sum_probs=155.5
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
|.+.+.....+.||+|-||.|.++..+.+..||||+++.... ...++|.+|+.+|.+++||||+.|+|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 445566677899999999999999999889999999986544 4558999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+|||++|+|..++.... ...+......+|+.||+.||+||.+. ++|||||.++|||++.++++||+|||+++..-.
T Consensus 614 ~EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999997421 12245667789999999999999998 999999999999999999999999999986554
Q ss_pred CCcccc--eeccccCCccccccccCCCC
Q 020072 306 QNKNNL--KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~--~~~gt~~y~aPE~l~~~~~t 331 (331)
.+.... ..+-+.+|||||.+..|+||
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFt 717 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFT 717 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhcccc
Confidence 443322 23457899999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=257.27 Aligned_cols=170 Identities=25% Similarity=0.364 Sum_probs=147.1
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.|+...++|+|+||.||+++.+ +|+.||||++.... +...+-.++|+.+|++++|+|+|.|+.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999876 58999999996543 33445678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
|+..-|.+.=+ ....++.+...+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.......
T Consensus 83 ~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 99876665432 334588899999999999999999999 999999999999999999999999999988775444
Q ss_pred ccceeccccCCcccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~ 327 (331)
.....+.|.+|.|||.+.+
T Consensus 157 ~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVG 175 (396)
T ss_pred hhhhhhhhhhccChhhhcc
Confidence 4456678999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=268.78 Aligned_cols=173 Identities=33% Similarity=0.455 Sum_probs=147.6
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 224 (331)
.+.|+..+.||+|.||.||+|+. .+|+.||+|++.... ........+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677788899999999999974 579999999997654 34456678999999999999999999998776 68999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|+|||++ +|.-++. ..+-.+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+...
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999985 6666665 3355799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcc-cceeccccCCccccccccC
Q 020072 305 SQNKN-NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~~-~~~~~gt~~y~aPE~l~~~ 328 (331)
..... ....+-|++|.|||.+++.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCC
Confidence 44432 3345679999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.40 Aligned_cols=176 Identities=28% Similarity=0.460 Sum_probs=152.1
Q ss_pred cCCcccceeeecCceEEEEEEEC----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
....+.++||.|.||.|++|+++ ....||||.++... +...++|+.|..+|.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567899999999999999875 24679999998654 44567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
.|||+||+|+.+|+. +...+++-+...++++||.||.||.+. ++|||||.++|||++.+..+|++|||+++...+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999984 445699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc-ccee--ccccCCccccccccCCCC
Q 020072 306 QNKN-NLKL--SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~-~~~~--~gt~~y~aPE~l~~~~~t 331 (331)
+... .... .-+.+|.|||.|.-++||
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFT 812 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFT 812 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccC
Confidence 4321 1111 125799999999988876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.68 Aligned_cols=181 Identities=33% Similarity=0.495 Sum_probs=152.5
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECC--C--ce-EEEEEecc---cCchhHHHHHHHHHHHhcCCCCcceeeeeeEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDD--N--LH-VAVKKLDC---ATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
++...++....+.||+|+||.||+|++.. + .. ||||..+. .......+|++|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44445566667899999999999998643 2 23 89999874 34667889999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
....+|+|||+|.||+|.++|.. ....++..++++++.+.|+||+|||++ +++||||.++|||++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999974 334699999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||++.............-+.+|+|||.+..+.||
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccc
Confidence 9986654222111111356799999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.83 Aligned_cols=174 Identities=31% Similarity=0.459 Sum_probs=157.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|...+.||+|.||.||||+.+ +.+.||+|.+++.. +.+.+.+.+|++++++++||||+.++++|+....+|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999765 57899999997553 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+.+ +|..+|. ....++++.+..++.|++.||.|||++ +|+|||+||+|||++.++.+|+||||+|+..+...
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9986 9999995 446799999999999999999999999 99999999999999999999999999998877766
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+.||+.|||||.+.++.|+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd 178 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYD 178 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCcc
Confidence 666677899999999999999885
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=243.67 Aligned_cols=173 Identities=33% Similarity=0.499 Sum_probs=151.4
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|...+.+|+|.||.||+|+. ++|+.||||+++..... ......+|+..|+.++|+||+.+++++-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566778899999999999975 57899999999754322 23567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
||+ .+|...++. +...++..+...++.++.+|++|||++ .|+||||||.|+|++++|.+||+|||+|+..+...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 688888864 456799999999999999999999999 99999999999999999999999999999988766
Q ss_pred cccceeccccCCccccccccCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
......+-|.+|.|||.+.+.+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSR 177 (318)
T ss_pred cccccceeeeeccChHHhccch
Confidence 6555557899999999997753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=263.08 Aligned_cols=177 Identities=29% Similarity=0.383 Sum_probs=153.4
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc----Cc-hhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA----TQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~ 221 (331)
..+.|...+.||+|.||+|+.|+. .++..||+|.++.. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788899999999999999975 46799999977543 11 23456778999999999 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLA 300 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla 300 (331)
.++||||+.+|+|.+++.. ...+.+.++.+++.|+++|++|||++ +|+||||||+|+|++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999964 46788999999999999999999999 99999999999999999 99999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCC-CC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGM-VN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~t 331 (331)
.............+||+.|+|||++.+.. |+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~ 200 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYS 200 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcC
Confidence 77632333344668999999999999876 64
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=251.74 Aligned_cols=172 Identities=33% Similarity=0.529 Sum_probs=146.8
Q ss_pred CCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC--eEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~ 228 (331)
++...+.||+|.||.||++...+ |...|||.....+....+.+.+|+.+|.+++|||||+++|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45567899999999999998754 8899999987654444677999999999999999999999855444 69999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCC--
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGS-- 305 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~-- 305 (331)
+++|+|.+++.+. +..+++..+.+++.||++||+|||++ +++||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999743 22799999999999999999999999 9999999999999999 79999999999865542
Q ss_pred -CCcccceeccccCCccccccccC
Q 020072 306 -QNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 306 -~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.........||+.|||||++.+|
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g 196 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNG 196 (313)
T ss_pred ccccccccccCCccccCchhhcCC
Confidence 22223356799999999999865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=256.41 Aligned_cols=175 Identities=24% Similarity=0.357 Sum_probs=155.4
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++... +++.-.+++|+++|+.|+||||+.++.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45677788999999999999975 679999999997553 44455688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||..+|.|++|+. ....|++.++..+++||..|+.|+|.+ +++|||||.+|||+|.|+++||+|||++.....
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999995 445799999999999999999999999 999999999999999999999999999966544
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .-.++||++-|.+||.+.+..|+
T Consensus 206 ~k-fLqTFCGSPLYASPEIvNG~PY~ 230 (668)
T KOG0611|consen 206 KK-FLQTFCGSPLYASPEIVNGTPYK 230 (668)
T ss_pred cc-HHHHhcCCcccCCccccCCCCCC
Confidence 33 33468999999999999998874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=240.53 Aligned_cols=177 Identities=28% Similarity=0.434 Sum_probs=155.7
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|+..+.||+|-||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578899999999999999999865 56789999985432 3345789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||..+|+++..|+. .....+++.....+..|+|.||.|+|.. .++||||||+|+|++.++..||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999975 2446688899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+.+||..|.+||+..+..+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd 200 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHD 200 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCcc
Confidence 3344567999999999999887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=262.84 Aligned_cols=174 Identities=30% Similarity=0.467 Sum_probs=157.2
Q ss_pred hcCCcccceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
...|..-..||+|+.|.||.|+ ..+++.||||+++...+...+-+.+|+.+|+..+|+|||+++..+...+++|.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3567777899999999999996 456889999999887777777899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
|++|+|.+.+. ...+++.+...|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++........
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999988874 34599999999999999999999999 999999999999999999999999999987766665
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
...+.+||+.|||||++....|
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y 446 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY 446 (550)
T ss_pred ccccccCCCCccchhhhhhccc
Confidence 6667899999999999998766
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=260.28 Aligned_cols=176 Identities=30% Similarity=0.395 Sum_probs=151.9
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
.-++|...+.||+|+|++|++|+. ++++++|||++.+. .+...+-+..|-++|.+| .||.|++|+..+.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346888999999999999999975 46899999999654 233345577899999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+|+||+++|+|.++++. .+.+++.....++.+|+.||+|||++ +||||||||+|||||+||.+||+|||-|+..
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999964 35699999999999999999999999 9999999999999999999999999999654
Q ss_pred CCCC-----------c--ccceeccccCCccccccccCCC
Q 020072 304 GSQN-----------K--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~-----------~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.+.. . ....++||..|.+||++.++..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~ 264 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA 264 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC
Confidence 3211 1 1145789999999999998865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.06 Aligned_cols=174 Identities=31% Similarity=0.422 Sum_probs=149.0
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCch-hHHHHHHHHHHHhcCC-CCcceeeeeeEEcCC-eEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQD-AGREFENEVDLLSNIH-HPNVVCLLGYSAHDD-TRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~-~~~lv 225 (331)
-++|...+.||.|.||.||+|+. ++|..||||+++..... +.-.-++|+..|++|+ ||||++|.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45777888999999999999975 46889999999755332 2223478999999998 999999999999988 99999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||||+ -+|+..+.++ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||....
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99997 5888888753 67899999999999999999999999 999999999999999999999999999988765
Q ss_pred CCcccceeccccCCcccccccc-CCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLD-GMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~-~~~ 330 (331)
..... ..+.|.+|+|||++.+ +-|
T Consensus 163 kpPYT-eYVSTRWYRAPEvLLrs~~Y 187 (538)
T KOG0661|consen 163 KPPYT-EYVSTRWYRAPEVLLRSGYY 187 (538)
T ss_pred CCCcc-hhhhcccccchHHhhhcccc
Confidence 55443 4568999999999854 444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=258.68 Aligned_cols=177 Identities=31% Similarity=0.504 Sum_probs=151.4
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
++++...+.+...+.||+|.||+||+|++.+ .||||.++.. +.+..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5667777777889999999999999999864 5999999765 34566889999999999999999999999998776
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.+|+.+|++.+|+.++|..+ ..++..+.+.||.|||.||.|||.+ +|||||||..||++.+++++||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999999643 6799999999999999999999999 99999999999999999999999999984
Q ss_pred eCCC--CCcccceeccccCCccccccccC
Q 020072 302 TDGS--QNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~--~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.... .........|...|||||++..+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmq 565 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQ 565 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhc
Confidence 3221 11122233578899999999754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=244.62 Aligned_cols=173 Identities=31% Similarity=0.471 Sum_probs=145.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCc-ceeeeeeEEcCC------e
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPN-VVCLLGYSAHDD------T 221 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~------~ 221 (331)
.|...+.||+|.||+||+|+.. +|+.||+|+++....+ ......+|+.++++|+|+| |++|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4455667999999999999764 6889999999755442 3455789999999999999 999999999877 7
Q ss_pred EEEEEEecCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
.++|+||++ -+|..++...... ..++...+..++.|+++||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999996 6888887653221 4577788999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+...-.........+|.+|.|||++.+.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs 195 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGS 195 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCC
Confidence 8766444434455789999999999887
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=280.65 Aligned_cols=179 Identities=32% Similarity=0.488 Sum_probs=152.8
Q ss_pred hcCCcccceeeecCceEEEEEEECC--C----ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD--N----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++.+..+.||+|.||.||.|...+ + ..||+|.+... +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4455567899999999999998653 3 34899999765 456678999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
++++|||++|+|..+|+..+ ....++..+.+.++.|||+|+.||+++ ++|||||.++||||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998642 145699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCccccee--ccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKL--SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~t 331 (331)
||++....+...... .-..+|||||.++++.||
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt 882 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT 882 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccc
Confidence 998654444333222 234699999999999886
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=242.95 Aligned_cols=173 Identities=34% Similarity=0.443 Sum_probs=148.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 225 (331)
++|+..+.|++|.||.||+|+++ +++.||+|+++..... -.-.-++||.+|.+.+|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45667889999999999999875 5789999999644321 123467999999999999999998887643 579999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||||+ -+|...+... .+++...+...++.|+++|++|||.+ -|+|||||++|+|++..|.+||+|||+|+..+.
T Consensus 156 Me~~E-hDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHH-hhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99998 4788888753 36799999999999999999999999 999999999999999999999999999999988
Q ss_pred CCcccceeccccCCccccccccCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
........+-|.+|.|||.+.+.+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~ 253 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAK 253 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCc
Confidence 877767778999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=253.08 Aligned_cols=146 Identities=29% Similarity=0.397 Sum_probs=134.1
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|+...+||+|+||.||+|+- ++|..+|+|++++.. ......++.|-.+|...++++||+|+..+.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 568899999999999999999975 468999999997653 3456678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
||||++||++..+|.. ...|++..+..++.+++.|++-||+. ++|||||||+|+|||..|.+||+||||+
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999963 45799999999999999999999999 9999999999999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=260.25 Aligned_cols=177 Identities=29% Similarity=0.415 Sum_probs=155.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
...++|...++||+|.||+|+++..+ +++.+|||.+++. ..++.+..+.|..++... +||.+++|+.++...+.+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999876 5788999999765 345566777888888777 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|.||||+.||++..+.+ ...+++..+..++..|+.||+|||++ +|||||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999544432 35699999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.-.......+++||+.|||||++.++.||
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt 546 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYT 546 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCccc
Confidence 76556677789999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=249.17 Aligned_cols=169 Identities=28% Similarity=0.329 Sum_probs=145.3
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
++||+|+||.||+++.. +|+.||+|++... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999998643 2334456889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccce
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99988853 34689999999999999999999999 9999999999999999999999999998754333333334
Q ss_pred eccccCCccccccccCCCC
Q 020072 313 LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~t 331 (331)
..||+.|+|||++.+..++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~ 173 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYG 173 (323)
T ss_pred eecCccccChhhhcCCCCC
Confidence 5799999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=248.10 Aligned_cols=174 Identities=30% Similarity=0.416 Sum_probs=144.6
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--------------hhHHHHHHHHHHHhcCCCCcceee
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------------DAGREFENEVDLLSNIHHPNVVCL 212 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l 212 (331)
+..++|+..+.||+|.||.|-+|... +++.||+|++.+... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578889999999999999999865 689999999953211 123578899999999999999999
Q ss_pred eeeEEcC--CeEEEEEEecCCCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 213 LGYSAHD--DTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 213 ~g~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
+.+..+. +.+|||+|||..|.+... ....+ +++.+++++++++..||+|||.+ +||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 589999999999988543 22334 99999999999999999999999 99999999999999999
Q ss_pred CcEEEEeccCceeCC-----CCCcccceeccccCCccccccccC
Q 020072 290 FNAKLSDFGLAITDG-----SQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 290 ~~~kl~Dfgla~~~~-----~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
|.+||+|||.+.... ..+..-....||+.|+|||...+|
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 999999999986552 222222335799999999999874
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=252.57 Aligned_cols=175 Identities=26% Similarity=0.346 Sum_probs=148.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999765 57899999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999863 35689999999999999999999999 9999999999999999999999999998643211
Q ss_pred Cc-----------------------------------ccceeccccCCccccccccCCCC
Q 020072 307 NK-----------------------------------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~-----------------------------------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....+||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 00 01134699999999999877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=248.11 Aligned_cols=169 Identities=28% Similarity=0.340 Sum_probs=144.7
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
+.||+|+||.||+++.. +|..||+|.+... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999998643 2334556788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccce
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99988853 34689999999999999999999999 9999999999999999999999999998654333222334
Q ss_pred eccccCCccccccccCCCC
Q 020072 313 LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~t 331 (331)
..|++.|+|||++.++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~ 173 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYG 173 (323)
T ss_pred ccCCcCcCCcccccCCCCC
Confidence 5689999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=247.24 Aligned_cols=169 Identities=27% Similarity=0.337 Sum_probs=144.9
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
++||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6889999998643 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccce
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
+|..++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99988853 34689999999999999999999999 9999999999999999999999999998654332222334
Q ss_pred eccccCCccccccccCCCC
Q 020072 313 LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~t 331 (331)
..||+.|+|||++.++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~ 173 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYG 173 (328)
T ss_pred ccCCcCccChhhhcCCCCC
Confidence 5789999999999876653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=248.12 Aligned_cols=172 Identities=27% Similarity=0.384 Sum_probs=149.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 5789999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999863 34688999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....|++.|+|||++.++.++
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~ 193 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHG 193 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCC
Confidence 2 234789999999999877653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=245.11 Aligned_cols=169 Identities=28% Similarity=0.331 Sum_probs=144.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
+.||+|+||.||+++.. ++..||+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999998643 2334466788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
+|..++.. ...+++..+..++.|++.||+|||+ . +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99988853 3468999999999999999999997 6 999999999999999999999999999875433322233
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYG 174 (325)
T ss_pred cccCCcccCCHHHHccCCCC
Confidence 45699999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=251.39 Aligned_cols=175 Identities=27% Similarity=0.373 Sum_probs=148.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999875 58899999996432 234456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999864 34689999999999999999999999 9999999999999999999999999998543211
Q ss_pred Cc--------------------------------------ccceeccccCCccccccccCCCC
Q 020072 307 NK--------------------------------------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~--------------------------------------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ......||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC
Confidence 00 00123589999999999877653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=249.93 Aligned_cols=180 Identities=30% Similarity=0.416 Sum_probs=146.0
Q ss_pred HhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCC
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 220 (331)
..++|+..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788899999999999999974 235689999986543 23456789999999999 8999999999887654
Q ss_pred -eEEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 020072 221 -TRFIVYELMENRSLDIQLHGPSH-------------------------------------------------------- 243 (331)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (331)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 68999999999999988864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccC
Q 020072 244 ---GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLG 318 (331)
Q Consensus 244 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~ 318 (331)
...+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....... ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13488899999999999999999999 999999999999999999999999999965432211 1112345678
Q ss_pred CccccccccCCCC
Q 020072 319 YVAPEYLLDGMVN 331 (331)
Q Consensus 319 y~aPE~l~~~~~t 331 (331)
|+|||++.++.++
T Consensus 242 y~aPE~~~~~~~~ 254 (338)
T cd05102 242 WMAPESIFDKVYT 254 (338)
T ss_pred ccCcHHhhcCCCC
Confidence 9999999877664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=251.31 Aligned_cols=145 Identities=27% Similarity=0.366 Sum_probs=130.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999764 6889999998543 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999853 35688999999999999999999999 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=248.53 Aligned_cols=172 Identities=28% Similarity=0.375 Sum_probs=148.3
Q ss_pred hcCCcccceeeecCceEEEEEEECC--CceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD--NLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|...+.||+|+||.||+|+..+ +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578889999999999999997543 368999998543 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999863 34689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccceeccccCCccccccccCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
... ....||+.|+|||++.+..+
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 183 TRT---YTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred CCc---ceecCChhhcCHHHHhCCCC
Confidence 322 24579999999999977654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=239.94 Aligned_cols=174 Identities=28% Similarity=0.380 Sum_probs=147.6
Q ss_pred CcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 153 FHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 468999999986432 22334678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|..++... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998877542 234689999999999999999999999 999999999999999999999999999976433222
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....|+..|+|||++.++.++
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYT 179 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCC
Confidence 1234689999999999887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=246.77 Aligned_cols=172 Identities=27% Similarity=0.343 Sum_probs=149.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 57899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999853 34689999999999999999999999 999999999999999999999999999965543
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......|++.|+|||++.++.++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~ 176 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYD 176 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCC
Confidence 12234689999999999877654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=244.09 Aligned_cols=171 Identities=26% Similarity=0.370 Sum_probs=148.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999875 68899999986432 234466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.....++.|++.||+|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999853 34689999999999999999999999 9999999999999999999999999998655332
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
. ....|++.|+|||++.+..+
T Consensus 155 ~---~~~~gt~~y~aPE~~~~~~~ 175 (291)
T cd05612 155 T---WTLCGTPEYLAPEVIQSKGH 175 (291)
T ss_pred c---ccccCChhhcCHHHHcCCCC
Confidence 2 23468999999999877654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=241.10 Aligned_cols=174 Identities=28% Similarity=0.390 Sum_probs=148.4
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..++|+..+.||.|..++||+|+. ..+..||||+++... ....+.+++|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788899999999999999964 467999999997543 334688999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
.||.+|++.+.+... ....+++..+..|++++++||.|||++ +.||||||+.||||+.+|.+||+|||.+......
T Consensus 104 pfMa~GS~ldIik~~-~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTY-YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHH-ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999888652 223489999999999999999999999 9999999999999999999999999987443222
Q ss_pred Ccc---c-ceeccccCCccccccc
Q 020072 307 NKN---N-LKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~~---~-~~~~gt~~y~aPE~l~ 326 (331)
... . ..+.||+.|||||+++
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred CceeeEeeccccCcccccChHHhh
Confidence 221 1 3457999999999964
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=244.11 Aligned_cols=167 Identities=26% Similarity=0.334 Sum_probs=143.8
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 5789999998643 233456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceec
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 314 (331)
.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999863 34689999999999999999999999 999999999999999999999999999875433333333457
Q ss_pred cccCCccccccccCCCC
Q 020072 315 GTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 315 gt~~y~aPE~l~~~~~t 331 (331)
||+.|+|||++.+..++
T Consensus 155 gt~~y~aPE~~~~~~~~ 171 (312)
T cd05585 155 GTPEYLAPELLLGHGYT 171 (312)
T ss_pred CCcccCCHHHHcCCCCC
Confidence 99999999999877654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=242.13 Aligned_cols=179 Identities=29% Similarity=0.431 Sum_probs=146.9
Q ss_pred hcCCcccceeeecCceEEEEEEECC-----------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCccee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-----------------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~ 211 (331)
.++|...+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3577888999999999999997532 3469999986543 334567999999999999999999
Q ss_pred eeeeEEcCCeEEEEEEecCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceE
Q 020072 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPS----------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275 (331)
Q Consensus 212 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iv 275 (331)
+++++.+.+..++||||+++|+|.+++.... ....+++.+.++++.|++.||+|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999998875421 113478899999999999999999999 999
Q ss_pred ecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 276 Hrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||||||+|||+++++.+||+|||+++........ .....++..|+|||++.++.++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 9999999999999999999999999754332211 1122357789999998877653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=249.87 Aligned_cols=144 Identities=26% Similarity=0.295 Sum_probs=129.3
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.|...+.||+|+||+||+|+.. +++.||+|++... .......+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999764 5789999998643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999863 34588999999999999999999999 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=249.50 Aligned_cols=144 Identities=26% Similarity=0.313 Sum_probs=129.1
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999864 57889999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999998864 24588999999999999999999999 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=248.04 Aligned_cols=145 Identities=26% Similarity=0.324 Sum_probs=129.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 57899999986432 233466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999864 34688999999999999999999999 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=242.82 Aligned_cols=168 Identities=29% Similarity=0.430 Sum_probs=142.8
Q ss_pred ceeeecCceEEEEEEE----CCCceEEEEEeccc----CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKL----DDNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+.||+|+||.||+++. .+++.||+|.+... .......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35789999998643 223345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.+++.. ...+.+..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999998853 34678889999999999999999999 999999999999999999999999999875433333
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......|++.|+|||++.+..+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~ 177 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGH 177 (323)
T ss_pred cccccCCCccccChhhccCCCC
Confidence 3334568999999999977654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=252.26 Aligned_cols=173 Identities=28% Similarity=0.374 Sum_probs=151.6
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
-|+.++.||+|+-|.|-+|+. .+|+.+|||.+... .......+.+|+-+|+-+.|||++++++++++...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 456678999999999999986 57999999999654 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|.|++++- ..+++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||.++++||+|||||....+.
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 999999999995 346799999999999999999999999 9999999999999999999999999999554332
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.--.+-||++-|.|||++++.+|+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCC
Confidence 222345899999999999999885
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=241.27 Aligned_cols=174 Identities=26% Similarity=0.306 Sum_probs=146.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCC-cceeeeeeEEcCCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHP-NVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 226 (331)
+|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999875 4678999998643 233456788899999999765 6888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988853 34689999999999999999999999 9999999999999999999999999998654332
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYG 179 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCC
Confidence 3333345789999999999887653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=242.49 Aligned_cols=169 Identities=24% Similarity=0.352 Sum_probs=144.2
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+++.. +++.||+|.++.. .....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999643 223445688999999998 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999888753 34699999999999999999999999 999999999999999999999999999865322222333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred cccCCccccCHHHHcCCCCC
Confidence 45789999999999877653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=246.66 Aligned_cols=174 Identities=24% Similarity=0.321 Sum_probs=148.4
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
...++|+..+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 5788999998532 2233456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998853 2478899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc-ccceeccccCCccccccccC
Q 020072 304 GSQNK-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
..... ......||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhcc
Confidence 43222 22244699999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=245.23 Aligned_cols=175 Identities=26% Similarity=0.351 Sum_probs=148.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++|+||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999875 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999853 34689999999999999999999999 9999999999999999999999999998543211
Q ss_pred C-----------------------------------cccceeccccCCccccccccCCCC
Q 020072 307 N-----------------------------------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. .......||+.|+|||++.+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 214 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC
Confidence 0 001124689999999999877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=241.57 Aligned_cols=169 Identities=25% Similarity=0.360 Sum_probs=143.3
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5788999998643 233445678899988877 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999888753 34689999999999999999999999 999999999999999999999999999865432222233
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||..|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred cccCCccccCHHHHcCCCCC
Confidence 45789999999999877653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=251.79 Aligned_cols=170 Identities=31% Similarity=0.488 Sum_probs=145.8
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+...+.....+-||.|+-|.||+|+++ ++.||||+++... +.+|.-|++|+|+||+.|.|+|.....+|+||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 333333344677999999999999996 6689999986322 35788899999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
|||..|.|++.|. .+..++......|..+||.||.|||.+ .|||||||.-||||+.+..+||+|||-++.....
T Consensus 192 EfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999995 456788999999999999999999999 9999999999999999999999999998766544
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ...++||..|||||+|.+...+
T Consensus 266 ST-kMSFaGTVaWMAPEvIrnePcs 289 (904)
T KOG4721|consen 266 ST-KMSFAGTVAWMAPEVIRNEPCS 289 (904)
T ss_pred hh-hhhhhhhHhhhCHHHhhcCCcc
Confidence 32 3367899999999999987653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=244.86 Aligned_cols=175 Identities=26% Similarity=0.339 Sum_probs=150.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999876 6889999998643 2244567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998642 5689999999999999999999998 9999999999999999999999999998654432
Q ss_pred C-----------------------------cccceeccccCCccccccccCCCC
Q 020072 307 N-----------------------------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. .......||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 2 112234689999999999877653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=236.90 Aligned_cols=172 Identities=30% Similarity=0.468 Sum_probs=145.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|...+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 67899999986443 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 98 588888753 234578999999999999999999999 999999999999999999999999999976543332
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......+++.|+|||++.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~ 178 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGS 178 (288)
T ss_pred cccCceecccccChHHhcCC
Confidence 22334689999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=240.89 Aligned_cols=169 Identities=30% Similarity=0.412 Sum_probs=141.1
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHH-HHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|+.. +|+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 6889999998643 2233345566655 46779999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999988853 35689999999999999999999999 999999999999999999999999999865433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...|++.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYD 174 (325)
T ss_pred cccCChhhCCHHHHcCCCCC
Confidence 45799999999999887654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=240.08 Aligned_cols=168 Identities=29% Similarity=0.383 Sum_probs=143.6
Q ss_pred ceeeecCceEEEEEEE----CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 157 NILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999986432 2234567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++..........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999998853 34689999999999999999999999 99999999999999999999999999987654433333
Q ss_pred ceeccccCCccccccccCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~ 330 (331)
....|++.|+|||.+.+..+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~ 175 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGH 175 (318)
T ss_pred ecccCChhhcCHHHHcCCCC
Confidence 34578999999999876654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=240.29 Aligned_cols=172 Identities=23% Similarity=0.311 Sum_probs=146.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999875 5788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999864 234689999999999999999999999 9999999999999999999999999998665433
Q ss_pred Cc-ccceeccccCCcccccccc
Q 020072 307 NK-NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~~ 327 (331)
.. ......|++.|+|||++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CceeeccccCCcccCCHHHHhc
Confidence 22 1223468999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=239.72 Aligned_cols=174 Identities=26% Similarity=0.308 Sum_probs=146.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+|...+.||+|+||.||+|+.. +++.||+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999876 56799999986432 22344567788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988853 34589999999999999999999999 9999999999999999999999999999754333
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCC
Confidence 3333345789999999999887664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=236.97 Aligned_cols=173 Identities=29% Similarity=0.423 Sum_probs=145.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999876 688999999864432 233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|++ ++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 677777653 335688999999999999999999999 99999999999999999999999999986543332
Q ss_pred cccceeccccCCccccccccC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.......+++.|+|||++.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred ccCCCCcccCCCCChHHHcCC
Confidence 222334688999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=239.43 Aligned_cols=169 Identities=32% Similarity=0.418 Sum_probs=140.8
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHH-HHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||+||+|+.. +++.||+|.+.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 68899999986432 223344555555 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYD 174 (323)
T ss_pred cccCChhhcChhhhcCCCCC
Confidence 45689999999999877654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=239.98 Aligned_cols=169 Identities=30% Similarity=0.391 Sum_probs=143.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|+.. +++.||+|.+... .....+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999998643 233456678888888877 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865433322333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.+..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred ccccCccccCHHHHcCCCCC
Confidence 45689999999999876553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=239.74 Aligned_cols=171 Identities=24% Similarity=0.318 Sum_probs=146.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999865 5789999998642 2234456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999863 234689999999999999999999999 9999999999999999999999999998654432
Q ss_pred Cc-ccceeccccCCccccccc
Q 020072 307 NK-NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~ 326 (331)
.. ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCccccceeccccccCHHHHh
Confidence 22 122246899999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=240.15 Aligned_cols=172 Identities=28% Similarity=0.388 Sum_probs=143.3
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHH---hcCCCCcceeeeeeEEcCCeEEEE
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLL---SNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++ ++++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999865 58899999986432 23345566666554 567899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|..+++. ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888753 4689999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........|++.|+|||++.++.++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~ 179 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYT 179 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCC
Confidence 33333345789999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=239.87 Aligned_cols=169 Identities=30% Similarity=0.380 Sum_probs=143.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998643 233445677899998876 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999875433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...|++.|+|||++.+..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYG 174 (321)
T ss_pred ccccCccccCHHHHcCCCCC
Confidence 45689999999999876653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=239.81 Aligned_cols=174 Identities=25% Similarity=0.306 Sum_probs=146.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 226 (331)
+|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667889999999999999865 6889999998643 2234456788999998886 577888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988853 34689999999999999999999999 9999999999999999999999999998754333
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........||+.|+|||++.++.++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCC
Confidence 3333345689999999999877653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=239.31 Aligned_cols=169 Identities=31% Similarity=0.403 Sum_probs=140.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHH-HHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|+.. +++.||+|.+.... .....++.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999986432 223344555554 67889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999888753 34688899999999999999999999 999999999999999999999999999865433223333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...|++.|+|||++.+..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYD 174 (321)
T ss_pred cccCCcccCCHHHhcCCCCC
Confidence 45689999999999876653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=238.49 Aligned_cols=169 Identities=28% Similarity=0.397 Sum_probs=141.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57889999986432 23344556677777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999976433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.+..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYN 174 (316)
T ss_pred cccCCccccCHHHHcCCCCC
Confidence 45789999999999877653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=250.07 Aligned_cols=177 Identities=20% Similarity=0.214 Sum_probs=150.1
Q ss_pred CCcccceeeecCceEEEEEEEC-C-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-D-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.|...+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999754 3 5778888876555555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 230 ENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 230 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++|+|.+++... ....++++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 2345689999999999999999999999 999999999999999999999999999976543221
Q ss_pred --ccceeccccCCccccccccCCCC
Q 020072 309 --NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 --~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+||+.|+|||++.++.++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCC
Confidence 12345699999999999877654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=236.87 Aligned_cols=168 Identities=29% Similarity=0.420 Sum_probs=135.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 225 (331)
.|...+++|.|+||.||+|+.. +++.||||+.-.+.. .--+|+++|++++|||||+|.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666899999999999999875 468999999743322 2236899999999999999988876432 34689
Q ss_pred EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCceeC
Q 020072 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITD 303 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~~ 303 (331)
||||+ -+|+..++.. ..+..++...+.-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 4777777531 2345678888889999999999999998 99999999999999976 99999999999877
Q ss_pred CCCCcccceeccccCCccccccccC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
....... +..-|..|+|||.+.+.
T Consensus 177 ~~~epni-SYicSRyYRaPELifga 200 (364)
T KOG0658|consen 177 VKGEPNI-SYICSRYYRAPELIFGA 200 (364)
T ss_pred ccCCCce-eEEEeccccCHHHHcCc
Confidence 6555443 44568899999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=233.45 Aligned_cols=170 Identities=27% Similarity=0.363 Sum_probs=143.8
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||+||++... +++.||+|.+.... ....+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999865 67899999986432 22335678899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccccee
Q 020072 235 DIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313 (331)
Q Consensus 235 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 313 (331)
..++... .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 8877532 2345689999999999999999999999 99999999999999999999999999997654333333344
Q ss_pred ccccCCccccccccCCCC
Q 020072 314 SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 314 ~gt~~y~aPE~l~~~~~t 331 (331)
.|++.|+|||++.++.++
T Consensus 158 ~g~~~y~aPE~~~~~~~~ 175 (280)
T cd05608 158 AGTPGFMAPELLQGEEYD 175 (280)
T ss_pred CCCcCccCHHHhcCCCCC
Confidence 689999999999887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=241.32 Aligned_cols=176 Identities=31% Similarity=0.400 Sum_probs=154.1
Q ss_pred HHhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 222 (331)
...+.|...+.||+|.||.||+++... |+.+|+|.+..... .....+.+|+.+|+++. |||||.+.+++++.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999998765 89999999965533 24468999999999998 99999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC----CcEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg 298 (331)
++|||++.+|.|.+.+... .+++..+..++.|++.+++|||+. +++||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998653 399999999999999999999998 99999999999999643 479999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++..... .......+||+.|+|||++....|+
T Consensus 185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~ 216 (382)
T KOG0032|consen 185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYG 216 (382)
T ss_pred CceEccC-CceEeeecCCccccCchhhcCCCCC
Confidence 9988776 4445567999999999999876653
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.93 Aligned_cols=169 Identities=30% Similarity=0.426 Sum_probs=142.1
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|+.. +++.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 47889999986432 23345567788888764 999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999998853 34689999999999999999999999 999999999999999999999999999875433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||..|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYN 174 (316)
T ss_pred eecCCccccCHHHHcCCCCC
Confidence 45789999999999877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=238.63 Aligned_cols=171 Identities=26% Similarity=0.316 Sum_probs=147.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+++.. +++.||+|.+.... .+..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999865 68899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998642 34689999999999999999999999 9999999999999999999999999999765433
Q ss_pred Cc-ccceeccccCCccccccc
Q 020072 307 NK-NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~ 326 (331)
.. ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CceeeecccCCccccCHHHhc
Confidence 22 122346899999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.06 Aligned_cols=169 Identities=24% Similarity=0.347 Sum_probs=144.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++.++ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 56889999996432 23456688999999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999988753 34699999999999999999999999 999999999999999999999999999865332222333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred cccCCcccCCHHHHCCCCCC
Confidence 45799999999999887664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=243.31 Aligned_cols=175 Identities=30% Similarity=0.417 Sum_probs=155.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..|...+.||+|.||.||+|... +++.||+|+++.. .+....++++|+.++++++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34556688999999999999764 6789999999755 455668899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+.+|++.+.|. .+..+++....-|++++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999884 344568888888999999999999999 999999999999999999999999999988776666
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...+++||+.|||||+++...|+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~ 189 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYD 189 (467)
T ss_pred ccccccccccccchhhhcccccc
Confidence 66788999999999999976664
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=237.88 Aligned_cols=169 Identities=30% Similarity=0.397 Sum_probs=139.1
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHH-HHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEV-DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 56789999986432 22233444444 456889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+.+.....++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999998853 34578888899999999999999999 999999999999999999999999999865433333333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYD 174 (325)
T ss_pred cccCCccccCHHHHcCCCCC
Confidence 45799999999999877653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=244.24 Aligned_cols=181 Identities=27% Similarity=0.352 Sum_probs=148.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
...++|...+.||+|+||.||+|+. +++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456788899999999999999963 245689999986432 33456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSH-------------------------------------------------------- 243 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (331)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999988864211
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 244 ----------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 244 ----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
...+++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12578999999999999999999999 99999999999999999999999999997654322
Q ss_pred cc--cceeccccCCccccccccCCCC
Q 020072 308 KN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....++..|+|||++.++.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 294 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYT 294 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCC
Confidence 11 1112345679999999877654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=237.29 Aligned_cols=169 Identities=27% Similarity=0.365 Sum_probs=142.1
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|+.. ++..||+|.++... ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 57899999986432 23445667788888754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++.++..++.|+++||+|||++ +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865432222333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||..|+|||++.++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred ccCCCcCccCHHHHcCCCCC
Confidence 45789999999999877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=231.24 Aligned_cols=177 Identities=28% Similarity=0.381 Sum_probs=147.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|+..+.||+|+||.||+|++. .+..||+|.++... ......+.+|+..+++++||||++++|++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346788899999999999999753 35689999987543 2344679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999864 234689999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcc-cceeccccCCccccccccCCCC
Q 020072 305 SQNKN-NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~-~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... .....++..|+|||.+.++.++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCcc
Confidence 22111 1122346789999999877654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=237.65 Aligned_cols=171 Identities=25% Similarity=0.335 Sum_probs=144.7
Q ss_pred CCcccceeeecCceEEEEEEE----CCCceEEEEEeccc----CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 152 SFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCA----TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
+|+..+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477789999999999999875 35789999998643 223345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998853 34689999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCC-cccceeccccCCccccccccC
Q 020072 303 DGSQN-KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~-~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..... .......||..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCC
Confidence 43222 222345799999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=242.17 Aligned_cols=173 Identities=24% Similarity=0.310 Sum_probs=147.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|+..+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999875 5789999998642 22334557899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998853 2478888999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc-ccceeccccCCccccccccC
Q 020072 305 SQNK-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
.... ......||+.|+|||++.+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccC
Confidence 3221 12234689999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=237.03 Aligned_cols=171 Identities=24% Similarity=0.322 Sum_probs=145.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+++.+ +++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999876 4678999998542 2233455889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999964 234689999999999999999999999 9999999999999999999999999998654322
Q ss_pred Cc-ccceeccccCCccccccc
Q 020072 307 NK-NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~ 326 (331)
.. ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CcceecccccCccccCHHHHh
Confidence 21 222346899999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=236.49 Aligned_cols=175 Identities=29% Similarity=0.389 Sum_probs=149.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468888999999999999999876 57889999886543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.. +++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999864 345899999999999999999999852 69999999999999999999999999986543322
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....|+..|+|||++.++.++
T Consensus 159 ~--~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 159 A--NSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred c--ccCCCCcCcCCHhHhcCCCCC
Confidence 1 234689999999999877654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=249.76 Aligned_cols=174 Identities=28% Similarity=0.400 Sum_probs=150.7
Q ss_pred cccceeeecCceEEEEEEE-CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------eEEEE
Q 020072 154 HESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TRFIV 225 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~lv 225 (331)
...+.||+|+||.||+|+. .+|+.||||.++.. .....+...+|+++|++++|+|||+++++-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3467899999999999995 57999999999754 3445677899999999999999999999876544 56899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC--CCC--cEEEEeccCce
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKF--NAKLSDFGLAI 301 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~Dfgla~ 301 (331)
||||.+|+|+..|.++.+...|++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999999998888999999999999999999999999 999999999999984 334 37999999998
Q ss_pred eCCCCCcccceeccccCCcccccccc-CCCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLD-GMVN 331 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t 331 (331)
...+.. ...++.||..|.+||++.+ +.|+
T Consensus 173 el~d~s-~~~S~vGT~~YLhPel~E~q~~y~ 202 (732)
T KOG4250|consen 173 ELDDNS-LFTSLVGTEEYLHPELYERQKKYT 202 (732)
T ss_pred cCCCCC-eeeeecCchhhcChHHHhhccCcC
Confidence 876655 4456789999999999985 5553
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=238.56 Aligned_cols=177 Identities=29% Similarity=0.419 Sum_probs=153.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.+.|..-++||+|+||.||-++.. +|+.+|.|++.+. ........++|-.+|.+++.+.||.+-..++..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 366788899999999999999764 6899999988543 233455678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+..|++|+|.-+|..... ..+++..+..++.+|+.||++||.. +||+||+||+|||||+.|.++|+|.|+|.....
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999988875332 5699999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ..+||.+|||||++.+++||
T Consensus 340 g~~~~-~rvGT~GYMAPEvl~ne~Y~ 364 (591)
T KOG0986|consen 340 GKPIR-GRVGTVGYMAPEVLQNEVYD 364 (591)
T ss_pred CCccc-cccCcccccCHHHHcCCccc
Confidence 43322 34799999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.81 Aligned_cols=175 Identities=23% Similarity=0.372 Sum_probs=147.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999876 57889999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|++++++..+.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765543 234689999999999999999999999 99999999999999999999999999996643222
Q ss_pred c-ccceeccccCCccccccccCCCC
Q 020072 308 K-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ......|+..|+|||++.++.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred cccccccccccccCCcHHHcCCCCC
Confidence 1 22234689999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=243.06 Aligned_cols=177 Identities=31% Similarity=0.418 Sum_probs=156.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe-EEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-RFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 226 (331)
++|...+++|+|+||.++..+.+ +++.+++|++.... ....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999988754 56789999986543 3344578899999999999999999999999887 99999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
+|++||++.+.+... ++..++++....++.|++.|+.|||++ .|+|||||+.||+++.++.+||+|||+|+..+..
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998764 367799999999999999999999998 9999999999999999999999999999988877
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+..||+.||.||.+.+-+|+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn 184 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN 184 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC
Confidence 6555677899999999999998874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=241.27 Aligned_cols=175 Identities=25% Similarity=0.321 Sum_probs=148.9
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
++...++|+..+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4445688999999999999999999876 5788999998532 22334567899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998853 2478889999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCCc-ccceeccccCCcccccccc
Q 020072 302 TDGSQNK-NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~-~~~~~~gt~~y~aPE~l~~ 327 (331)
....... ......||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhc
Confidence 6543221 2224469999999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=231.06 Aligned_cols=175 Identities=29% Similarity=0.382 Sum_probs=147.6
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999864 68899999986432 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887642 234689999999999999999999999 99999999999999999999999999987643222
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ....|+..|+|||++.++.++
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd05605 157 TI-RGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred cc-ccccCCCCccCcHHhcCCCCC
Confidence 21 234689999999999876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=240.11 Aligned_cols=165 Identities=27% Similarity=0.430 Sum_probs=139.8
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445778999999999999865 688999999864433 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|... ....+..+..++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++........
T Consensus 155 ~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGT-------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99998643 2356778889999999999999999 9999999999999999999999999999765433322
Q ss_pred cceeccccCCccccccc
Q 020072 310 NLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~ 326 (331)
.....|+..|+|||++.
T Consensus 225 ~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 CNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccccccCccccCccccc
Confidence 23346899999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=231.47 Aligned_cols=179 Identities=29% Similarity=0.444 Sum_probs=154.6
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...++|...+.||+|+||.||+|...++..+++|.+.........++.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888899999999999999988899999999976666566789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... .+..+++..+++++.|++.||+|||++ +++||||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999753 345689999999999999999999999 99999999999999999999999999986554332
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......++..|+|||++.++.+
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~ 181 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTF 181 (261)
T ss_pred ccccCCCCceEecCHHHHccCCC
Confidence 22222345678999999877655
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=237.15 Aligned_cols=175 Identities=29% Similarity=0.399 Sum_probs=148.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468888999999999999999876 57888999886543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ...+++.....++.|++.||+|||+.. +++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999853 345889999999999999999999742 69999999999999999999999999986543221
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....|+..|+|||++.+..++
T Consensus 159 ~--~~~~~~~~y~aPE~~~~~~~~ 180 (333)
T cd06650 159 A--NSFVGTRSYMSPERLQGTHYS 180 (333)
T ss_pred c--ccCCCCccccCHHHhcCCCCC
Confidence 1 234689999999999876553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=235.08 Aligned_cols=169 Identities=30% Similarity=0.373 Sum_probs=143.5
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|+.. +++.||+|.+... .......+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 4789999998643 233455678899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|..++.. ...+++..+..++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865333223333
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...|+..|+|||++.+..++
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred ceecCccccCHHHhcCCCCC
Confidence 45689999999999877654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=235.02 Aligned_cols=171 Identities=29% Similarity=0.368 Sum_probs=152.6
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
-|.+...||+|+||.||+|.. ++|+.||+|++.. ..+.+++.+|+.+|++.+.|++|++||.+.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 455678899999999999965 4799999999864 3467889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
.|+..+.++. +.++|++.+...++.+-++||+|||.. .-+|||||+.|||++.+|.+||+|||.|-.+.+.....
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999873 557899999999999999999999998 89999999999999999999999999997776665555
Q ss_pred ceeccccCCccccccccCC
Q 020072 311 LKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~ 329 (331)
.+..||+.|||||+++.=-
T Consensus 187 NTVIGTPFWMAPEVI~EIG 205 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIG 205 (502)
T ss_pred CccccCcccccHHHHHHhc
Confidence 6678999999999997533
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=247.96 Aligned_cols=165 Identities=33% Similarity=0.453 Sum_probs=142.4
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.|.+.+-||.|+||.||-|+.. +...||||++.-. +.+.++++.+|+..|.+++|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4566788999999999999764 6788999998644 34567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
||- |+..+.+.. ..+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.|....+.
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 996 566666542 346799999999999999999999999 9999999999999999999999999988554332
Q ss_pred cccceeccccCCccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~ 326 (331)
..++|||.|||||+|.
T Consensus 180 ---nsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVIL 195 (948)
T ss_pred ---hcccCCccccchhHhe
Confidence 2468999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=261.19 Aligned_cols=168 Identities=28% Similarity=0.478 Sum_probs=140.3
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
....+...++||+|+||.||+|+. .++..||||++...... ...|++.+++++||||++++|+|.+.+..|+|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677788999999999999987 47899999998643322 2346889999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.++++ .++|.++.+++.|+++||+|||+.+.++++||||||+||+++.++.+++. ||.........
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 999999999985 28999999999999999999997767799999999999999999998876 66553322111
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...++..|+|||++.++.|+
T Consensus 837 ----~~~~t~~y~aPE~~~~~~~~ 856 (968)
T PLN00113 837 ----KCFISSAYVAPETRETKDIT 856 (968)
T ss_pred ----CccccccccCcccccCCCCC
Confidence 22578999999999887764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=224.96 Aligned_cols=177 Identities=31% Similarity=0.449 Sum_probs=150.0
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----ch---hHHHHHHHHHHHhcC-CCCcceeeeeeE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QD---AGREFENEVDLLSNI-HHPNVVCLLGYS 216 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~---~~~~~~~e~~~l~~l-~H~niv~l~g~~ 216 (331)
+...+.|...+++|.|..+.|.++..+ +|++.|+|++.... ++ ..+.-.+|+.+|+++ -||||+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 345567788899999999999888654 67899999985321 11 123456799999999 599999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
+.+...++|+|.|+.|.|.++|.. .-.+++++..+|++|+.+|++|||.+ .||||||||+|||+|+|.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999954 35699999999999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+++....... -...|||++|+|||.+.-..|
T Consensus 167 FGFa~~l~~Gek-LrelCGTPgYLAPEtikC~m~ 199 (411)
T KOG0599|consen 167 FGFACQLEPGEK-LRELCGTPGYLAPETIKCSMY 199 (411)
T ss_pred cceeeccCCchh-HHHhcCCCcccChhheeeecc
Confidence 999987765433 345799999999999875543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=240.57 Aligned_cols=175 Identities=26% Similarity=0.364 Sum_probs=153.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
...|...+.||+|.|+.|.+|+.. ++..||+|.+++...+ ..+.+.+|+++|+.|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788899999999999999754 6899999999765433 3355889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+.+|.+++++.. ...+.+..+..+..|+.+|++|||++ .|+|||||++|+||+.++++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999963 34566688899999999999999999 9999999999999999999999999999776533
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....+.+|++.|.|||++.+.+|+
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~ 232 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYD 232 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccC
Confidence 233456899999999999988774
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=241.57 Aligned_cols=181 Identities=28% Similarity=0.413 Sum_probs=147.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
...++|+..+.||+|+||.||+|+. +++..||+|++.... ......+.+|+++++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3456788899999999999999874 234579999997543 33456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCC---------------------------------------------------------
Q 020072 220 DTRFIVYELMENRSLDIQLHGPS--------------------------------------------------------- 242 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 242 (331)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999998875311
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc--c
Q 020072 243 ----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--N 310 (331)
Q Consensus 243 ----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~ 310 (331)
....+++.++++++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 112478899999999999999999999 9999999999999999999999999998654322211 1
Q ss_pred ceeccccCCccccccccCCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~t 331 (331)
....++..|+|||++.++.++
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~ 292 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYT 292 (374)
T ss_pred cCCCCccceeCHHHhcCCCCC
Confidence 112345689999999877654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=240.89 Aligned_cols=182 Identities=27% Similarity=0.383 Sum_probs=148.6
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCc-hhHHHHHHHHHHHhcCC-CCcceeeeeeEEc
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAH 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~ 218 (331)
+...++|...+.||+|+||.||+|+.. .+..||+|++..... ...+.+.+|++++++++ ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445678888999999999999999753 234799999965433 34467999999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCC--------------------------------------------------------
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPS-------------------------------------------------------- 242 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 242 (331)
.+..|+||||+++|+|.++++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998875421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEE
Q 020072 243 -------------------------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (331)
Q Consensus 243 -------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nil 285 (331)
....+++.++..++.|++.||+|||+. +++||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 013478889999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 286 LDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 286 l~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++++.+||+|||+++....... ......++..|+|||++.++.++
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 99999999999999975432221 11123467789999999877653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=254.23 Aligned_cols=178 Identities=26% Similarity=0.354 Sum_probs=148.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999875 58899999986432 233567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 227 ELMENRSLDIQLHGPS--------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
||+++|+|.+++.... ....+++..+++++.|+++||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886311 123466788899999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCC------------------cccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQN------------------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++...... .......||+.|+|||++.++.+|
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S 209 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence 996541110 011124689999999999877654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=250.89 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=146.6
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCC-ceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeee-EEc-----
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGY-SAH----- 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~-~~~----- 218 (331)
+....++.+.++|.+|||+.||.|....+ ..+|+|++-..++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 33455667789999999999999998766 999999998778888999999999999997 9999999993 221
Q ss_pred -CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 219 -DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
.-+.+|.||||.+|.|-+++..+.. ..|++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1268999999999999999875433 3499999999999999999999985 788999999999999999999999999
Q ss_pred cCceeC--CCCCccc-------ceeccccCCcccccc
Q 020072 298 GLAITD--GSQNKNN-------LKLSGTLGYVAPEYL 325 (331)
Q Consensus 298 gla~~~--~~~~~~~-------~~~~gt~~y~aPE~l 325 (331)
|.+... ....... .....|+.|+|||++
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 998432 2211111 112368999999998
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=239.02 Aligned_cols=169 Identities=23% Similarity=0.318 Sum_probs=143.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|...+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++...+..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999864 67899999753 23568899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC-C
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ-N 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~-~ 307 (331)
+. ++|..++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 788888753 24589999999999999999999999 9999999999999999999999999998643221 1
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.......||+.|+|||++.++.++
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred cccccccCccCCCChhhhcCCCCC
Confidence 222235799999999999877654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=225.10 Aligned_cols=174 Identities=27% Similarity=0.385 Sum_probs=146.4
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|+..+.||+|+||.||+++++++..+|+|.+.... ....++.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888899999886432 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc-
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN- 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 309 (331)
+|+|.++++.. ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988642 23689999999999999999999999 9999999999999999999999999998654322211
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||++.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKY 178 (256)
T ss_pred cCCCCCchhhCChhhcccCcc
Confidence 112234568999999876554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=228.13 Aligned_cols=175 Identities=32% Similarity=0.434 Sum_probs=140.5
Q ss_pred cCCcccceeeecCceEEEEEEEC--CCceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeeEEc-----
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSAH----- 218 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~----- 218 (331)
++|+..+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 467899998864322 2234566777777665 69999999999852
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
....++||||++ ++|.+++... ....+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 6888888642 234589999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++...... ......|++.|+|||++.++.++
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 187 (290)
T cd07862 156 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYA 187 (290)
T ss_pred ceEeccCCc-ccccccccccccChHHHhCCCCC
Confidence 997654332 22234689999999999776653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=232.29 Aligned_cols=175 Identities=29% Similarity=0.449 Sum_probs=144.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.+|+..+.||+|+||.||+|++. ++. .||+|.+.... ....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999986543 34557899999999999999999999999864 5789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+++|+|.+++.. ....+++...++++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999874 234688999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccc--ceeccccCCccccccccCCCC
Q 020072 305 SQNKNN--LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~--~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... ....++..|+|||++.++.++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 189 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYT 189 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCC
Confidence 322211 112246689999999876653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=227.88 Aligned_cols=172 Identities=40% Similarity=0.597 Sum_probs=141.5
Q ss_pred ccceeeecCceEEEEEEEC-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 155 ESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..+.||.|.||.||+|.+. .+..|+||.+.... .+..++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 35789999996543 34578899999999999999999999999988889999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.++|... ....+++.+++.|+.|+++||+|||++ +++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999753 246799999999999999999999999 999999999999999999999999999977632221
Q ss_pred --ccceeccccCCccccccccCCC
Q 020072 309 --NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 --~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..........|+|||.+.++.+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~ 182 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEY 182 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEE
T ss_pred cccccccccccccccccccccccc
Confidence 1122346789999999877654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=227.88 Aligned_cols=163 Identities=20% Similarity=0.254 Sum_probs=138.8
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchh---HHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeEEEEEEe
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA---GREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVYEL 228 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 228 (331)
...||+|++|.||+|++ +|+.||||++....... .+.+.+|+.++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999998 58899999997543322 4678899999999999999999999877 3478999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.+++.. ...+++...++++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++.......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 999999999864 346899999999999999999999732 788999999999999999999999999865433222
Q ss_pred ccceeccccCCcccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~ 327 (331)
...++..|+|||++.+
T Consensus 179 ---~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 179 ---KNVNFMVYFSYKMLND 194 (283)
T ss_pred ---cccCcccccCHHHhhh
Confidence 2357899999999865
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=233.88 Aligned_cols=169 Identities=28% Similarity=0.397 Sum_probs=140.0
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (331)
+|+..+.||+|+||.||+|+.. ++..||+|++... .......+.+|++++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677899999999999999865 6899999998643 2234457889999999999999999999886432 579
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 688888753 34689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC---cccceeccccCCcccccccc
Q 020072 304 GSQN---KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... .......|+..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc
Confidence 2221 11123468999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=224.49 Aligned_cols=171 Identities=27% Similarity=0.369 Sum_probs=148.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999986 46789999998765555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.++++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998853 34689999999999999999999999 999999999999999999999999999875543322
Q ss_pred ccceeccccCCccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~ 326 (331)
......++..|+|||.+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccCccccCccccCHhHcc
Confidence 223346889999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=232.93 Aligned_cols=164 Identities=29% Similarity=0.375 Sum_probs=136.4
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC---CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI---HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
||+|+||+||+|+.. +++.||+|++.... ......+..|..++.+. +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 58899999986432 22333455677777665 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865433333333
Q ss_pred eeccccCCccccccccC
Q 020072 312 KLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~ 328 (331)
...||..|+|||++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (330)
T cd05586 155 TFCGTTEYLAPEVLLDE 171 (330)
T ss_pred CccCCccccCHHHHcCC
Confidence 45799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-28 Score=231.73 Aligned_cols=169 Identities=25% Similarity=0.307 Sum_probs=143.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
..|...+.||+|+||.||+|... .++.||+|... ...+.+|++++++++|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46888999999999999999875 47889999642 234678999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
. ++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5 788888753 234699999999999999999999999 999999999999999999999999999975432211
Q ss_pred -ccceeccccCCccccccccCCCC
Q 020072 309 -NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 -~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......||..|+|||++.++.++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC
Confidence 12234689999999999887664
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=244.69 Aligned_cols=181 Identities=26% Similarity=0.288 Sum_probs=150.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD---- 220 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~---- 220 (331)
...++|...+.||+|+||+||+|+. .+++.||+|.+... .......+.+|+..+..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 46899999998644 3344567889999999999999999987765432
Q ss_pred ----eEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEE
Q 020072 221 ----TRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (331)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 295 (331)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988642 2345689999999999999999999999 99999999999999999999999
Q ss_pred eccCceeCCCC--CcccceeccccCCccccccccCCCC
Q 020072 296 DFGLAITDGSQ--NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 296 Dfgla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|||+++..... ........||+.|+|||++.++.++
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 223 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCC
Confidence 99999764322 1122345799999999999887664
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=227.53 Aligned_cols=180 Identities=27% Similarity=0.419 Sum_probs=147.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
.+++|+..+.||+|+||.||+|... ++..||+|++.... .....++.+|+.+++.++|+||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678889999999999999999753 34679999985432 2345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 222 RFIVYELMENRSLDIQLHGPSH-------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999998864221 23467889999999999999999998 9999999999999999999999
Q ss_pred EeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 295 SDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|||++......... .....++..|+|||++.++.++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 199 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC
Confidence 999998654322211 1112356789999999876653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=225.19 Aligned_cols=174 Identities=28% Similarity=0.374 Sum_probs=146.5
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
|...+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|+|++.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556788999999999999875 68899999986432 22345578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888642 234699999999999999999999999 999999999999999999999999999865432221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....|+..|+|||++.++.++
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~ 179 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYT 179 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCC
Confidence 1234689999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=229.63 Aligned_cols=172 Identities=30% Similarity=0.467 Sum_probs=144.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|...+.||+|+||.||+|+.. ++..||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 578899999864432 2334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 77777753 234588999999999999999999999 999999999999999999999999999865443332
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred ccccccccccccCCHHHhCC
Confidence 22234678999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=224.19 Aligned_cols=177 Identities=26% Similarity=0.402 Sum_probs=150.0
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 457888999999999999999988888999999864332 3567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998652 345689999999999999999999998 999999999999999999999999999976543221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++..+.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~ 182 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFT 182 (261)
T ss_pred ccCCCccceecCCHHHhccCCCC
Confidence 11122356789999998776653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=221.08 Aligned_cols=176 Identities=27% Similarity=0.366 Sum_probs=151.3
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|++|.||+|... +++.|++|.+... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4667889999999999999875 6789999998643 344567799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.++++.. ....+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998753 245789999999999999999999998 999999999999999999999999999876554433
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+++.|+|||++.++.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYN 179 (256)
T ss_pred hhhccccCccccCHHHhcCCCCC
Confidence 33344688999999999877653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=222.88 Aligned_cols=178 Identities=29% Similarity=0.413 Sum_probs=150.0
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..++|...+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998888899999986543 2356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.... +..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999986532 45689999999999999999999999 999999999999999999999999999976543221
Q ss_pred cc-ceeccccCCccccccccCCCC
Q 020072 309 NN-LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~-~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....+..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~ 182 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFS 182 (261)
T ss_pred cccCCCcCceeccCccccccCCCC
Confidence 11 111234579999998776543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=226.23 Aligned_cols=172 Identities=31% Similarity=0.430 Sum_probs=145.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEec--ccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-----CCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-----DDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~ 221 (331)
...|...+.||+|+||.|..+... +|..||+|++. .......++-.+|+.+|+.++|+||+.+.+++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999764 68999999997 4455667788999999999999999999998765 357
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+|+|+| ..+|...++ .+..|+......+++|+++||.|+|+. +++||||||+|+|++.+...||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 89999999 468888874 344599999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCC--CcccceeccccCCccccccccC
Q 020072 302 TDGSQ--NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..... ....+..+.|.+|.|||.+.+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhcc
Confidence 87532 2233445789999999998653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=223.14 Aligned_cols=176 Identities=28% Similarity=0.429 Sum_probs=147.3
Q ss_pred cCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|...+.||+|+||.||+|++.. ...||+|.++... .....+|.+|+.++++++|+||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998742 4579999986543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++..+++++.|++.||+|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999864 234789999999999999999999998 999999999999999999999999999976542
Q ss_pred CCc--ccceeccccCCccccccccCCCC
Q 020072 306 QNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......++..|+|||.+.++.++
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 186 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFT 186 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCc
Confidence 111 11112346789999998876553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=232.71 Aligned_cols=170 Identities=32% Similarity=0.463 Sum_probs=145.9
Q ss_pred cceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
.++||+|-||+||-|+.+ +|+.||||++++. .......+++|+.+|++++||.||.|...|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 478999999999999864 7999999999654 23344779999999999999999999999999999999999996 5
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEEEeccCceeCCCCCcc
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~ 309 (331)
+..+.+.. .....|++.....+..||+.||.|||.+ +|+|+||||+|||+.+. -++||||||+|+..+.....
T Consensus 648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55455544 3345799999999999999999999999 99999999999999754 46999999999999877665
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ..+||+.|+|||++.++-|+
T Consensus 724 r-sVVGTPAYLaPEVLrnkGyN 744 (888)
T KOG4236|consen 724 R-SVVGTPAYLAPEVLRNKGYN 744 (888)
T ss_pred h-hhcCCccccCHHHHhhcccc
Confidence 4 56899999999999988774
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=223.50 Aligned_cols=168 Identities=28% Similarity=0.386 Sum_probs=140.9
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||.||+++.. +|+.+|+|.+.... ......+..|++++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 58999999986432 22334566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceec
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 314 (331)
.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........ .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 155 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA 155 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-eeccC
Confidence 8887542 234588999999999999999999999 999999999999999999999999999865543221 12346
Q ss_pred cccCCccccccccCCCC
Q 020072 315 GTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 315 gt~~y~aPE~l~~~~~t 331 (331)
|+..|+|||++.++.++
T Consensus 156 ~~~~y~aPE~~~~~~~~ 172 (277)
T cd05607 156 GTNGYMAPEILKEEPYS 172 (277)
T ss_pred CCCCccCHHHHccCCCC
Confidence 89999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=225.08 Aligned_cols=176 Identities=30% Similarity=0.413 Sum_probs=145.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-----CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (331)
++|+..+.||+|+||.||++..+ ++..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777899999999999999742 5789999999766666677899999999999999999999987543 4689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999864 234689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCcc---cceeccccCCccccccccCCCC
Q 020072 304 GSQNKN---NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... .....++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 189 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFS 189 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcC
Confidence 322211 0111234569999999876553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=224.38 Aligned_cols=174 Identities=29% Similarity=0.385 Sum_probs=146.4
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999865 67899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++... ....+++.++..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999888542 234589999999999999999999998 999999999999999999999999999865432222
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....|+..|+|||++.++.++
T Consensus 158 ~-~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05630 158 I-KGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred c-cCCCCCccccChHHHcCCCCC
Confidence 1 223689999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=225.17 Aligned_cols=178 Identities=31% Similarity=0.495 Sum_probs=146.1
Q ss_pred cCCcccceeeecCceEEEEEEE-----CCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..+.||+|+||.||+|.. .++..|++|.+.... .+...++.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999974 246789999986433 3344678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 225 VYELMENRSLDIQLHGPS--------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
+|||+++++|.+++.... ....+++.+.+.++.|++.||+|||++ +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 123588999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||++........ ......++..|+|||++.++.++
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS 204 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC
Confidence 999999999865432221 11223456789999999876553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=224.77 Aligned_cols=176 Identities=27% Similarity=0.423 Sum_probs=149.0
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|+..+.||+|.|+.||++.. .+|+.+|+|.++.. +....+++.+|+.+.+.|+||||++|.....+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345677788999999999999854 57889999887533 344678899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgla~~ 302 (331)
+|+|++++|...+-. ....++..+-..++||+++|.|+|.+ +|||||+||+|+|+... --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999765532 24577888889999999999999999 99999999999999643 3499999999988
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+ .........||++|||||++...+|+
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~ 190 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYS 190 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCC
Confidence 77 44445567899999999999887764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=222.56 Aligned_cols=177 Identities=28% Similarity=0.380 Sum_probs=149.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999864 6889999987532 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++|+|.+++... .....+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887532 2234588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.........++..|+|||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~ 183 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCC
Confidence 3322223468889999999876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=221.95 Aligned_cols=179 Identities=28% Similarity=0.413 Sum_probs=150.3
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777789999999999999865 577899999876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCce
Q 020072 225 VYELMENRSLDIQLHGPSHGSAL--TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAI 301 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~ 301 (331)
++||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999987422 234 7888999999999999999999 9999999999999986 6799999999986
Q ss_pred eCCCCCcccceeccccCCccccccccCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.............++..|+|||++.++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 185 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGP 185 (268)
T ss_pred ecccCCCccccCCCCccccChhhhcccc
Confidence 5433222222345789999999986543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=223.16 Aligned_cols=169 Identities=30% Similarity=0.465 Sum_probs=145.7
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999876 4678899988766556667899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999888763 234689999999999999999999999 999999999999999999999999999865443322223
Q ss_pred eeccccCCccccccc
Q 020072 312 KLSGTLGYVAPEYLL 326 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~ 326 (331)
...++..|+|||++.
T Consensus 162 ~~~~~~~y~aPE~~~ 176 (282)
T cd06643 162 SFIGTPYWMAPEVVM 176 (282)
T ss_pred cccccccccCHhhcc
Confidence 346889999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=223.27 Aligned_cols=170 Identities=27% Similarity=0.387 Sum_probs=147.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46667788999999999999864 58899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ...+++.+.+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999998853 34689999999999999999999999 9999999999999999999999999998665433333
Q ss_pred cceeccccCCccccccc
Q 020072 310 NLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~ 326 (331)
.....|+..|+|||++.
T Consensus 163 ~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 163 RKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccccCcccccChhhhc
Confidence 33446899999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=223.38 Aligned_cols=172 Identities=29% Similarity=0.434 Sum_probs=149.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+.|+..+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778899999999999999875 47899999997766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 99999887753 234689999999999999999999998 9999999999999999999999999998654333332
Q ss_pred cceeccccCCcccccccc
Q 020072 310 NLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~ 327 (331)
.....++..|+|||++.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred cceecCCccccCceeecc
Confidence 334468899999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=221.50 Aligned_cols=173 Identities=27% Similarity=0.375 Sum_probs=146.1
Q ss_pred CCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+|...+.||+|+||.||+|+..++..+|+|.+..... ...++.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 5667889999999999999987777899999864432 346789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc-c
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-N 310 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 310 (331)
|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ .
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999998642 23689999999999999999999999 9999999999999999999999999998654332211 1
Q ss_pred ceeccccCCccccccccCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~ 330 (331)
....++..|+|||++.++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~ 178 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKF 178 (256)
T ss_pred CCCccChhhCCHHHHhcCcc
Confidence 11234578999999987655
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=224.00 Aligned_cols=145 Identities=28% Similarity=0.354 Sum_probs=131.4
Q ss_pred CCcccceeeecCceEEEEEEECC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
+|+..+.||.|.-|+||++++++ +...|+|++++.. .....+.+.|-+||+.++||.+..||+.++.++..|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45557789999999999999875 5889999997653 3455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
||+||+|...++. +.+..+++..+..++.+++-||+|||.. |||+|||||+||||.++|.+-|+||.|+
T Consensus 158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence 9999999988875 4567899999999999999999999999 9999999999999999999999999996
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=219.63 Aligned_cols=177 Identities=28% Similarity=0.381 Sum_probs=151.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++|+|++++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7899999988532 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++|+|.+++... .....+++.+++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888642 2345689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.........++..|+|||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~ 183 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred CCcccceecCCccccCHHHhccCCC
Confidence 3333334468889999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=224.21 Aligned_cols=178 Identities=29% Similarity=0.448 Sum_probs=148.6
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|...+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999763 3478999998765444 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 224 IVYELMENRSLDIQLHGPS-----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
++|||+++++|.+++.... ....+++.++..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986421 224588999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 293 KLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||+++....... ......++..|+|||++.++.++
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT 202 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc
Confidence 9999999865432221 11122356789999999887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=224.92 Aligned_cols=173 Identities=32% Similarity=0.456 Sum_probs=150.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456778889999999999999875 5789999998766666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998863 234699999999999999999999999 999999999999999999999999999865443333
Q ss_pred ccceeccccCCcccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~ 327 (331)
......++..|+|||++..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred ccceeecchhhcCHHHHhh
Confidence 3334568999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=223.52 Aligned_cols=178 Identities=33% Similarity=0.525 Sum_probs=147.1
Q ss_pred cCCcccceeeecCceEEEEEEECC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|+..+.||+|+||.||+|.... ...|++|.+.... .....+|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778899999999999997643 2579999986443 334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 224 IVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
++|||+++|+|.+++..... ...+++.+.+.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999998864211 14588999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||+++....... ......+++.|+|||++.++.++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc
Confidence 999999999865432221 11223467889999999877654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=221.20 Aligned_cols=168 Identities=29% Similarity=0.414 Sum_probs=144.1
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..++||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999976 46789999998644 334456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 9999996542 468888999999999999999999 999999999999999999999999999865543222
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
....++..|+|||++.++.+
T Consensus 151 --~~~~~~~~y~aPE~~~~~~~ 170 (279)
T cd06619 151 --KTYVGTNAYMAPERISGEQY 170 (279)
T ss_pred --cCCCCChhhcCceeecCCCC
Confidence 23468999999999987665
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=225.50 Aligned_cols=181 Identities=27% Similarity=0.408 Sum_probs=147.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
...++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678889999999999999999653 24579999886443 233456889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 221 TRFIVYELMENRSLDIQLHGPSH-------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
..++||||+++|+|.+++..... ....++..+..++.|++.||.|||++ +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999864211 23457788899999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 294 LSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+|||+++........ .....++..|+|||.+.++.++
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 199 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 199 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCC
Confidence 9999998654322211 1122346789999999877653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=224.11 Aligned_cols=178 Identities=29% Similarity=0.452 Sum_probs=148.4
Q ss_pred hcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|...+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35678889999999999999974 234568999987666666778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 224 IVYELMENRSLDIQLHGPS----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
++|||+++++|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999886321 223589999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCcc--cceeccccCCccccccccCCC
Q 020072 294 LSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|+|||++......... .....++..|+|||++.++.+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 9999998654322211 112235678999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=222.44 Aligned_cols=173 Identities=30% Similarity=0.488 Sum_probs=145.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|++|.||+|+.. ++..||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 68899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ ++|.+++.....+..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888876544446799999999999999999999999 999999999999999999999999999865543322
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......+++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred cccCCcccccccChHHhcCC
Confidence 22233568899999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=224.92 Aligned_cols=173 Identities=30% Similarity=0.386 Sum_probs=146.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 57788889886543 23446688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999864 256899999999999999999999732 89999999999999999999999999986543221
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||.+.+..+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred -cccCCCCcCccChhHhcCCCC
Confidence 123468899999999876654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=224.27 Aligned_cols=174 Identities=26% Similarity=0.379 Sum_probs=151.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788899999999999999986 47899999999766555667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998853 3578999999999999999999999 999999999999999999999999999866543333
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+++.|+|||.+.++.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC
Confidence 2233468889999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=217.02 Aligned_cols=175 Identities=26% Similarity=0.363 Sum_probs=149.0
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+|+..+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++++.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999865 5789999988543 3345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++.. .....+++...+.++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999988754 2345688999999999999999999999 9999999999999999999999999998765443332
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~ 177 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY 177 (255)
T ss_pred cccccCCccccCHHHHccCCc
Confidence 334568899999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=220.20 Aligned_cols=177 Identities=28% Similarity=0.445 Sum_probs=148.3
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...++|+..+.||+|+||.||+|..++++.||+|.+..... ...++.+|++++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34567888999999999999999988899999999875433 3467899999999999999999999874 467899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... .+..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999988653 345789999999999999999999998 99999999999999999999999999986654222
Q ss_pred c-ccceeccccCCccccccccCCC
Q 020072 308 K-NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
. ......++..|+|||++..+.+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~ 180 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTF 180 (260)
T ss_pred cccccCCcccccccCHHHhccCCc
Confidence 1 1112245678999999876654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=220.77 Aligned_cols=176 Identities=29% Similarity=0.457 Sum_probs=145.7
Q ss_pred cCCcccceeeecCceEEEEEEEC----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999763 23479999986543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999864 234689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccc---ceeccccCCccccccccCCCC
Q 020072 306 QNKNN---LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~---~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ....++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 187 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccC
Confidence 22111 111235679999999876553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=219.32 Aligned_cols=174 Identities=27% Similarity=0.360 Sum_probs=145.6
Q ss_pred CCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+|+..+.||+|+||.||+|+++++..+|+|.+..... ...++.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4667889999999999999988777899999864332 335688999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc-
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN- 310 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 310 (331)
++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998642 23689999999999999999999999 99999999999999999999999999987654322111
Q ss_pred ceeccccCCccccccccCCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~t 331 (331)
....++..|+|||.+.++.++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred CCCCCCccccCHHHhccCCCC
Confidence 111234579999999876653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=224.06 Aligned_cols=173 Identities=26% Similarity=0.383 Sum_probs=149.8
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.+|...+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4778888999999999999986 467899999997665556677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999998853 3588999999999999999999999 9999999999999999999999999998654333222
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....+++.|+|||.+.++.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred cCcccCCccccCHHHHcCCCC
Confidence 233468899999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=231.11 Aligned_cols=170 Identities=28% Similarity=0.406 Sum_probs=142.2
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eEE
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (331)
+|+..+.||+|+||.||++.. .+++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999986 46899999998643 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 577777643 34689999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCc-ccceeccccCCccccccccC
Q 020072 304 GSQNK-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
..... ......++..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCC
Confidence 33221 12223578899999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=217.98 Aligned_cols=170 Identities=31% Similarity=0.450 Sum_probs=141.4
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
+.||+|+||.||+|+.. +++.||+|.+.... .+....+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999874 68899999876443 34456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc--ce
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN--LK 312 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~ 312 (331)
.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......... ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999863 234689999999999999999999999 99999999999999999999999999986533221110 01
Q ss_pred eccccCCccccccccCCCC
Q 020072 313 LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~t 331 (331)
...+..|+|||.+.++.++
T Consensus 156 ~~~~~~y~aPE~~~~~~~~ 174 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYS 174 (252)
T ss_pred CCCceeecCchhhcCCCCC
Confidence 1234579999999877653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=219.77 Aligned_cols=162 Identities=29% Similarity=0.430 Sum_probs=136.7
Q ss_pred ceeeecCceEEEEEEECC-------------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 157 NILGEGGFGCVYKAKLDD-------------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2358899887655556668899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc-------EEEEe
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-------AKLSD 296 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-------~kl~D 296 (331)
++|||+++|+|..++.. ....+++..+++++.|+++||+|||++ +++||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988863 335689999999999999999999999 9999999999999987664 89999
Q ss_pred ccCceeCCCCCcccceeccccCCcccccccc
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
||++....... ...++..|+|||.+.+
T Consensus 156 ~g~~~~~~~~~----~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 156 PGIPITVLSRQ----ECVERIPWIAPECVED 182 (262)
T ss_pred CCCCccccCcc----cccccccccChhhhcC
Confidence 99986543221 2357889999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=219.29 Aligned_cols=179 Identities=28% Similarity=0.393 Sum_probs=151.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...++|...+.||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34578888999999999999999988888999999874433 34678999999999999999999999999899999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... .+..+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999998752 335689999999999999999999999 99999999999999999999999999986654321
Q ss_pred cc-cceeccccCCccccccccCCCC
Q 020072 308 KN-NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~-~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ......+..|+|||.+.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~ 182 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFT 182 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcC
Confidence 11 1112245689999998876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=203.94 Aligned_cols=171 Identities=29% Similarity=0.423 Sum_probs=145.4
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|...+.||+|.||+||+|+.. +++.||+|+++.. ++.......+|+.+++.++|+|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444567999999999999864 5788999988644 3334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
. .+|..+..+ -+..++.+.+..++.|+.+||.|+|++ .+.|||+||.|.||+.+|+.|++|||+++-++-....
T Consensus 84 d-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 84 D-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 6 467766653 345789999999999999999999999 9999999999999999999999999999888766544
Q ss_pred cceeccccCCccccccccCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~ 329 (331)
....+.|.+|.+|.++.+.+
T Consensus 158 ysaevvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_pred eeceeeeeeccCcceeeeee
Confidence 44446799999999997754
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=221.00 Aligned_cols=175 Identities=26% Similarity=0.347 Sum_probs=142.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..+.||+|+||.||+|++. ++. .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46677889999999999999864 343 47788875432 2344678889999999999999999998764 56788
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999864 234689999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCc--ccceeccccCCccccccccCCCC
Q 020072 305 SQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......++..|+|||++.++.+|
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 189 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYT 189 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcC
Confidence 2221 11223467789999999877664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=220.78 Aligned_cols=177 Identities=28% Similarity=0.382 Sum_probs=149.3
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||++.. .++..+++|.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999986 47889999987543 2334467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++++|.+++... .....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999888632 2345689999999999999999999999 999999999999999999999999999865543
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.........++..|+|||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~ 183 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCc
Confidence 3322223468899999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=230.14 Aligned_cols=180 Identities=30% Similarity=0.396 Sum_probs=145.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC-
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD- 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~- 219 (331)
..++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4457888999999999999999632 34789999986443 33446688999999999 899999999988754
Q ss_pred CeEEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSH-------------------------------------------------------- 243 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (331)
...++++||+++|+|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578899999999999988853211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCC
Q 020072 244 --GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGY 319 (331)
Q Consensus 244 --~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y 319 (331)
...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999999 999999999999999999999999999965432211 11223456789
Q ss_pred ccccccccCCCC
Q 020072 320 VAPEYLLDGMVN 331 (331)
Q Consensus 320 ~aPE~l~~~~~t 331 (331)
+|||++.++.+|
T Consensus 242 ~aPE~~~~~~~~ 253 (337)
T cd05054 242 MAPESIFDKVYT 253 (337)
T ss_pred cCcHHhcCCCCC
Confidence 999999877654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=221.74 Aligned_cols=171 Identities=32% Similarity=0.408 Sum_probs=148.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999875 57899999985432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999864 35689999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....+++.|+|||.+.++.+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~ 175 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGY 175 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCC
Confidence 223468899999999876654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=219.41 Aligned_cols=176 Identities=30% Similarity=0.424 Sum_probs=146.2
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|+..+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 456778899999999999999988888999999875433 3457899999999999999999999875 45689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++++|.++++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998652 234589999999999999999999999 999999999999999999999999999965433221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~ 181 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred cccCCCCCccccChHHHhcCCCc
Confidence 11122356689999998776543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=232.79 Aligned_cols=182 Identities=27% Similarity=0.408 Sum_probs=147.8
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCc-hhHHHHHHHHHHHhcCC-CCcceeeeeeEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSA 217 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~ 217 (331)
++...++|...+.||+|+||.||+|++. .+..||+|++..... ...+.+.+|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445566777899999999999999863 346899999975432 33457899999999997 999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCC-------------------------------------------------------
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPS------------------------------------------------------- 242 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 242 (331)
..+..++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCC
Q 020072 243 ----------------------------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSS 282 (331)
Q Consensus 243 ----------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~ 282 (331)
....+++...+.++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467888999999999999999998 9999999999
Q ss_pred CEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCC
Q 020072 283 NILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 283 Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|||+++++.+||+|||+++....... ......++..|+|||.+.++.+
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 99999999999999999965432111 1112346788999999987655
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=215.89 Aligned_cols=170 Identities=31% Similarity=0.447 Sum_probs=142.9
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
++||+|+||.||+|...++..+|+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999865433 33457899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc-ceec
Q 020072 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN-LKLS 314 (331)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 314 (331)
+++.. ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 98864 234589999999999999999999999 99999999999999999999999999986543222111 1123
Q ss_pred cccCCccccccccCCCC
Q 020072 315 GTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 315 gt~~y~aPE~l~~~~~t 331 (331)
++..|+|||++.++.++
T Consensus 156 ~~~~y~aPE~~~~~~~~ 172 (250)
T cd05085 156 IPIKWTAPEALNYGRYS 172 (250)
T ss_pred CcccccCHHHhccCCCC
Confidence 45679999999877653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=219.72 Aligned_cols=168 Identities=37% Similarity=0.539 Sum_probs=144.1
Q ss_pred CcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHH--HHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGR--EFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|+..+.||+|+||+||+++... ++.+|+|.+......... ...+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998764 568999999766443322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++. ....+++..++.++.|+++||+|||+. +++||||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999986 345689999999999999999999999 9999999999999999999999999999764222233
Q ss_pred cceeccccCCccccccc
Q 020072 310 NLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~ 326 (331)
.....++..|+|||++.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp BSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccccccc
Confidence 33456899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=217.63 Aligned_cols=174 Identities=29% Similarity=0.402 Sum_probs=150.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999875 5778999999766666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ....+++.++..++.|++.||+|||++ +++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998864 225689999999999999999999998 999999999999999999999999999865443322
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||.+.+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred ccccccCCccccCchhhccc
Confidence 22334678899999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=222.48 Aligned_cols=173 Identities=26% Similarity=0.399 Sum_probs=150.7
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.+|...+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999975 468899999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998853 3589999999999999999999999 9999999999999999999999999998654433332
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||.+.++.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred CCCcCCCccccCcchhcCCCC
Confidence 233468889999999887655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=220.19 Aligned_cols=176 Identities=27% Similarity=0.374 Sum_probs=146.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.+|...+.||+|+||.||+|... .++.||+|.+... .....++.+|++++++++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35677889999999999999865 4788999998643 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998642 335689999999999999999999999 9999999999999999999999999998654432211
Q ss_pred c-ceeccccCCccccccccCCCC
Q 020072 310 N-LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~-~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....++..|+|||.+.++.++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~ 183 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFS 183 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCC
Confidence 1 112235689999998776653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=235.05 Aligned_cols=171 Identities=27% Similarity=0.410 Sum_probs=136.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-------- 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------- 219 (331)
..++|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999874 67899999885332 2345799999999999999999876432
Q ss_pred CeEEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEec
Q 020072 220 DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDF 297 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Df 297 (331)
...++||||+++ +|.+++.. ......+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 56555432 23345799999999999999999999999 999999999999999664 7999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
|+++....... .....||+.|+|||++.++
T Consensus 216 Gla~~~~~~~~-~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 216 GSAKNLLAGQR-SVSYICSRFYRAPELMLGA 245 (440)
T ss_pred ccchhccCCCC-cccCCCCcCccCHHHhcCC
Confidence 99975433222 2234689999999998764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=219.02 Aligned_cols=176 Identities=28% Similarity=0.409 Sum_probs=145.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|...+.||+|+||.||+|+.+++..||+|.+..... ..+++.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456888999999999999999987777899999874333 34578999999999999999999998754 5689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998642 234689999999999999999999999 9999999999999999999999999998655432221
Q ss_pred -cceeccccCCccccccccCCCC
Q 020072 310 -NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 -~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~ 181 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFT 181 (262)
T ss_pred cccCCcccceecCHhHhccCCCC
Confidence 1122456789999998776553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=229.00 Aligned_cols=170 Identities=26% Similarity=0.288 Sum_probs=142.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...+|...+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++.+.+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999875 4678899875322 23568999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+. ++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 688887753 345789999999999999999999999 99999999999999999999999999986533221
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......||..|+|||++.++.++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~ 234 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYN 234 (357)
T ss_pred -ccccccccccccCCeecCCCCCC
Confidence 12234689999999999887664
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=221.29 Aligned_cols=175 Identities=27% Similarity=0.335 Sum_probs=153.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
-++|...++||+|.||.|-+++-+ +++.+|+|++++. .++....-+.|-++|+.-+||.+..|...+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999754 6889999999754 334445567889999999999999999899999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+.+|.|.-+|.+ ...+++.....+-..|+.||.|||++ +||+||||.+|.|+|+||.+||+|||+++..-.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988854 35688888889999999999999999 999999999999999999999999999977655
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......+|||+.|+|||++.+..|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY 345 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY 345 (516)
T ss_pred ccceeccccCChhhcCchhhccccc
Confidence 5566667899999999999998776
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.83 Aligned_cols=172 Identities=31% Similarity=0.476 Sum_probs=147.8
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|+..+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356778899999999999999875 78899999975544 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999986422 23689999999999999999999999 999999999999999999999999999866532221
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
....+..|+|||++.++.+
T Consensus 158 --~~~~~~~~~ape~~~~~~~ 176 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKF 176 (256)
T ss_pred --cCCCcccccCchhhcCCcC
Confidence 2234668999999887665
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=223.14 Aligned_cols=179 Identities=28% Similarity=0.423 Sum_probs=145.4
Q ss_pred hcCCcccceeeecCceEEEEEEECC---------------CceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD---------------NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLL 213 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~ 213 (331)
.++|+..+.||+|+||.||+++..+ ...||+|.+... .......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 235899998654 233456799999999999999999999
Q ss_pred eeEEcCCeEEEEEEecCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 214 GYSAHDDTRFIVYELMENRSLDIQLHGPS---------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 214 g~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
+++...+..++||||+++++|.+++.... ....+++..+++++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999885421 112478899999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 285 LLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++++++.+||+|||++......... .....++..|+|||++.++.++
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 209 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT 209 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC
Confidence 9999999999999998654322211 1122346789999998877653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=220.97 Aligned_cols=162 Identities=27% Similarity=0.407 Sum_probs=134.6
Q ss_pred eeeecCceEEEEEEECC-------------------------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceee
Q 020072 158 ILGEGGFGCVYKAKLDD-------------------------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 212 (331)
.||+|+||.||+|.+.. ...|++|.+.........++.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998875555556678899999999999999999
Q ss_pred eeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC--
Q 020072 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-- 290 (331)
Q Consensus 213 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-- 290 (331)
+++|.+.+..++||||+++|+|..++.. ....+++..++.++.|+++||+|||++ +++||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988863 234689999999999999999999998 999999999999998654
Q ss_pred -----cEEEEeccCceeCCCCCcccceeccccCCccccccccC
Q 020072 291 -----NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 291 -----~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.+|++|||++....... ...++..|+|||.+.++
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~aPe~~~~~ 195 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE----ERVERIPWIAPECVPGG 195 (274)
T ss_pred cCccceeeecCCcccccccccc----ccccCCcccCchhhcCC
Confidence 38999999875432221 12467889999988653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=221.38 Aligned_cols=178 Identities=28% Similarity=0.429 Sum_probs=148.2
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677889999999999999742 345689999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc
Q 020072 225 VYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 291 (331)
||||+++++|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986421 123589999999999999999999999 9999999999999999999
Q ss_pred EEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 292 AKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+||+|||++........ ......++..|+|||++.++.++
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 203 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC
Confidence 99999999865433221 11223467889999998876653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=220.92 Aligned_cols=174 Identities=26% Similarity=0.412 Sum_probs=146.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35777889999999999999876 6889999988654 333456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|..++........+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999988865333447899999999999999999999632 899999999999999999999999999865432222
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
....++..|+|||.+.++
T Consensus 159 --~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSG 176 (286)
T ss_pred --ccCCCccCccCcchhcCC
Confidence 123578899999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=222.62 Aligned_cols=182 Identities=30% Similarity=0.415 Sum_probs=148.9
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSA 217 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 217 (331)
++...++|+..+.||+|+||.||++... +...+|+|.+... ......++.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445567888899999999999999764 2367899988653 233456789999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
.++..+++|||+++|+|..+++.. .....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999998642 2245689999999999999999999998 999999999999
Q ss_pred EECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCC
Q 020072 285 LLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~ 330 (331)
++++++.+||+|||+++........ .....++..|+|||++.++.+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence 9999999999999999754432211 111234568999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.55 Aligned_cols=175 Identities=31% Similarity=0.402 Sum_probs=151.0
Q ss_pred hcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++|+||+++++++.+.+..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578888999999999999998865 78999999864432 67899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999863 335789999999999999999999999 999999999999999999999999999866544332
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++.+..+|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~ 177 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN 177 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC
Confidence 22334578899999998776543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=241.21 Aligned_cols=171 Identities=28% Similarity=0.457 Sum_probs=148.7
Q ss_pred CcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
|.+..-||.|+||.||+|..++ +...|.|++.....+...+|+-||++|+..+||+||+|++.|...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445669999999999998765 445577888888888899999999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|-.+..+- .-+..|++.++..+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...........
T Consensus 114 GAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred chHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99887664 3456799999999999999999999999 999999999999999999999999999855444444445
Q ss_pred eeccccCCccccccccC
Q 020072 312 KLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~ 328 (331)
.+.||++|||||+++-.
T Consensus 189 sFIGTPYWMAPEVvmCE 205 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCE 205 (1187)
T ss_pred cccCCcccccchheeec
Confidence 67899999999998643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=228.01 Aligned_cols=173 Identities=30% Similarity=0.372 Sum_probs=142.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----- 220 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----- 220 (331)
..++|...+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 5889999998643 3344567889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 221 -TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
..|+||||+++ +|...++ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999975 4555553 2478889999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... .....||..|+|||++.+..++
T Consensus 170 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 200 (359)
T cd07876 170 ARTACTNFM-MTPYVVTRYYRAPEVILGMGYK 200 (359)
T ss_pred ccccccCcc-CCCCcccCCCCCchhccCCCCC
Confidence 965432221 2234689999999999877653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=220.34 Aligned_cols=175 Identities=26% Similarity=0.437 Sum_probs=144.9
Q ss_pred CCcccceeeecCceEEEEEEE-----CCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEE
Q 020072 152 SFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (331)
.|+..+.||+|+||.||+++. .++..||+|.+.... ......+.+|++++++++|+|++++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456788999999999999974 357889999986543 33456799999999999999999999998875 5789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc---ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......++..|+|||++.++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 190 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCC
Confidence 33221 11123467789999998776553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=215.17 Aligned_cols=175 Identities=25% Similarity=0.374 Sum_probs=149.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.||.++.. ++..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998754 5788999988644 344556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.... ...+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986532 45689999999999999999999998 999999999999999999999999999876544332
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+++.|+|||++.+..+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~ 178 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKY 178 (256)
T ss_pred cccccCCCccccCHhhcCCCCC
Confidence 2234468999999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=215.88 Aligned_cols=174 Identities=31% Similarity=0.433 Sum_probs=146.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|...+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68899999885432 1234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 34588999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccc---ceeccccCCccccccccCCC
Q 020072 305 SQNKNN---LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~~~---~~~~gt~~y~aPE~l~~~~~ 330 (331)
...... ....++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCC
Confidence 221111 12357889999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=219.15 Aligned_cols=171 Identities=27% Similarity=0.419 Sum_probs=145.5
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999876 58899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|...+.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877642 34589999999999999999999998 99999999999999999999999999997654433
Q ss_pred cccceeccccCCcccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~ 327 (331)
.......++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred ccccCcccccccCCHHHHhC
Confidence 22223457889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=228.23 Aligned_cols=180 Identities=30% Similarity=0.407 Sum_probs=144.3
Q ss_pred HhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC-
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD- 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~- 219 (331)
..++|+..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346788899999999999999963 356789999997543 33456788999999999 689999999988654
Q ss_pred CeEEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSH-------------------------------------------------------- 243 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (331)
...+++|||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467999999999999988864210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--cccee
Q 020072 244 --------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKL 313 (331)
Q Consensus 244 --------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~ 313 (331)
...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12478889999999999999999999 999999999999999999999999999865432211 11122
Q ss_pred ccccCCccccccccCCCC
Q 020072 314 SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 314 ~gt~~y~aPE~l~~~~~t 331 (331)
.++..|+|||++.++.++
T Consensus 242 ~~~~~y~aPE~~~~~~~~ 259 (343)
T cd05103 242 RLPLKWMAPETIFDRVYT 259 (343)
T ss_pred CCCcceECcHHhcCCCCC
Confidence 356789999998776553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=222.02 Aligned_cols=172 Identities=30% Similarity=0.483 Sum_probs=144.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 57899999986443 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ ++|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588888764 234688999999999999999999999 999999999999999999999999999865433222
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGS 179 (301)
T ss_pred cccccceeecccCcHHHhCC
Confidence 22233578899999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=223.61 Aligned_cols=181 Identities=28% Similarity=0.417 Sum_probs=148.4
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSA 217 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 217 (331)
...++|...+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567788899999999999999641 2457999988643 234557799999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
..+..+++|||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999986532 124588999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 285 LLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++++++.+||+|||+++........ .....++..|+|||++.++.+|
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC
Confidence 9999999999999999765432221 1122356789999999877653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=224.04 Aligned_cols=180 Identities=28% Similarity=0.404 Sum_probs=146.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEc
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 218 (331)
..++|...+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|+++++++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467888999999999999999752 23569999987542 34456788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEE
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nil 285 (331)
.+..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||++ +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999865321 23589999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 286 LDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 286 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++++.+||+|||++......... .....++..|+|||++.++.++
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 220 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC
Confidence 999999999999998654322211 1111245689999998876653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=220.18 Aligned_cols=180 Identities=26% Similarity=0.393 Sum_probs=148.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
..++|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3467888899999999999999764 23689999986443 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 222 RFIVYELMENRSLDIQLHGPS-------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 999999999999999986422 123478999999999999999999998 9999999999999999999999
Q ss_pred EeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 295 SDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 295 ~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|||+++....... ......++..|+|||.+.++.++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 199 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC
Confidence 99999865433221 11223467899999998776553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=215.65 Aligned_cols=166 Identities=27% Similarity=0.469 Sum_probs=136.4
Q ss_pred eeecCceEEEEEEEC---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD---DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||.||+|.+. ++..||+|.+.... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 35579999986553 334567999999999999999999999886 4578999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc---cc
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN---NL 311 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~---~~ 311 (331)
.+++.. ....+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999864 234689999999999999999999999 9999999999999999999999999998654332211 11
Q ss_pred eeccccCCccccccccCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~ 330 (331)
...++..|+|||.+.++.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05115 157 AGKWPLKWYAPECINFRKF 175 (257)
T ss_pred CCCCCcccCCHHHHccCCC
Confidence 1123578999999876654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=218.69 Aligned_cols=176 Identities=27% Similarity=0.371 Sum_probs=143.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCc----eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|+..+.||+|+||+||+|++. ++. .||+|.+... ......++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356778899999999999999753 443 4899998654 33445678999999999999999999999975 4578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+++||+++|+|.++++. ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999864 234689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcc--cceeccccCCccccccccCCCC
Q 020072 304 GSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... .....++..|+|||.+.++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFT 189 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCC
Confidence 422211 1112346789999999877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=218.54 Aligned_cols=167 Identities=26% Similarity=0.361 Sum_probs=135.1
Q ss_pred eeeecCceEEEEEEECC---CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 158 ILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|++.++.++|+||+++++.+.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888775433 3345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--c
Q 020072 234 LDIQLHGPSH--GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--N 309 (331)
Q Consensus 234 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~ 309 (331)
|.+++..... ....++...+.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865322 23356788899999999999999999 999999999999999999999999999854322211 1
Q ss_pred cceeccccCCcccccccc
Q 020072 310 NLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~ 327 (331)
.....++..|+|||++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 159 KDCHAVPLRWLAPELVEI 176 (269)
T ss_pred cCCCCCcccccCHHHHhh
Confidence 112245678999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=233.30 Aligned_cols=179 Identities=27% Similarity=0.396 Sum_probs=151.4
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECC---C--ceEEEEEecc-cCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDD---N--LHVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
+..++.....++||+|-||.||+|.+.+ | -.||||..+. ...+..+.|+.|..+|++++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3344455567899999999999997632 2 4688998875 355667889999999999999999999999987 5
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..|+|||.++-|.|..||+. +...|+......++.||+.||+|||+. .+|||||..+|||+....-+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999985 445788999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccce-eccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLK-LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~t 331 (331)
+...+....... ..-+..|||||.+.=.+||
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFT 570 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFT 570 (974)
T ss_pred hhccccchhhccccccceeecCccccchhccc
Confidence 988766655433 2346689999999877665
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=216.39 Aligned_cols=173 Identities=29% Similarity=0.415 Sum_probs=145.8
Q ss_pred CCcccceeeecCceEEEEEEECCCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466788999999999999998889999999886432 12335688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 24588999999999999999999998 999999999999999999999999999854321
Q ss_pred C------CcccceeccccCCccccccccCCC
Q 020072 306 Q------NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~------~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
. ........++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 185 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCC
Confidence 1 111122357889999999877654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=218.34 Aligned_cols=177 Identities=25% Similarity=0.376 Sum_probs=147.2
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56778899999999999999864 3467899988654443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 224 IVYELMENRSLDIQLHGPSHG------SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998753321 2689999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCC-cccceeccccCCccccccccCCC
Q 020072 298 GLAITDGSQN-KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 298 gla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|++....... .......++..|+|||.+.++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 9986433221 11122346778999999876654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=214.99 Aligned_cols=171 Identities=34% Similarity=0.540 Sum_probs=145.7
Q ss_pred ceeeecCceEEEEEEECC----CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|++.+..++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 788999998755443 367899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 232 RSLDIQLHGPSH------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 232 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
++|.+++..... ...+++.+++.++.|++.||+|||++ +++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999875311 36799999999999999999999998 999999999999999999999999999976543
Q ss_pred CC--cccceeccccCCccccccccCCC
Q 020072 306 QN--KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~--~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. .......++..|+|||.+.++.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIF 184 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCc
Confidence 32 11223357889999999876544
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=221.62 Aligned_cols=180 Identities=26% Similarity=0.348 Sum_probs=148.2
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
...++|...+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467888999999999999999741 34579999886543 33456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
+..+++|||+++|+|.++++.. ....+++.++..++.|++.||+|||++ +++|+||||+|||+++++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999998742 234489999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+........ ......++..|+|||++.++.++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 221 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT 221 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCC
Confidence 865432221 11122356789999998776653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=222.45 Aligned_cols=170 Identities=32% Similarity=0.402 Sum_probs=145.7
Q ss_pred cccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
.....||+|+||.||++... ++..||+|.+........+.+.+|+..+++++|+||+++++.+...+..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999864 57899999987655556677899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccce
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
+|.+++.. ..+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||++............
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 99988743 3588999999999999999999999 9999999999999999999999999998654333222233
Q ss_pred eccccCCccccccccCCC
Q 020072 313 LSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~~ 330 (331)
..++..|+|||++.+..+
T Consensus 178 ~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 178 LVGTPYWMAPEVISRLPY 195 (292)
T ss_pred eecCccccCHHHHccCCC
Confidence 468899999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=220.24 Aligned_cols=179 Identities=29% Similarity=0.424 Sum_probs=147.5
Q ss_pred hcCCcccceeeecCceEEEEEEECC-----------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCccee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-----------------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~ 211 (331)
.++|+..+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987642 2458999986543 345568999999999999999999
Q ss_pred eeeeEEcCCeEEEEEEecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPS--------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 212 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986422 123689999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++++++.++|+|||+++....... ......++..|+|||++.++.++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT 210 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC
Confidence 9999999999999999865433221 11123456789999998876553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=235.86 Aligned_cols=166 Identities=27% Similarity=0.424 Sum_probs=139.9
Q ss_pred ccceeeecCceEEEEEEEC-CCceEEEEEec--c--cCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe--EEEEEE
Q 020072 155 ESNILGEGGFGCVYKAKLD-DNLHVAVKKLD--C--ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT--RFIVYE 227 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e 227 (331)
...+||+|+|-+||+|.+. +|.+||.-.++ . ......++|..|+.+|+.|+|+||++++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999764 57888754332 1 234455889999999999999999999999987664 788999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 306 (331)
.+..|+|..|+. +...++.+....|++||++||.|||++ .|+|+|||||.+||+|+. -|.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999985 445688999999999999999999997 789999999999999985 589999999999765544
Q ss_pred CcccceeccccCCccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~ 326 (331)
... ...|||.|||||++.
T Consensus 200 ~ak--svIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 200 HAK--SVIGTPEFMAPEMYE 217 (632)
T ss_pred ccc--eeccCccccChHHHh
Confidence 333 358999999999986
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=218.45 Aligned_cols=174 Identities=29% Similarity=0.458 Sum_probs=146.5
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC------
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~------ 219 (331)
.+++.|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888899999999999999865 57889999986443 3346788999999999 799999999998753
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
+..+++|||+++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999988652 335689999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCccccccc
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
+..............|+..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred ceecccccccCCcccccccccCHhHhc
Confidence 976543333333456899999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=216.28 Aligned_cols=161 Identities=29% Similarity=0.442 Sum_probs=135.7
Q ss_pred ceeeecCceEEEEEEECCCc-----------eEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 157 NILGEGGFGCVYKAKLDDNL-----------HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999876432 4777876544333 6788999999999999999999999988 788999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-------cEEEEecc
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-------NAKLSDFG 298 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-------~~kl~Dfg 298 (331)
+||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998642 23689999999999999999999998 999999999999999888 79999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
++...... ....++..|+|||++.+.
T Consensus 154 ~a~~~~~~----~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 154 IPITVLSR----EERVERIPWIAPECIRNG 179 (259)
T ss_pred cccccccc----cccccCCCccChhhhcCC
Confidence 98765431 123467789999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=218.80 Aligned_cols=178 Identities=28% Similarity=0.414 Sum_probs=148.1
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.+|...+.||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45667889999999999999642 356889999876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 225 VYELMENRSLDIQLHGPSH------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
++||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998864221 13589999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 293 KLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||+++........ .....+++.|+|||++.++.++
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 202 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC
Confidence 99999998654322211 1122346789999998877653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=217.19 Aligned_cols=175 Identities=29% Similarity=0.469 Sum_probs=144.5
Q ss_pred CCcccceeeecCceEEEEEEECC-C---ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+|+..+.||+|+||.||+|.... + ..||+|.+... ......+|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998653 3 36999998754 3344578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998642 34689999999999999999999999 9999999999999999999999999998654322
Q ss_pred Ccc---cceec--cccCCccccccccCCCC
Q 020072 307 NKN---NLKLS--GTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~---~~~~~--gt~~y~aPE~l~~~~~t 331 (331)
... ..... .+..|+|||++.++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCccc
Confidence 111 11111 23579999999877653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=220.64 Aligned_cols=177 Identities=29% Similarity=0.415 Sum_probs=144.4
Q ss_pred CCcccceeeecCceEEEEEEEC------CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+|...+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556778999999999999763 2478999999754433 34668899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc
Q 020072 225 VYELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 291 (331)
++||+++++|.+++... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999887421 1123588899999999999999999999 9999999999999999999
Q ss_pred EEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 292 AKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+||+|||+++........ .....+++.|+|||++.++.++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence 999999998654332211 1122356789999999877653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=213.52 Aligned_cols=176 Identities=28% Similarity=0.414 Sum_probs=147.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 227 (331)
+|+..+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777899999999999999865 46889999986432 3345678999999999999999999988764 446899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988642 345689999999999999999999999 99999999999999999999999999987654333
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.......+++.|+|||++.++.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~ 180 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYN 180 (257)
T ss_pred CccccccCCcCccChhHhcCCCCC
Confidence 333344688999999999877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=217.24 Aligned_cols=168 Identities=24% Similarity=0.320 Sum_probs=137.6
Q ss_pred ceeeecCceEEEEEEECC---CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 157 NILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
+.||+|+||.||+|+..+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998653 3578999886543 234457899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc-
Q 020072 233 SLDIQLHGPS--HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN- 309 (331)
Q Consensus 233 ~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 309 (331)
+|.++++... .....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986422 223467788889999999999999999 9999999999999999999999999998654322211
Q ss_pred -cceeccccCCcccccccc
Q 020072 310 -NLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 310 -~~~~~gt~~y~aPE~l~~ 327 (331)
.....++..|+|||++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred cCCCcCCcccccCHhHhcc
Confidence 112346788999999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=219.39 Aligned_cols=176 Identities=31% Similarity=0.414 Sum_probs=143.5
Q ss_pred CCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+|+..+.||+|+||.||+|... ....+++|.+.... .....++.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667889999999999999753 23568888876443 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 225 VYELMENRSLDIQLHGPS---------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
++||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875421 123588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+++++.+||+|||+++....... ......++..|+|||++.+..+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 9999999999999999865432211 1112245678999999876654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=215.67 Aligned_cols=174 Identities=30% Similarity=0.396 Sum_probs=143.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (331)
++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999865 58899999875321 22346788999999999999999999988764 468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
+++|||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++||||||+||++++++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 23578899999999999999999999 999999999999999999999999999864
Q ss_pred CCCCC---cccceeccccCCccccccccCCC
Q 020072 303 DGSQN---KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... .......++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCC
Confidence 33211 11122358889999999877654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=222.88 Aligned_cols=182 Identities=29% Similarity=0.409 Sum_probs=147.4
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYS 216 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~ 216 (331)
+...++|...+.||+|+||.||+++.. ....+|+|.+.... .....++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 334567888999999999999999742 24578999886442 33456789999999999 699999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
.+.+..++++||+++|+|.+++.... ....+++.++.+++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99999999999999999999986421 124589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+++++.+||+|||+++........ .....++..|+|||++.++.++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC
Confidence 99999999999999999654332211 1112244679999999877653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=220.11 Aligned_cols=177 Identities=29% Similarity=0.466 Sum_probs=143.5
Q ss_pred cCCcccceeeecCceEEEEEEECC-C--ceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD-N--LHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..++||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998753 3 34788887643 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
+||+++|+|.++++... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986421 123588999999999999999999998 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||++........ ......+..|+|||++.++.++
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 196 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYT 196 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhccCCCC
Confidence 9999999854321111 1111235679999998776653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=215.74 Aligned_cols=176 Identities=28% Similarity=0.401 Sum_probs=145.2
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|...+.||+|++|.||+|..+++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34677788999999999999998877789999876433 23467889999999999999999999875 45689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999998652 334589999999999999999999999 999999999999999999999999999966533221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~ 181 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcC
Confidence 11122356789999998776553
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=217.99 Aligned_cols=179 Identities=25% Similarity=0.355 Sum_probs=147.7
Q ss_pred HhcCCcccceeeecCceEEEEEEECC-----CceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~ 221 (331)
..++|...++||+|+||.||+|...+ +..|++|++... .......+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999998765 688999988644 33445678999999999999999999998876 467
Q ss_pred EEEEEEecCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 222 RFIVYELMENRSLDIQLHGPSHG-----SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
.++++||+++|+|.+++...... ..+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653222 5689999999999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCcc--cceeccccCCccccccccCCC
Q 020072 297 FGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 297 fgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+++........ .....++..|+|||++.+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 9999754322211 111235678999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=221.57 Aligned_cols=176 Identities=31% Similarity=0.516 Sum_probs=142.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCc--eEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..+.||+|+||.||+|.++ ++. .+++|.+... .......+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999864 343 4677777543 334456789999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
+||+++|+|.++++... ....+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986422 123589999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+|||++........ .....++..|+|||++.++.+
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 200 (303)
T cd05088 164 KIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVY 200 (303)
T ss_pred EeCccccCcccchhhh-cccCCCcccccCHHHHhccCC
Confidence 9999999853321111 111234668999999876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=213.68 Aligned_cols=171 Identities=33% Similarity=0.488 Sum_probs=146.4
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+|+..+.||+|+||.||+|... ++..|++|.+.... ++..+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999876 78899999885432 23456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999863 34588999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcccceeccccCCccccccccCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.. ......++..|+|||.+.++.
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~ 177 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQG 177 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCC
Confidence 32 122345888999999986654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=218.96 Aligned_cols=170 Identities=36% Similarity=0.498 Sum_probs=144.1
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch-----hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+|+..+.||+|+||.||+|... +++.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999865 6889999998654322 345678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986422 3699999999999999999999999 999999999999999999999999999976544
Q ss_pred CCcccceeccccCCcccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.........++..|+|||.+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred CCccccccccceeeeCHHHHhC
Confidence 3322222346788999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=222.00 Aligned_cols=169 Identities=28% Similarity=0.354 Sum_probs=145.4
Q ss_pred ccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 155 ESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999865 688999999876555556678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccccee
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 313 (331)
|..++.. ..+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.............
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9987742 4589999999999999999999999 99999999999999999999999999986543333223345
Q ss_pred ccccCCccccccccCCC
Q 020072 314 SGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 314 ~gt~~y~aPE~l~~~~~ 330 (331)
.++..|+|||++.+..+
T Consensus 178 ~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 178 VGTPYWMAPEVISRTPY 194 (297)
T ss_pred ecCccccCHHHHccCCC
Confidence 68999999999977654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=215.25 Aligned_cols=177 Identities=25% Similarity=0.382 Sum_probs=147.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...++|...+.||+|+||.||++..+++..+++|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345678889999999999999999888888999988643 2345678999999999999999999999887 78899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999998753 345688999999999999999999998 99999999999999999999999999986543322
Q ss_pred c-ccceeccccCCccccccccCCC
Q 020072 308 K-NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
. ......++..|+|||++..+.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~ 180 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF 180 (260)
T ss_pred cccccCCcccccccCHhHhccCCc
Confidence 1 1112235677999999977654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=217.74 Aligned_cols=173 Identities=29% Similarity=0.392 Sum_probs=143.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
+++|...+.||+|+||.||+|... ++..|++|.+..... .....+.+|++++++++|+||+++++++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888999999999999999764 688999999865432 233467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+. +++.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 667666543 224578888999999999999999999 99999999999999999999999999986543322
Q ss_pred cccceeccccCCccccccccC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.......++..|+|||++.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred CCCCCccccccccCCceeecC
Confidence 222233578899999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=218.47 Aligned_cols=171 Identities=30% Similarity=0.476 Sum_probs=143.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|++|.||+|+.. +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 6789999998644322 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ ++|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 4898887642 34689999999999999999999999 999999999999999999999999999865432222
Q ss_pred ccceeccccCCcccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~ 327 (331)
......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred cccccccccccCCcHHhhc
Confidence 2222346789999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=215.52 Aligned_cols=177 Identities=26% Similarity=0.426 Sum_probs=146.0
Q ss_pred hcCCcccceeeecCceEEEEEEECC-C---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|+..+.||+|+||.||+|+... + ..+++|.++... ....+++.+|++++++++|+|++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788999999999999998752 3 368999886543 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999864 235689999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcccc---eeccccCCccccccccCCCC
Q 020072 305 SQNKNNL---KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~---~~~gt~~y~aPE~l~~~~~t 331 (331)
....... ....+..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcC
Confidence 2221111 11234579999998876653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=216.32 Aligned_cols=173 Identities=31% Similarity=0.389 Sum_probs=150.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999865 57899999986543 44556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999863 2789999999999999999999999 999999999999999999999999999976654433
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......++..|+|||++.++.+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~ 175 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGY 175 (274)
T ss_pred ccccccCCccccChhhhccCCC
Confidence 3334468889999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=219.35 Aligned_cols=179 Identities=30% Similarity=0.421 Sum_probs=147.4
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEE-----
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSA----- 217 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~----- 217 (331)
.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34557789999999999999999999875 57889999876432 2345688899999999 7999999999874
Q ss_pred cCCeEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 345789999999999999887532 2335688999999999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCcccceeccccCCcccccccc
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
||++..............|+..|+|||++..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhch
Confidence 9998765433222233468999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=226.26 Aligned_cols=173 Identities=29% Similarity=0.370 Sum_probs=142.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 219 (331)
..++|...+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 5789999998643 233456788999999999999999999988644
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||++ +++||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5655553 2488899999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... .....||..|+|||++.+..++
T Consensus 166 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 196 (355)
T cd07874 166 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYK 196 (355)
T ss_pred cccCCCccc-cCCccccCCccCHHHHcCCCCC
Confidence 976543322 1234689999999999876653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=218.49 Aligned_cols=173 Identities=27% Similarity=0.387 Sum_probs=150.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
++|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999754 67889999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ..+++.++..++.|++.||.|||++ +++||||+|+||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998853 3478999999999999999999999 9999999999999999999999999998655443333
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....+++.|+|||.+.++.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred cccccCChhhcCchhhccCCC
Confidence 333468889999999877655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=229.53 Aligned_cols=171 Identities=26% Similarity=0.322 Sum_probs=143.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
...+|...+.||+|+||.||++... .+..|++|.+... ....+|++++++++||||+++++++...+..+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999753 3578999987532 3456899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||++. ++|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 67888773 335699999999999999999999999 999999999999999999999999999865443
Q ss_pred CCc--ccceeccccCCccccccccCCCC
Q 020072 306 QNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......||..|+|||++..+.|+
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 265 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYC 265 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCC
Confidence 222 12235689999999999877653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=218.64 Aligned_cols=172 Identities=28% Similarity=0.399 Sum_probs=146.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455678999999999999865 57889999886443 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999988752 4589999999999999999999998 9999999999999999999999999998665433322
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||++.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~ 178 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred hhcccCcccccCHHHhCcCCC
Confidence 233457889999999987655
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=214.33 Aligned_cols=172 Identities=28% Similarity=0.444 Sum_probs=144.2
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccCch---------hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD---------AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
|.....||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999764 5789999988543221 235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999853 34688999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC------cccceeccccCCccccccccCCC
Q 020072 303 DGSQN------KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~------~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... .......|+..|+|||.+.++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 189 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCC
Confidence 43211 11112357889999999887655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=212.48 Aligned_cols=175 Identities=26% Similarity=0.377 Sum_probs=148.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.+|+++.. +++.|++|.+... ......++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777899999999999999764 6789999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++... ....+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988642 234578999999999999999999998 999999999999999999999999999866544332
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......|+..|+|||++.++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~ 178 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPY 178 (256)
T ss_pred hhhhccCCccccCHHHhCCCCC
Confidence 2223457889999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=218.83 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=145.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-----------------CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCccee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-----------------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVC 211 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~ 211 (331)
.++|+..+.||+|+||.||++... ++..||+|.+... ......++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 2346899998754 3334568999999999999999999
Q ss_pred eeeeEEcCCeEEEEEEecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPS--------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 212 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
+++++...+..+++|||+++|+|.+++.... ....+++.+...++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 9999999999999999999999999886521 123478889999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+++++.++|+|||++......... .....++..|+|||+..++.++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 210 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT 210 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc
Confidence 99999999999999998654322211 1112346789999988777653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=212.73 Aligned_cols=174 Identities=28% Similarity=0.414 Sum_probs=151.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|++|.||+|+.. +++.|++|++..... .....+.+|++.+.+++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46788899999999999999876 489999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998642 568999999999999999999999 8 99999999999999999999999999987655443
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~ 177 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESY 177 (264)
T ss_pred CcccceeecccccCHhhhCCCCC
Confidence 33334467899999999877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=225.04 Aligned_cols=173 Identities=29% Similarity=0.366 Sum_probs=143.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 219 (331)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999864 5788999998643 233456788999999999999999999987643
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
...|+||||+++ +|...+. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6666653 2478899999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... .....++..|+|||++.+..++
T Consensus 173 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 203 (364)
T cd07875 173 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYK 203 (364)
T ss_pred ccccCCCCc-ccCCcccCCcCCHHHHhCCCCC
Confidence 976543322 1234689999999999877653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=216.70 Aligned_cols=174 Identities=32% Similarity=0.441 Sum_probs=138.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeeEEcC-----C
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSAHD-----D 220 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~-----~ 220 (331)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999865 688999999864322 2234556777777665 799999999988642 4
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++++||++ ++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999998 5888877642 234589999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........ .....++..|+|||++.++.++
T Consensus 156 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 185 (288)
T cd07863 156 RIYSCQMA-LTPVVVTLWYRAPEVLLQSTYA 185 (288)
T ss_pred ccccCccc-CCCccccccccCchHhhCCCCC
Confidence 76543222 1233578999999999876653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=219.02 Aligned_cols=176 Identities=26% Similarity=0.352 Sum_probs=148.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 488999999865432 24567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998864 2345789999999999999999999999 9999999999999999999999999998543211
Q ss_pred Cc-----------------------------ccceeccccCCccccccccCCC
Q 020072 307 NK-----------------------------NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ......|+..|+|||++.++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 10 0112357889999999977654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=212.78 Aligned_cols=170 Identities=29% Similarity=0.411 Sum_probs=142.2
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEE-cCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA-HDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 229 (331)
++|...+.||+|+||.||++... +..|++|...... ..+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999875 6789999886432 3467899999999999999999999765 456789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 999999998642 234589999999999999999999999 999999999999999999999999999865433221
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
...++..|+|||++.++.+
T Consensus 158 --~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 158 --TGKLPVKWTAPEALREKKF 176 (256)
T ss_pred --CCccceeecCHHHHccCCC
Confidence 2234668999999877655
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=217.65 Aligned_cols=180 Identities=34% Similarity=0.453 Sum_probs=146.2
Q ss_pred HhcCCcccceeeecCceEEEEEEECC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
.+++|...+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 5678999886443 3344679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC---cEEE
Q 020072 222 RFIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~kl 294 (331)
.++||||+++++|.+++.... ....+++..+++++.||+.||+|||++ +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 999999999999999886532 123589999999999999999999999 999999999999998754 5999
Q ss_pred EeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 295 SDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|||+++........ ......+..|+|||++.++.+|
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT 199 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC
Confidence 999999765322211 1111235689999999877654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=218.94 Aligned_cols=179 Identities=28% Similarity=0.420 Sum_probs=147.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 46789999986543 33456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 223 FIVYELMENRSLDIQLHGPS-------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999986311 113478899999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++++++.+||+|||++......... ......+..|+|||++.++.++
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence 99999999999999998654322211 1112346679999998876653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=215.60 Aligned_cols=174 Identities=28% Similarity=0.433 Sum_probs=143.3
Q ss_pred cCCcccceeeecCceEEEEEEECC-C----ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD-N----LHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..+.||+|+||.||+|...+ | ..+|+|.+.... .....++.+|++++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467778999999999999998642 3 258999886543 3345678999999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999864 234589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCcccc--eeccccCCccccccccCCC
Q 020072 305 SQNKNNL--KLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~~~~--~~~gt~~y~aPE~l~~~~~ 330 (331)
....... ...++..|+|||.+.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIY 188 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCc
Confidence 3221111 1123568999999877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=218.70 Aligned_cols=171 Identities=29% Similarity=0.421 Sum_probs=145.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46778899999999999999876 578999998754322 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.++... ...+++.+++.++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877643 23589999999999999999999999 99999999999999999999999999986654333
Q ss_pred cccceeccccCCcccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~ 327 (331)
.......++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred cccCcccceeeccCcHHhcc
Confidence 32223457889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=213.72 Aligned_cols=169 Identities=29% Similarity=0.400 Sum_probs=142.4
Q ss_pred ceeeecCceEEEEEEECC--C--ceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDD--N--LHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++|+||+++++++.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999976655 566789999999999999999999999988 899999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc---
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--- 308 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--- 308 (331)
|+|.+++..... ..+++...+.++.|++.||+|||++ +++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999875332 5689999999999999999999999 999999999999999999999999999866543211
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred cccCCCCCceecCHHHhcccCc
Confidence 1112346788999999877654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=223.14 Aligned_cols=168 Identities=30% Similarity=0.424 Sum_probs=141.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 219 (331)
..++|...+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 678999999864322 2345678999999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
...|+++|++ +++|..++. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 678887764 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCcccccccc
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
++...... ....|+..|+|||++.+
T Consensus 165 ~~~~~~~~---~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 165 ARQADDEM---TGYVATRWYRAPEIMLN 189 (343)
T ss_pred ceecCCCc---CCccccccccCchHhcC
Confidence 97654322 23468999999999876
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=212.97 Aligned_cols=174 Identities=29% Similarity=0.400 Sum_probs=144.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTR 222 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~ 222 (331)
.+|...+.||+|+||.||+|... ++..|++|++.... ......+.+|++++++++|+||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999764 58899999885332 2234568899999999999999999998875 3578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999998853 34588999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC---cccceeccccCCccccccccCCC
Q 020072 303 DGSQN---KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... .......++..|+|||.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCC
Confidence 43211 11112357889999999977654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=219.90 Aligned_cols=167 Identities=30% Similarity=0.416 Sum_probs=133.1
Q ss_pred cceeeecCceEEEEEEEC---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEEEEEEecC
Q 020072 156 SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVYELME 230 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 230 (331)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 45789999986432 23457889999999999999999998854 456899999986
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE----CCCCcEEEEeccCc
Q 020072 231 NRSLDIQLHGP------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA 300 (331)
Q Consensus 231 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgla 300 (331)
++|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4776665421 1223589999999999999999999999 99999999999999 45678999999999
Q ss_pred eeCCCCCc---ccceeccccCCccccccccC
Q 020072 301 ITDGSQNK---NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 328 (331)
+....... ......+|+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCC
Confidence 76543221 12234689999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=228.85 Aligned_cols=173 Identities=29% Similarity=0.356 Sum_probs=148.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-C-----CcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-H-----PNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~ 222 (331)
.-+|++.++||+|.||.|-+|... +++.||||+++.. +...++-..|+.+|..|+ | -|+|++++++...+..
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 337888999999999999999764 6899999999743 344566678999999997 4 5899999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC--CcEEEEeccCc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLA 300 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfgla 300 (331)
|||+|.++ -+|+++|... +...++......|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+
T Consensus 264 ciVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999985 6999999763 445699999999999999999999999 99999999999999753 46999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+....... ...-+..|+|||+|.+.+|+
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~ 366 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYD 366 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCC
Confidence 88765444 34678899999999999985
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=231.51 Aligned_cols=168 Identities=30% Similarity=0.440 Sum_probs=149.2
Q ss_pred ceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 157 NILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
-+||+|.||+||-|++.+ ...+|||.+.....+..+-+..||.+-++|+|+|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999998754 5678999998887778888999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCCCCcccce
Q 020072 236 IQLHGPSHGSAL--TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 236 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
+.|+. +-+++ .+.+.-.+..||++||.|||++ .|||||||-+|||++. .|.+||+|||-++....-.....+
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 99974 44556 7778888999999999999999 9999999999999975 799999999999776655566667
Q ss_pred eccccCCccccccccCC
Q 020072 313 LSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~~~ 329 (331)
+.||..|||||+|-.|+
T Consensus 736 FTGTLQYMAPEvIDqG~ 752 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGP 752 (1226)
T ss_pred cccchhhhChHhhccCC
Confidence 88999999999997664
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=214.37 Aligned_cols=175 Identities=29% Similarity=0.416 Sum_probs=139.6
Q ss_pred cccceeeecCceEEEEEEECCCc---eEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------CeE
Q 020072 154 HESNILGEGGFGCVYKAKLDDNL---HVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------DTR 222 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~ 222 (331)
...+.||+|+||.||+|++.++. .||+|.++.. .....+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 35678999999999999876432 5899988643 344557789999999999999999999987542 246
Q ss_pred EEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 223 FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
++++||+++|+|.+++... .....+++.....++.|++.||+|||++ +++||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998876421 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++........ .....++..|+|||++.++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcC
Confidence 8764332211 1122356789999999876553
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=223.00 Aligned_cols=182 Identities=29% Similarity=0.402 Sum_probs=147.4
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYS 216 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~ 216 (331)
+....+|...+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+++++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334457888999999999999999642 12368999886443 33457899999999999 899999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
...+..++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986421 123588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+++++.+||+|||+++........ .....++..|+|||++.++.++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC
Confidence 99999999999999999765432211 1112345679999999876653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=217.40 Aligned_cols=174 Identities=28% Similarity=0.392 Sum_probs=145.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999875 56889999986543 234457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999853 34689999999999999999999999 9999999999999999999999999998532110
Q ss_pred Cc---------------ccceeccccCCccccccccCCC
Q 020072 307 NK---------------NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~---------------~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ......++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 193 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCC
Confidence 00 0011346789999999877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=214.50 Aligned_cols=172 Identities=27% Similarity=0.393 Sum_probs=147.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999875 57899999986443 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998853 3588999999999999999999999 9999999999999999999999999999665443333
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||++.++.+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~ 178 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAY 178 (277)
T ss_pred cccccCcccccCHhHhccCCC
Confidence 333457889999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=217.83 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=143.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.||+|+.. +|..||+|++.... ......+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999875 68899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ ++|.+++.. ....+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++..+....
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 577777653 234689999999999999999999999 999999999999999999999999999876543322
Q ss_pred ccceeccccCCccccccccCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~ 329 (331)
......++..|+|||++.++.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~ 175 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAK 175 (284)
T ss_pred CcCCCccccCCcChHHHhCCc
Confidence 222335788999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=215.13 Aligned_cols=170 Identities=27% Similarity=0.348 Sum_probs=140.1
Q ss_pred cccceeeecCceEEEEEEE-----CCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEE
Q 020072 154 HESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 225 (331)
...+.||+|+||+||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6788999999999988653 3577899999865432 3456788999999999999999999988754 368999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999853 3489999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcc---cceeccccCCccccccccCCC
Q 020072 306 QNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.... .....++..|+|||.+.++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 187 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF 187 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC
Confidence 2111 111235667999999877654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=210.69 Aligned_cols=170 Identities=33% Similarity=0.464 Sum_probs=143.1
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
+.||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877999999998755443 5567999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc--cee
Q 020072 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN--LKL 313 (331)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 313 (331)
+++... ...+++..++.++.+++.||+|||++ +++||||+|+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998642 34688999999999999999999999 99999999999999999999999999986543211111 111
Q ss_pred ccccCCccccccccCCCC
Q 020072 314 SGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 314 ~gt~~y~aPE~l~~~~~t 331 (331)
..+..|+|||.+.++.++
T Consensus 156 ~~~~~y~~PE~~~~~~~~ 173 (251)
T cd05041 156 QIPIKWTAPEALNYGRYT 173 (251)
T ss_pred cceeccCChHhhccCCCC
Confidence 235679999998877653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=213.34 Aligned_cols=175 Identities=29% Similarity=0.425 Sum_probs=141.9
Q ss_pred CcccceeeecCceEEEEEEECC----CceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe-----
Q 020072 153 FHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----- 221 (331)
|...+.||+|+||.||+|+... +..||+|.+... .......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998643 23345679999999999999999999999876554
Q ss_pred -EEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 222 -RFIVYELMENRSLDIQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
.++++||+++|+|..++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999998875422 234689999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCCcc--cceeccccCCccccccccCCC
Q 020072 298 GLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 298 gla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|+++........ .....++..|+|||++.++.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCC
Confidence 998754332211 111234678999999876654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=216.80 Aligned_cols=182 Identities=32% Similarity=0.436 Sum_probs=149.7
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC-
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD- 219 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~- 219 (331)
...+..+.++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3445567889999999999999999999874 67899999986432 2345678899999999 899999999998754
Q ss_pred ----CeEEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 220 ----DTRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 220 ----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
+..++|+||+++++|.++++.. .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999887532 2345689999999999999999999998 9999999999999999999999
Q ss_pred EeccCceeCCCCCcccceeccccCCccccccccC
Q 020072 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+|||++..............++..|+|||++..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCC
Confidence 9999986544332222234688899999998543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=212.64 Aligned_cols=172 Identities=28% Similarity=0.398 Sum_probs=146.6
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
-|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4566788999999999999864 67899999886433 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999988853 3589999999999999999999998 9999999999999999999999999998665433322
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||.+.++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~ 178 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred hccccCCccccChhhhccCCC
Confidence 223457889999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=211.60 Aligned_cols=172 Identities=33% Similarity=0.509 Sum_probs=147.4
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 678999999875544 3667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999863 34588999999999999999999999 999999999999999999999999999865443222
Q ss_pred ccc----eeccccCCccccccccCC
Q 020072 309 NNL----KLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 309 ~~~----~~~gt~~y~aPE~l~~~~ 329 (331)
... ...++..|+|||++.++.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred cccccccCCcCCcCccChhhccCCC
Confidence 111 245788999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-28 Score=214.61 Aligned_cols=173 Identities=28% Similarity=0.430 Sum_probs=145.0
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+|+..+.||+|++|.||+|+.. +|..||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999875 588999999875433 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++ +|.+++........+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 84 8888776533345689999999999999999999999 9999999999999999999999999998654332222
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
.....++..|++||++.++
T Consensus 157 ~~~~~~~~~y~~PE~~~~~ 175 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGS 175 (284)
T ss_pred cccccccccccChHHhcCC
Confidence 2233568899999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=211.91 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=136.9
Q ss_pred eeeecCceEEEEEEEC---CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 158 ILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 56889999986443 234567999999999999999999999886 45679999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc---
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--- 309 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--- 309 (331)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999853 34689999999999999999999999 9999999999999999999999999998655433221
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKF 175 (257)
T ss_pred cCCCCCCccccCHhHhccCCc
Confidence 111234578999999876554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=236.58 Aligned_cols=171 Identities=27% Similarity=0.386 Sum_probs=146.7
Q ss_pred ccceeeecCceEEEEEEE-CCC----ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 155 ESNILGEGGFGCVYKAKL-DDN----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..++||+|+||+||+|.+ .+| .+||+|++... ..+...+++.|+.+|.+|+|||+++|+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367899999999999965 233 57899988644 4556789999999999999999999999999866 8899999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
|+.|+|.++++. ....+..+..+.|..|||+||.|||++ +++||||.++|||+.+-..+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999974 556788899999999999999999999 999999999999999999999999999987765554
Q ss_pred ccce--eccccCCccccccccCCCC
Q 020072 309 NNLK--LSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~--~~gt~~y~aPE~l~~~~~t 331 (331)
+... ..-.+.|||=|.+....||
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~t 878 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYT 878 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCC
Confidence 3322 2346789999999888875
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=215.34 Aligned_cols=173 Identities=32% Similarity=0.496 Sum_probs=144.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999875 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+. ++|..++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888887642 345689999999999999999999999 999999999999999999999999999865543322
Q ss_pred ccceeccccCCccccccccCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~ 329 (331)
......++..|+|||++.+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~ 176 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCK 176 (284)
T ss_pred ccccccccccccCCeEEecCC
Confidence 222335688999999886543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=212.87 Aligned_cols=170 Identities=32% Similarity=0.524 Sum_probs=138.0
Q ss_pred ceeeecCceEEEEEEECC-Cc--eEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDD-NL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
++||+|+||.||+|++.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 4688887643 334556789999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 232 RSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 232 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 123588999999999999999999998 99999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
++........ ......+..|+|||++.++.+
T Consensus 158 l~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 158 LSRGQEVYVK-KTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred Cccccchhhh-ccCCCCccccCChHHHccCCC
Confidence 9853221111 111234567999999876655
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=230.93 Aligned_cols=183 Identities=28% Similarity=0.381 Sum_probs=154.8
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
+++|-...+....+.||-|-||.||.|.|+. ...||||.++.... ..++|+.|..+|+.++|||+|+|+|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455555566677899999999999999875 56899999986554 568899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|+|+|||.+|+|.+||+.. ....++.-..+.+|.||+.||+||..+ .+|||||.++|||+.++..+|++||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999863 335577788899999999999999999 999999999999999999999999999988
Q ss_pred CCCCCcccc-eeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNL-KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~-~~~gt~~y~aPE~l~~~~~t 331 (331)
...+..... ...-...|.|||.+.-+.|+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFS 444 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFS 444 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccc
Confidence 765544321 11235689999998766553
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=210.94 Aligned_cols=174 Identities=24% Similarity=0.375 Sum_probs=146.2
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
.+|+..+.||+|+||.||++.+.++..+|+|.+..... ...++.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35667889999999999999887788999998864332 34578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc-
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN- 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 309 (331)
+++|.+++.. ....++++.++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999864 234688999999999999999999999 9999999999999999999999999998655332211
Q ss_pred cceeccccCCccccccccCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.....++.+|+|||++.++.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~ 178 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKY 178 (256)
T ss_pred cCCCccchhhcCHhHhccCCc
Confidence 111234678999999987655
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=213.93 Aligned_cols=167 Identities=25% Similarity=0.390 Sum_probs=135.0
Q ss_pred eeeecCceEEEEEEECCC---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 158 ILGEGGFGCVYKAKLDDN---LHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 345667665433 3345789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC--ccc
Q 020072 234 LDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNN 310 (331)
Q Consensus 234 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~ 310 (331)
|.++++... .....++.....++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987532 223467778889999999999999998 99999999999999999999999999985422111 111
Q ss_pred ceeccccCCcccccccc
Q 020072 311 LKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~ 327 (331)
....++..|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 159 DDKCVPLRWLAPELVGE 175 (268)
T ss_pred cCCcCcccccCchhccc
Confidence 23457889999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=213.03 Aligned_cols=175 Identities=26% Similarity=0.353 Sum_probs=143.5
Q ss_pred hcCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|...+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3467778999999999999998643 2468999886554 4456689999999999999999999999875 56789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998642 34589999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcc-cceeccccCCccccccccCCC
Q 020072 305 SQNKN-NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~~-~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... .....++..|+|||++..+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRF 185 (270)
T ss_pred cccceecCCCCccccccChhhhccCCC
Confidence 33211 112234568999999876654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=216.11 Aligned_cols=172 Identities=32% Similarity=0.446 Sum_probs=143.5
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 225 (331)
++|+..+.||+|+||.||+|+.. +++.+++|.++.... .....+.+|++++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999876 578899999864432 2234577899999999999999999998877 899999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||++ ++|.+.+... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5888887642 23689999999999999999999999 999999999999999999999999999876554
Q ss_pred CCcccceeccccCCccccccccC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.........++..|+|||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred CccccccccccccccCchhhcCC
Confidence 32222233578899999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=212.90 Aligned_cols=173 Identities=28% Similarity=0.467 Sum_probs=144.9
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+|+..+.||+|++|.||+++. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999986 468899999986432 1234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~ 303 (331)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 34688999999999999999999999 999999999999998775 6999999998654
Q ss_pred CCCCc----ccceeccccCCccccccccCCC
Q 020072 304 GSQNK----NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~~----~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... ......++..|+|||.+.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 185 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCC
Confidence 33211 1122357889999999876654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=213.13 Aligned_cols=171 Identities=28% Similarity=0.462 Sum_probs=147.0
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 226 (331)
.|+..+.||+|+||.||+|.. .++..|++|.+... ......++.+|+.++++++ |+|++++++++.+++..+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999986 46889999998654 3344567889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998853 2689999999999999999999999 9999999999999999999999999998765544
Q ss_pred CcccceeccccCCccccccccCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
........|+..|+|||.+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGK 177 (277)
T ss_pred ccccccccCCcceeCHHHhccCC
Confidence 33333456889999999987653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=213.56 Aligned_cols=171 Identities=29% Similarity=0.356 Sum_probs=146.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.||+|+.. ++..|++|++.... ......+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999875 68899999986543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+ +++|.+++... ...+++.+++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988642 35699999999999999999999999 999999999999999999999999999866543321
Q ss_pred -ccceeccccCCccccccccC
Q 020072 309 -NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 -~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||++.++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred CccccccCcccccCceeeecc
Confidence 12234588999999998654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=215.79 Aligned_cols=173 Identities=27% Similarity=0.380 Sum_probs=146.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46677889999999999999865 57889999876443 34457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++||||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 999999988853 346899999999999999999999732 799999999999999999999999999854322211
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
....|+..|+|||++.++.+
T Consensus 160 --~~~~~~~~~~aPE~~~~~~~ 179 (284)
T cd06620 160 --DTFVGTSTYMSPERIQGGKY 179 (284)
T ss_pred --CccccCcccCCHHHHccCCC
Confidence 23468999999999877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=214.80 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=145.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||.||+|... +++.|++|.++.. .......+.+|++++++++|+||+++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999876 5789999988643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|++++.+...... ...+++.++..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998877766532 34589999999999999999999999 99999999999999999999999999986654332
Q ss_pred c-ccceeccccCCccccccccC
Q 020072 308 K-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
. ......++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred cccccCcccccCCcCCchhcCC
Confidence 2 22234578899999999776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=211.51 Aligned_cols=169 Identities=30% Similarity=0.483 Sum_probs=136.7
Q ss_pred ceeeecCceEEEEEEEC----CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEEEEEEecC
Q 020072 157 NILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIVYELME 230 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 230 (331)
+.||+|+||.||+|++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2357999988543 33455788899999999999999999998764 556899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-- 308 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-- 308 (331)
+|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998642 33467888899999999999999998 999999999999999999999999999865432211
Q ss_pred --ccceeccccCCccccccccCCC
Q 020072 309 --NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 --~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......++..|+|||.+.++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred ecccccCcCCccccChhHhccCcc
Confidence 1112235678999999877655
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=213.78 Aligned_cols=176 Identities=30% Similarity=0.403 Sum_probs=150.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++.|+..+.||+|++|.||+|..+ ++..+++|.+..... ....+.+|++.+++++|+|++++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567778889999999999999876 678999999975544 56678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997532 4799999999999999999999998 99999999999999999999999999875443322
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......++..|+|||.+.++.+
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~ 193 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDY 193 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCC
Confidence 22223357889999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=212.99 Aligned_cols=172 Identities=30% Similarity=0.392 Sum_probs=147.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445679999999999999864 678999999875555556678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+++|.+++.. ..+++.++..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++..........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999998864 3589999999999999999999999 99999999999999999999999999886543332222
Q ss_pred ceeccccCCccccccccCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~ 330 (331)
....|+..|+|||.+.++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred ccccCCccccCHHHhcCCCC
Confidence 23458899999999877655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=237.35 Aligned_cols=170 Identities=26% Similarity=0.363 Sum_probs=147.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999876 68899999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+.+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999999863 24588999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcccceeccccCCccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~ 326 (331)
........+++.|++||...
T Consensus 158 ~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 158 ELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred cccccccccCccccCccccc
Confidence 44444567899999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=212.30 Aligned_cols=174 Identities=28% Similarity=0.399 Sum_probs=144.7
Q ss_pred CCcccceeeecCceEEEEEEEC-----CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~ 223 (331)
+|...+.||+|+||.||+|+++ ++..+|+|.+...... ...+|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5666789999999999999864 3678999999755443 56789999999999999999999999887 55789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
++|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999998642 33699999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCCcc---cceeccccCCccccccccCCC
Q 020072 304 GSQNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
...... .....++..|+|||.+.++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 422111 111234567999999876654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=210.33 Aligned_cols=176 Identities=29% Similarity=0.409 Sum_probs=146.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 226 (331)
+|+..+.||.|+||.||++... ++..||+|.+... .....+++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999764 6788999988643 33445678899999999999999999998764 45689999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLH-----EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH-----~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
||+++++|.+++... .....+++..++.++.|++.||.||| +. +++||||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999888642 23457999999999999999999999 66 9999999999999999999999999998
Q ss_pred eeCCCCCcccceeccccCCccccccccCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..............++..|+|||++.++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~ 187 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSY 187 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCC
Confidence 766544332233468999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=215.63 Aligned_cols=167 Identities=30% Similarity=0.417 Sum_probs=132.8
Q ss_pred cceeeecCceEEEEEEEC---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEEEEEEecC
Q 020072 156 SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVYELME 230 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 230 (331)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++++||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999999999865 34789999886432 23467899999999999999999998854 457899999987
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE----CCCCcEEEEeccCc
Q 020072 231 NRSLDIQLHGP------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA 300 (331)
Q Consensus 231 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgla 300 (331)
+ +|.+++... .....+++..+..++.|++.||+|||+. +++||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666555321 1223588999999999999999999999 99999999999999 56779999999999
Q ss_pred eeCCCCCc---ccceeccccCCccccccccC
Q 020072 301 ITDGSQNK---NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 328 (331)
+....... ......+|..|+|||++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCC
Confidence 76543221 12234689999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=214.88 Aligned_cols=163 Identities=25% Similarity=0.368 Sum_probs=137.5
Q ss_pred ceeeecCceEEEEEEECC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997632 234888888665555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc--------EEEEeccCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--------AKLSDFGLA 300 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~kl~Dfgla 300 (331)
+++|+|..+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998742 34689999999999999999999999 9999999999999987765 699999988
Q ss_pred eeCCCCCcccceeccccCCccccccccC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
...... ....++..|+|||++.++
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 156 ITVLPK----EILLERIPWVPPECIENP 179 (258)
T ss_pred cccCCc----hhccccCCccCchhccCC
Confidence 554322 123578899999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=216.52 Aligned_cols=174 Identities=30% Similarity=0.437 Sum_probs=140.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCc----eEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46677889999999999999764 343 478888764432 3345789999999999999999999998764 5678
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999863 234689999999999999999999999 99999999999999999999999999996543
Q ss_pred CCCc--ccceeccccCCccccccccCCC
Q 020072 305 SQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.... ......++..|+|||++.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKF 188 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCC
Confidence 2221 1112235678999999877654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=217.55 Aligned_cols=168 Identities=18% Similarity=0.244 Sum_probs=137.9
Q ss_pred cceeeec--CceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 156 SNILGEG--GFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 156 ~~~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
.++||+| +|++||++... +|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 5679999 68899999764 68999999986542 2344567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc--
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-- 308 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-- 308 (331)
+|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999988542 234589999999999999999999999 999999999999999999999999986533211100
Q ss_pred -----ccceeccccCCcccccccc
Q 020072 309 -----NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 -----~~~~~~gt~~y~aPE~l~~ 327 (331)
......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccceecccChHHhhc
Confidence 0112246778999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=212.50 Aligned_cols=171 Identities=27% Similarity=0.402 Sum_probs=147.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
+|+..+.||.|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999876 58899999986432 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.. ...+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999854 25789999999999999999999999 99999999999999999999999999986554332
Q ss_pred cccceeccccCCccccccccCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
. .....++..|+|||.+.+..
T Consensus 155 ~-~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 155 L-TTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred c-ccccCCChhhcCHHHHcccC
Confidence 1 12345788999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=209.71 Aligned_cols=175 Identities=29% Similarity=0.412 Sum_probs=148.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 67889999986443 23567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++........+++.....++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999987533335689999999999999999999999 999999999999999999999999999854432221
Q ss_pred ----ccceeccccCCccccccccC
Q 020072 309 ----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ----~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||++..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccccCChhhcChHHHccc
Confidence 11234588999999998765
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=209.78 Aligned_cols=174 Identities=29% Similarity=0.399 Sum_probs=144.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (331)
++|...+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987432 223456789999999999999999999998764 468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998853 24588999999999999999999999 999999999999999999999999999865
Q ss_pred CCCC---CcccceeccccCCccccccccCCC
Q 020072 303 DGSQ---NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~---~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.... ........++..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCC
Confidence 4321 111123457889999999877554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=212.77 Aligned_cols=175 Identities=33% Similarity=0.489 Sum_probs=147.6
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~------ 220 (331)
++++|+..+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999875 578899998865433 346789999999999 7999999999997644
Q ss_pred eEEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 221 TRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998876422 245789999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCcccccccc
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+..............++..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcc
Confidence 8655433333333468899999998854
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=208.54 Aligned_cols=173 Identities=35% Similarity=0.497 Sum_probs=144.8
Q ss_pred cccceeeecCceEEEEEEECC-----CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...+.||.|+||.||+++..+ +..||+|.+...... ..+.+.+|++.+..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998754 478999999755443 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999986422 12289999999999999999999999 99999999999999999999999999986654332
Q ss_pred cccc-eeccccCCccccccccCCC
Q 020072 308 KNNL-KLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~-~~~gt~~y~aPE~l~~~~~ 330 (331)
.... ...++..|+|||.+.++.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~ 181 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKF 181 (258)
T ss_pred ccccccCCCcccccChHHhccCCC
Confidence 2111 1236789999999866544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=209.00 Aligned_cols=168 Identities=29% Similarity=0.416 Sum_probs=137.8
Q ss_pred ceeeecCceEEEEEEECC----CceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|++.. +..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899999875543 34567999999999999999999999876 4568999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc-
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN- 310 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 310 (331)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999642 3689999999999999999999998 99999999999999999999999999986553322211
Q ss_pred --ceeccccCCccccccccCCCC
Q 020072 311 --LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 --~~~~gt~~y~aPE~l~~~~~t 331 (331)
....++..|+|||.+.++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~ 176 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFS 176 (257)
T ss_pred cccCccccccccCHHHhcCCCCC
Confidence 111234679999998776653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=243.49 Aligned_cols=178 Identities=24% Similarity=0.290 Sum_probs=153.9
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
+++....++|.+.++||+|+||.|..++.+ +++.+|+|++.+. .......|..|-++|.--+.+-|++++-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 445556789999999999999999999875 5788999999753 334556799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
+++|||||||+||+|-..+.. ...++++.+..++..|+-||.-||+. |+|||||||+|||||..|.+||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999998853 33799999999999999999999999 999999999999999999999999998
Q ss_pred ceeCCCC-CcccceeccccCCcccccccc
Q 020072 300 AITDGSQ-NKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 300 a~~~~~~-~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+.....+ .......+|||.|++||++..
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHh
Confidence 8554433 333345679999999999954
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=207.56 Aligned_cols=174 Identities=26% Similarity=0.404 Sum_probs=146.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999764 6789999998644 234467799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++... ....+++..+..++.|+++||+|||++ +++||||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998642 245689999999999999999999999 99999999999999865 568999999997654332
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ....++..|+|||.+.+..+
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08220 157 KA-YTVVGTPCYISPELCEGKPY 178 (256)
T ss_pred cc-cccccCCcccCchhccCCCC
Confidence 21 23457889999999977654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=209.96 Aligned_cols=170 Identities=32% Similarity=0.506 Sum_probs=141.8
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|...+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|+|++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57789999986432 345789999999999999999999998764 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999998653 234689999999999999999999998 999999999999999999999999999865432211
Q ss_pred ceeccccCCccccccccCCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~t 331 (331)
....+..|+|||.+.++.++
T Consensus 156 -~~~~~~~y~~pe~~~~~~~~ 175 (254)
T cd05083 156 -NSKLPVKWTAPEALKHKKFS 175 (254)
T ss_pred -CCCCCceecCHHHhccCCcC
Confidence 12345689999999877653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=212.82 Aligned_cols=174 Identities=29% Similarity=0.401 Sum_probs=142.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCe-----
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDT----- 221 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~----- 221 (331)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 68899999876432 223457889999999995 6999999999887665
Q ss_pred EEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEecc
Q 020072 222 RFIVYELMENRSLDIQLHGPSH--GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFG 298 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg 298 (331)
.|++|||+++ +|.+++..... ...+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78877754222 35689999999999999999999999 9999999999999998 8999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
++..............+++.|+|||++.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 186 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGS 186 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCC
Confidence 987543332222223568899999988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=220.36 Aligned_cols=176 Identities=27% Similarity=0.358 Sum_probs=152.1
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchh--HHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDA--GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..-|...+.||+|.|..|-+|+. -+|..||||++++...+. ...+.+|++.|+-++|||||+||.+...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34566678899999999999964 379999999998665443 456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~ 305 (331)
|+-++|+|++|+- +....+.+....+++.||+.|+.|+|+. .+|||||||+||.+- +-|.+||+|||++..+.+
T Consensus 97 ELGD~GDl~DyIm--KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIM--KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHH--hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999996 4556799999999999999999999999 999999999998764 568899999999966554
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... -...+|++.|-|||.+.+..|+
T Consensus 172 G~k-L~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 172 GKK-LTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred cch-hhcccchhhccCchhhhcCccC
Confidence 333 3356899999999999998875
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=212.19 Aligned_cols=173 Identities=31% Similarity=0.419 Sum_probs=147.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|++|.||++... +++.|++|.+.... .....++.+|++++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35677889999999999999876 57899999986553 34556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++.... ..+++.....++.|++.||+|||+ . +++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986422 578999999999999999999999 7 99999999999999999999999999985543221
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ...++..|+|||.+.+..+
T Consensus 156 ~~--~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 156 AK--TFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred hh--cccCChhccCHHHHcCCCC
Confidence 11 1467889999999877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=239.19 Aligned_cols=180 Identities=24% Similarity=0.373 Sum_probs=145.1
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCe
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDT 221 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~ 221 (331)
+...++|.+.+.||+|+||+||+|+.. ++..||+|.+... .......+..|+.++++|+||||+++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445678999999999999999999875 4678899988643 33345678999999999999999999998754 357
Q ss_pred EEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CceEecCCCCCCEEECC--------
Q 020072 222 RFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCN----PAVIHRDLKSSNILLDS-------- 288 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~ivHrdlk~~Nill~~-------- 288 (331)
+|+||||+++|+|.++|... .....+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988642 223569999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 289 ---------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 289 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
...+||+|||++........ .....||+.|+|||++.+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhc
Confidence 23489999999976543222 123468999999999854
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=209.87 Aligned_cols=172 Identities=26% Similarity=0.444 Sum_probs=143.3
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc----------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ----------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666789999999999999764 688999998753211 12346788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998642 5689999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCC--cccceeccccCCccccccccCC
Q 020072 301 ITDGSQN--KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 301 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
....... .......++..|+|||++.++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred ccccccccccccccccCCccccCHHHhcccc
Confidence 6543221 1122345788999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=205.49 Aligned_cols=172 Identities=32% Similarity=0.493 Sum_probs=148.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|++|.||+++.. +++.|++|.+..... .....+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4667889999999999999765 578999999875543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988542 5689999999999999999999999 999999999999999999999999999976654433
Q ss_pred ccceeccccCCccccccccCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~ 329 (331)
......++..|+|||...+..
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred cccccccchhhcCHhhhcCCC
Confidence 233446889999999886553
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=211.94 Aligned_cols=171 Identities=27% Similarity=0.366 Sum_probs=143.7
Q ss_pred CCcccceeeecCceEEEEEEE----CCCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 152 SFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
+|+..+.||+|+||.||+++. .+|..||+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 466788999999999999976 368899999986432 22346688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+. +++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999863 34688999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-ccceeccccCCccccccccC
Q 020072 303 DGSQNK-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
...... ......|+..|+|||.+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGG 181 (290)
T ss_pred cccccccccccccCCcccCChhhccCC
Confidence 433221 12234588999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=209.51 Aligned_cols=175 Identities=26% Similarity=0.472 Sum_probs=144.8
Q ss_pred CCcccceeeecCceEEEEEEECC--CceEEEEEeccc----------CchhHHHHHHHHHHHhc-CCCCcceeeeeeEEc
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD--NLHVAVKKLDCA----------TQDAGREFENEVDLLSN-IHHPNVVCLLGYSAH 218 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~ 218 (331)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36678899999999999998765 678999987532 12234567788988875 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 219 DDTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
++..+++|||+++++|.+++.. ......+++..++.++.|++.||.|||+ . +++||||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999888753 1234568999999999999999999996 5 899999999999999999999999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||++....... ......++..|+|||.+.++.+
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCC
Confidence 99986654332 2233468899999999987765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=228.27 Aligned_cols=176 Identities=22% Similarity=0.287 Sum_probs=139.1
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC------CcceeeeeeEE
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHH------PNVVCLLGYSA 217 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~g~~~ 217 (331)
+++...++|...+.||+|+||+||+|... +++.||||+++... ...+++..|++++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999864 57889999986432 233455667777777654 45888988887
Q ss_pred cC-CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCC-----
Q 020072 218 HD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKF----- 290 (331)
Q Consensus 218 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~----- 290 (331)
.. +..|+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 65 4788999988 5778877753 3469999999999999999999997 5 899999999999998765
Q ss_pred -----------cEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 291 -----------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 -----------~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||++...... .....||+.|+|||++.+..|+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~ 323 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWM 323 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCC
Confidence 4999999987543221 2245799999999999887764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=213.05 Aligned_cols=167 Identities=31% Similarity=0.381 Sum_probs=144.0
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
..||+|+||.||++... ++..||+|++..........+.+|+.++++++|+|++++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999874 68899999986555555677999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceecc
Q 020072 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315 (331)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~g 315 (331)
+++.. ..+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..............+
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 88742 3588999999999999999999999 9999999999999999999999999998654333222233468
Q ss_pred ccCCccccccccCCC
Q 020072 316 TLGYVAPEYLLDGMV 330 (331)
Q Consensus 316 t~~y~aPE~l~~~~~ 330 (331)
+..|+|||++.++.+
T Consensus 179 ~~~y~~pE~~~~~~~ 193 (292)
T cd06657 179 TPYWMAPELISRLPY 193 (292)
T ss_pred CccccCHHHhcCCCC
Confidence 899999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=208.77 Aligned_cols=175 Identities=28% Similarity=0.433 Sum_probs=146.7
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999875 57889999986432 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988642 334689999999999999999999999 999999999999999885 46999999986554333
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......|+..|+|||++.++.+
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~ 179 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPY 179 (257)
T ss_pred ccccccCCCccccCHHHHcCCCC
Confidence 22223458889999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=214.69 Aligned_cols=173 Identities=28% Similarity=0.397 Sum_probs=140.6
Q ss_pred CCcccceeeecCceEEEEEEECC---CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (331)
.|...+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36678899999999999998754 7899999987532 33446678999999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC----CCcEEEEec
Q 020072 224 IVYELMENRSLDIQLHGP--SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDF 297 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~----~~~~kl~Df 297 (331)
+||||+++ +|.+.+... .....+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 565555321 1223689999999999999999999999 9999999999999999 999999999
Q ss_pred cCceeCCCCCc---ccceeccccCCccccccccC
Q 020072 298 GLAITDGSQNK---NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 298 gla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 328 (331)
|++........ ......++..|+|||++.++
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 99865433221 12233578899999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=207.98 Aligned_cols=164 Identities=26% Similarity=0.413 Sum_probs=140.3
Q ss_pred cceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.++||+|+|+.|--++ +.+|.++|||++++.......++.+|++++.+. .|+||+.|+.++++++.+|||||-|.+|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4679999999999885 678999999999877666778899999999998 49999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEeccCceeC---CC--
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITD---GS-- 305 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla~~~---~~-- 305 (331)
|..+++. ...+++.++.++..+|+.||.|||.+ +|.|||+||+|||-.+-.. +||+||.++.-. ++
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999864 45699999999999999999999999 9999999999999865433 899999987321 11
Q ss_pred --CCcccceeccccCCcccccc
Q 020072 306 --QNKNNLKLSGTLGYVAPEYL 325 (331)
Q Consensus 306 --~~~~~~~~~gt~~y~aPE~l 325 (331)
....-.+.+|+..|||||++
T Consensus 237 pastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCCccccCcccchhhcchhHH
Confidence 11222345789999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=210.97 Aligned_cols=167 Identities=30% Similarity=0.392 Sum_probs=140.3
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||+||++... +|+.+|+|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceec
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 314 (331)
.+++.... ...+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRA 155 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-cccccc
Confidence 99886532 24689999999999999999999999 99999999999999999999999999986543221 112235
Q ss_pred cccCCccccccccCCC
Q 020072 315 GTLGYVAPEYLLDGMV 330 (331)
Q Consensus 315 gt~~y~aPE~l~~~~~ 330 (331)
++..|+|||++.++.+
T Consensus 156 ~~~~y~~PE~~~~~~~ 171 (277)
T cd05577 156 GTPGYMAPEVLQGEVY 171 (277)
T ss_pred CCCCcCCHHHhcCCCC
Confidence 7889999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=210.20 Aligned_cols=173 Identities=28% Similarity=0.416 Sum_probs=140.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHH-HhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDL-LSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 58999999986542 2334456666665 566789999999999999999999999
Q ss_pred ecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 228 LMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 228 ~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
|++ |+|.+++.. ......+++..++.++.|++.||+|||+++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 678777653 223457899999999999999999999853 7999999999999999999999999998654332
Q ss_pred CcccceeccccCCcccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.. .....++..|+|||++.+
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 158 VA-KTIDAGCKPYMAPERINP 177 (283)
T ss_pred cc-cccccCCccccChhhcCC
Confidence 21 122357889999998864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=210.61 Aligned_cols=176 Identities=30% Similarity=0.383 Sum_probs=146.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 226 (331)
++|...+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999875 57889999886443 24556799999999999999999999988654 4789999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++++|.+++... .....+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876531 2345689999999999999999999999 999999999999999999999999999855432
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ....++..|+|||.+.++.+|
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~ 181 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYS 181 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCC
Confidence 221 123578899999999877654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=207.84 Aligned_cols=165 Identities=30% Similarity=0.355 Sum_probs=141.7
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||.|++|.||+++.. +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 47899999986432 23456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceec
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 314 (331)
.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 999864 24589999999999999999999998 99999999999999999999999999986654332 122346
Q ss_pred cccCCccccccccCCC
Q 020072 315 GTLGYVAPEYLLDGMV 330 (331)
Q Consensus 315 gt~~y~aPE~l~~~~~ 330 (331)
++..|+|||.+.+..+
T Consensus 154 ~~~~~~~PE~~~~~~~ 169 (262)
T cd05572 154 GTPEYVAPEIILNKGY 169 (262)
T ss_pred CCcCccChhHhcCCCC
Confidence 7889999999877654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=210.63 Aligned_cols=179 Identities=30% Similarity=0.453 Sum_probs=147.6
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc--
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH-- 218 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~-- 218 (331)
...+..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444556778888999999999999999874 57889999886433 3345688999999998 79999999999853
Q ss_pred ----CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 219 ----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 219 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
.+..+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||+|+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988642 234588899999999999999999999 9999999999999999999999
Q ss_pred EeccCceeCCCCCcccceeccccCCccccccc
Q 020072 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
+|||++..............|+..|+|||.+.
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcC
Confidence 99999865433222223346889999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=210.72 Aligned_cols=173 Identities=31% Similarity=0.472 Sum_probs=141.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 688999999864432 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 306 (331)
|++ ++|.+++... ....+++.....++.||+.||+|||++ +++||||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5777776432 233468888899999999999999999 9999999999999985 567999999999654432
Q ss_pred CcccceeccccCCccccccccC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
........++..|+|||++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGS 178 (294)
T ss_pred ccccccCceeecccCHHHHhCC
Confidence 2222233578899999998654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=228.52 Aligned_cols=172 Identities=27% Similarity=0.416 Sum_probs=148.4
Q ss_pred ccceeeecCceEEEEEEEC--CC--ceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 155 ESNILGEGGFGCVYKAKLD--DN--LHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
..++||+|.||.|++|.|. +| ..||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ...+||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3678999999999999875 23 46899999766554 67899999999999999999999999998 7889999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+.|+|.+.|+. .....+.......++.|||.||.||.++ ++|||||.++|+|+.....+||+||||.+.++..+..
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999987 4556788889999999999999999999 9999999999999999999999999999887655432
Q ss_pred cc---eeccccCCccccccccCCCC
Q 020072 310 NL---KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~---~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ...-...|+|||.+..+.||
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFS 293 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFS 293 (1039)
T ss_pred eEecCCCcCcccccCHhHhcccccc
Confidence 21 11235689999999998875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=204.97 Aligned_cols=176 Identities=25% Similarity=0.390 Sum_probs=151.1
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|+||.||++... ++..+++|++..... .....+.+|++++++++|+|++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999875 578999999875433 5567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++.... ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886521 246799999999999999999999999 99999999999999999999999999987655443
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......+++.|+|||.+.+..+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred ceecceeeeecccChhHhccCCC
Confidence 22333468899999999876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=229.85 Aligned_cols=180 Identities=21% Similarity=0.281 Sum_probs=137.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEECC--CceEEEEE--------------ec---ccCchhHHHHHHHHHHHhcCCCCc
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDD--NLHVAVKK--------------LD---CATQDAGREFENEVDLLSNIHHPN 208 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~e~~~l~~l~H~n 208 (331)
...++|...+.||+|+||+||++..+. +...+.|. +. .........+.+|++++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986532 22222221 10 112223456889999999999999
Q ss_pred ceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE
Q 020072 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSH--GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (331)
Q Consensus 209 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill 286 (331)
|+++++++.+.+..|+++|++. ++|.+++..... .......+...++.|++.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999986 566666543211 12234566778999999999999999 99999999999999
Q ss_pred CCCCcEEEEeccCceeCCCCCc-ccceeccccCCccccccccCCCC
Q 020072 287 DSKFNAKLSDFGLAITDGSQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 287 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+.++.+||+|||+++....... ......||..|+|||++.++.|+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 346 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC
Confidence 9999999999999976543322 22235689999999999887664
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=209.56 Aligned_cols=171 Identities=32% Similarity=0.499 Sum_probs=142.9
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|+..+.||+|++|.||+|... +|..||+|++.... ......+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999865 68999999986443 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+ ++|.+++.... ...+++..++.++.|+++||+|||++ +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68988886422 24689999999999999999999998 9999999999999999999999999998654332222
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
.....++..|+|||++.++
T Consensus 156 ~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred cCccccccCCCCCceeecC
Confidence 2223568899999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=211.05 Aligned_cols=167 Identities=34% Similarity=0.463 Sum_probs=141.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.+.|...+.||+|+||.||+|+.. +++.||+|.+.... .+..+++.+|+++++.++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 345778899999999999999875 68899999885432 23446789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||++ |++.+.+.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 566666542 234689999999999999999999998 999999999999999999999999999865433
Q ss_pred CCcccceeccccCCccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~ 326 (331)
.. ...++..|+|||++.
T Consensus 168 ~~----~~~~~~~y~aPE~~~ 184 (307)
T cd06607 168 AN----SFVGTPYWMAPEVIL 184 (307)
T ss_pred CC----CccCCccccCceeee
Confidence 22 235788999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=212.51 Aligned_cols=173 Identities=38% Similarity=0.481 Sum_probs=142.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 224 (331)
.++|+..+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999875 588999999864432 2234567899999999999999999998765 56899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||++ ++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999997 4787777532 35689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccceeccccCCccccccccC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..........++..|+|||.+.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred CccCCCCcccccccccChhhhcCC
Confidence 432222223457889999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=202.57 Aligned_cols=173 Identities=33% Similarity=0.491 Sum_probs=150.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+|...+.||+|++|.||++... ++..+++|++........+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999876 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 99999988642 25689999999999999999999998 999999999999999999999999999866544332 2
Q ss_pred ceeccccCCccccccccCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~ 330 (331)
....++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~ 174 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY 174 (253)
T ss_pred cceecCCcccCHHHHcCCCC
Confidence 34468899999999876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=208.28 Aligned_cols=166 Identities=30% Similarity=0.417 Sum_probs=141.0
Q ss_pred eeecCceEEEEEEECC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||.||+++..+ ++.+++|.+..... .....+.+|++++++++|+||+++++.+..++..|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 89999999864433 4556789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc------
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK------ 308 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------ 308 (331)
.+++.+. ..+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998642 3689999999999999999999999 999999999999999999999999999854332211
Q ss_pred --ccceeccccCCccccccccCCC
Q 020072 309 --NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 --~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~ 178 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGH 178 (265)
T ss_pred cccccCcccCccccCHHHhcCCCC
Confidence 2223457889999999876643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=225.15 Aligned_cols=180 Identities=31% Similarity=0.449 Sum_probs=155.8
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc--
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH-- 218 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~-- 218 (331)
++.+...++.|++.++||.|.+|.||+++. ++++.+|+|++... .+...+.+.|.++++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 444455678889999999999999999975 46788889887643 33446678889999988 69999999999864
Q ss_pred ---CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEE
Q 020072 219 ---DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (331)
Q Consensus 219 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 295 (331)
++.+|||||||.+|+.-++..+.. +..+.|.....|++.++.|+.+||.+ .++|||||-.|||+++++.+||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999988744 78899999999999999999999999 99999999999999999999999
Q ss_pred eccCceeCCCCCcccceeccccCCcccccccc
Q 020072 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 296 Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
|||.+...+.......+..||+.|||||++.-
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeec
Confidence 99999887776666667789999999999953
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=232.75 Aligned_cols=184 Identities=31% Similarity=0.448 Sum_probs=153.3
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeee
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLG 214 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g 214 (331)
.+|...++....+.||+|.||.|++|... ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45556666667779999999999999743 1467999999754 345678899999999999 7999999999
Q ss_pred eEEcCCeEEEEEEecCCCChhhhhcCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCC
Q 020072 215 YSAHDDTRFIVYELMENRSLDIQLHGPS-------H----G--SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281 (331)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~ 281 (331)
+|..++..++|.||+..|+|.++|+..+ . . ..++..+.+.++.|||.||+||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999997644 0 0 2489999999999999999999999 999999999
Q ss_pred CCEEECCCCcEEEEeccCceeCCCCCcccce-ec--cccCCccccccccCCCC
Q 020072 282 SNILLDSKFNAKLSDFGLAITDGSQNKNNLK-LS--GTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 282 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~-~~--gt~~y~aPE~l~~~~~t 331 (331)
+|||++++..+||+|||+++........... .. -...|||||.+....||
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc
Confidence 9999999999999999999876554443321 12 24579999999987775
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=208.43 Aligned_cols=163 Identities=32% Similarity=0.410 Sum_probs=132.5
Q ss_pred eeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHHHH---HhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDL---LSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..+ +...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 578999998864321 222334444433 344579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999988853 34699999999999999999999999 999999999999999999999999999865543222
Q ss_pred ceeccccCCccccccccC
Q 020072 311 LKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~ 328 (331)
....|+..|+|||.+.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~ 170 (279)
T cd05633 153 HASVGTHGYMAPEVLQKG 170 (279)
T ss_pred cCcCCCcCccCHHHhcCC
Confidence 223689999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=200.35 Aligned_cols=178 Identities=29% Similarity=0.383 Sum_probs=150.1
Q ss_pred HhcCCcccceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TR 222 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~ 222 (331)
..++|.+.+.+|+|||.-||.++ ..++..+|+|++.+...++.+..++|++.-++++|||++++++++..+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35688999999999999999997 5678899999999888888899999999999999999999999876543 58
Q ss_pred EEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 223 FIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
|++++|...|+|.+.+... .++..+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999988763 3456899999999999999999999997 4469999999999999999999999999874
Q ss_pred eCCC-----CC----cccceeccccCCcccccccc
Q 020072 302 TDGS-----QN----KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~-----~~----~~~~~~~gt~~y~aPE~l~~ 327 (331)
...- .. ..+....-|..|.|||.+.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV 212 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence 3221 11 11122235889999998853
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=209.34 Aligned_cols=174 Identities=31% Similarity=0.434 Sum_probs=147.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv 225 (331)
++|...+.||+|+||.||+|... +++.|++|.+... .....+.+.+|.+++++++ |+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999875 6899999998643 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999864 34699999999999999999999999 999999999999999999999999999865433
Q ss_pred CC--------------------cccceeccccCCccccccccCCC
Q 020072 306 QN--------------------KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~--------------------~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. .......++..|+|||.+.++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 22 11123357889999999876654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=209.07 Aligned_cols=172 Identities=37% Similarity=0.533 Sum_probs=140.2
Q ss_pred ceeeecCceEEEEEEECC-------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKLDD-------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+.||+|+||.||+|+..+ +..+++|.+.... .....++.+|++++++++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999875433 24456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-----cEEEEeccC
Q 020072 229 MENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-----NAKLSDFGL 299 (331)
Q Consensus 229 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Dfgl 299 (331)
+++++|.+++.... ....+++.+++.++.|++.||+|||+. +++|+||+|+||++++++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986421 223588999999999999999999998 999999999999999887 899999999
Q ss_pred ceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+........ ......++..|+|||++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 191 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT 191 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcc
Confidence 865432211 11122356789999999877653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=212.29 Aligned_cols=164 Identities=23% Similarity=0.201 Sum_probs=128.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC--CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCccee-eeeeEEcC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHD 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~-l~g~~~~~ 219 (331)
...++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|++. +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 45678999999999999999999764 5777899987532 1223556999999999999999985 443 2
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCC-CCCCEEECCCCcEEEEecc
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL-KSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfg 298 (331)
+..|+||||+++++|... . .. . ...++.+++++|+|||++ +|+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~--~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R--PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C--cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 467999999999999632 1 11 1 146788999999999999 9999999 9999999999999999999
Q ss_pred CceeCCCCCcc--------cceeccccCCccccccccC
Q 020072 299 LAITDGSQNKN--------NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~--------~~~~~gt~~y~aPE~l~~~ 328 (331)
+++........ -....++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99765432211 0234578889999998654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=205.95 Aligned_cols=163 Identities=33% Similarity=0.413 Sum_probs=132.9
Q ss_pred eeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHH---HHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEV---DLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+||+|+||.||+|... +++.||+|.+..... .....+..|. ..++..+|+||+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 578999998864321 1122233443 34455689999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+|+|..++.. ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999988853 34699999999999999999999998 999999999999999999999999999865433222
Q ss_pred ceeccccCCccccccccC
Q 020072 311 LKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~ 328 (331)
....|+..|+|||++.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 153 HASVGTHGYMAPEVLQKG 170 (278)
T ss_pred cCcCCCcCCcCcHHhcCC
Confidence 234689999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=209.23 Aligned_cols=176 Identities=31% Similarity=0.410 Sum_probs=143.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC---
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--- 220 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--- 220 (331)
+...++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678899999999999999999875 57899999986432 223456788999999999999999999987655
Q ss_pred -------eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 221 -------TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 221 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
..++++||+++ ++...+.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 66666653 234689999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCc-ccceeccccCCccccccccC
Q 020072 294 LSDFGLAITDGSQNK-NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 294 l~Dfgla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~ 328 (331)
|+|||++........ ......++..|+|||.+.++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCC
Confidence 999999865433221 11122457789999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=201.78 Aligned_cols=172 Identities=31% Similarity=0.457 Sum_probs=148.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVY 226 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 226 (331)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|++.+++++|+||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667889999999999999876 688999999865442 4567899999999999999999999999988 8999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998642 3799999999999999999999998 9999999999999999999999999998765544
Q ss_pred Cc--ccceeccccCCccccccccCC
Q 020072 307 NK--NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 307 ~~--~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.. ......++..|+|||.+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~ 179 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEE 179 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCC
Confidence 32 122346888999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=208.02 Aligned_cols=176 Identities=30% Similarity=0.414 Sum_probs=142.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC---C--CceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD---D--NLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~ 221 (331)
...|+....||+|.||.||+|.-. + ...+|+|+++.... .......+|+.+++.++|||++.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 456788899999999999999533 2 24789999965422 233567899999999999999999999877 778
Q ss_pred EEEEEEecCCCChhhhh--cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC----CcEEEE
Q 020072 222 RFIVYELMENRSLDIQL--HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLS 295 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l--~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~kl~ 295 (331)
.+|++||.+. +|...+ |+......++...+..|+.||++|+.|||++ =|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999986 454444 3334456799999999999999999999999 79999999999999877 899999
Q ss_pred eccCceeCCCCCc---ccceeccccCCccccccccCC
Q 020072 296 DFGLAITDGSQNK---NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 296 Dfgla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~ 329 (331)
|+|+++....... .....+.|.+|.|||.+.+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 9999987654332 222346799999999998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=235.27 Aligned_cols=178 Identities=33% Similarity=0.477 Sum_probs=140.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-----
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD----- 219 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----- 219 (331)
....++|+..++||+||||.||+++.+ ||+.+|||++... +......+.+|+..+++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 455678888999999999999999876 8999999999654 344557789999999999999999987532100
Q ss_pred --------------------------------------------------------------------------------
Q 020072 220 -------------------------------------------------------------------------------- 219 (331)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (331)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020072 220 ----------------------------------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265 (331)
Q Consensus 220 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y 265 (331)
..+|+-||||+..+++++++...... .....+++.++|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 12467788888888887775422111 466789999999999999
Q ss_pred HhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC------------------CCCcccceeccccCCcccccccc
Q 020072 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG------------------SQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 266 LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+|++ +||||||||.||+++++..+||+|||+|.... .........+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999996510 11112234579999999999966
Q ss_pred CC
Q 020072 328 GM 329 (331)
Q Consensus 328 ~~ 329 (331)
..
T Consensus 790 ~~ 791 (1351)
T KOG1035|consen 790 TS 791 (1351)
T ss_pred cc
Confidence 54
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=217.38 Aligned_cols=172 Identities=26% Similarity=0.341 Sum_probs=144.3
Q ss_pred cCCcccceeeecCceEEEEEEECC-CceEEEEEecccCch--------hHHHHHHHHHHHhcCC---CCcceeeeeeEEc
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD--------AGREFENEVDLLSNIH---HPNVVCLLGYSAH 218 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---H~niv~l~g~~~~ 218 (331)
.+|...+.+|+|+||.|+.|..+. ...|++|.+.+..-- ..-.+-.||++|+.|+ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 457888999999999999998764 578899988543210 1112456999999998 9999999999999
Q ss_pred CCeEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 219 DDTRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 219 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
++.+||+||-...| +|++++.. ...+++.++..|..||+.|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 99999999987655 88899853 45699999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|.+......... .++||.+|.|||++-+.+|
T Consensus 715 gsaa~~ksgpfd--~f~gtv~~aapevl~g~~y 745 (772)
T KOG1152|consen 715 GSAAYTKSGPFD--VFVGTVDYAAPEVLGGEKY 745 (772)
T ss_pred cchhhhcCCCcc--eeeeeccccchhhhCCCcc
Confidence 998554333332 4689999999999998876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=213.22 Aligned_cols=173 Identities=28% Similarity=0.356 Sum_probs=143.3
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 219 (331)
..++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 6889999998643 233445678899999999999999999988644
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 577777642 288899999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... .....++..|+|||.+.+..++
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 195 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYK 195 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCCCCC
Confidence 976543322 2233578899999999876653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=208.13 Aligned_cols=165 Identities=35% Similarity=0.489 Sum_probs=139.6
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.|...+.||+|+||.||+++.. ++..||+|.+... ..+....+.+|++++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4667889999999999999864 6789999998643 22344578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|++ |+|.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 997 577766643 235689999999999999999999999 99999999999999999999999999986543221
Q ss_pred cccceeccccCCccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~ 326 (331)
...++..|+|||++.
T Consensus 180 ----~~~~~~~y~aPE~~~ 194 (317)
T cd06635 180 ----SFVGTPYWMAPEVIL 194 (317)
T ss_pred ----cccCCccccChhhhh
Confidence 235788999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=204.98 Aligned_cols=175 Identities=29% Similarity=0.429 Sum_probs=139.4
Q ss_pred CcccceeeecCceEEEEEEEC----CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 153 FHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
|...+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999753 3688999998643 3344567899999999999999999999886542
Q ss_pred eEEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 221 TRFIVYELMENRSLDIQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
..++++||+.+|+|.+++.... ....+++...+.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988764321 223578999999999999999999998 9999999999999999999999999
Q ss_pred cCceeCCCCCc--ccceeccccCCccccccccCCC
Q 020072 298 GLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 298 gla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|+++....... ......++..|++||.+.++.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence 99865432221 1112235678999999876654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=212.21 Aligned_cols=170 Identities=30% Similarity=0.454 Sum_probs=140.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~ 222 (331)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468899999999999999999764 68899999986432 334567889999999999999999999876543 57
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++++||++ ++|...+.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 477776642 4689999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc---ccceeccccCCcccccccc
Q 020072 303 DGSQNK---NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~l~~ 327 (331)
...... ......|+..|+|||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhC
Confidence 432221 1122457899999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=219.60 Aligned_cols=177 Identities=23% Similarity=0.346 Sum_probs=134.7
Q ss_pred HhcCCcccceeeecCceEEEEEEE-----------------CCCceEEEEEecccCchhHHH--------------HHHH
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-----------------DDNLHVAVKKLDCATQDAGRE--------------FENE 197 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 197 (331)
..++|...++||+|+||.||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235679999986544333333 3447
Q ss_pred HHHHhcCCCCcc-----eeeeeeEEc--------CCeEEEEEEecCCCChhhhhcCCCC---------------------
Q 020072 198 VDLLSNIHHPNV-----VCLLGYSAH--------DDTRFIVYELMENRSLDIQLHGPSH--------------------- 243 (331)
Q Consensus 198 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 243 (331)
+.++.+++|.|+ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677787753 3568999999999999998874211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-ccceeccccCCccc
Q 020072 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-NNLKLSGTLGYVAP 322 (331)
Q Consensus 244 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~gt~~y~aP 322 (331)
...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....... ......+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788899999999999999999 999999999999999999999999999865432211 11112347899999
Q ss_pred cccccC
Q 020072 323 EYLLDG 328 (331)
Q Consensus 323 E~l~~~ 328 (331)
|.+...
T Consensus 380 E~l~~~ 385 (507)
T PLN03224 380 EELVMP 385 (507)
T ss_pred hhhcCC
Confidence 998643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=207.79 Aligned_cols=173 Identities=29% Similarity=0.400 Sum_probs=139.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999875 58899999885432 222345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 221 --TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 221 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
..++||||++ ++|.+.+.. ....+++.+++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999997 477777753 234689999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcc----cceeccccCCccccccccC
Q 020072 299 LAITDGSQNKN----NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~----~~~~~gt~~y~aPE~l~~~ 328 (331)
++......... .....++..|+|||.+.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 98654322211 1123467889999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=204.95 Aligned_cols=169 Identities=33% Similarity=0.473 Sum_probs=141.6
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEEEE
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVYE 227 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 227 (331)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999876 47899999997553 33456788999999999999999999999988 89999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9984 888877542 24789999999999999999999999 99999999999999999999999999986654332
Q ss_pred c-ccceeccccCCcccccccc
Q 020072 308 K-NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~l~~ 327 (331)
. ......++..|+|||.+.+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred cccccccccccccCCceeeEc
Confidence 1 1122346788999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=211.98 Aligned_cols=172 Identities=33% Similarity=0.448 Sum_probs=141.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC--CeE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD--DTR 222 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~--~~~ 222 (331)
..++|...+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999875 5789999988542 233445678899999999 999999999998654 368
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||++ ++|..++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888753 2688999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-----ccceeccccCCccccccccC
Q 020072 303 DGSQNK-----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~ 328 (331)
...... ......|+..|+|||++.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc
Confidence 432221 12234578899999988653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=211.69 Aligned_cols=171 Identities=32% Similarity=0.481 Sum_probs=141.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----e
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----T 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~ 221 (331)
.++|...+.||+|+||+||+|+.. ++..||+|.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999864 6889999998643 2333456788999999999999999999886543 4
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688887753 35699999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCCcccceeccccCCcccccccc
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.............++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccCCCcccccccccccCccChHHHhc
Confidence 65433222223457889999998865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=201.35 Aligned_cols=164 Identities=27% Similarity=0.348 Sum_probs=135.5
Q ss_pred ceeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHHHHH-hcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDLL-SNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 578999999864322 2223445555544 455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++...... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----K 151 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----c
Confidence 999999853 34689999999999999999999999 9999999999999999999999999998654331 2
Q ss_pred eeccccCCccccccccCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~ 330 (331)
...++..|+|||.+.++.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~ 170 (260)
T cd05611 152 KFVGTPDYLAPETILGVGD 170 (260)
T ss_pred cCCCCcCccChhhhcCCCC
Confidence 3357889999999887654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.10 Aligned_cols=171 Identities=30% Similarity=0.367 Sum_probs=139.2
Q ss_pred cCCc-ccceeeecCceEEEEEEEC-CCceEEEEEecccCchh--------------HHHHHHHHHHHhcCCCCcceeeee
Q 020072 151 DSFH-ESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA--------------GREFENEVDLLSNIHHPNVVCLLG 214 (331)
Q Consensus 151 ~~~~-~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~g 214 (331)
++|. ..+.||+|+||.||+|... +++.||+|.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 3567999999999999865 68899999885432211 125789999999999999999999
Q ss_pred eEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
++...+..+++|||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888853 34589999999999999999999998 9999999999999999999999
Q ss_pred EeccCceeCCCC--------------CcccceeccccCCccccccccC
Q 020072 295 SDFGLAITDGSQ--------------NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 295 ~Dfgla~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+|||++...... ........++..|+|||++.++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999998654411 1111122467889999998754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=210.60 Aligned_cols=170 Identities=33% Similarity=0.432 Sum_probs=143.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (331)
+|...+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677899999999999999875 48899999986543 345567999999999999999999999988775 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
++|||++ ++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 578888753 23799999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCC---cccceeccccCCccccccccC
Q 020072 304 GSQN---KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.... .......++..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred cccccccccccccccccCcCCceeeecc
Confidence 4332 112233578899999998766
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=200.19 Aligned_cols=168 Identities=23% Similarity=0.259 Sum_probs=135.6
Q ss_pred HhcCCccccee--eecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNIL--GEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~i--g~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +|+||+++++++...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666665 99999999999864 578899998864322111 22222222 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~ 303 (331)
||||+++++|.+++.. ...+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999864 23799999999999999999999999 999999999999999998 9999999998665
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ...++..|+|||++.++.++
T Consensus 161 ~~~~----~~~~~~~y~aPE~~~~~~~~ 184 (267)
T PHA03390 161 GTPS----CYDGTLDYFSPEKIKGHNYD 184 (267)
T ss_pred CCCc----cCCCCCcccChhhhcCCCCC
Confidence 4322 23578999999999877653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=202.01 Aligned_cols=174 Identities=29% Similarity=0.404 Sum_probs=147.5
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|+..+.||+|+||.||+++.. +++.+++|.+... ......++.+|++++++++|+||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999765 6789999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
+++++|.+++... .....+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999887542 1235689999999999999999999999 99999999999999999999999999986654432
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
. ....++..|+|||.+.+..+
T Consensus 158 ~--~~~~~~~~~~~Pe~~~~~~~ 178 (256)
T cd08530 158 A--KTQIGTPHYMAPEVWKGRPY 178 (256)
T ss_pred c--ccccCCccccCHHHHCCCCC
Confidence 2 12357889999999977655
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=204.84 Aligned_cols=172 Identities=27% Similarity=0.357 Sum_probs=143.2
Q ss_pred CCcccceeeecCceEEEEEEE----CCCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 152 SFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
+|...+.||+|++|.||+++. .++..||+|.+.... ......+.+|++++.++ +|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366788999999999999874 356889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++|+|.+++.. ...+++.....++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998853 34688999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-ccceeccccCCccccccccCC
Q 020072 303 DGSQNK-NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 303 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~ 329 (331)
...... ......++..|+|||.+.++.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGS 182 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCC
Confidence 433221 122345889999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=208.97 Aligned_cols=170 Identities=28% Similarity=0.397 Sum_probs=142.0
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC---
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--- 220 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--- 220 (331)
....++|...+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 445778999999999999999999754 68899999985432 223456889999999999999999999987654
Q ss_pred ---eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 221 ---TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 221 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 6788877742 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCCcccceeccccCCcccccccc
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
|++....... ....++..|+|||++.+
T Consensus 163 g~~~~~~~~~---~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 163 GLARQTDSEM---TGYVVTRWYRAPEVILN 189 (343)
T ss_pred ccccccccCc---cccccCCcccCHHHHhC
Confidence 9986543322 12357889999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=238.30 Aligned_cols=174 Identities=33% Similarity=0.484 Sum_probs=146.9
Q ss_pred HhcCCcccceeeecCceEEEEEE-ECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.+-+++....||.|.||.||-|. .++|...|+|-+... .......+.+|+.++..++|||+|+++|+-.+.+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34566778899999999999996 457888999987543 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||||++|+|.+.+. .+...++.....+..|++.|+.|||++ +||||||||.||+|+.+|.+|++|||.|+....
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999985 444567777778899999999999999 999999999999999999999999999976543
Q ss_pred CC----cccceeccccCCccccccccC
Q 020072 306 QN----KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 306 ~~----~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.. ..-....||+.|||||++.+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhccc
Confidence 32 122345799999999999764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=202.22 Aligned_cols=167 Identities=26% Similarity=0.317 Sum_probs=136.5
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeEEcC--CeEEEEEE
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHD--DTRFIVYE 227 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 227 (331)
|+..+.||+|+||.||+|+.. ++..||+|++.... ........+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999864 67899999986542 222334567899999995 99999999999987 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|++ |+|.+.+.. ....+++.++..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 577777753 224689999999999999999999999 9999999999999999 999999999986654322
Q ss_pred cccceeccccCCcccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~ 327 (331)
.. ....++..|+|||++..
T Consensus 154 ~~-~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 154 PY-TEYISTRWYRAPECLLT 172 (282)
T ss_pred Cc-CCCCCCcccCChhHhhc
Confidence 21 12357889999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=209.84 Aligned_cols=171 Identities=29% Similarity=0.418 Sum_probs=141.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~ 222 (331)
.++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999865 58899999986432 2345667889999999999999999998763 3468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++|+||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888753 34589999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc----ccceeccccCCcccccccc
Q 020072 303 DGSQNK----NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 303 ~~~~~~----~~~~~~gt~~y~aPE~l~~ 327 (331)
...... ......++..|+|||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcC
Confidence 432211 1122367889999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=208.32 Aligned_cols=174 Identities=30% Similarity=0.415 Sum_probs=143.7
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
...+....++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445566789999999999999999999975 468899999986432 22345688899999999999999999987643
Q ss_pred ------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 220 ------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 220 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
+..++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3468888876 6788877642 3589999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
|+|||++....... ....++..|+|||.+.+
T Consensus 161 l~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 161 ILDFGLARHTDDEM---TGYVATRWYRAPEIMLN 191 (345)
T ss_pred Eecccccccccccc---cccccCCCccCHHHHhC
Confidence 99999986543221 22357889999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=204.24 Aligned_cols=170 Identities=34% Similarity=0.489 Sum_probs=143.4
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|+..+.||+|++|.||+|+.. +++.+++|.+.... ......+.+|++++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999876 48999999987543 334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+ ++|.+++... ...+++..+..++.|++.||+|||++ +++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 5899988642 24699999999999999999999999 9999999999999999999999999998765433322
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
.....++..|+|||.+.++
T Consensus 155 ~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred cCccccCcCcCChHHhcCC
Confidence 2223457789999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=198.32 Aligned_cols=165 Identities=32% Similarity=0.389 Sum_probs=141.7
Q ss_pred eeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
||+|+||.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 48899999986442 22456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceec
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 314 (331)
.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..............
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 999864 23689999999999999999999998 999999999999999999999999999876544322233446
Q ss_pred cccCCccccccccCC
Q 020072 315 GTLGYVAPEYLLDGM 329 (331)
Q Consensus 315 gt~~y~aPE~l~~~~ 329 (331)
++..|+|||.+.+..
T Consensus 155 ~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 155 GTPEYLAPEVLLGKG 169 (250)
T ss_pred CCccccChHHhCCCC
Confidence 788999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=202.99 Aligned_cols=164 Identities=34% Similarity=0.476 Sum_probs=138.3
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
|...+.||+|+||+||+|+.. ++..|++|.+.... ......+.+|++++++++|+|++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 67899999986432 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+. |++.+.+.. ....+++.+++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 96 577666653 235689999999999999999999999 9999999999999999999999999998543221
Q ss_pred ccceeccccCCccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~ 326 (331)
....|+..|+|||++.
T Consensus 175 --~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 175 --NSFVGTPYWMAPEVIL 190 (313)
T ss_pred --CCccccccccChhhcc
Confidence 1346888999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=202.64 Aligned_cols=170 Identities=31% Similarity=0.496 Sum_probs=143.3
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|...+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999875 688899999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++ +|..++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 78777754 235789999999999999999999999 9999999999999999999999999998766544322
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
.....++..|+|||.+.++
T Consensus 155 ~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred ccCccCcccccCcHHHhcC
Confidence 2223578899999998765
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=202.34 Aligned_cols=170 Identities=31% Similarity=0.407 Sum_probs=141.3
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEec
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
|...+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999976 478899999864432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+|+|.+++.... ...+++.++..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789988886432 34689999999999999999999999 9999999999999999999999999998665432221
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
....++..|+|||++.++
T Consensus 156 -~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRS 173 (283)
T ss_pred -CCCCCcccccCceeeecC
Confidence 123578899999988543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=209.44 Aligned_cols=174 Identities=32% Similarity=0.457 Sum_probs=142.5
Q ss_pred cCCcccceeeecCceEEEEEE-ECCCceEEEEEeccc-------CchhHHHHHHHHHHHhcCCCCcceeeeeeEE-cCCe
Q 020072 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA-------TQDAGREFENEVDLLSNIHHPNVVCLLGYSA-HDDT 221 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~ 221 (331)
++|-..++||+|||+.||+|. +...+-||||+-... .....+...+|.++-+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 445567899999999999995 456788999976322 1222345678999999999999999999986 5568
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEecc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFG 298 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg 298 (331)
+|-|+|||++.+|+-||. ....++++++..|++||+.||.||.+. +++|||-||||.|||+.+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 999999999999999995 445699999999999999999999986 789999999999999954 5789999999
Q ss_pred CceeCCCCCcc-------cceeccccCCccccccccC
Q 020072 299 LAITDGSQNKN-------NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~ 328 (331)
+++..+++... .....||.+|++||.+.-|
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg 655 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG 655 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecC
Confidence 99765443322 2345799999999998655
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=200.12 Aligned_cols=172 Identities=33% Similarity=0.445 Sum_probs=139.6
Q ss_pred CcccceeeecCceEEEEEEECC-CceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeeEEcCCe-----
Q 020072 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSAHDDT----- 221 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~----- 221 (331)
|+..+.||+|+||.||+|+.+. ++.||+|.+..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999864 88999999864322 2234566787777665 69999999999998776
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.+++|||++ ++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999997 4788887642 224689999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCCcccceeccccCCccccccccCCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
........ ....++..|+|||++.++.+
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~ 183 (287)
T cd07838 156 IYSFEMAL-TSVVVTLWYRAPEVLLQSSY 183 (287)
T ss_pred eccCCccc-ccccccccccChHHhccCCC
Confidence 65433221 12347889999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=202.67 Aligned_cols=172 Identities=31% Similarity=0.471 Sum_probs=139.9
Q ss_pred hcCCcccceeeecCceEEEEEEECC-CceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++|+..+.||+|+||.||+|+.++ ++.||||.+.... .....++..|+.++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4567888999999999999999875 8899999986543 234456777888777774 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||++ +++.+.+.. ....+++..+..++.|++.||+|||+ . +++||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9986 466665543 23478999999999999999999997 5 899999999999999999999999999865433
Q ss_pred CCcccceeccccCCccccccccC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.... ....++..|+|||++.+.
T Consensus 168 ~~~~-~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 168 SKAK-TRSAGCAAYMAPERIDPP 189 (296)
T ss_pred CCcc-cCCCCCccccCHhhcCCC
Confidence 2221 123478899999998755
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=203.46 Aligned_cols=172 Identities=30% Similarity=0.407 Sum_probs=138.3
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999865 57899999986443 344567899999999996 99999999999999999999999
Q ss_pred cCCCChhhh---hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 229 MENRSLDIQ---LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 229 ~~~g~L~~~---l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+.. ++.++ +.. .....+++..+..++.|++.||+|||+.. +++||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 874 44332 221 22356899999999999999999999732 899999999999999999999999999865433
Q ss_pred CCcccceeccccCCccccccccC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.... ....++..|+|||++.++
T Consensus 161 ~~~~-~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 161 SIAK-TRDAGCRPYMAPERIDPS 182 (288)
T ss_pred CCcc-ccccCccCccCHHHhccc
Confidence 2221 223578899999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=205.03 Aligned_cols=167 Identities=23% Similarity=0.261 Sum_probs=135.5
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.+.+|.|+++.||+++. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33455555666666554 6889999998654 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-----
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK----- 308 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~----- 308 (331)
|.+++... ....+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99998742 234588999999999999999999999 999999999999999999999999998854322111
Q ss_pred --ccceeccccCCcccccccc
Q 020072 309 --NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 309 --~~~~~~gt~~y~aPE~l~~ 327 (331)
......++..|+|||++..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred ccccccccccccccCHHHhcC
Confidence 1112346778999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=208.19 Aligned_cols=174 Identities=26% Similarity=0.315 Sum_probs=147.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 225 (331)
.+|....+||+|+||.|.+|..+ +.+.+|||+++..- .++.+--+.|-++|+-. +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46778899999999999999765 35778999987542 22333345677777766 578999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+.+|+|-.+++. ...+.+..+..+|.+||-||-|||++ +|++||||.+|||+|.+|.+||+|||+++..-.
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888864 34578888999999999999999999 999999999999999999999999999977655
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+++||+.|+|||.+.-++|
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY 527 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY 527 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc
Confidence 5555667899999999999987766
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=200.15 Aligned_cols=175 Identities=27% Similarity=0.378 Sum_probs=140.3
Q ss_pred CCcccceeeecCceEEEEEEECC-CceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+|...+.||+|+||.||+++... +..+++|.++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998653 344555554321 223344677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
+||+++++|.+++... .....+++.+++.++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887531 2345799999999999999999999999 9999999999999975 569999999986654
Q ss_pred CCCcccceeccccCCccccccccCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..........++..|+|||.+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~ 182 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGY 182 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCC
Confidence 33333333457889999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=202.94 Aligned_cols=166 Identities=33% Similarity=0.467 Sum_probs=139.5
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+.|...+.||+|+||.||+|+.. ++..+++|.+... .....+++.+|++++++++|+|++++.+++...+..++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999865 5788999988532 2234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+. |++.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 677776643 234689999999999999999999998 9999999999999999999999999998654432
Q ss_pred CcccceeccccCCccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~ 326 (331)
. ...++..|+|||.+.
T Consensus 169 ~----~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 N----XFVGTPYWMAPEVIL 184 (308)
T ss_pred c----cccCCccccCHHHHh
Confidence 2 235788999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=213.24 Aligned_cols=144 Identities=26% Similarity=0.343 Sum_probs=127.5
Q ss_pred cCCcccceeeecCceEEEEEE-ECCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.-|...+.||-|+||.|.+++ .++...+|.|.+++.+ .+....+..|.+||+.-+.+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 446677889999999999985 5567788999986543 344556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
||+++|++-.+|-+ -..+.++.+..++.++.+|+++.|.. ++|||||||+|||||.+|.+||+||||+
T Consensus 709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 99999999888853 34688888888999999999999999 9999999999999999999999999998
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=203.88 Aligned_cols=169 Identities=31% Similarity=0.443 Sum_probs=141.3
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRF 223 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~ 223 (331)
..+++|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++.+++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35788999999999999999999765 7889999988542 22345678899999999999999999999875 56789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+++||+. ++|..++.. ..+++.....++.|++.||+|||+. +++||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELLG-TDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehhc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999984 688877742 3578888899999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcccceeccccCCcccccccc
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... ....++..|+|||.+.+
T Consensus 159 ~~~~---~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 159 DPQM---TGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CCCc---CCCcccccccCceeeec
Confidence 3221 12356889999998865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=204.05 Aligned_cols=169 Identities=29% Similarity=0.420 Sum_probs=136.6
Q ss_pred CCcccceeeecCceEEEEEEEC-C--CceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC----Ce
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-D--NLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD----DT 221 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~----~~ 221 (331)
+|...+.||+|+||.||+++.. + +..||+|++... .....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667889999999999999865 3 678999998643 223356788999999999 599999999875432 45
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++++||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899986 688888753 35689999999999999999999999 99999999999999999999999999996
Q ss_pred eCCCCCc----ccceeccccCCcccccccc
Q 020072 302 TDGSQNK----NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~----~~~~~~gt~~y~aPE~l~~ 327 (331)
....... ......|+..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhC
Confidence 5432211 1122458899999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=198.36 Aligned_cols=173 Identities=28% Similarity=0.331 Sum_probs=140.6
Q ss_pred HhcCCccc-ceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc----CCe
Q 020072 149 ATDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH----DDT 221 (331)
Q Consensus 149 ~~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~ 221 (331)
.+++|.+. ++||-|-.|.|..+..+ +++.+|+|++. +....++|+++--+. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566543 68999999999998654 68899999885 233456788876555 69999999999864 357
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEecc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFG 298 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg 298 (331)
+++|||.|+||.|...++. +....++++++-.|+.||+.|++|||+. .|.||||||+|+|.+. |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999998876 3456799999999999999999999999 9999999999999964 5679999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|+....... ..+.+-|+.|.|||++-..+|+
T Consensus 210 FAK~t~~~~~-L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 210 FAKETQEPGD-LMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccccCCCcc-ccCCcccccccCHHHhCchhcC
Confidence 9976553222 2345789999999999887774
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=187.61 Aligned_cols=178 Identities=28% Similarity=0.399 Sum_probs=141.8
Q ss_pred HHHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
+...++......||+|++|.|-+-++ .+|+..|+|++... ..+..++.++|+.+..+- ..|.+|.++|...+....+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 44445555567799999999888765 47899999999654 344556788888876554 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 224 IVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
+.||.|+ .+|+.+-.. -.++..+++.-.-+||..+.+||.|||++. .++|||+||+||||+.+|++|+||||.+-.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999996 455433221 245678999999999999999999999885 899999999999999999999999999866
Q ss_pred CCCCCcccceeccccCCccccccccC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+.+.-... ...|-..|||||.+..+
T Consensus 199 L~dSiAkt-~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 199 LVDSIAKT-MDAGCKPYMAPERINPE 223 (282)
T ss_pred ehhhhHHH-HhcCCCccCChhhcCcc
Confidence 55443322 23578899999998654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.06 Aligned_cols=173 Identities=32% Similarity=0.431 Sum_probs=138.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|...+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999865 578999998854322 22346788999999999999999999875433
Q ss_pred --eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 221 --TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 221 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
..++|+||+++ ++...+.. ....+++.++..++.|+++||+|||++ +++||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56666653 234699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcc-----------cceeccccCCccccccccC
Q 020072 299 LAITDGSQNKN-----------NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~~-----------~~~~~gt~~y~aPE~l~~~ 328 (331)
+++........ .....++..|+|||.+.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE 201 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence 98654322111 1123467889999988654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=203.83 Aligned_cols=167 Identities=27% Similarity=0.385 Sum_probs=138.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999864 68999999986432 223456889999999999999999999987543
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46999999974 6665542 3588999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCCcccceeccccCCccccccccC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+...... ....++..|+|||++.++
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~ 189 (342)
T cd07879 165 RHADAEM---TGYVVTRWYRAPEVILNW 189 (342)
T ss_pred cCCCCCC---CCceeeecccChhhhcCc
Confidence 6543221 123578899999998663
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=199.26 Aligned_cols=176 Identities=22% Similarity=0.314 Sum_probs=127.6
Q ss_pred HhcCCcccceeeecCceEEEEEEECCC----ceEEEEEecccCchhH-----------HHHHHHHHHHhcCCCCcceeee
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDN----LHVAVKKLDCATQDAG-----------REFENEVDLLSNIHHPNVVCLL 213 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~l~ 213 (331)
..++|...++||+|+||.||+|...++ ..+++|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346788999999999999999987543 4556665432221111 1122344556678999999999
Q ss_pred eeEEcCC----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 214 GYSAHDD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 214 g~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +++||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 9766543 34677787643 45555432 23357888899999999999999999 99999999999999999
Q ss_pred CcEEEEeccCceeCCCCC-------cccceeccccCCccccccccCCCC
Q 020072 290 FNAKLSDFGLAITDGSQN-------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 290 ~~~kl~Dfgla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+.++|+|||+++...... .......||+.|+|||+..+..++
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~ 211 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT 211 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC
Confidence 999999999996543211 111223689999999998877664
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=203.11 Aligned_cols=167 Identities=23% Similarity=0.311 Sum_probs=135.0
Q ss_pred eeeec--CceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 158 ILGEG--GFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 158 ~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
.||+| +||+||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999874 78999999986433 233467899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC---CCc-
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS---QNK- 308 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~---~~~- 308 (331)
+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..... ...
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999988652 224589999999999999999999998 999999999999999999999999986422111 000
Q ss_pred ---ccceeccccCCccccccccC
Q 020072 309 ---NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ---~~~~~~gt~~y~aPE~l~~~ 328 (331)
......++..|+|||++.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred cccccccccCccCccChhhhcCC
Confidence 00011345679999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=196.72 Aligned_cols=176 Identities=23% Similarity=0.343 Sum_probs=153.3
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
..++|...++||+|+|.+|..+++. +.+.+|+|++++. ..++.+..+.|-.+..+- +||.+|.|..++.....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478899999999999999999875 4678899988643 344556678888888776 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+|.||+++|+|--+.+ ....++++.+..+...|.-||.|||++ +|++||||.+|||+|.+|.+||+|+|+++..
T Consensus 328 fvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999976664 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccceeccccCCccccccccCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
-.+.....+++||+.|.|||.+.+..|
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred CCCCcccccccCCCcccchhhhccccc
Confidence 555666678899999999999998876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=203.75 Aligned_cols=171 Identities=27% Similarity=0.364 Sum_probs=139.5
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC---------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--------- 219 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------- 219 (331)
..+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357888999999999999999864 5889999998766656667789999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEE
Q 020072 220 -----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAK 293 (331)
Q Consensus 220 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~k 293 (331)
...++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35799999997 588877742 3588999999999999999999999 999999999999997 456799
Q ss_pred EEeccCceeCCCCCc---ccceeccccCCccccccccC
Q 020072 294 LSDFGLAITDGSQNK---NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 294 l~Dfgla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 328 (331)
|+|||++........ ......++..|+|||.+.++
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 193 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP 193 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCc
Confidence 999999865432211 11122468899999987553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=190.90 Aligned_cols=155 Identities=23% Similarity=0.209 Sum_probs=129.1
Q ss_pred cCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcC
Q 020072 162 GGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG 240 (331)
Q Consensus 162 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (331)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 67899999986432 234455556667799999999999999999999999999999998853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCc
Q 020072 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320 (331)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~ 320 (331)
...+++.....++.|++.||+|||+. +++||||||+||+++.++.++++|||++........ ...++..|+
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~y~ 149 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD---GEAVENMYC 149 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc---cCCcCcccc
Confidence 23589999999999999999999998 999999999999999999999999998755443211 224577899
Q ss_pred cccccccCCC
Q 020072 321 APEYLLDGMV 330 (331)
Q Consensus 321 aPE~l~~~~~ 330 (331)
|||.+.++.+
T Consensus 150 aPE~~~~~~~ 159 (237)
T cd05576 150 APEVGGISEE 159 (237)
T ss_pred CCcccCCCCC
Confidence 9999876654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-27 Score=197.85 Aligned_cols=171 Identities=28% Similarity=0.415 Sum_probs=135.4
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecc-c-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--------C
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDC-A-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--------D 220 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~ 220 (331)
.|+...+||+|.||.||+|+.. +|+.||+|++-. . ....-..-.+|+.+|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3444678999999999999764 577889887532 2 222234568899999999999999999988643 3
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
.+|||+++|++ +|...|.. ....++..++.+++.++.+||.|+|.. .|+|||+|+.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999974 67666653 235688999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCc----ccceeccccCCccccccccC
Q 020072 301 ITDGSQNK----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~~----~~~~~~gt~~y~aPE~l~~~ 328 (331)
+.+..... .....+.|.+|.+||.+.+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~ 203 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD 203 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcc
Confidence 65543222 11233569999999999764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=202.60 Aligned_cols=168 Identities=30% Similarity=0.429 Sum_probs=141.6
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe----
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT---- 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~---- 221 (331)
..++|...+.||+|++|.||+|+.. +++.||+|++... .......+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678889999999999999999875 5789999998643 23344667889999999999999999998776554
Q ss_pred --EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 222 --RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 222 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888753 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCcccceeccccCCcccccccc
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+....... ....++..|+|||.+.+
T Consensus 165 ~~~~~~~~---~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 165 ARHTDDEM---TGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccccccc---cCCcccccccCHHHHhC
Confidence 86653321 22357889999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-27 Score=196.38 Aligned_cols=169 Identities=30% Similarity=0.400 Sum_probs=136.0
Q ss_pred cccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+....||.|+||+|+|-..+ .|+..|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..|+.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 33567999999999998765 689999999976544 5667888998876655 78999999999999999999999996
Q ss_pred CCChh---hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 231 NRSLD---IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 231 ~g~L~---~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
-+|+ .+.+. .....+++...-.|+.-..+||.||-+.. .|||||+||+|||++..|.+||||||.+-.+...-
T Consensus 147 -~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 147 -ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred -hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 3443 33332 23356888888899999999999998764 89999999999999999999999999986554333
Q ss_pred cccceeccccCCcccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~ 327 (331)
... ..+|-..|||||.+..
T Consensus 223 AkT-~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 223 AKT-VDAGCRPYMAPERIDP 241 (361)
T ss_pred Hhh-hccCCccccChhccCC
Confidence 222 3368889999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=193.79 Aligned_cols=185 Identities=27% Similarity=0.339 Sum_probs=153.6
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeE
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYS 216 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~ 216 (331)
+++.....+++...++.+|.||.||+|.+. +.+.|.+|.++.. ++-....++.|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445555677888889999999999999553 4567788887543 444567899999999999999999999998
Q ss_pred EcC-CeEEEEEEecCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 217 AHD-DTRFIVYELMENRSLDIQLH-----GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 217 ~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
.+. +..+.+|.++.-|+|..+|. .......++..+...++.|++.||+|||.+ ++||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 754 57899999999999999998 455556788899999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCCcccc--eeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQNKNNL--KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~t 331 (331)
++||+|-.+++...+.+.... ....+..||+||.+.+..|+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys 476 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS 476 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc
Confidence 999999999988765544221 12356799999999998875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=209.15 Aligned_cols=171 Identities=27% Similarity=0.336 Sum_probs=147.5
Q ss_pred CCcccceeeecCceEEEEEEECCCc-eEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNL-HVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
+++....||-|+||.|-+.+.++.. .+|+|.+++. .....+.+..|-.+|...+.+.||++|-.+.++...||+||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567999999999999876543 3777777543 34455668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
-|-+|.|...|+. ...++..+...++..+.+|++|||.+ +||+|||||+|++++.+|.+||-|||+|+..+...
T Consensus 501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999964 45688888999999999999999999 99999999999999999999999999998877554
Q ss_pred cccceeccccCCccccccccCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
. ..+++||+.|.|||.+.+.-
T Consensus 575 K-TwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 575 K-TWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred c-eeeecCCcccccchhhhccC
Confidence 4 45789999999999998764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=211.56 Aligned_cols=171 Identities=23% Similarity=0.256 Sum_probs=120.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-C----CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeee------EE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-D----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY------SA 217 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~------~~ 217 (331)
..++|...+.||+|+||.||+|++. + +..||+|++...... +.+..| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 3 689999987543221 111111 1222222333222211 24
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCC
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPSHG-----------------SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk 280 (331)
..+..++|+||+++++|.+++...... .......+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999888642110 1112344567999999999999999 99999999
Q ss_pred CCCEEECC-CCcEEEEeccCceeCCCC-CcccceeccccCCccccccc
Q 020072 281 SSNILLDS-KFNAKLSDFGLAITDGSQ-NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 281 ~~Nill~~-~~~~kl~Dfgla~~~~~~-~~~~~~~~gt~~y~aPE~l~ 326 (331)
|+|||+++ ++.+||+|||+++..... ........+++.|+|||.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99999986 689999999999754322 22223457899999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-26 Score=211.93 Aligned_cols=173 Identities=29% Similarity=0.422 Sum_probs=155.7
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
...++|+....+|.|.||.|||++.. +++..|+|.++....++..-.++|+-+++.-+|+||+.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 35678888999999999999999864 68899999998887778888899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
|||.+|+|.+.-+. ..++++.+....++...+||.|||+. +-+|||||-.|||+++.+.+|++|||.+-..+..
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999887653 35799999999999999999999999 8999999999999999999999999998777666
Q ss_pred CcccceeccccCCccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~ 326 (331)
..+...+.||+.|||||+-.
T Consensus 166 i~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhhcccCCccccchhHHH
Confidence 66666788999999999863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=186.90 Aligned_cols=166 Identities=29% Similarity=0.434 Sum_probs=135.1
Q ss_pred cceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEecCCC
Q 020072 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~g 232 (331)
...||.|..|.|++++.. +|...|||.+... +.+..++++..++++.+- +.|.||+.+||+..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 556999999999999876 5789999998654 556667888888888776 48999999999999999999999985 2
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccce
Q 020072 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (331)
Q Consensus 233 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 312 (331)
.++.+|.+ ...++++..+-++...+.+||.||-++. +|+|||+||+|||+|+.|++|+||||.+-...+... ...
T Consensus 176 C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-htr 250 (391)
T KOG0983|consen 176 CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-HTR 250 (391)
T ss_pred HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-ccc
Confidence 34444442 3356889889999999999999998775 999999999999999999999999999844433222 223
Q ss_pred eccccCCcccccccc
Q 020072 313 LSGTLGYVAPEYLLD 327 (331)
Q Consensus 313 ~~gt~~y~aPE~l~~ 327 (331)
.+|-+.|||||.+--
T Consensus 251 sAGC~~YMaPERidp 265 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDP 265 (391)
T ss_pred ccCCccccCccccCC
Confidence 468999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=179.39 Aligned_cols=168 Identities=35% Similarity=0.429 Sum_probs=144.2
Q ss_pred CcccceeeecCceEEEEEEECC-CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4456789999999999998875 789999999765554 66789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC-cc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-KN 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~~ 309 (331)
+++|.+++.... ..+++.....++.++++++.|||+. +++|+|++++||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999986422 1288999999999999999999999 99999999999999999999999999986654332 11
Q ss_pred cceeccccCCcccccc
Q 020072 310 NLKLSGTLGYVAPEYL 325 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l 325 (331)
.....++..|++||.+
T Consensus 156 ~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 156 LKTVKGTPFYLAPEVL 171 (225)
T ss_pred ccceeccCCcCCHhHh
Confidence 2234578899999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-26 Score=193.00 Aligned_cols=169 Identities=30% Similarity=0.424 Sum_probs=138.0
Q ss_pred cccceeeecCceEEEEEEE-CCCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-----eEEEE
Q 020072 154 HESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRFIV 225 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 225 (331)
+..+-||-|+||.||-.++ ++|+.||.|++....+ ...+.+.+|+.+|..++|.|++..++...-.. +.|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457799999999999876 4799999999864433 34577899999999999999999988765432 56788
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+|.|. .+|...+- ....++.+...-+.+||++||.|||+. +|.||||||.|.|++.|..+||||||+++..+.
T Consensus 136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88885 56766663 345688888889999999999999999 999999999999999999999999999987665
Q ss_pred CCcc-cceeccccCCccccccccCC
Q 020072 306 QNKN-NLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 306 ~~~~-~~~~~gt~~y~aPE~l~~~~ 329 (331)
+... ....+.|..|.|||.+++.+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGAR 233 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcch
Confidence 4432 22345688999999998754
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=196.73 Aligned_cols=173 Identities=27% Similarity=0.369 Sum_probs=142.9
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecc--cCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 227 (331)
..|+..+.||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+|++|++|...++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45777889999999999999988888999988743 34556678999999999995 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|= .-+|..+|... ......| .+..+..||+.++.+.|++ +|||.||||.|+|+- +|.+||+|||.|.....+.
T Consensus 441 ~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 84 46898888753 2233334 6778999999999999999 999999999999985 4689999999996554333
Q ss_pred --cccceeccccCCccccccccCCC
Q 020072 308 --KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 --~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+||+.||+||.+....+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s 538 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSS 538 (677)
T ss_pred cceeeccccCcccccCHHHHhhccc
Confidence 23345589999999999976554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=178.09 Aligned_cols=139 Identities=15% Similarity=0.185 Sum_probs=107.9
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCch--h-------H-----------------HHHHHHHHHHhcCCCCcc
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--A-------G-----------------REFENEVDLLSNIHHPNV 209 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~H~ni 209 (331)
...||+|+||.||+|...+|+.||+|+++..... . . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998643211 1 1 122359999999988776
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceEecCCCCCCEEECC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivHrdlk~~Nill~~ 288 (331)
.....+.. ...++||||++++++..... ....+++.+...++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333322 23389999999887754432 224688999999999999999999 687 999999999999998
Q ss_pred CCcEEEEeccCceeC
Q 020072 289 KFNAKLSDFGLAITD 303 (331)
Q Consensus 289 ~~~~kl~Dfgla~~~ 303 (331)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=205.39 Aligned_cols=170 Identities=31% Similarity=0.379 Sum_probs=133.9
Q ss_pred CCcccceeeecCce-EEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFG-CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
-|...+++|.|+.| .||+|..+ |+.||||++-. +......+|+..|+.- +|||||++++...++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34556789999987 68999985 77999999842 2334567899999888 6999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---C--CcEEEEeccCceeC
Q 020072 230 ENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---K--FNAKLSDFGLAITD 303 (331)
Q Consensus 230 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~--~~~kl~Dfgla~~~ 303 (331)
. -+|.+++... .......-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 6899998753 1111111134578899999999999998 9999999999999976 2 56999999999765
Q ss_pred CCCCc---ccceeccccCCccccccccCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~ 329 (331)
..... ......||.+|+|||++....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~ 690 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR 690 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc
Confidence 43322 233457999999999997654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=179.86 Aligned_cols=161 Identities=33% Similarity=0.422 Sum_probs=138.3
Q ss_pred CceEEEEEEECC-CceEEEEEecccCchh-HHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcC
Q 020072 163 GFGCVYKAKLDD-NLHVAVKKLDCATQDA-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG 240 (331)
Q Consensus 163 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (331)
+||.||+|+..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998864 8899999997655444 67899999999999999999999999999999999999999999998864
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCc
Q 020072 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320 (331)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~ 320 (331)
. ..+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 2 2389999999999999999999999 99999999999999999999999999986654432 122345788999
Q ss_pred cccccccCCC
Q 020072 321 APEYLLDGMV 330 (331)
Q Consensus 321 aPE~l~~~~~ 330 (331)
+||.+.++.+
T Consensus 154 ~pE~~~~~~~ 163 (244)
T smart00220 154 APEVLLGKGY 163 (244)
T ss_pred CHHHHccCCC
Confidence 9999875544
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=171.72 Aligned_cols=165 Identities=39% Similarity=0.569 Sum_probs=141.4
Q ss_pred eeecCceEEEEEEECC-CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChhh
Q 020072 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 236 (331)
||+|.+|.||++...+ ++.+++|.+...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 889999998755432 45679999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCCCCcccceecc
Q 020072 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNKNNLKLSG 315 (331)
Q Consensus 237 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~g 315 (331)
++... ...+++..+..++.+++++++|||+. +++|+||+|.||++++ ++.++|+|||.+..............+
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 98642 14689999999999999999999999 9999999999999999 899999999999766543312223457
Q ss_pred ccCCccccccccC
Q 020072 316 TLGYVAPEYLLDG 328 (331)
Q Consensus 316 t~~y~aPE~l~~~ 328 (331)
...|++||.+...
T Consensus 156 ~~~~~~pe~~~~~ 168 (215)
T cd00180 156 TPAYMAPEVLLGK 168 (215)
T ss_pred CCCccChhHhccc
Confidence 8899999998664
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=172.19 Aligned_cols=141 Identities=18% Similarity=0.145 Sum_probs=111.0
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCch--------------------------hHHHHHHHHHHHhcCCCCcc
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--------------------------AGREFENEVDLLSNIHHPNV 209 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~H~ni 209 (331)
...||+|++|.||+|+..+|+.||||.++..... ....+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998644211 01224678999999999987
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~ 288 (331)
.....+... ..++||||++++++..... ....++..+...++.|++.++.+||+ . +++||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 554444333 2489999999886543321 12357788899999999999999999 8 999999999999999
Q ss_pred CCcEEEEeccCceeCCC
Q 020072 289 KFNAKLSDFGLAITDGS 305 (331)
Q Consensus 289 ~~~~kl~Dfgla~~~~~ 305 (331)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=190.79 Aligned_cols=169 Identities=28% Similarity=0.344 Sum_probs=138.7
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++.|.....+|.|+|+.|-.+... +++..+||.+... ..+-.+|+.++... +|+||+++.+++.++...|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4667777888999999999998654 6788999999754 22334577666665 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE-CCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL-DSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill-~~~~~~kl~Dfgla~~~~~ 305 (331)
|++.++-+.+.+... +....++..|+.+|+.++.|||++ +++||||||+|||+ ++.+.++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999887766432 222267778999999999999999 99999999999999 6899999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ..+.+-|..|.|||++....||
T Consensus 469 ~---~~tp~~t~~y~APEvl~~~~yt 491 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVLAIQEYT 491 (612)
T ss_pred h---hcccchhhcccChhhhccCCCC
Confidence 4 2234678999999999987775
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-23 Score=169.97 Aligned_cols=166 Identities=23% Similarity=0.397 Sum_probs=137.9
Q ss_pred hcCCcccceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCC--eEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDD--TRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~~~lv 225 (331)
.++|+..+.+|+|-++.||.|. ..+++.++||.++. ...+.+.+|+.+|..|+ ||||++|+++..+.. ..-||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999996 45678899999864 34467889999999997 999999999987754 67899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~ 304 (331)
+||+++.+....- ..++......++.+++.||.|+|+. ||.|||+||.|++||. .-.++|+|+|+|-...
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876543 3477788889999999999999999 9999999999999996 4569999999997665
Q ss_pred CCCcccceeccccCCccccccccC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+....+.. +.+..|.-||.+.+-
T Consensus 185 p~~eYnVR-VASRyfKGPELLVdy 207 (338)
T KOG0668|consen 185 PGKEYNVR-VASRYFKGPELLVDY 207 (338)
T ss_pred CCceeeee-eehhhcCCchheeec
Confidence 54444332 457778899998653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=173.98 Aligned_cols=175 Identities=26% Similarity=0.320 Sum_probs=141.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC--Cc----ceeeeeeEEcC
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PN----VVCLLGYSAHD 219 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~n----iv~l~g~~~~~ 219 (331)
+..+++|.+...+|+|.||.|-++.+. .+..||+|+++.-.+ ..+.-+-|+++|+++.+ || ++.+.+|+.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 345788999999999999999999765 468899999864322 33456779999999942 22 67788889999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-----------
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS----------- 288 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~----------- 288 (331)
+..|+|+|.+ +-++++++.. .+..+++...+..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 9999999998 3588999865 3456789999999999999999999999 9999999999999832
Q ss_pred ---------CCcEEEEeccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 289 ---------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 289 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
+..+||.|||.|....... ..++.|..|.|||++++-.+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGw 286 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGW 286 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCc
Confidence 2358999999997755443 35678999999999987443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=163.77 Aligned_cols=136 Identities=16% Similarity=0.226 Sum_probs=106.7
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-----CCCcceeeeeeEEcCC---e-EEE
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-----HHPNVVCLLGYSAHDD---T-RFI 224 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 224 (331)
...+.||+|+||.||. .-+++.. +||++........+++.+|+.+++.+ +||||++++|+++++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 2233444 79988665444567899999999999 5799999999998874 3 347
Q ss_pred EEEe--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCceEecCCCCCCEEECC----CCcEEEEe-
Q 020072 225 VYEL--MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL-EYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSD- 296 (331)
Q Consensus 225 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivHrdlk~~Nill~~----~~~~kl~D- 296 (331)
|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 558999999953 135554 35678888888 999999 9999999999999974 34799999
Q ss_pred ccCc
Q 020072 297 FGLA 300 (331)
Q Consensus 297 fgla 300 (331)
||..
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=167.65 Aligned_cols=167 Identities=24% Similarity=0.336 Sum_probs=134.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeee-EEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY-SAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~-~~~~~~~~lv 225 (331)
..+.|.+.+.+|+|.||.+-++..+ +.+.+++|.+.. .....++|.+|...--.| .|.||+.-+++ ++..+.+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4567888999999999999999876 457788887753 334567899998766666 58999988776 5667788899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC--CCCcEEEEeccCceeC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFGLAITD 303 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfgla~~~ 303 (331)
+||++.|+|..-+. ...+.+....+++.|+++|+.|||++ .+||||||.+||||- +...+||||||+.+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999987653 24577888899999999999999999 999999999999993 3557999999998776
Q ss_pred CCCCcccceeccccCCccccccc
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
+..-... ..+..|.+||...
T Consensus 174 g~tV~~~---~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 174 GTTVKYL---EYVNNYHAPELCD 193 (378)
T ss_pred Cceehhh---hhhcccCCcHHHh
Confidence 5443322 3466799999763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=172.16 Aligned_cols=168 Identities=29% Similarity=0.350 Sum_probs=135.1
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------eE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TR 222 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~ 222 (331)
+|....-+|.|.- .|..+-+. .++.||+|++... .....++..+|...+..++|+||++++.++.-.. +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555666777776 45555332 5789999988533 3334566789999999999999999999986443 67
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|+|||||. .+|...++ ..++-++...|..|+++|++|||+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 99999996 67776664 3477788889999999999999999 999999999999999999999999999988
Q ss_pred CCCCCcccceeccccCCccccccccCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.+.. ......+.|..|.|||++.+-.|
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccCC
Confidence 7655 44556678999999999977544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=175.19 Aligned_cols=185 Identities=21% Similarity=0.250 Sum_probs=151.6
Q ss_pred cccHHHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC------CCcceee
Q 020072 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH------HPNVVCL 212 (331)
Q Consensus 140 ~~~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l 212 (331)
++.....|....+|.+....|+|-|++|.+|... .|+.||||++..+ +.-.+.=+.|+++|++|+ --++++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4455566777889999999999999999999865 4789999999743 223344578999999996 3579999
Q ss_pred eeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-Cc
Q 020072 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FN 291 (331)
Q Consensus 213 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~ 291 (331)
+..|...+.+|||+|-+. -+|.+.|........|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 999999999999999874 68888887666666788999999999999999999887 99999999999999975 56
Q ss_pred EEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+||||||.|...+..... ....+-.|.|||.|.+-.|+
T Consensus 576 LKLCDfGSA~~~~eneit--PYLVSRFYRaPEIiLG~~yd 613 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT--PYLVSRFYRAPEIILGLPYD 613 (752)
T ss_pred eeeccCcccccccccccc--HHHHHHhccCcceeecCccc
Confidence 899999998665543322 23456789999999998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=161.44 Aligned_cols=143 Identities=17% Similarity=0.129 Sum_probs=111.0
Q ss_pred CCcccceeeecCceEEEEEE--ECCCceEEEEEecccCch------------------------hHHHHHHHHHHHhcCC
Q 020072 152 SFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQD------------------------AGREFENEVDLLSNIH 205 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 205 (331)
.|...+.||+|+||.||+|. ..+|+.||+|.+...... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998643210 1123578999999997
Q ss_pred CCc--ceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc-eEecCCCCC
Q 020072 206 HPN--VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA-VIHRDLKSS 282 (331)
Q Consensus 206 H~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivHrdlk~~ 282 (331)
+.+ +.+.+++ ...++||||+++++|...... ...+...+...++.|++.+++|||+. + ++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 633 3334432 235899999999888655421 23455666789999999999999999 8 999999999
Q ss_pred CEEECCCCcEEEEeccCceeCCC
Q 020072 283 NILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 283 Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++ ++.++|+|||.+...+.
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999865443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=156.93 Aligned_cols=141 Identities=13% Similarity=0.133 Sum_probs=115.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHH---------HHHHHHHHhcCCCCcceeeeeeEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE---------FENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
+...++|...+++|.|+||.||.... ++..+|+|.+.......... +++|+..+.+++|++|.....++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999766 56789999997543332222 689999999999999999988865
Q ss_pred cC--------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 218 HD--------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 218 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
.. +..+++|||+++.+|.+... ++. ....+++.+|..||+. +++|||++|+|++++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 43 35799999999999977631 222 3456999999999999 99999999999999999
Q ss_pred CcEEEEeccCceeC
Q 020072 290 FNAKLSDFGLAITD 303 (331)
Q Consensus 290 ~~~kl~Dfgla~~~ 303 (331)
+ ++|+|||.....
T Consensus 172 g-i~liDfg~~~~~ 184 (232)
T PRK10359 172 G-LRIIDLSGKRCT 184 (232)
T ss_pred C-EEEEECCCcccc
Confidence 8 999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=156.19 Aligned_cols=135 Identities=21% Similarity=0.256 Sum_probs=113.4
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|++++..++|+|+.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 567899997643221 1124578899999999999988877777777888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+++++|.+.+... .+ .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999888531 12 7889999999999999999 999999999999999 789999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=151.49 Aligned_cols=132 Identities=21% Similarity=0.213 Sum_probs=105.9
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCch----hHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEec
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD----AGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
....|++|+||+||.+.. .+..++.+.+...... ..+.+.+|+++|++|+ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 467899999999997765 6778887877644331 1235889999999995 5889999886 4569999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCC-CCCCEEECCCCcEEEEeccCceeCC
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL-KSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
.+.+|...+. . ....++.|++.+|+++|++ +|+|||| ||.|||+++++.++|+|||++....
T Consensus 81 ~G~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP---R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh---h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9988864331 0 1235778999999999999 9999999 7999999999999999999997544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=175.74 Aligned_cols=139 Identities=19% Similarity=0.247 Sum_probs=113.1
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEE-eccc-C------chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKK-LDCA-T------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
...|...+.||+|+||.||+|.+.+.. +++|+ .... . ....+++.+|++++++++|+|++....++.+.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999876543 44443 2211 1 1123568899999999999999988888887778
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988874 3568999999999999999 99999999999999 67899999999997
Q ss_pred eCC
Q 020072 302 TDG 304 (331)
Q Consensus 302 ~~~ 304 (331)
...
T Consensus 476 ~~~ 478 (535)
T PRK09605 476 YSD 478 (535)
T ss_pred cCC
Confidence 643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=152.97 Aligned_cols=141 Identities=19% Similarity=0.121 Sum_probs=110.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCch----------------------hHHHHHHHHHHHhcCC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD----------------------AGREFENEVDLLSNIH 205 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 205 (331)
.....|...+.||+|+||.||++...+|+.||||++...... ....+.+|...+.++.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333347778999999999999999888999999987532210 1123677899999998
Q ss_pred CCc--ceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 206 HPN--VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 206 H~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
|++ +...++ ....+++|||+++++|...... .....++.+++.++.++|+. +++||||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 874 444443 2455899999999998754320 23567889999999999998 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~ 304 (331)
|++++++.++|+|||++....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999995544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=164.49 Aligned_cols=173 Identities=25% Similarity=0.337 Sum_probs=134.8
Q ss_pred CCcccceeeecCceEEEEEEECCC--ceEEEEEecccCchhHHHHHHHHHHHhcCCC----CcceeeeeeE-EcCCeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDN--LHVAVKKLDCATQDAGREFENEVDLLSNIHH----PNVVCLLGYS-AHDDTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~g~~-~~~~~~~l 224 (331)
+|...+.||+|+||.||++...+. ..+|+|.-..........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999987653 4678887654433332367888888888863 5888888888 47778899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-----CcEEEEeccC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-----FNAKLSDFGL 299 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~Dfgl 299 (331)
||+.+ +-+|.++..... ...++..+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 578887664322 56799999999999999999999999 99999999999999865 4699999999
Q ss_pred ce--eCCCCC------c-c-cceeccccCCccccccccCC
Q 020072 300 AI--TDGSQN------K-N-NLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 300 a~--~~~~~~------~-~-~~~~~gt~~y~aPE~l~~~~ 329 (331)
++ ...... . . .....||.+|+++..-.+.+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e 213 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE 213 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc
Confidence 97 321111 1 1 22345999999998766554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=163.69 Aligned_cols=144 Identities=27% Similarity=0.372 Sum_probs=124.8
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC----CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCe
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDT 221 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~ 221 (331)
....+.|...+.||+|.|++||++.+. ....||+|.+...+ ...++.+|++.|..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345567888999999999999999753 46789999986432 3456889999999994 8999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLA 300 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla 300 (331)
..+|+||+++....++.. .++..++..+++.+..||+++|.+ +||||||||+|+|.+. -+.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999998888774 366888899999999999999999 9999999999999986 466889999998
Q ss_pred e
Q 020072 301 I 301 (331)
Q Consensus 301 ~ 301 (331)
.
T Consensus 181 ~ 181 (418)
T KOG1167|consen 181 Q 181 (418)
T ss_pred H
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=151.76 Aligned_cols=131 Identities=24% Similarity=0.329 Sum_probs=106.5
Q ss_pred eeeecCceEEEEEEECCCceEEEEEecccC---c-----hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCAT---Q-----DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+||+|+||.||+|.+ ++..|++|...... . ....++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56789999864321 1 12356788999999999887665555666667789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
++++|.+.+... . ..++.+++.+|.+||+. +++|||++|+||+++ ++.+++.|||++...
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998877421 1 08899999999999999 999999999999999 889999999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-18 Score=156.31 Aligned_cols=170 Identities=35% Similarity=0.486 Sum_probs=141.5
Q ss_pred CcccceeeecCceEEEEEEECCCceEEEEEecccCch---hHHHHHHHHHHHhcCCCC-cceeeeeeEEcCCeEEEEEEe
Q 020072 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHP-NVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 228 (331)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ |++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999877 78899998654332 467899999999999988 799999999877788999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeCCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQN 307 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 307 (331)
+.++++.+.+........+.......+..|++.+++|+|+. +++|||+||+||+++.++ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999996664321113688999999999999999999999 999999999999999998 79999999987544332
Q ss_pred c------ccceeccccCCcccccccc
Q 020072 308 K------NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~------~~~~~~gt~~y~aPE~l~~ 327 (331)
. ......|+..|+|||.+.+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccccccCCHHHhcC
Confidence 1 2234579999999999876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=144.15 Aligned_cols=166 Identities=22% Similarity=0.326 Sum_probs=129.2
Q ss_pred hcCCcccceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcCCC-CcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||.|+||.+|.|. ..+|..||+|.-.... ....+.-|..+...|++ ..|..+..+..+.+.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678889999999999999996 5689999999854322 23456778888888875 577777888888888999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgla~~~~ 304 (331)
.. +-+|.+.+.- -...++..+.+-.+-|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+++..-
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 4577766542 234588999999999999999999999 99999999999998643 568999999995432
Q ss_pred CCCc-------ccceeccccCCcccc
Q 020072 305 SQNK-------NNLKLSGTLGYVAPE 323 (331)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE 323 (331)
+... ......||.+|.+--
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred cccccccCccccCCccceeeeehhhh
Confidence 2111 122346888887643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=136.40 Aligned_cols=135 Identities=24% Similarity=0.225 Sum_probs=114.4
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCC--CcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.+.||+|.++.||++..++ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 5679999999999999865 6899998864433 4678999999999976 589999998888889999999999877
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+..+ +......++.++++++++||.....+++|+|++|+||++++++.+++.|||.+...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7432 55667788999999999999864457999999999999999999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=140.40 Aligned_cols=136 Identities=21% Similarity=0.198 Sum_probs=97.5
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCch--hHHH----------------------HHHHHHHHhcCCCCc--c
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--AGRE----------------------FENEVDLLSNIHHPN--V 209 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~H~n--i 209 (331)
.+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988643211 1111 134555565654432 3
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEEC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQ-LHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLD 287 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~ 287 (331)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|. . +++||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 333332 245899999999654321 21100 11 5678999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeccCceeCC
Q 020072 288 SKFNAKLSDFGLAITDG 304 (331)
Q Consensus 288 ~~~~~kl~Dfgla~~~~ 304 (331)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=145.62 Aligned_cols=169 Identities=23% Similarity=0.340 Sum_probs=130.4
Q ss_pred CCcccceeeecCceEEEEEE-ECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+|.+.+.||+|.||.++.|+ +-+++.||||.=.. +...-++..|....+.|. .++|...+-+-.++..-.||+|+.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999997 45789999997432 233456677888787774 688888887777777778999988
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-----CCcEEEEeccCceeCC
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-----KFNAKLSDFGLAITDG 304 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfgla~~~~ 304 (331)
. -+|.+++.- -+..++.+++.-+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.+.|||+|+..-
T Consensus 107 G-PSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 G-PSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred C-cCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 3 466665532 245699999999999999999999999 9999999999999964 3469999999997543
Q ss_pred CCCc-------ccceeccccCCccccccccC
Q 020072 305 SQNK-------NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~l~~~ 328 (331)
+... +.....||.+||+=-.-++.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr 211 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR 211 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccc
Confidence 3222 22345799999985544433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=167.45 Aligned_cols=178 Identities=21% Similarity=0.223 Sum_probs=137.8
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCe
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDT 221 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~ 221 (331)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+=+..... +|---.+++.+|+ -+-|+.+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 344556778889999999999999999888999999987544332 2222233344444 2345556666666788
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-------CCCcEEE
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-------SKFNAKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-------~~~~~kl 294 (331)
.+||+||.+.|+|.+++. ..+.++|...+.+..|+++-++.||.. +|||+||||+|+||. ++..++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999996 456799999999999999999999999 999999999999994 2456999
Q ss_pred EeccCceeCC--CCCcccceeccccCCccccccccCCCC
Q 020072 295 SDFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 295 ~Dfgla~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|||.+.... .+...-...++|-.+-.+|+..+...|
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt 881 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT 881 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc
Confidence 9999985432 222333345789999999999887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=149.22 Aligned_cols=134 Identities=31% Similarity=0.411 Sum_probs=109.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-----C---CcceeeeeeEEcC--
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----H---PNVVCLLGYSAHD-- 219 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~g~~~~~-- 219 (331)
.+|...++||-|.|++||++.+. +.+.||+|+.+.. +...+.-+.||.+|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68889999999999999999764 5678999998643 334456788999999984 3 4699999999864
Q ss_pred --CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 220 --DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 220 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
...|||+|+.. .+|..++.. .....++...+..|++||+.||.|||.+| +|||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 47899999985 456566654 23456889999999999999999999998 99999999999999644
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=138.84 Aligned_cols=137 Identities=19% Similarity=0.193 Sum_probs=106.1
Q ss_pred cceee-ecCceEEEEEEECCCceEEEEEecccC-------------chhHHHHHHHHHHHhcCCCCcc--eeeeeeEEcC
Q 020072 156 SNILG-EGGFGCVYKAKLDDNLHVAVKKLDCAT-------------QDAGREFENEVDLLSNIHHPNV--VCLLGYSAHD 219 (331)
Q Consensus 156 ~~~ig-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~~ 219 (331)
..+|| .|+.|+||..... +..+++|.+.... ......+.+|++++.+|+|++| ...+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46798 8999999999885 6688998774311 1233567899999999998875 6677764433
Q ss_pred C----eEEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 220 D----TRFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 220 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
. ..++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888743 234443 357899999999999 9999999999999999999999
Q ss_pred EeccCceeCC
Q 020072 295 SDFGLAITDG 304 (331)
Q Consensus 295 ~Dfgla~~~~ 304 (331)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999986543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-18 Score=170.89 Aligned_cols=123 Identities=17% Similarity=0.181 Sum_probs=90.3
Q ss_pred cCCC-CcceeeeeeE-------EcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCce
Q 020072 203 NIHH-PNVVCLLGYS-------AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (331)
Q Consensus 203 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 274 (331)
.++| .||.++++++ .+.+.+++++||+ +++|.++|... ...+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4556 5888888877 2334677888987 56999999642 35699999999999999999999999 99
Q ss_pred EecCCCCCCEEECCC-------------------CcEEEEeccCceeCCCCC----------------cccceeccccCC
Q 020072 275 IHRDLKSSNILLDSK-------------------FNAKLSDFGLAITDGSQN----------------KNNLKLSGTLGY 319 (331)
Q Consensus 275 vHrdlk~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~----------------~~~~~~~gt~~y 319 (331)
+||||||+||||+.. +.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 455666666654321100 000113478889
Q ss_pred ccccccccCCCC
Q 020072 320 VAPEYLLDGMVN 331 (331)
Q Consensus 320 ~aPE~l~~~~~t 331 (331)
||||++.++.|+
T Consensus 182 ~APE~~~~~~~~ 193 (793)
T PLN00181 182 TSPEEDNGSSSN 193 (793)
T ss_pred EChhhhccCCCC
Confidence 999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-17 Score=160.83 Aligned_cols=171 Identities=25% Similarity=0.286 Sum_probs=131.1
Q ss_pred cccceeeecCceEEEEEEEC-CCceEEEEEec-----ccCchh-HHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLD-----CATQDA-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
...+++|.|++|.|+..... .....+.|... ...... ...+..|..+-..++|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776532 23333333322 111111 122667888889999999988888877777777779
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||++. +|...+.. ...++..++..+..|+.+|++|||+. ++.|||+|++|++++.++.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99988853 24688889999999999999999999 9999999999999999999999999998443221
Q ss_pred C----cccceeccccCCccccccccCCCC
Q 020072 307 N----KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~----~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. .....++|+..|+|||++.+.+|+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~yd 502 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYD 502 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccC
Confidence 1 334456899999999999998875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.2e-17 Score=136.57 Aligned_cols=164 Identities=24% Similarity=0.391 Sum_probs=129.3
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecc--cCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
..+|.+...|..|+|+++.+ .+++|++.. .+....++|..|.-.|+-+.||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34578888999999999755 556666643 344556789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEE--eccCceeCCCCCcccc
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS--DFGLAITDGSQNKNNL 311 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~--Dfgla~~~~~~~~~~~ 311 (331)
|+..||.. .+-..+..++.+++.++|+|++|||+. .+-|----|.++.+++|++.+++|+ |--++-. ..
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-------e~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------EV 344 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------cc
Confidence 99999873 345578889999999999999999997 3334444699999999999998875 3222211 11
Q ss_pred eeccccCCccccccccCC
Q 020072 312 KLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~ 329 (331)
...-.+.||+||.++..+
T Consensus 345 gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKP 362 (448)
T ss_pred ccccCcccCCHHHHhcCc
Confidence 123468899999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=141.22 Aligned_cols=141 Identities=21% Similarity=0.184 Sum_probs=100.0
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchh----------------------------------------HHHHH
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA----------------------------------------GREFE 195 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 195 (331)
.+.||.|++|.||+|++.+|+.||||+.+....+. .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999985431110 01244
Q ss_pred HHHHHHhcC----CCCcceeeeeeEE-cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhC
Q 020072 196 NEVDLLSNI----HHPNVVCLLGYSA-HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR-GLEYLHEH 269 (331)
Q Consensus 196 ~e~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~ 269 (331)
+|...+.++ +|.+-+.+-.++. .....+|||||+++++|.+....... .. .+..++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555554 2333334333333 23467999999999999876542111 12 23466766666 46788988
Q ss_pred CCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 270 ~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
+++|+|++|.||++++++.++++|||++....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.1e-16 Score=145.09 Aligned_cols=159 Identities=26% Similarity=0.322 Sum_probs=129.8
Q ss_pred eeeecCceEEEEEE----ECCCceEEEEEecccCch--hHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEecC
Q 020072 158 ILGEGGFGCVYKAK----LDDNLHVAVKKLDCATQD--AGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|+|.||.|++++ .+.+..+|.|.+...+.. .......|..++...+ ||.++++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999763 345677888877543211 1125567888888996 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 310 (331)
+|.|...+. .....++.....+...++-+++++|+. +++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988774 334566777777888999999999999 9999999999999999999999999999765443332
Q ss_pred ceeccccCCccccccc
Q 020072 311 LKLSGTLGYVAPEYLL 326 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~ 326 (331)
+||..|||||++.
T Consensus 154 ---cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN 166 (612)
T ss_pred ---ccchhhhhhHhhh
Confidence 8999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-15 Score=148.34 Aligned_cols=168 Identities=24% Similarity=0.261 Sum_probs=128.5
Q ss_pred CCcccceeeecCceEEEEEEECCCceEEEEEecccC-chhHHHHHHHHHH--HhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT-QDAGREFENEVDL--LSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++...+.||.+.|=+|.+|+.++|. |+||++-... .-..+.|.++++- ...++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999999886 8899985443 2334444444333 4556899999998887778888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC--CC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG--SQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~--~~ 306 (331)
+. .+|++.|. ....+..-+..-|+.|++.||..+|.. +|+|||||.+||||+...-+.|+||..-+... .+
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 85 58888874 445678888889999999999999999 99999999999999999999999998654321 11
Q ss_pred Cc--ccc---eeccccCCcccccccc
Q 020072 307 NK--NNL---KLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~~--~~~---~~~gt~~y~aPE~l~~ 327 (331)
+. ... +-..-..|.|||.+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhc
Confidence 11 100 1123458999999865
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.3e-14 Score=134.81 Aligned_cols=145 Identities=17% Similarity=0.122 Sum_probs=92.6
Q ss_pred HhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCch----------------------------------hHH-
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD----------------------------------AGR- 192 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~- 192 (331)
.-..|+. +-||.|++|.||+|++.+ |+.||||+.+..-.. ..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3345665 789999999999999987 999999998643100 011
Q ss_pred -----HHHHHHHHHhcCC----CCcceeeeeeEEc-CCeEEEEEEecCCCChhhhhcCCCCCC---CCCHHHHHHHHHHH
Q 020072 193 -----EFENEVDLLSNIH----HPNVVCLLGYSAH-DDTRFIVYELMENRSLDIQLHGPSHGS---ALTWHMRMKIALDT 259 (331)
Q Consensus 193 -----~~~~e~~~l~~l~----H~niv~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~---~l~~~~~~~i~~~i 259 (331)
+|.+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-...+. .+.......++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 2344444444432 3333443333333 346789999999999976421111111 12222222333333
Q ss_pred HHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEeccCceeCC
Q 020072 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFGLAITDG 304 (331)
Q Consensus 260 a~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgla~~~~ 304 (331)
... +++|+|++|.||+++.++ .+++.|||+.....
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999988 99999999986554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-13 Score=112.25 Aligned_cols=130 Identities=22% Similarity=0.164 Sum_probs=95.7
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcce-eeeeeEEcCCeEEEEEEecCCCChh
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
+.++.|.++.||+++.. +..+++|....... ....+.+|+..+..+.+.+++ +++++. .+..++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56888999999999875 67899998754322 233567899999988665544 444443 33458999999998875
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC--NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.. .. ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~--------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE--------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc--------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 32 01 11345678999999999872 12369999999999999 66899999999854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.6e-13 Score=115.64 Aligned_cols=167 Identities=20% Similarity=0.305 Sum_probs=106.1
Q ss_pred CcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCC----------CcceeeeeeE--
Q 020072 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHH----------PNVVCLLGYS-- 216 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H----------~niv~l~g~~-- 216 (331)
+...+.||.|+++.||.+++. +++.+|+|.+... .....+++++|.-....+.+ -.++.-++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345688999999999999876 5899999988433 23355677777766655433 1111111111
Q ss_pred -------EcC---C-----eEEEEEEecCCCChhhhhc---C-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEec
Q 020072 217 -------AHD---D-----TRFIVYELMENRSLDIQLH---G-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277 (331)
Q Consensus 217 -------~~~---~-----~~~lv~e~~~~g~L~~~l~---~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHr 277 (331)
... + ..+++|+-+ .++|.+.+. . ......+....++.+..|+++.+++||+. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 236677776 467765542 2 11123355666778889999999999999 99999
Q ss_pred CCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCccccccc
Q 020072 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 278 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
||+|+|++++++|.++|+||+.....+..... ...+..|.+||...
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELES 215 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhh
Confidence 99999999999999999999987665543221 23457899999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.5e-13 Score=111.37 Aligned_cols=82 Identities=28% Similarity=0.216 Sum_probs=69.5
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccc
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|+|.+++.. .+..+++.+++.++.|+++||+|||++ + ||+|||++.++.+|+ ||+++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~--- 64 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS--- 64 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC---
Confidence 688888863 245699999999999999999999998 5 999999999999999 999876543221
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
.|++.|||||++.++.|+
T Consensus 65 --~g~~~y~aPE~~~~~~~~ 82 (176)
T smart00750 65 --RVDPYFMAPEVIQGQSYT 82 (176)
T ss_pred --CCcccccChHHhcCCCCc
Confidence 578999999999888764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.5e-13 Score=125.82 Aligned_cols=123 Identities=29% Similarity=0.439 Sum_probs=102.4
Q ss_pred HhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCce-EecCC
Q 020072 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV-IHRDL 279 (331)
Q Consensus 201 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-vHrdl 279 (331)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...+.++++.||+|||.- +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4578999999999999999999999999999999999974 456789999999999999999999986 55 99999
Q ss_pred CCCCEEECCCCcEEEEeccCceeCCCC--CcccceeccccCCccccccccC
Q 020072 280 KSSNILLDSKFNAKLSDFGLAITDGSQ--NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 280 k~~Nill~~~~~~kl~Dfgla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+++|+++|..+.+||+|||+....... ........-..-|.|||.+.+.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 999999999999999999998554321 1111112245679999999774
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.5e-12 Score=104.13 Aligned_cols=136 Identities=13% Similarity=0.158 Sum_probs=98.2
Q ss_pred ceeeecCceEEEEEEECC-------CceEEEEEecccC----------------------chhHHHHH----HHHHHHhc
Q 020072 157 NILGEGGFGCVYKAKLDD-------NLHVAVKKLDCAT----------------------QDAGREFE----NEVDLLSN 203 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~ 203 (331)
..||.|--+.||.|...+ +..+|||..+... .+..+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 4789999774210 01122233 79999988
Q ss_pred CCC--CcceeeeeeEEcCCeEEEEEEecCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceEecCC
Q 020072 204 IHH--PNVVCLLGYSAHDDTRFIVYELMENRSLDI-QLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDL 279 (331)
Q Consensus 204 l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivHrdl 279 (331)
+.. -++...+++ ..-++||||++++.+.. .+. ...++..+...+..+++.+|..| |+. +++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 455556654 45689999998754422 221 12345556678889999999999 787 9999999
Q ss_pred CCCCEEECCCCcEEEEeccCceeCC
Q 020072 280 KSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 280 k~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++.|||++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.6e-12 Score=106.87 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=110.6
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCC--CcceeeeeeEEcCC---eEEEEEEecC
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHH--PNVVCLLGYSAHDD---TRFIVYELME 230 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~---~~~lv~e~~~ 230 (331)
+.|+.|..+.+|++...+|..+++|....... ....++.+|.++++.+++ .++.+++.+....+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778899998754322 234678999999999976 34566777766543 6689999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC---------------------------------------- 270 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 270 (331)
+.++...+.. ..++..+...++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 34777888889999999999998521
Q ss_pred -------------CCceEecCCCCCCEEECC--CCcEEEEeccCcee
Q 020072 271 -------------NPAVIHRDLKSSNILLDS--KFNAKLSDFGLAIT 302 (331)
Q Consensus 271 -------------~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~ 302 (331)
...++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 67789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.1e-13 Score=122.94 Aligned_cols=105 Identities=29% Similarity=0.446 Sum_probs=90.6
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
.+|+.|++|...+|.++|.++......++...+.++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999887788889999999999999999999 6 8999999999999999999999999997
Q ss_pred eeCCCCC------cccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQN------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....... .......||..||+||.|.+..|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~ 440 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS 440 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhh
Confidence 5433222 223345699999999999988774
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.2e-13 Score=129.26 Aligned_cols=173 Identities=25% Similarity=0.366 Sum_probs=133.3
Q ss_pred cCCcccceeeecCceEEEEEEEC--CCceEEEEEecccC--chhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv 225 (331)
..|...+.||+|.|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35566777999999999887653 34556666665443 223344455777777776 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~ 303 (331)
.||..++++.+-+.. ......+....-.+..|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|...
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999887721 12224556667789999999999999 77 999999999999999999 9999999999544
Q ss_pred CC---CCcccceecc-ccCCcccccccc
Q 020072 304 GS---QNKNNLKLSG-TLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~---~~~~~~~~~g-t~~y~aPE~l~~ 327 (331)
.. ........+| ++.|+|||...+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc
Confidence 33 2222234568 999999999877
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-11 Score=110.30 Aligned_cols=114 Identities=29% Similarity=0.425 Sum_probs=83.9
Q ss_pred CCCcceeeeeeEEc---------------------------CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 020072 205 HHPNVVCLLGYSAH---------------------------DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257 (331)
Q Consensus 205 ~H~niv~l~g~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 257 (331)
+|||||++.+++.+ ...+|+||.-.+ -+|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999987643 235688887664 478888753 2456677778899
Q ss_pred HHHHHHHHHhhCCCCceEecCCCCCCEEEC--CCC--cEEEEeccCceeCCC---CC---cccceeccccCCccccccc
Q 020072 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKF--NAKLSDFGLAITDGS---QN---KNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 258 ~ia~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~Dfgla~~~~~---~~---~~~~~~~gt~~y~aPE~l~ 326 (331)
|+++|+.|||.+ ++.|||+|++|||+. +|+ ...|+|||++.-... .. .......|...-||||+..
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999983 444 478899998733221 11 1112335788899999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-10 Score=93.27 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=98.0
Q ss_pred eeeecCceEEEEEEECCCceEEEEEe-cccC--ch-----hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 158 ILGEGGFGCVYKAKLDDNLHVAVKKL-DCAT--QD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~~~~vavK~~-~~~~--~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.+++|+-+.+|.+.+.+. .+.+|.- .+.. ++ ...+-.+|..++.+++--.|..-.=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977543 4555543 2211 11 1234678999998886555444444566677888999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++|+++..+. +.++||||+....
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999888532 256777777888889999 999999999999998775 9999999996543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=93.22 Aligned_cols=144 Identities=19% Similarity=0.184 Sum_probs=102.3
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEe-ccc-------CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKL-DCA-------TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
...++-+|+-+.|+++.+. |+...||.- .+. .+-..++..+|+..|.+++--.|.--.=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568999999999999985 666666643 211 1123456788999999886544443333555666668999
Q ss_pred EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEeccCcee
Q 020072 227 ELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAIT 302 (331)
Q Consensus 227 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla~~ 302 (331)
||+++ .++.+++...-. ...........+.+|-+.+.-||.+ .++|+||..+||++.+++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 367777764222 1222233368888999999999999 9999999999999976553 58999999844
Q ss_pred C
Q 020072 303 D 303 (331)
Q Consensus 303 ~ 303 (331)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.8e-12 Score=122.93 Aligned_cols=137 Identities=28% Similarity=0.434 Sum_probs=91.2
Q ss_pred hcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..++|..|+||.||..+.+. .+.+|+|.-+ .+ -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 4678889999999999999998763 5667774321 11 11111 22233334333
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC---
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS--- 305 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~--- 305 (331)
|+-...+.. ..+++-. ++.+++|||+. +|+|||+||+|.+|+.-|.+|++|||+++....
T Consensus 136 ---gDc~tllk~---~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 333333422 2233322 27889999999 999999999999999999999999999743110
Q ss_pred ------------CCcccceeccccCCccccccccCC
Q 020072 306 ------------QNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 306 ------------~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
........+||+.|.|||++...-
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg 234 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG 234 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhc
Confidence 011112357999999999997763
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.7e-10 Score=108.14 Aligned_cols=122 Identities=18% Similarity=0.276 Sum_probs=101.0
Q ss_pred ECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHH
Q 020072 172 LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251 (331)
Q Consensus 172 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 251 (331)
..++.+|.|...+...........+-++.|+.++||||++++...+..+..|+|+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44678899988876666445557778899999999999999999999999999999874 45555532 33555
Q ss_pred HHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 252 ~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
....+.||+.||.|||+.| +++|++|.-..|++++.|..||++|-++...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 6677899999999999765 8999999999999999999999999987443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.4e-11 Score=110.97 Aligned_cols=171 Identities=27% Similarity=0.252 Sum_probs=132.8
Q ss_pred cCCcccceeee--cCceEEEEEEE---CCCceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 151 DSFHESNILGE--GGFGCVYKAKL---DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 151 ~~~~~~~~ig~--G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
..|....-+|. |.+|.+|.+.. .++..+|+|+-+... ......=.+|....+++ .|+|.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566778999 99999999976 467889999843322 22233335677777777 499999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEec
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDF 297 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 297 (331)
++-+|++. .+|..+.+. ....++....+.+..+... ||.++|+. .++|-|+||.||++.++ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999986 777777764 3344677778888888888 99999999 99999999999999999 89999999
Q ss_pred cCceeCCCCCcccce-----eccccCCcccccccc
Q 020072 298 GLAITDGSQNKNNLK-----LSGTLGYVAPEYLLD 327 (331)
Q Consensus 298 gla~~~~~~~~~~~~-----~~gt~~y~aPE~l~~ 327 (331)
|+....+........ ..|...|++||.+.+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 998766554432222 257788999998865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-09 Score=89.78 Aligned_cols=126 Identities=23% Similarity=0.246 Sum_probs=83.0
Q ss_pred EEEEEEECCCceEEEEEecccC--------------c-------h-----hHHHHHHHHHHHhcCCCC--cceeeeeeEE
Q 020072 166 CVYKAKLDDNLHVAVKKLDCAT--------------Q-------D-----AGREFENEVDLLSNIHHP--NVVCLLGYSA 217 (331)
Q Consensus 166 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~e~~~l~~l~H~--niv~l~g~~~ 217 (331)
.||.|...+|..+|+|..+... . . ......+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999873210 0 0 123467899999999765 455665442
Q ss_pred cCCeEEEEEEecC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 218 HDDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 218 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
.-.+||||++ +..+...... .++......++.+++..+..+ |.. +++|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999999 5555443321 111334567777888866664 677 99999999999999988 9999
Q ss_pred EeccCceeCC
Q 020072 295 SDFGLAITDG 304 (331)
Q Consensus 295 ~Dfgla~~~~ 304 (331)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999986654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.5e-09 Score=93.16 Aligned_cols=142 Identities=15% Similarity=0.101 Sum_probs=101.2
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCch-----------hHHHHHHHHHHHhcCCCCcc--eeeeeeEEc----
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-----------AGREFENEVDLLSNIHHPNV--VCLLGYSAH---- 218 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~---- 218 (331)
.+++-+-....|++..+ +|+.+.||+....... ....+.+|...+.++...+| ...+++.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555566777776 4678999977433211 11147788888888853333 334445443
Q ss_pred -CCeEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-------C
Q 020072 219 -DDTRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-------K 289 (331)
Q Consensus 219 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-------~ 289 (331)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||+. +++|+|++++|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999976 7888874311 23455677789999999999999999 9999999999999975 5
Q ss_pred CcEEEEeccCcee
Q 020072 290 FNAKLSDFGLAIT 302 (331)
Q Consensus 290 ~~~kl~Dfgla~~ 302 (331)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998854
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-10 Score=99.20 Aligned_cols=126 Identities=24% Similarity=0.320 Sum_probs=93.3
Q ss_pred HHHhcCCCCcceeeeeeEEcCC-----eEEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 020072 199 DLLSNIHHPNVVCLLGYSAHDD-----TRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNP 272 (331)
Q Consensus 199 ~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 272 (331)
.-|-++.|.|||+++.|+.+.. +..++.|||+.|++..+|++.+ ....+......+|+.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455667999999999876543 5788999999999999998633 34568888888999999999999999 689
Q ss_pred ceEecCCCCCCEEECCCCcEEEEeccCceeCC----CCCcccceeccccCCcccccc
Q 020072 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDG----SQNKNNLKLSGTLGYVAPEYL 325 (331)
Q Consensus 273 ~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~----~~~~~~~~~~gt~~y~aPE~l 325 (331)
+|+|+++..+.|++..++-+|+.--....... ........-.+-++|.|||+=
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 99999999999999999999975322211100 001111112356788888863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-08 Score=93.02 Aligned_cols=137 Identities=18% Similarity=0.149 Sum_probs=106.6
Q ss_pred CceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEE----cCCeEEEEEEecCCC-Chhh
Q 020072 163 GFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA----HDDTRFIVYELMENR-SLDI 236 (331)
Q Consensus 163 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----~~~~~~lv~e~~~~g-~L~~ 236 (331)
.-.+.|++.. .||..++.|++.............-++.++++.|.|+|++..++. .+..+++||+|.++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457888864 478899999994333322223345678999999999999998876 345789999999864 6765
Q ss_pred hhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 237 QLHGP------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 237 ~l~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
+-... ..+...++...|.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 43321 2234578899999999999999999999 999999999999999999999998887643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.1e-08 Score=83.93 Aligned_cols=134 Identities=20% Similarity=0.159 Sum_probs=94.7
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccC------------------ch----hHHHHHHHHHHHhcCCCC--cc
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT------------------QD----AGREFENEVDLLSNIHHP--NV 209 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~----~~~~~~~e~~~l~~l~H~--ni 209 (331)
...+.||.|--+.||.|...+|.++|||.-+... .+ .....++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568899999999999999999999999542110 00 122357899999998654 55
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
.+-+++ +.-.+||||+++-.|...- ++.+..-.++..|++-+.-+-.. ++||+|+++-||++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 555544 4568999999987664321 12223334444444444444455 99999999999999999
Q ss_pred CcEEEEeccCcee
Q 020072 290 FNAKLSDFGLAIT 302 (331)
Q Consensus 290 ~~~kl~Dfgla~~ 302 (331)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-07 Score=78.47 Aligned_cols=139 Identities=14% Similarity=0.064 Sum_probs=101.4
Q ss_pred eeecCceEEEEEEECCCceEEEEEecccC------chhHHHHHHHHHHHhcCCCC--cceeeeeeEEcC----CeEEEEE
Q 020072 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHP--NVVCLLGYSAHD----DTRFIVY 226 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~~~----~~~~lv~ 226 (331)
-|+||-+.|++-..++. .+-+|+-.... +.....|.+|...+.+|... .+.+........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 45688888998877544 68888764221 33556799999999998643 344444222111 1468999
Q ss_pred EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc--EEEEeccCcee
Q 020072 227 ELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAIT 302 (331)
Q Consensus 227 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgla~~ 302 (331)
|-+++ -+|.+++... ...+.+...+..+..+++..+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 4888887532 223567778889999999999999999 9999999999999986667 99999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.4e-09 Score=99.53 Aligned_cols=148 Identities=23% Similarity=0.259 Sum_probs=117.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC--CCceEEEEEecccCchhHH--HHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCATQDAGR--EFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
.+.+|.....||.|.|+.|++...+ ++..+++|.+......... .=..|+.+...+ .|.++++.+..+...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3456777888999999999987543 5778898887544322222 224566666666 5889999888888888888
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCcee
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAIT 302 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~ 302 (331)
+--||++++++...+ .....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 999999999887665 2334578888999999999999999998 99999999999999886 8899999998843
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-07 Score=79.68 Aligned_cols=108 Identities=20% Similarity=0.201 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhcCCCC--cceeeeeeEEcCC----eEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 020072 191 GREFENEVDLLSNIHHP--NVVCLLGYSAHDD----TRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGL 263 (331)
Q Consensus 191 ~~~~~~e~~~l~~l~H~--niv~l~g~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 263 (331)
.....+|...+..+... ...+.+++.+... ..++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34577788877777533 3445555555432 458999999975 788888542 1256667889999999999
Q ss_pred HHHhhCCCCceEecCCCCCCEEECCCC---cEEEEeccCceeCC
Q 020072 264 EYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLSDFGLAITDG 304 (331)
Q Consensus 264 ~yLH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgla~~~~ 304 (331)
.-||+. +++|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 999999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.7e-08 Score=91.71 Aligned_cols=139 Identities=19% Similarity=0.193 Sum_probs=89.7
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCch------------------------------h----------HHHHHH
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD------------------------------A----------GREFEN 196 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------------------~----------~~~~~~ 196 (331)
+-|+.++-|.||+|++.+|+.||||+.+..-.+ . .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578999999999999999999999987432110 0 112334
Q ss_pred HHHHHhcCC-----CCcceeeeeeEE-cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHhhC
Q 020072 197 EVDLLSNIH-----HPNVVCLLGYSA-HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG-LEYLHEH 269 (331)
Q Consensus 197 e~~~l~~l~-----H~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~yLH~~ 269 (331)
|..-+.+++ .++ +.+=.+++ -.....|+|||++|-.+.+...-.. ...+. ..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhc
Confidence 444444432 232 22323333 3467789999999988877642211 22332 2333333332 2222223
Q ss_pred CCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 270 ~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++.|.|..|.||+++.++.+.+.|||+.....
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999985544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-06 Score=73.46 Aligned_cols=139 Identities=13% Similarity=0.137 Sum_probs=93.7
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHH---------HHHHHHHhcCCCC---cceeeeee
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF---------ENEVDLLSNIHHP---NVVCLLGY 215 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~H~---niv~l~g~ 215 (331)
...++|...+++-......|.+-..+ |....+|..+.......+.| .+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 35577888888888777777777664 56888998765544333332 3444444444332 22232333
Q ss_pred EE-----cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 216 SA-----HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 216 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
.+ -....+|+|||++|..|.+... ++. .++..+..++.-||+. |+.|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence 22 2245679999999988865431 222 3556677889999999 999999999999999654
Q ss_pred cEEEEeccCcee
Q 020072 291 NAKLSDFGLAIT 302 (331)
Q Consensus 291 ~~kl~Dfgla~~ 302 (331)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.6e-07 Score=76.05 Aligned_cols=139 Identities=18% Similarity=0.192 Sum_probs=85.0
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--ceeeeeeEEcCCeEEEEEEecCCCC-
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRS- 233 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g~- 233 (331)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24456778765322 2345688999998886443 4667788888888889999999863
Q ss_pred hhhh---------------------hcCCC-CCCCCCHHHHHHHHH----------HHHH-HHHHHhhC-CCCceEecCC
Q 020072 234 LDIQ---------------------LHGPS-HGSALTWHMRMKIAL----------DTAR-GLEYLHEH-CNPAVIHRDL 279 (331)
Q Consensus 234 L~~~---------------------l~~~~-~~~~l~~~~~~~i~~----------~ia~-~l~yLH~~-~~~~ivHrdl 279 (331)
+... +|... ....+.... .++-. .+.. ..++|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 22210 011111000 00000 0011 12222211 1336799999
Q ss_pred CCCCEEECCCCcEEEEeccCcee
Q 020072 280 KSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 280 k~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.|.||++++++ +.+.||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999998743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.4e-06 Score=72.95 Aligned_cols=152 Identities=20% Similarity=0.190 Sum_probs=95.2
Q ss_pred cHHHHHHHhcCCcccce---eeecCceEEEEEEECCCceEEEEEecccCchhH------------------------HHH
Q 020072 142 EYKLLEKATDSFHESNI---LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG------------------------REF 194 (331)
Q Consensus 142 ~~~~l~~~~~~~~~~~~---ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~ 194 (331)
+...+....+......+ |++|--+.||+|...++..+|||++........ ...
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444455555544444 556677799999988899999999854321110 012
Q ss_pred HHHHHHHhcCC--CCcceeeeeeEEcCCeEEEEEEecCCCCh-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 020072 195 ENEVDLLSNIH--HPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271 (331)
Q Consensus 195 ~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 271 (331)
.+|..-|.++. +-.+.+-+++. .-.|||||+..... .-.|. ..++...+...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 34555555442 11222222221 23689999975421 11121 122334467778888888888887632
Q ss_pred CceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 272 ~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+||+.-|||+. ++.+.|+|+|-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 8899999999885543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=2e-06 Score=73.93 Aligned_cols=143 Identities=24% Similarity=0.255 Sum_probs=85.0
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC--cceeeeeeEEc---CCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLLGYSAH---DDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~~~~---~~~~~lv~e~~~~ 231 (331)
+.++.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999877 58999987544 4556788888888888533 34566664433 3357999999998
Q ss_pred CChhh----------------h---hcCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh-
Q 020072 232 RSLDI----------------Q---LHGP-SHGSALTWHMR---------MKI------------ALDTAR-GLEYLHE- 268 (331)
Q Consensus 232 g~L~~----------------~---l~~~-~~~~~l~~~~~---------~~i------------~~~ia~-~l~yLH~- 268 (331)
..+.. . ++.. .......+... ... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 1 1111 01111111110 000 111222 3333332
Q ss_pred ---CCCCceEecCCCCCCEEEC-CCCcEEEEeccCcee
Q 020072 269 ---HCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAIT 302 (331)
Q Consensus 269 ---~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~ 302 (331)
.....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234799999999999999 666678999998744
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-06 Score=73.28 Aligned_cols=103 Identities=26% Similarity=0.173 Sum_probs=81.4
Q ss_pred HHHHHHHhcCCC-CcceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc
Q 020072 195 ENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273 (331)
Q Consensus 195 ~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 273 (331)
..|.-+++.+++ +++.+++|+|-+ +++.||.+.+++...-.........+|..+.+||.++++.+++|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 699999999943 678999998766422100012234789999999999999999999854336
Q ss_pred eEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 274 VIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 274 ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
+...|++++|+-+++++.+|+.|.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 7889999999999999999999998763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-06 Score=73.92 Aligned_cols=140 Identities=19% Similarity=0.183 Sum_probs=84.8
Q ss_pred eeecCc-eEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEecCCCChhh
Q 020072 159 LGEGGF-GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236 (331)
Q Consensus 159 ig~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 236 (331)
|..|.. ..||+...+ +..+.+|...... ...+.+|++++..+. +--+.+++++....+..++|||++++.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998765 4677788765332 345678888888873 4445577777776677899999999877653
Q ss_pred h-------------------hcCCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----CC
Q 020072 237 Q-------------------LHGPSH-GSALTW--HMRMKIAL--------------------DTARGLEYLHE----HC 270 (331)
Q Consensus 237 ~-------------------l~~~~~-~~~l~~--~~~~~i~~--------------------~ia~~l~yLH~----~~ 270 (331)
. +|.... ..+... ........ .+...++.|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 2 122110 001110 00010000 01111222211 12
Q ss_pred CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 271 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34699999999999999988889999998743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.5e-05 Score=81.51 Aligned_cols=147 Identities=16% Similarity=0.263 Sum_probs=91.6
Q ss_pred cceeeecCceEEEEEEECCC---ceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCcc--eeeeeeEEcC---CeEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDN---LHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNV--VCLLGYSAHD---DTRFIV 225 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 225 (331)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688899999999877654 356677654322 223457889999999995 6665 7788888764 467899
Q ss_pred EEecCCCChhh-----------------------hhcCCCC--------CCCCCH--HHHHHHH---------------H
Q 020072 226 YELMENRSLDI-----------------------QLHGPSH--------GSALTW--HMRMKIA---------------L 257 (331)
Q Consensus 226 ~e~~~~g~L~~-----------------------~l~~~~~--------~~~l~~--~~~~~i~---------------~ 257 (331)
|||+++..+.+ .||.... +.+..+ .+..++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1222110 011111 1111111 1
Q ss_pred HHHHHHHHHhhCCC--------CceEecCCCCCCEEECCC-C-cEEEEeccCcee
Q 020072 258 DTARGLEYLHEHCN--------PAVIHRDLKSSNILLDSK-F-NAKLSDFGLAIT 302 (331)
Q Consensus 258 ~ia~~l~yLH~~~~--------~~ivHrdlk~~Nill~~~-~-~~kl~Dfgla~~ 302 (331)
.+...+++|..+.. +.++|+|+++.||+++.+ . ..-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344667754322 359999999999999853 3 357899998744
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-07 Score=90.02 Aligned_cols=159 Identities=21% Similarity=0.175 Sum_probs=111.7
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeEEcCCeEEEEEEecCCC-C
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVYELMENR-S 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~~g-~ 233 (331)
-+-+++++++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..++.++++..+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3457789999999887543334444444321 44566889999999999 777777777778899999999887 2
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCccccee
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 313 (331)
-..... .....+...+...+.+.-.++++|||+. .=+||| ||+..+ +..|..||+......... .....
T Consensus 322 ~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~ 390 (829)
T KOG0576|consen 322 SALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTA 390 (829)
T ss_pred ccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-ccccC
Confidence 221110 1112344445566777788899999987 568998 777655 688999999886665543 23345
Q ss_pred ccccCCccccccccCCC
Q 020072 314 SGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 314 ~gt~~y~aPE~l~~~~~ 330 (331)
.+++.|+|||+...+.+
T Consensus 391 ~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTI 407 (829)
T ss_pred CCCCCCCCchhhccccc
Confidence 78999999999988765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.4e-06 Score=77.48 Aligned_cols=141 Identities=18% Similarity=0.175 Sum_probs=86.5
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchh-------------------------------------HHHHHHHH
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA-------------------------------------GREFENEV 198 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~e~ 198 (331)
.+-||..+.|.||+|++++|+.||||+-+..-+.. .-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999874321100 01233343
Q ss_pred HHH----hcCCCCcc---eeeeeeEEc-CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 020072 199 DLL----SNIHHPNV---VCLLGYSAH-DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270 (331)
Q Consensus 199 ~~l----~~l~H~ni---v~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~ 270 (331)
+-. ..++|-+. |.+=.++++ .....|+||||+|..+.+...-.+ ..++.. .++..+.++. +++-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHHH--HHHHH
Confidence 322 22334441 112223332 357899999999987765432111 224443 3333333332 22222
Q ss_pred CCceEecCCCCCCEEECC----CCcEEEEeccCceeC
Q 020072 271 NPAVIHRDLKSSNILLDS----KFNAKLSDFGLAITD 303 (331)
Q Consensus 271 ~~~ivHrdlk~~Nill~~----~~~~kl~Dfgla~~~ 303 (331)
..|++|.|-.|.||+++. ++.+.+-|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 238999999999999984 678999999997544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.8e-05 Score=67.81 Aligned_cols=78 Identities=10% Similarity=0.101 Sum_probs=57.0
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCC---CcceeeeeeEEcC---CeEEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH---PNVVCLLGYSAHD---DTRFIVYE 227 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~g~~~~~---~~~~lv~e 227 (331)
...+-||.|..+.||+....++ .+.+|..+. ......+.+|.+.|+.|.- -.+.+++++|... +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876666 456666432 1133578999999988853 3577888887643 56899999
Q ss_pred ecCCCCh
Q 020072 228 LMENRSL 234 (331)
Q Consensus 228 ~~~~g~L 234 (331)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.5e-05 Score=63.54 Aligned_cols=132 Identities=21% Similarity=0.326 Sum_probs=91.1
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccC----------------chhHHHHHHHHHHHhcCC------CCcceee
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT----------------QDAGREFENEVDLLSNIH------HPNVVCL 212 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------H~niv~l 212 (331)
....||+|+.-.||.- .+....+||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3568999999999963 445567888876444 223456677776655555 8899999
Q ss_pred eeeEEcCCeEEEEEEecCC--C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE
Q 020072 213 LGYSAHDDTRFIVYELMEN--R----SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (331)
Q Consensus 213 ~g~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill 286 (331)
+|+.+++...-+|+|.+.+ | +|.+++.. ..++. .+...+-+-.+||-+. .|+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 9999999888899987653 2 56667632 23444 2333333445677777 89999999999999
Q ss_pred CCCC----cEEEEe-ccC
Q 020072 287 DSKF----NAKLSD-FGL 299 (331)
Q Consensus 287 ~~~~----~~kl~D-fgl 299 (331)
..+. .+.|.| ||-
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 6432 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.5e-05 Score=65.54 Aligned_cols=73 Identities=15% Similarity=0.207 Sum_probs=43.7
Q ss_pred ceeeecCce-EEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC---cceeeeeeEEcC---CeEEEEEEec
Q 020072 157 NILGEGGFG-CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP---NVVCLLGYSAHD---DTRFIVYELM 229 (331)
Q Consensus 157 ~~ig~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~~~---~~~~lv~e~~ 229 (331)
+-++.|+.. .||+. +..+.+|.... ......+.+|.+.+..+... .+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346666665 58875 22466665442 22345788999999877532 233344433332 2358899999
Q ss_pred CCCChh
Q 020072 230 ENRSLD 235 (331)
Q Consensus 230 ~~g~L~ 235 (331)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.3e-05 Score=61.08 Aligned_cols=128 Identities=21% Similarity=0.223 Sum_probs=85.1
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCccee-eeeeEEcCCeEEEEEEecCCCC
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
..+.|++|.+|.||+|.+.. ..+|+|+-... .....++.|.++|..++-.++.+ ++.|-.+ ++.|||+++-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 35679999999999999864 48888886533 34467899999999998766654 4444322 34599999878
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCC-CCCEEECCCCcEEEEeccCcee
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK-SSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk-~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|.+.-.. .+.+...+++-. |.. |-.. +|-|+.|. |...+|..+..+.|+||.-|..
T Consensus 99 L~~~~~~------~~rk~l~~vlE~-a~~---LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------GDRKHLLRVLEK-AYK---LDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------ccHHHHHHHHHH-HHH---HHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8655321 133333333332 222 3333 89999887 5444444555999999998853
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.0001 Score=61.66 Aligned_cols=125 Identities=25% Similarity=0.393 Sum_probs=88.8
Q ss_pred cCCcccceeeecCc-eEEEEEEECCCceEEEEEecc---cC--------c----------hhHHHHHHHHHHHhcCC---
Q 020072 151 DSFHESNILGEGGF-GCVYKAKLDDNLHVAVKKLDC---AT--------Q----------DAGREFENEVDLLSNIH--- 205 (331)
Q Consensus 151 ~~~~~~~~ig~G~f-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 205 (331)
.+++..+.||.|.- |.||+++.. |+.+|+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57777899999999 999999995 66999999421 00 0 11235788988888875
Q ss_pred CCcc--eeeeeeEEcCC------------------eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020072 206 HPNV--VCLLGYSAHDD------------------TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265 (331)
Q Consensus 206 H~ni--v~l~g~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y 265 (331)
+.++ |+.+||..-.. ..-+|.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4466 89999863220 1246777665432 122 3445667777888
Q ss_pred HhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 266 LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
+|.. +|+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 9998 9999999999986 5689999854
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=62.75 Aligned_cols=141 Identities=19% Similarity=0.191 Sum_probs=80.9
Q ss_pred ceeeecCceEEEEEEECC--CceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 157 NILGEGGFGCVYKAKLDD--NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
+.|..|-...+|+....+ +..+++|....... ...+..+|+.+++.+...+ ..++++.+. + .++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 456677788999988764 66888887654322 1223457888888885433 334444332 2 37999999876
Q ss_pred hhhh-----------------hcCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 020072 234 LDIQ-----------------LHGPSHG--------SAL-TWHMRMKIAL----------------------DTARGLEY 265 (331)
Q Consensus 234 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~l~y 265 (331)
+... +|..... ... .+.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5211 2221111 011 1222111111 11111112
Q ss_pred H----hhC-CCCceEecCCCCCCEEECC-CCcEEEEeccCcee
Q 020072 266 L----HEH-CNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAIT 302 (331)
Q Consensus 266 L----H~~-~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~ 302 (331)
| -.. ....++|+|+.+.|||+++ ++.+.+.||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2347999999999999998 57899999998744
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.9e-05 Score=64.80 Aligned_cols=138 Identities=17% Similarity=0.216 Sum_probs=77.7
Q ss_pred eeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEEEecCCCChhh-
Q 020072 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELMENRSLDI- 236 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~g~L~~- 236 (331)
+..|-.+.+|+... ++..+++|..........-+..+|.++++.+....+ .++++.+. -++|+||+++..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 44566778998874 466788887543322211245788888888864333 23343332 368999999866532
Q ss_pred ----------------hhcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHhhC-----CCCceEecCCCCCCE
Q 020072 237 ----------------QLHGPS-HGSALTWHMR-MKIALD---------TARGLEYLHEH-----CNPAVIHRDLKSSNI 284 (331)
Q Consensus 237 ----------------~l~~~~-~~~~l~~~~~-~~i~~~---------ia~~l~yLH~~-----~~~~ivHrdlk~~Ni 284 (331)
.+|... ...+++.... .....+ +...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 123211 1112222211 111111 11112222111 123689999999999
Q ss_pred EECCCCcEEEEeccCcee
Q 020072 285 LLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~ 302 (331)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999887 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00025 Score=65.92 Aligned_cols=76 Identities=16% Similarity=0.140 Sum_probs=53.8
Q ss_pred cceeeecCceEEEEEEECCC-ceEEEEEeccc----C---chhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDN-LHVAVKKLDCA----T---QDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~l 224 (331)
.+.||.|.+..||+....+| +.|.||.-... . .-..+++..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35689999999999998877 48999985311 1 123456777888887763 2456667766 3456789
Q ss_pred EEEecCCCC
Q 020072 225 VYELMENRS 233 (331)
Q Consensus 225 v~e~~~~g~ 233 (331)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00047 Score=61.80 Aligned_cols=143 Identities=20% Similarity=0.179 Sum_probs=85.2
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--ceeeeee------EEcCCeEEEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGY------SAHDDTRFIVYE 227 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 227 (331)
.+.+..|....+|+...+++ .+++|.... ....+...|++++..+.+.+ +.+.+.. ....+..++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45566777789999876554 678888753 22345667787777774332 3444332 123456789999
Q ss_pred ecCCCChhh--------------hhcCCC--------CCCCCCHHHHH----------HHHHHHHHHHHHHhh----CCC
Q 020072 228 LMENRSLDI--------------QLHGPS--------HGSALTWHMRM----------KIALDTARGLEYLHE----HCN 271 (331)
Q Consensus 228 ~~~~g~L~~--------------~l~~~~--------~~~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~ 271 (331)
|++|..+.. .+|... ......|.... .....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 111100 00111222211 011223344555543 123
Q ss_pred CceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 272 ~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
..++|+|+.|.|++++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999988889999998743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=4.1e-06 Score=83.78 Aligned_cols=145 Identities=21% Similarity=0.232 Sum_probs=101.3
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..+.+...+-+.+|.++.++.++-. .|...+.|..... ...+.+....+-.++-..+||-++...-.+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666677888999998877532 2333333333211 12223333444444444556777766555555678899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
+++|..+++|...|+... ..+.+-.......+..+++|||.. .+.|||++|.|.|+..++..+++|||.
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence 999999999999887532 355555556667788899999997 799999999999999999999999984
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0011 Score=59.83 Aligned_cols=143 Identities=19% Similarity=0.217 Sum_probs=81.6
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC--cceeeeee------EEcCCeEEEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLLGY------SAHDDTRFIVYE 227 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~------~~~~~~~~lv~e 227 (331)
.+.++.|....+|+.+.+++ .+++|...... ...+...|.+++..|... ++.+.+.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34566676678999876655 56678764321 123445566666666422 23343332 122456789999
Q ss_pred ecCCCChhh--------------hhcCCCCC------C---CCCHHHHH------------HHHHHHHHHHHHHhh----
Q 020072 228 LMENRSLDI--------------QLHGPSHG------S---ALTWHMRM------------KIALDTARGLEYLHE---- 268 (331)
Q Consensus 228 ~~~~g~L~~--------------~l~~~~~~------~---~l~~~~~~------------~i~~~ia~~l~yLH~---- 268 (331)
|++|..+.. .+|....+ . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855421 12211110 0 01111110 011223345555543
Q ss_pred CCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 269 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
....+++|+|+.+.|+++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999998878999999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.002 Score=58.41 Aligned_cols=142 Identities=17% Similarity=0.209 Sum_probs=76.3
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-----CCcceeee-e--eEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----HPNVVCLL-G--YSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~e~ 228 (331)
+.++.|....+|+.+.++| .+++|+..... ......|+.++..|. -|.++.-. | +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4466677778999887666 67888875212 223334445554442 23333211 1 12234567899999
Q ss_pred cCCCChhh--------------hhcCCCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHhh----
Q 020072 229 MENRSLDI--------------QLHGPSH--------GSALTW-HMRMKI------------A-LDTARGLEYLHE---- 268 (331)
Q Consensus 229 ~~~g~L~~--------------~l~~~~~--------~~~l~~-~~~~~i------------~-~~ia~~l~yLH~---- 268 (331)
++|..+.. .+|.... ...+.| .....- . ..+...++.+.+
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1221110 011112 111111 1 111122233321
Q ss_pred CCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 269 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
....+++|+|+.+.||+++.+...-|.||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1345899999999999999776678999998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00051 Score=61.82 Aligned_cols=140 Identities=24% Similarity=0.278 Sum_probs=82.0
Q ss_pred eeeecCceEEEEEEECC-------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEEEec
Q 020072 158 ILGEGGFGCVYKAKLDD-------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~ 229 (331)
.+..|-...+|+....+ +..+++|....... ...+..+|.+++..+....+ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45556667899887654 47888888754332 23455778888888753333 345555432 3589999
Q ss_pred CCCChhhh-----------------hcCCCCCC------CC--CHHHHHH--------------------------HHHH
Q 020072 230 ENRSLDIQ-----------------LHGPSHGS------AL--TWHMRMK--------------------------IALD 258 (331)
Q Consensus 230 ~~g~L~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~~ 258 (331)
+|..+... +|...... .. -|..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766321 22211110 11 1111111 1122
Q ss_pred HHHHHHHHhh------CCCCceEecCCCCCCEEECCC----CcEEEEeccCcee
Q 020072 259 TARGLEYLHE------HCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAIT 302 (331)
Q Consensus 259 ia~~l~yLH~------~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgla~~ 302 (331)
+..-+++|-. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2233444432 234578999999999999985 8899999998843
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=61.43 Aligned_cols=74 Identities=20% Similarity=0.285 Sum_probs=48.6
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
..+.++.|....+|+.+ .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+|++||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35668888889999987 567789999875 334467888988888883 34577888888777778999999987
Q ss_pred C
Q 020072 232 R 232 (331)
Q Consensus 232 g 232 (331)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00025 Score=68.52 Aligned_cols=70 Identities=29% Similarity=0.546 Sum_probs=52.1
Q ss_pred HHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc---------cceeccccCCccccccc
Q 020072 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN---------NLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 256 ~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~---------~~~~~gt~~y~aPE~l~ 326 (331)
+.++++||.|+|.. +++||++|.|++|.++.++..||+.|+++......... ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34555999999975 49999999999999999999999999987543321110 00112456899999986
Q ss_pred c
Q 020072 327 D 327 (331)
Q Consensus 327 ~ 327 (331)
+
T Consensus 183 ~ 183 (700)
T KOG2137|consen 183 G 183 (700)
T ss_pred c
Confidence 5
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0064 Score=55.31 Aligned_cols=139 Identities=17% Similarity=0.243 Sum_probs=94.0
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEeccc-----C-----------------chhH----HHHHHHHHHHhcCCCCcc
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCA-----T-----------------QDAG----REFENEVDLLSNIHHPNV 209 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~-----~-----------------~~~~----~~~~~e~~~l~~l~H~ni 209 (331)
..+|..|--+.||.|.-.+|..+|||+++.. + .+.. -....|++-|++|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4568889999999999999999999987421 0 0011 123457777777764443
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
.----... ..-.|||+|+....-. .-.-+...++...+..+-.+++.-|.-|.+.| ++||.||.--|+|+- +
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 21100001 2346899999632221 11123345777778888889999999998887 999999999999985 5
Q ss_pred CcEEEEeccCcee
Q 020072 290 FNAKLSDFGLAIT 302 (331)
Q Consensus 290 ~~~kl~Dfgla~~ 302 (331)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 6899999987744
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0098 Score=53.59 Aligned_cols=128 Identities=18% Similarity=0.265 Sum_probs=74.2
Q ss_pred CceEEEEEec--ccCchhHHHHHHHHHHHhcCCC--CcceeeeeeEEcCC--eEEEEEEecCCCChhhhhcCCCC-----
Q 020072 175 NLHVAVKKLD--CATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDD--TRFIVYELMENRSLDIQLHGPSH----- 243 (331)
Q Consensus 175 ~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~----- 243 (331)
++...++ .. ...........+|..+++.+.- --+-..+++|.++. ..+.||+|+++..+.+.+.....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6667777 32 1223345566788888888743 23445577787766 77999999987444222211000
Q ss_pred ----------------------C-------CC-CCHHHHHHHH--------HHHHHHHHHHhhCC-----CCceEecCCC
Q 020072 244 ----------------------G-------SA-LTWHMRMKIA--------LDTARGLEYLHEHC-----NPAVIHRDLK 280 (331)
Q Consensus 244 ----------------------~-------~~-l~~~~~~~i~--------~~ia~~l~yLH~~~-----~~~ivHrdlk 280 (331)
+ .+ -.|...++.+ -....-..||+++. .+.++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 0 00 0111111000 01122244554432 2468999999
Q ss_pred CCCEEECCCCcEEEEeccCceeC
Q 020072 281 SSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 281 ~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+.|++++++.-+=|.||+++..-
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999988999999998543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0069 Score=55.87 Aligned_cols=163 Identities=15% Similarity=0.196 Sum_probs=99.2
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeee----EE---cCCeEEEEE
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY----SA---HDDTRFIVY 226 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~----~~---~~~~~~lv~ 226 (331)
..+-||+|+-+.+|-.- +-...+.|+......-...+ .++.|.+. .||-+-.=+.+ .. .+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35679999999999532 11122346654333322222 23334444 56543321111 01 112245666
Q ss_pred EecCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 227 ELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 227 e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
..+.+..--..+.+ +.......|.-.++.++.+|.+.+-||.. +.+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 66655421112222 23334578999999999999999999999 999999999999999999999998653222
Q ss_pred CCCCCcccceeccccCCccccccc
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
. .........+|...|.+||.-.
T Consensus 167 ~-~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 167 N-ANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred c-cCCceEecccCccccCCHHHhc
Confidence 1 1122222346889999999754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0091 Score=54.83 Aligned_cols=140 Identities=19% Similarity=0.217 Sum_probs=80.1
Q ss_pred eeeecCceEEEEEEECC-----CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcce-eeeeeEEcCCeEEEEEEecCC
Q 020072 158 ILGEGGFGCVYKAKLDD-----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~ 231 (331)
.+..|-.-.+|+....+ +..|.+|.......... +-.+|..+++.+...++. ++++.+... .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446667888886532 35788888765433222 236788888888544443 445555332 58999987
Q ss_pred CChhhh-----------------hcCCC-CC--CCCCHHHHHHHHHH-----------------HHHHHHHHh----h-C
Q 020072 232 RSLDIQ-----------------LHGPS-HG--SALTWHMRMKIALD-----------------TARGLEYLH----E-H 269 (331)
Q Consensus 232 g~L~~~-----------------l~~~~-~~--~~l~~~~~~~i~~~-----------------ia~~l~yLH----~-~ 269 (331)
.++... +|... .. ....+.+..++..+ +...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666321 22211 01 11223333233211 111222222 1 2
Q ss_pred CCCceEecCCCCCCEEECC-CCcEEEEeccCcee
Q 020072 270 CNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAIT 302 (331)
Q Consensus 270 ~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~ 302 (331)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2347899999999999986 47899999998844
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0089 Score=53.10 Aligned_cols=31 Identities=29% Similarity=0.453 Sum_probs=25.8
Q ss_pred CceEecCCCCCCEEECCCCc-EEEEeccCcee
Q 020072 272 PAVIHRDLKSSNILLDSKFN-AKLSDFGLAIT 302 (331)
Q Consensus 272 ~~ivHrdlk~~Nill~~~~~-~kl~Dfgla~~ 302 (331)
+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999998555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.017 Score=51.99 Aligned_cols=29 Identities=28% Similarity=0.376 Sum_probs=25.4
Q ss_pred CceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 272 ~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999988 578999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.035 Score=51.82 Aligned_cols=73 Identities=14% Similarity=0.092 Sum_probs=48.5
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEeccc----Cc---hhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCA----TQ---DAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv 225 (331)
.+.||.|....||+.... +..++||+-... .. -...+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456888999999998764 456889876411 11 12333344566665553 347778888887 456788
Q ss_pred EEecCC
Q 020072 226 YELMEN 231 (331)
Q Consensus 226 ~e~~~~ 231 (331)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.027 Score=48.09 Aligned_cols=73 Identities=19% Similarity=0.225 Sum_probs=49.7
Q ss_pred eeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
+.-|.--..|.... +..++.||.- ..+....|..|+.-|..|. --++.+.+.+-.+.+..|+|+||.+.|.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 33343334444332 4567888874 3445577888887776664 345777888888889999999999987765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0027 Score=56.73 Aligned_cols=132 Identities=17% Similarity=0.158 Sum_probs=88.1
Q ss_pred CcccceeeecCceEEEEEEECCCceEEEEEeccc---------C-------ch-h-----HHHHHHHHHHHhcCC-CCc-
Q 020072 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA---------T-------QD-A-----GREFENEVDLLSNIH-HPN- 208 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~---------~-------~~-~-----~~~~~~e~~~l~~l~-H~n- 208 (331)
+...+.||-|--+.||.+-..+|.+.++|.-+.. . .+ . .-...+|...|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4668899999999999999988998888843110 0 00 0 112356788888874 322
Q ss_pred ceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC
Q 020072 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 209 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~ 288 (331)
+.+-++ -+..++|||++.+-.|...-+ ..+.. .+...+..-+.-|-.+ ++||+|..-=||++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 222332 356689999998887754321 11222 2333333444455566 9999999999999999
Q ss_pred CCcEEEEeccCc
Q 020072 289 KFNAKLSDFGLA 300 (331)
Q Consensus 289 ~~~~kl~Dfgla 300 (331)
++.++++||--.
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.02 Score=52.47 Aligned_cols=73 Identities=15% Similarity=0.089 Sum_probs=46.8
Q ss_pred eeeecCceEEEEEEECCC-ceEEEEEecc-------cCchhHHHHHHHHHHHhcCC--CC-cceeeeeeEEcCCeEEEEE
Q 020072 158 ILGEGGFGCVYKAKLDDN-LHVAVKKLDC-------ATQDAGREFENEVDLLSNIH--HP-NVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--H~-niv~l~g~~~~~~~~~lv~ 226 (331)
.||-|....||++...+| +.|+||.-.. .-+-..++..-|.+.|+... -| .+.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 378899999999997654 5899997521 11223445556777776653 24 344444 33455667999
Q ss_pred EecCCC
Q 020072 227 ELMENR 232 (331)
Q Consensus 227 e~~~~g 232 (331)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.028 Score=51.28 Aligned_cols=140 Identities=19% Similarity=0.244 Sum_probs=77.3
Q ss_pred eeeecCceEEEEEEECC----CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcce-eeeeeEEcCCeEEEEEEecCCC
Q 020072 158 ILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMENR 232 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g 232 (331)
.|..|-...+|+....+ +..|.+|....... ..-+-.+|..+++.+...++. ++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34445566788876543 23788887754433 222346788888888655543 4555553 22 589999776
Q ss_pred Chhh-----------------hhcCCC-C--CCCCCHHHHHHHHHHH----------------------HHHHHHHhh--
Q 020072 233 SLDI-----------------QLHGPS-H--GSALTWHMRMKIALDT----------------------ARGLEYLHE-- 268 (331)
Q Consensus 233 ~L~~-----------------~l~~~~-~--~~~l~~~~~~~i~~~i----------------------a~~l~yLH~-- 268 (331)
.+.. .+|... . ..+--|....++..++ ..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6521 122211 0 0111233222222111 111222211
Q ss_pred ---CCCCceEecCCCCCCEEECC-CCcEEEEeccCcee
Q 020072 269 ---HCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAIT 302 (331)
Q Consensus 269 ---~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~ 302 (331)
....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11224799999999999975 57899999998743
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.044 Score=49.85 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=80.3
Q ss_pred eeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc------ceeeeee----EEcCCeEEEEEEe
Q 020072 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN------VVCLLGY----SAHDDTRFIVYEL 228 (331)
Q Consensus 159 ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~----~~~~~~~~lv~e~ 228 (331)
|.+ .-..+|+...++|.. ++|..... ....+..-|+..+..|.-.+ +..+-|- .......+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 446789988887766 77777654 34455666777776663211 2222221 1111377889999
Q ss_pred cCCCChhh-h--------------hcC---------CCCCCCCCHHH-------------HHHHHHHHHHHHHHHhhCC-
Q 020072 229 MENRSLDI-Q--------------LHG---------PSHGSALTWHM-------------RMKIALDTARGLEYLHEHC- 270 (331)
Q Consensus 229 ~~~g~L~~-~--------------l~~---------~~~~~~l~~~~-------------~~~i~~~ia~~l~yLH~~~- 270 (331)
++|..+.. . +|. +.......|.. ......++...++.+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99887762 0 110 00011233330 0123334444455554321
Q ss_pred ---CCc---eEecCCCCCCEEECCCCc-EEEEeccCce
Q 020072 271 ---NPA---VIHRDLKSSNILLDSKFN-AKLSDFGLAI 301 (331)
Q Consensus 271 ---~~~---ivHrdlk~~Nill~~~~~-~kl~Dfgla~ 301 (331)
... +||+|+.|.||+++.+.. +-+.||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 999999999999999885 8999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.016 Score=52.76 Aligned_cols=72 Identities=21% Similarity=0.224 Sum_probs=55.9
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
+.|++|++. ++++. . ...-.+++.+.++.+.+.-+.-+.... ++=|||+.-.||||+ +|++.|+||-++
T Consensus 300 y~yl~~kdh-gt~is-~------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPIS-I------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceee-e------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 556666664 33442 1 123568889999999888888887654 899999999999999 999999999999
Q ss_pred eeC
Q 020072 301 ITD 303 (331)
Q Consensus 301 ~~~ 303 (331)
+..
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.076 Score=47.94 Aligned_cols=32 Identities=22% Similarity=0.281 Sum_probs=28.5
Q ss_pred CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 271 ~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.12 Score=47.16 Aligned_cols=72 Identities=18% Similarity=0.164 Sum_probs=43.7
Q ss_pred cCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC--ccee---eee--eEEcCCeEEEEEEecCCCCh
Q 020072 162 GGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVC---LLG--YSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 162 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~---l~g--~~~~~~~~~lv~e~~~~g~L 234 (331)
+.-..||+...+++..+++|..+... ....++..|.+.+..|... .++. .-| +...++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34467999988888888888875322 2345566677777666321 1222 122 22334567889999987643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.098 Score=55.01 Aligned_cols=141 Identities=23% Similarity=0.311 Sum_probs=76.8
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-------CCCcceeee-e----eEEc-CC--e
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-------HHPNVVCLL-G----YSAH-DD--T 221 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~H~niv~l~-g----~~~~-~~--~ 221 (331)
+.|+ |..-..|+.+..+|..+++|+.+.... ......|...|..| .-|.+++-. | .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 445778988888888899999865422 22333444455433 233444322 1 1111 22 4
Q ss_pred EEEEEEecCCCChhhh-----------------hc----C---CCCCCCCCHHH-----------------HHHHHHHHH
Q 020072 222 RFIVYELMENRSLDIQ-----------------LH----G---PSHGSALTWHM-----------------RMKIALDTA 260 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~-----------------l~----~---~~~~~~l~~~~-----------------~~~i~~~ia 260 (331)
.+-+++|+++..+.+. ++ + +.....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6778999998766431 01 0 00011122321 112222222
Q ss_pred HHHH-----HHhhCCCCceEecCCCCCCEEECCCC--cEE-EEeccCce
Q 020072 261 RGLE-----YLHEHCNPAVIHRDLKSSNILLDSKF--NAK-LSDFGLAI 301 (331)
Q Consensus 261 ~~l~-----yLH~~~~~~ivHrdlk~~Nill~~~~--~~k-l~Dfgla~ 301 (331)
...+ .+ .....++||+|+.+.|||++.+. .+. |+|||.+.
T Consensus 188 ~~~~~~v~p~l-~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRL-AALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHH-hcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 12 22345899999999999999875 555 99999874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.043 Score=50.94 Aligned_cols=74 Identities=19% Similarity=0.231 Sum_probs=48.1
Q ss_pred cceeeecCceEEEEEEECC-CceEEEEEecc------cCchhHHHHHHHHHHHhcCC--CC-cceeeeeeEEcCCeEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDC------ATQDAGREFENEVDLLSNIH--HP-NVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--H~-niv~l~g~~~~~~~~~lv 225 (331)
.+.||-|.-..||++...+ +..|+||.-.. .-.-..++..-|.+.|+... -| .+.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4568999999999998753 56799997521 11223455666777777653 34 34445433 44566788
Q ss_pred EEecCC
Q 020072 226 YELMEN 231 (331)
Q Consensus 226 ~e~~~~ 231 (331)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.011 Score=46.41 Aligned_cols=29 Identities=10% Similarity=0.276 Sum_probs=17.3
Q ss_pred ccceeEEehhHHHHHHHHHHHHHHHHhhh
Q 020072 67 HHKLLIALIIACSALCLIILALLCLWLYH 95 (331)
Q Consensus 67 ~~~~~i~~~v~~~~~~~l~~~~~~~~~~~ 95 (331)
.+.++|+++|.+++.++++++++++++|+
T Consensus 47 nknIVIGvVVGVGg~ill~il~lvf~~c~ 75 (154)
T PF04478_consen 47 NKNIVIGVVVGVGGPILLGILALVFIFCI 75 (154)
T ss_pred CccEEEEEEecccHHHHHHHHHhheeEEE
Confidence 44577788777666666554555444443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PF06679 DUF1180: Protein of unknown function (DUF1180); InterPro: IPR009565 This entry consists of several hypothetical eukaryotic proteins thought to be membrane proteins | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.2 Score=40.39 Aligned_cols=8 Identities=13% Similarity=0.439 Sum_probs=3.1
Q ss_pred HHhhhhcc
Q 020072 91 LWLYHLKY 98 (331)
Q Consensus 91 ~~~~~~~~ 98 (331)
+..+|.|+
T Consensus 114 ir~~R~r~ 121 (163)
T PF06679_consen 114 IRTFRLRR 121 (163)
T ss_pred HHHHhhcc
Confidence 33344343
|
Their function is unknown. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.0071 Score=36.04 Aligned_cols=26 Identities=19% Similarity=0.223 Sum_probs=12.3
Q ss_pred ccceeEEehhHHHHHHHHHHHHHHHH
Q 020072 67 HHKLLIALIIACSALCLIILALLCLW 92 (331)
Q Consensus 67 ~~~~~i~~~v~~~~~~~l~~~~~~~~ 92 (331)
++...|++++++-+++++++++++++
T Consensus 8 ~~~vaIa~~VvVPV~vI~~vl~~~l~ 33 (40)
T PF08693_consen 8 SNTVAIAVGVVVPVGVIIIVLGAFLF 33 (40)
T ss_pred CceEEEEEEEEechHHHHHHHHHHhh
Confidence 44555665555444444444433333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.17 Score=47.09 Aligned_cols=73 Identities=19% Similarity=0.226 Sum_probs=43.5
Q ss_pred eeeecCceEEEEEEECCC--c-----eEEEEEecccCchhHHHHHHHHHHHhcCCCCccee-eeeeEEcCCeEEEEEEec
Q 020072 158 ILGEGGFGCVYKAKLDDN--L-----HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~ 229 (331)
.|..|-...+|++...++ . .|.++..... .+..-+-.+|.++++.+...++.+ +++.+.. .+++||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 444566788999876433 1 2444443222 122223467888999987655544 4444432 5999999
Q ss_pred CCCChh
Q 020072 230 ENRSLD 235 (331)
Q Consensus 230 ~~g~L~ 235 (331)
++.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.12 Score=44.05 Aligned_cols=115 Identities=17% Similarity=0.129 Sum_probs=70.4
Q ss_pred CceEEEEEEECCCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcC-CeEEEEEEecCCCChhhhhcC
Q 020072 163 GFGCVYKAKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYELMENRSLDIQLHG 240 (331)
Q Consensus 163 ~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~~~g~L~~~l~~ 240 (331)
+..+.-.++.+-| ...+|++....-. ...-|..+.++++++. .|++|. .+. -.+-++.|+|-.-..
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCccc------
Confidence 3344444433333 4456666543333 3345778888888874 466665 222 245577888742111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
+. ..+..-=.++|.-.|+. ..+.+|||-.|+||+-|.+|.+||-|=+.-
T Consensus 142 ------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 ------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11 12222224667778864 458999999999999999999999998753
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.066 Score=49.60 Aligned_cols=61 Identities=16% Similarity=0.050 Sum_probs=42.5
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~ 288 (331)
..|+-+|+.+-++..++.. ...++..+.+++.-.++|+--|-... .++|.|+.|.||++-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3566678888788877753 23445566777777777765443321 7999999999999943
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.061 Score=45.58 Aligned_cols=29 Identities=38% Similarity=0.496 Sum_probs=21.0
Q ss_pred ceEecCCCCCCEEE-CCCCcEEEEeccCce
Q 020072 273 AVIHRDLKSSNILL-DSKFNAKLSDFGLAI 301 (331)
Q Consensus 273 ~ivHrdlk~~Nill-~~~~~~kl~Dfgla~ 301 (331)
-+.|.|+.+.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 67999999999999 889999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 331 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 4e-92
Identities = 82/192 (42%), Positives = 114/192 (59%), Gaps = 3/192 (1%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA-TQDAGREFENEVDLL 201
+ L+ A+D+F NILG GGFG VYK +L D VAVK+L TQ +F+ EV+++
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTA 260
S H N++ L G+ R +VY M N S+ L L W R +IAL +A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGY 319
RGL YLH+HC+P +IHRD+K++NILLD +F A + DFGLA + D + GT+G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 320 VAPEYLLDGMVN 331
+APEYL G +
Sbjct: 202 IAPEYLSTGKSS 213
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 3e-85
Identities = 78/195 (40%), Positives = 109/195 (55%), Gaps = 16/195 (8%)
Query: 143 YKLLEKATDSFHE------SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG----R 192
+ L+ T++F E N +GEGGFG VYK +++ VAVKKL +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQ 75
Query: 193 EFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR 252
+F+ E+ +++ H N+V LLG+S+ D +VY M N SL +L L+WHMR
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNN 310
KIA A G+ +LHE+ IHRD+KS+NILLD F AK+SDFGLA +Q
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 311 LKLSGTLGYVAPEYL 325
++ GT Y+APE L
Sbjct: 193 SRIVGTTAYMAPEAL 207
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 9e-84
Identities = 83/230 (36%), Positives = 129/230 (56%), Gaps = 17/230 (7%)
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEG 162
+K +K+ +S N + SS+L F S R + ++ LE+AT++F ++G G
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYR--------VPLVD---LEEATNNFDHKFLIGHG 50
Query: 163 GFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222
FG VYK L D VA+K+ + EFE E++ LS HP++V L+G+ +
Sbjct: 51 VFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110
Query: 223 FIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281
++Y+ MEN +L L+G + ++W R++I + ARGL YLH A+IHRD+KS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKS 167
Query: 282 SNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
NILLD F K++DFG++ T+ Q + + GTLGY+ PEY + G
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR 217
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-62
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEV 198
+ + L + + G FGCV+KA+L + +VAVK + E EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFP-IQDKQSWQNEYEV 69
Query: 199 DLLSNIHHPNVVCLLGYSAHDDT----RFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
L + H N++ +G + +++ E SL L ++W+
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125
Query: 255 IALDTARGLEYLHEH-------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--DGS 305
IA ARGL YLHE PA+ HRD+KS N+LL + A ++DFGLA+ G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGM 329
+ GT Y+APE L +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAI 209
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-55
Identities = 58/169 (34%), Positives = 87/169 (51%), Gaps = 4/169 (2%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V++A+ VAVK L + EF EV ++ + HPN+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
IV E + SL LH L R+ +A D A+G+ YLH + NP +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+HR+LKS N+L+D K+ K+ DFGL+ S ++ +GT ++APE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 2e-52
Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 30/207 (14%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVD--LLSN 203
D+ ++G G +G VYK LD+ VAVK + F NE + +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFS---FANRQNFINEKNIYRVPL 63
Query: 204 IHHPNVVCLLGYSAHDDTR-----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+ H N+ + +V E N SL L + W ++A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHS 119
Query: 259 TARGLEYLHE------HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--------DG 304
RGL YLH H PA+ HRDL S N+L+ + +SDFGL++ G
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331
++ + GT+ Y+APE L+G VN
Sbjct: 180 EEDNAAISEVGTIRYMAPEV-LEGAVN 205
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-51
Identities = 55/176 (31%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
++G G FG V KAK VA+K+++ ++ + F E+ LS ++HPN+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G A + +V E E SL LHG T M L ++G+ YLH
Sbjct: 65 KLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 271 NPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPE 323
A+IHRDLK N+LL + K+ DFG + + + G+ ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNNKGSAAWMAPE 173
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-49
Identities = 58/186 (31%), Positives = 97/186 (52%), Gaps = 21/186 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL-------DCATQDAGREFENEVDLLS 202
+ +G+GGFG V+K + + D VA+K L + + +EF+ EV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
N++HPN+V L G + +V E + L +L +H + W +++++ LD A G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSK-----FNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+EY+ + NP ++HRDL+S NI L S AK++DFGL+ + L G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNF 190
Query: 318 GYVAPE 323
++APE
Sbjct: 191 QWMAPE 196
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-49
Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 12/179 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPN 208
+ L E G ++K + N + VK L + R+F E L HPN
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 209 VVCLLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
V+ +LG S ++ M SL LH + + +K ALD ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFL 127
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H P + L S ++++D A++S + + S + +VAPE L
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEAL 180
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-48
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLG 214
++G+G FG VY + VA++ +D +D + F+ EV H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
I+ L + R+L + L + +IA + +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLS-GTLGYVAPEYL 325
+H+DLKS N+ D+ ++DFGL + + ++ L++ G L ++APE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-47
Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 22/189 (11%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G +G V+ K VAVK T++A E E+ + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWRGE-KVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
+++ + EN SL L + L +K+A + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-----GTLGYVAP 322
PA+ HRDLKS NIL+ ++D GLA+ + N + + GT Y+ P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNEVDIPPNTRVGTKRYMPP 215
Query: 323 EYLLDGMVN 331
E +LD +N
Sbjct: 216 E-VLDESLN 223
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-47
Identities = 55/180 (30%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKL----DCATQDAGREFENEVDLLSNIHHPNVVCL 212
I+G GGFG VY+A VAVK D E L + + HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G + +V E L+ L G + + + A+ ARG+ YLH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 273 AVIHRDLKSSNILLDSKF--------NAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
+IHRDLKSSNIL+ K K++DFGLA + + +G ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA---AGAYAWMAPE 184
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G +G V++ +VAVK + + E E+ + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
+++ E SL L + L ++I L A GL +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAPE 323
PA+ HRDLKS NIL+ ++D GLA + S N+ ++ + GT Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 324 YLLDGMVN 331
+LD +
Sbjct: 188 -VLDETIQ 194
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 20/182 (10%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+LG+G FG K + + +K+L ++ R F EV ++ + HPNV+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + E ++ +L + S S W R+ A D A G+ YLH +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA--------------ITDGSQNKNNLKLSGTLGYVA 321
HRDL S N L+ N ++DFGLA K + G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 322 PE 323
PE
Sbjct: 191 PE 192
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-45
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 20/188 (10%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V++ K VAVK + ++ E E+ + H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
D+ ++V + E+ SL L+ + +T +K+AL TA GL +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAPE 323
PA+ HRDLKS NIL+ ++D GLA D + + ++ + GT Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 324 YLLDGMVN 331
+LD +N
Sbjct: 222 -VLDDSIN 228
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-45
Identities = 63/171 (36%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG VYK K VAVK L T + F+NEV +L H N++ +GYS
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
IV + E SL LH + + IA TARG++YLH ++IH
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
RDLKS+NI L K+ DFGLA + S + +LSG++ ++APE +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG+G FG VY+ + VA+K + + A+ EF NE ++ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + ++ ELM RSL + + + +++A + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 263 LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ YL+ +HRDL + N ++ F K+ DFG+
Sbjct: 151 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 49/144 (34%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 159 LGEGGFGCVYKAKL-DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ +L DN VAVK + D +F E +L HPN+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV EL++ L + G+ L +++ D A G+EYL C IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA 300
RDL + N L+ K K+SDFG++
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMS 260
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 18/186 (9%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC 211
+ LGEGGF V + L D A+K++ C Q E + E D+ +HPN++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 212 LLGYSAHDDTR----FIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
L+ Y + +++ + +L + G+ LT + + L RGLE +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---------GTL 317
H HRDLK +NILL + L D G + + + T+
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 318 GYVAPE 323
Y APE
Sbjct: 208 SYRAPE 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FGCVY L DN +H AVK L +F E ++ + HPNV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 212 LLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-H 269
LLG + + +V M++ L + + T + L A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N +LD KF K++DFGLA
Sbjct: 149 F----VHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 26/199 (13%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
+ + ++ F E ++G GGFG V+KAK D +K++ + A E EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKA 57
Query: 201 LSNIHHPNVVCLLGY----------------SAHDDTRFIVYELMENRSLDIQLHGPSHG 244
L+ + H N+V G + FI E + +L+ Q G
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRG 116
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
L + +++ +G++Y+H +I+RDLK SNI L K+ DFGL +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 305 SQNKNNLKLSGTLGYVAPE 323
+ K + GTL Y++PE
Sbjct: 174 NDGKRT-RSKGTLRYMSPE 191
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NILGEGGFGCVYKAKLDD----NLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVV 210
ILGEG FG V + L +L VAVK KLD ++Q EF +E + + HPNV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 211 CLLGYSAHDDTR-----FIVYELMENRSLD--IQLHGP-SHGSALTWHMRMKIALDTARG 262
LLG ++ ++ M+ L + + + +K +D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+EYL +HRDL + N +L ++DFGL+
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPN 208
F LG GGFG V++AK D+ + A+K++ ++ RE EV L+ + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 209 VVCLLGYSAHDDTR------------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIA 256
+V +T +I +L +L ++G + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA------------ITDG 304
L A +E+LH ++HRDLK SNI K+ DFGL +T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 305 SQNKNNLKLSGTLGYVAPE 323
+ GT Y++PE
Sbjct: 182 PAYARHTGQVGTKLYMSPE 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LGEG FG V+ A+ D + VAVK L A++ A ++F+ E +LL+ + H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD--IQLHGP----------SHGSALTWHMRMKIALD 258
G +V+E M + L+ ++ HGP L + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+ YL +HRDL + N L+ K+ DFG++
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 9/170 (5%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+LG+G +G VY + L + + +A+K++ + E+ L ++ H N+V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+ + I E + SL L GL+YLH++ ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 277 RDLKSSNILLDSKF-NAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
RD+K N+L+++ K+SDFG + + + GTL Y+APE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPE 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VYK + + VA + T+ + F+ E ++L + HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 215 Y----SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V ELM + +L ++ + + +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHT 147
Query: 269 HCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
P +IHRDLK NI + + K+ D GLA + + GT ++APE +
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEMYEE 204
Query: 328 G 328
Sbjct: 205 K 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKL-DCATQDAGREFENEVDLLSNI 204
LGEG FG V + D VAVK L + + + + E+++L N+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 205 HHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+H N+V G + ++ E + + SL L P + + + ++K A+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 263 LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++YL +HRDL + N+L++S+ K+ DFGL
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 51/165 (30%), Positives = 70/165 (42%), Gaps = 25/165 (15%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LGE FG VYK L + VA+K L D A EF +E L + + HPNV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD-------------IQLHGPSHGSALTWHMRMKIA 256
VCLLG D +++ + L + SAL + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 257 LDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+EYL H +H+DL + N+L+ K N K+SD GL
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FGCVY L DN +H AVK L +F E ++ + HPNV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 212 LLGYSAHDDT-RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-H 269
LLG + +V M++ L + + T + L A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N +LD KF K++DFGLA
Sbjct: 213 F----VHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L T A ++F+ E +LL+N+ H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 213 LGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMKIALDT 259
G D +V+E M++ L + L + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A G+ YL +HRDL + N L+ + K+ DFG++
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 157 NILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
+LG G FG VYK + VA+K+L + + A +E +E +++++ +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG T ++ +LM L + H + + + A+G+ YL +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++HRDL + N+L+ + + K++DFGLA
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 154 HESNILGEGGFGCVYKAKLDD----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPN 208
H ++G+G FG VY + D + A+K L F E L+ ++HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 209 VVCLLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V+ L+G + ++ M + L + S T + L ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 268 E-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
E +HRDL + N +LD F K++DFGLA
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 45/143 (31%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG G FG V K VAVK + + EF E + + HP +V G +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+ +IV E + N L L SHG L +++ D G+ +L H IHR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 278 DLKSSNILLDSKFNAKLSDFGLA 300
DL + N L+D K+SDFG+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMT 151
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 10/179 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
+F +G G F VY+A L D + VA+KK+ + E+DLL ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLE 264
PNV+ D+ IV EL + L I+ + K + LE
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALE 150
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
++H V+HRD+K +N+ + + KL D GL S+ L GT Y++PE
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 50/162 (30%), Positives = 85/162 (52%), Gaps = 21/162 (12%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 212 LLGYSAHDDTRFIVYELMENRSLD-------------IQLHGPSHGSALTWHMRMKIALD 258
LLG H ++ E + +L S S L+ + A D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
ARG++YL + IHRDL + NIL+ + AK++DFGL+
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 20/160 (12%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVV 210
+LG+G FG V +A+L + VAVK K D EF E + HP+V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 211 CLLGYSAHDDTR------FIVYELMENRSLD--IQLHGPSH-GSALTWHMRMKIALDTAR 261
L+G S + ++ M++ L + L ++ +D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 262 GLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
G+EYL + IHRDL + N +L ++DFGL+
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVKKL +T++ R+FE E+++L
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
++ H N+V G YSA ++ E + SL L H + ++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQIC 124
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+G+EYL IHRDL + NIL++++ K+ DFGL
Sbjct: 125 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLT 161
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 58/204 (28%), Positives = 85/204 (41%), Gaps = 38/204 (18%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
F E +LG+G FG V KA+ D+ + A+KK+ T++ +EV LL++++H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 209 VVCLLG-------------YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRM 253
VV T FI E EN +L I + W +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----------IT 302
+I L Y+H +IHRDLK NI +D N K+ DFGLA +
Sbjct: 124 QILE----ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 303 DGSQNKNNLKLS---GTLGYVAPE 323
+ ++ L+ GT YVA E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE 200
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG G FG VY+ ++ L VAVK L + ++ +F E ++S +H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQL----HGPSHGSALTWHMRMKIALDTARGLEY 265
V +G S RFI+ ELM L L PS S+L + +A D A G +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 266 LHE-HCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA 300
L E H IHRD+ + N LL AK+ DFG+A
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 7/176 (3%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +GEG FG K +D +K+++ + + E EV +L+N+ HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V + + +IV + E L + G + + L+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ ++HRD+KS NI L +L DFG+A S + GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVKKL +T++ R+FE E+++L
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
++ H N+V G YSA ++ E + SL L H + ++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQIC 155
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+G+EYL IHRDL + NIL++++ K+ DFGL
Sbjct: 156 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLT 192
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 49/149 (32%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG V +L + VA+K L T+ R+F E ++ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G IV E MEN SLD L H + T + + A G++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + NIL++S K+SDFGL
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 6/144 (4%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ + VA+K + +F E +++ + HP +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+V E ME+ L L + + + LD G+ YL E C VIH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA 300
RDL + N L+ K+SDFG+
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMT 151
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 41/144 (28%), Positives = 60/144 (41%), Gaps = 6/144 (4%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V K VA+K + + EF E ++ N+ H +V L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
FI+ E M N L L +++ D +EYL +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA 300
RDL + N L++ + K+SDFGL+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG G FG VY+ ++ L VAVK L + ++ +F E ++S +H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQL----HGPSHGSALTWHMRMKIALDTARGLEY 265
V +G S RFI+ ELM L L PS S+L + +A D A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 266 LHE-HCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA 300
L E H IHRD+ + N LL AK+ DFG+A
Sbjct: 197 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 33/173 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
+GEG FG V++A+ + VAVK L + A+ D +F+ E L++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 210 VCLLGYSAHDDTRFIVYELMENRSL---------------------DIQLHGPSHGSALT 248
V LLG A +++E M L L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++ IA A G+ YL E +HRDL + N L+ K++DFGL+
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 50/186 (26%), Positives = 74/186 (39%), Gaps = 22/186 (11%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYS 216
L EGGF VY+A+ + A+K+L ++ R EV + + HPN+V +
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 217 AH-----DDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ D + L E L L L+ +KI T R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS------------GTL 317
P +IHRDLK N+LL ++ KL DFG A T + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 318 GYVAPE 323
Y PE
Sbjct: 215 MYRTPE 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
I+G G G V +L ++ VA+K L T+ R+F +E ++ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G IV E MEN SLD L +H T + + G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N+L+DS K+SDFGL+
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 24/164 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A D L VAVK L A D +E+ ++S++ H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 209 VVCLLGYSAHDDTRFIVYELMEN-----------RSLDIQLHGPSHGSALTWHMRMKIAL 257
+V LLG H ++ E R L+ S + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 258 DTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A+G+ +L +C IHRD+ + N+LL + AK+ DFGLA
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 33/173 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LGEG FG V KA VAVK L + A+ R+ +E ++L ++HP+V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VCLLGYSAHDDTRFIVYELMENRSL---------------------DIQLHGPSHGSALT 248
+ L G + D ++ E + SL + ALT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ A ++G++YL E +HRDL + NIL+ K+SDFGL+
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLS 197
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 24/173 (13%)
Query: 144 KLLEKATDS--FHESNI-----LGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDA 190
L + D FH+ + LGEG FG V D VAVK L A
Sbjct: 17 VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH 76
Query: 191 GREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
++ E+D+L ++H +++ G A + +V E + SL L S +
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IG 132
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ A G+ YLH H IHRDL + N+LLD+ K+ DFGLA
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 157 NILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
+LG G FG VYK + VA+K+L + + A +E +E +++++ +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG T ++ +LM L + H + + + A+G+ YL +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
++HRDL + N+L+ + + K++DFGLA
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVK+L + D R+F+ E+ +L
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+H +V G Y + +V E + + L L H + L + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQIC 137
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+G+EYL C +HRDL + NIL++S+ + K++DFGLA
Sbjct: 138 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLA 174
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 159 LGEGGFGCVYKAKL---DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + + VA+K L + E E ++ + +P +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +V E+ L L G + ++ + G++YL E
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---F 131
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N+LL ++ AK+SDFGL+
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 21/161 (13%)
Query: 158 ILGEGGFGCVYKAKL--------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
LG+G F ++K V +K LD A ++ F ++S + H ++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V G D +V E ++ SLD L + + + ++++A A + +L E+
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 270 CNPAVIHRDLKSSNILLDSKFN--------AKLSDFGLAIT 302
+IH ++ + NILL + + KLSD G++IT
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 158 ILGEGGFGCVYKAKL-----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG VYK L + VA+K L T+ +F E ++ H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G + I+ E MEN +LD L + + + A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + NIL++S K+SDFGL+
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G F VY+A+ + L VA+K +D + +NEV + + HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 215 YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
Y D ++V E+ N ++ L + + + G+ YLH H
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAPE 323
++HRDL SN+LL N K++DFGLA + + L GT Y++PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQ--LKMPHEKHYTLCGTPNYISPE 182
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 28/168 (16%)
Query: 157 NILGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HH 206
LGEG FG V A+ + + VAVK L D AT+ + +E++++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRM 253
N++ LLG D +++ E +L +T+ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
ARG+EYL C IHRDL + N+L+ K++DFGLA
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 28/168 (16%)
Query: 157 NILGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HH 206
LGEG FG V A+ + + VAVK L D AT+ + +E++++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRM 253
N++ LLG D +++ E +L +T+ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
ARG+EYL C IHRDL + N+L+ K++DFGLA
Sbjct: 207 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L L + ++ + + +A + +EYL + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N L+ K++DFGL+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLS 158
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 49/236 (20%), Positives = 89/236 (37%), Gaps = 30/236 (12%)
Query: 102 SSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISF--IEYKLLEKATDSFHESNIL 159
S K + E + S LG + S IS Y +L++ +
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ----------I 64
Query: 160 GEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGY 215
G GG V++ + A+K L+ A + NE+ L+ + + ++ L Y
Sbjct: 65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 216 SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D ++V E N L+ ++ + R + + +H+H
Sbjct: 125 EITDQYIYMVME-CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
++H DLK +N L+ KL DFG+A + + + G + Y+ PE + D
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG G FG V+ A + + VAVK + + F E +++ + H +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + +I+ E M SL L GS + + A G+ ++ +
Sbjct: 247 KLHAVVTKEPI-YIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL+++NIL+ + K++DFGLA
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L L + ++ + + +A + +EYL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HR+L + N L+ K++DFGL+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLS 365
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 48/174 (27%), Positives = 69/174 (39%), Gaps = 18/174 (10%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G G FG V++ K AVKK+ E+ + + P +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
I EL+E SL + L + GLEYLH ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 276 HRDLKSSNILLDSK-FNAKLSDFGLA--ITDGSQNKNNLK---LSGTLGYVAPE 323
H D+K+ N+LL S A L DFG A + K+ L + GT ++APE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 20/184 (10%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVV 210
SF ++LG G G + + DN VAVK++ + + EV LL HPNV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
++I EL + ++ +H + + T GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLHSL 137
Query: 270 CNPAVIHRDLKSSNILL-----DSKFNAKLSDFGLA--ITDGSQNKNNLK-LSGTLGYVA 321
++HRDLK NIL+ K A +SDFGL + G + + + GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 322 PEYL 325
PE L
Sbjct: 195 PEML 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 51/167 (30%), Positives = 70/167 (41%), Gaps = 27/167 (16%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A VAVK L + AT R +E+ +L +I HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 209 VVCLLGY-SAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMK 254
VV LLG + ++ E + +L + LT +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 255 IALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ A+G+E+L C IHRDL + NILL K K+ DFGLA
Sbjct: 153 YSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 50/181 (27%), Positives = 73/181 (40%), Gaps = 34/181 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+GGF ++ D A K + + + E+ + ++ H +VV G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ +D F+V EL RSL + + AR G +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQ 155
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAP 322
YLH + VIHRDLK N+ L+ K+ DFGLA + K L GT Y+AP
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAP 210
Query: 323 E 323
E
Sbjct: 211 E 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY- 215
+G+G FG V N VAVK + + F E +++ + H N+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+IV E M SL L S L +K +LD +EYL + +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N+L+ AK+SDFGL
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
ILGEG FG VY+ + ++VAVK T D +F +E ++ N+ HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L + ++L + +L + + YL
Sbjct: 79 IGIIE-EEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRD+ NIL+ S KL DFGL+
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 41/194 (21%), Positives = 78/194 (40%), Gaps = 28/194 (14%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVD 199
Y +L++ +G GG V++ + A+K L+ A + NE+
Sbjct: 10 IYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 200 LLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
L+ + + ++ L Y D ++V E N L+ ++ + R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-----IDPWERKSY 113
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ + +H+H ++H DLK +N L+ KL DFG+A + + +
Sbjct: 114 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 314 SGTLGYVAPEYLLD 327
GT+ Y+ PE + D
Sbjct: 170 VGTVNYMPPEAIKD 183
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNI 204
+ +LG G FG V+K + V +K + D + + + + + + + ++
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H ++V LLG + +V + + SL + H AL + + + A+G+
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQIAKGMY 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
YL EH ++HR+L + N+LL S +++DFG+A
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 41/194 (21%), Positives = 78/194 (40%), Gaps = 28/194 (14%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVD 199
Y +L++ +G GG V++ + A+K L+ A + NE+
Sbjct: 29 IYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 200 LLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
L+ + + ++ L Y D ++V E N L+ ++ + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-----IDPWERKSY 132
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ + +H+H ++H DLK +N L+ KL DFG+A + + +
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 314 SGTLGYVAPEYLLD 327
GT+ Y+ PE + D
Sbjct: 189 VGTVNYMPPEAIKD 202
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 33/173 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
+LG G FG V A ++ VAVK L + A +E+ +++ + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL--------------------DIQLHGPSHGSALT 248
+V LLG ++++E L +L + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ + A A+G+E+L C +HRDL + N+L+ K+ DFGLA
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG V++ + L VA+K +C + +F E + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L +L + A + L YL
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRD+ + N+L+ S KL DFGL+
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 50/181 (27%), Positives = 73/181 (40%), Gaps = 34/181 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+GGF ++ D A K + + + E+ + ++ H +VV G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ +D F+V EL RSL + + AR G +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQ 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAP 322
YLH + VIHRDLK N+ L+ K+ DFGLA + K L GT Y+AP
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAP 184
Query: 323 E 323
E
Sbjct: 185 E 185
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 46/168 (27%), Positives = 64/168 (38%), Gaps = 28/168 (16%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A D + VAVK L A +E+ +LS + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL---------------DIQLHGPSHGSALTWHMRM 253
+V LLG ++ E L AL +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ A+G+ +L +C IHRDL + NILL K+ DFGLA
Sbjct: 149 SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 48/182 (26%), Positives = 70/182 (38%), Gaps = 11/182 (6%)
Query: 151 DSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNI-HH 206
SF + LG G +G V+K +D AVK+ + EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P V L ++ EL +Q H + G++L DT L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP---SLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H ++H D+K +NI L + KL DFGL + G+ G Y+APE L
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQEGDPRYMAPELLQ 229
Query: 327 DG 328
Sbjct: 230 GS 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
++ LG G FG V+ + + VAVK L + F E +L+ + H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + +I+ E MEN SL L PS G LT + + +A A G+ ++ E
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL+++NIL+ + K++DFGLA
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 27/176 (15%)
Query: 159 LGEGGFGCVYKAKLDDNLH---VAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLG 214
+ GG G +Y A D N++ V +K L + +A E L+ + HP++V +
Sbjct: 88 IAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 215 YSAHDDTR-----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ H D +IV E + +SL L + L+ L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
+++ DLK NI+L + KL D G I L GT G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPE 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 51/178 (28%), Positives = 74/178 (41%), Gaps = 14/178 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+GEG G V A+ VAVK +D Q NEV ++ + H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
VV + + +++ E ++ +L DI L + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH 158
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
VIHRD+KS +ILL KLSDFG I+ + + L GT ++APE
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 211
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 6/170 (3%)
Query: 131 VSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA 190
+ E +S LG+G FG V+ + VA+K L T
Sbjct: 247 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP 306
Query: 191 GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH 250
F E ++ + H +V L ++ +IV E M SL L G + G L
Sbjct: 307 -EAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLP 363
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ +A A G+ Y+ +HRDL+++NIL+ K++DFGLA
Sbjct: 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ +G+G G VY A + VA+++++ Q NE+ ++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V L D ++V E + SL D+ + + + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLH 133
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
+ VIHRD+KS NILL + KL+DFG IT ++ + GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 25/194 (12%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVD 199
+Y+L E +G G V A VA+K+++ Q + E E+
Sbjct: 16 DYELQEV----------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMR-MKIAL 257
+S HHPN+V D ++V +L+ S+ DI H + G + + IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 258 ---DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
+ GLEYLH++ IHRD+K+ NILL + +++DFG++ + G N
Sbjct: 126 ILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 313 LS---GTLGYVAPE 323
GT ++APE
Sbjct: 183 RKTFVGTPCWMAPE 196
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 49/181 (27%), Positives = 75/181 (41%), Gaps = 8/181 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +G G +G K + D + K+LD + + +EV+LL + HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 208 NVVCLLG--YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLE 264
N+V + T +IV E E L + G L +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 265 YLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
H + V+HRDLK +N+ LD K N KL DFGLA GT Y++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 323 E 323
E
Sbjct: 186 E 186
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG+G FG V+ + VA+K L T F E ++ + H +V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L ++ +IV E M SL L G + G L + +A A G+ Y+
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL+++NIL+ K++DFGLA
Sbjct: 301 ---YVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVV 210
LG+G FG V + + + VAVK L + +A +F EV+ + ++ H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G +V EL SL +L H + A+ A G+ YL
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
IHRDL + N+LL ++ K+ DFGL
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ + LG+G FG VYKAK + A K ++ +++ ++ E+++L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V LLG HD +I+ E ++ I L LT + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
+IHRDLK+ N+L+ + + +L+DFG++ Q +++ GT ++APE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 187
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LG G FG V K VAVK K + E E +++ + +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +V E+ E L+ L + +++ + G++YL E
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRDL + N+LL ++ AK+SDFGL+
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 28/166 (16%)
Query: 159 LGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V A+ + VAVK L AT+ + +E++++ I H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMKI 255
++ LLG D +++ E +L + L+ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 256 ALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A ARG+EYL C IHRDL + N+L+ K++DFGLA
Sbjct: 197 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 52/199 (26%), Positives = 76/199 (38%), Gaps = 29/199 (14%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLS-NIHHPNV 209
+ ILG G G V VAVK++ D E+ LL+ + HPNV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMR--MKIALDTARGLEY 265
+ D +I EL +L ++ S + + + A G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 266 LHEHCNPAVIHRDLKSSNILLDSK-------------FNAKLSDFGLA-ITDGSQNKNNL 311
LH +IHRDLK NIL+ + +SDFGL D Q+
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 312 KLS---GTLGYVAPEYLLD 327
L+ GT G+ APE L +
Sbjct: 188 NLNNPSGTSGWRAPELLEE 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 159 LGEGGFGCVYKAKL---DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + + VA+K L + E E ++ + +P +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +V E+ L L + ++ + G++YL E
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA 300
+HR+L + N+LL ++ AK+SDFGL+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V N VAVK + + F E +++ + H N+V LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 217 AHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ IV E M SL L S L +K +LD +EYL + +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA 300
HRDL + N+L+ AK+SDFGL
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG V++ + + VA+K +C + +F E + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L +L + A + L YL
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+HRD+ + N+L+ S KL DFGL+
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 16/185 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
+ S+ILG+G V++ + A+K + + E ++L ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 209 VVCLLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L + ++ E SL L PS+ L + + D G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 267 HEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
E+ ++HR++K NI+ D + KL+DFG A + D Q L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182
Query: 321 APEYL 325
P+
Sbjct: 183 HPDMY 187
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 48/198 (24%), Positives = 70/198 (35%), Gaps = 31/198 (15%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKK--LDCATQDAGREFENEVDLLSNI-H 205
T FHE +G G FG V+K K D A+K+ A + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H +VV A DD I E SL D S + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLD-------------------SKFNAKLSDFGLAITDGS 305
Y+H +++H D+K SNI + +K K+ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----T 182
Query: 306 QNKNNLKLSGTLGYVAPE 323
+ + G ++A E
Sbjct: 183 RISSPQVEEGDSRFLANE 200
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 18/172 (10%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGRE--FENEVDLLSNIHHPNVVCLLG 214
LG+G FG VY A+ +A+K L + AG E EV++ S++ HPN++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 215 YSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y HD TR +++ E ++ ++Q + A L Y H
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSK-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
VIHRD+K N+LL S K++DFG ++ + + L GTL Y+ PE
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPE 177
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 64/182 (35%), Positives = 94/182 (51%), Gaps = 12/182 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-----EVDLLSNI 204
+ + + LGEG F VYKA+ + N VA+KK+ + ++ N E+ LL +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HPN++ LL H +V++ ME D+++ + LT L T +GLE
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLH+H ++HRDLK +N+LLD KL+DFGLA + GS N+ T Y APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 325 LL 326
L
Sbjct: 184 LF 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKL--DCATQDAGRE-FENEVDLLSNIHHPNVVCLL 213
+G GG G VY+A+ D VA+K + ++ R + E + P+VV +
Sbjct: 42 VGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 214 GYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
+ D ++ L+ L ++ GP L + I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
HRD+K NIL+ + A L DFG+A TD + + GTL Y+APE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 330 V 330
Sbjct: 212 A 212
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 35/191 (18%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLD-----------------CATQDAGREFENEVDLL 201
L +G F + + DN A+KK + + + +F+NE+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 202 SNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGP---SHGSALTWHMRMKI 255
++I + + G + +I+YE MEN S+ + ++ + + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS- 314
Y+H N + HRD+K SNIL+D KLSDFG S+ + K+
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE-----SEYMVDKKIKG 209
Query: 315 --GTLGYVAPE 323
GT ++ PE
Sbjct: 210 SRGTYEFMPPE 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI 204
+ + + +GEG +G VYKAK VA+K++ +D G RE + LL +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKEL 76
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HHPN+V L+ + +V+E ME D++ + + L RG+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+ H+H ++HRDLK N+L++S KL+DFGLA G ++ TL Y AP+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 325 LL 326
L+
Sbjct: 191 LM 192
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 17/183 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + +GEG +G V+KAK + + VA+K++ D G RE + LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKE 57
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ H N+V L D +V+E + D++ + S L + +GL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ H V+HRDLK N+L++ KL++FGLA G + TL Y P+
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 324 YLL 326
L
Sbjct: 172 VLF 174
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 29/190 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVK--KLDCAT-QDAGREFENE 197
YK+++K LG GG VY A+ D L+ VA+K + ++ + FE E
Sbjct: 13 YKIVDK----------LGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFERE 61
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
V S + H N+V ++ DD ++V E +E +L I+ HGP L+ +
Sbjct: 62 VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINF 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
G+++ H+ ++HRD+K NIL+DS K+ DFG+A +++ S + N L
Sbjct: 117 TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 314 SGTLGYVAPE 323
GT+ Y +PE
Sbjct: 174 -GTVQYFSPE 182
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 16/185 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
+ S+ILG+G V++ + A+K + + E ++L ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 209 VVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L TR ++ E SL L PS+ L + + D G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 267 HEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
E+ ++HR++K NI+ D + KL+DFG A + D Q L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182
Query: 321 APEYL 325
P+
Sbjct: 183 HPDMY 187
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 53/190 (27%), Positives = 77/190 (40%), Gaps = 19/190 (10%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNI 204
+ + LG GGFG V + D VA+K+ RE + E+ ++ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 205 HHPNVVCLL------GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+HPNVV A +D + E E L L+ + L + D
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLA--ITDGSQNKNNLKL 313
+ L YLHE+ +IHRDLK NI+L K+ D G A + G +
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---EF 183
Query: 314 SGTLGYVAPE 323
GTL Y+APE
Sbjct: 184 VGTLQYLAPE 193
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 38/197 (19%), Positives = 71/197 (36%), Gaps = 34/197 (17%)
Query: 143 YKLLEKATDSFHESNILGEG--GFGCVYKAK-LDDNLHVAVKK--LDCATQDAGREFENE 197
Y+LL +G+G V A+ +V V++ L+ + + + E
Sbjct: 27 YELLTV----------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIA 256
+ + +HPN+V D+ ++V M S D+ G IA
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IA 131
Query: 257 L---DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNL 311
+ L+Y+H +HR +K+S+IL+ LS + Q + +
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 312 KLS-----GTLGYVAPE 323
L +++PE
Sbjct: 189 HDFPKYSVKVLPWLSPE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIH 205
F + +G G FG VY A+ + ++ VA+KK+ + + + +++ EV L +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HPN + G + T ++V E + D+ H L + +GL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
LH H +IHRD+K+ NILL KL DFG A N GT ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPAN-SFVGTPYWMAPE 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI 204
+ +H +GEG +G VYKA+ + A+KK+ +D G RE + +L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKEL 57
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H N+V L +V+E ++ D++ L L G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
Y H+ V+HRDLK N+L++ + K++DFGLA G + TL Y AP+
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 325 LL 326
L+
Sbjct: 172 LM 173
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC-ATQDAGREFENEVDL 200
+ LEK +G+G FG V+K VA+K +D +D + + E+ +
Sbjct: 24 FTKLEK----------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDT 259
LS P V G D +I+ E + S D+ GP L I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREI 128
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+GL+YLH IHRD+K++N+LL KL+DFG+A +TD +N GT
Sbjct: 129 LKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTP 183
Query: 318 GYVAPE 323
++APE
Sbjct: 184 FWMAPE 189
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDA 190
K+ A + K+ E D F + + LG G G V+K L +A K + + A
Sbjct: 14 RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73
Query: 191 GREF-ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTW 249
R E+ +L + P +V G D I E M+ SLD L +
Sbjct: 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPE 130
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNK 308
+ K+++ +GL YL E ++HRD+K SNIL++S+ KL DFG++ S
Sbjct: 131 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188
Query: 309 NNLKLSGTLGYVAPE 323
+ + GT Y++PE
Sbjct: 189 SFV---GTRSYMSPE 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 149 ATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQD-----AGREFENEVDLLS 202
++ F + LG G + VYK ++VA+K++ +++ A RE + L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N+V L ++ +V+E M+N + + L ++
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
+GL + HE+ ++HRDLK N+L++ + KL DFGLA G TL Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 321 APEYLL 326
AP+ L+
Sbjct: 176 APDVLM 181
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 9/179 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHP 207
+ + + +GEG +G V+K + D VA+KK + D + E+ +L + HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LL +V+E ++ + + + H+ I T + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH---TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
+H IHRD+K NIL+ KL DFG A + T Y +PE L+
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 36/199 (18%), Positives = 64/199 (32%), Gaps = 24/199 (12%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLDCATQDAGREFENEVD 199
+ + + ++LGEG F VY+A D +K A ++
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIAL 257
L + + +V EL +L I L+ + + + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILL-----------DSKFNAKLSDFGLAITDGSQ 306
+E +H+ +IH D+K N +L D L D G +I
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 307 NKNNL--KLSGTLGYVAPE 323
K + T G+ E
Sbjct: 237 PKGTIFTAKCETSGFQCVE 255
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
++F + +GEG +G VYKA+ VA+KK+ T+ G RE + LL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKE 58
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTA 260
++HPN+V LL ++ ++V+E + + +D + ++
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-----LL 113
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
+GL + H H V+HRDLK N+L++++ KL+DFGLA G + TL Y
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 321 APEYLL 326
APE LL
Sbjct: 171 APEILL 176
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 16/182 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQD-----AGREFENEVDLLSNI 204
+++ + + LGEG + VYK K + VA+K++ ++ A RE V LL ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H N+V L + + +V+E ++ D++ + G+ + H RGL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
Y H V+HRDLK N+L++ + KL+DFGLA K TL Y P+
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 325 LL 326
LL
Sbjct: 172 LL 173
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ F LGEG +G VYKA + VA+K++ + +E E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
VV G + +IV E S+ DI LT I T +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
IHRD+K+ NILL+++ +AKL+DFG+A +TD +N + GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPE 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G FG VY A+ + +A+K L + + + E+++ S++ HPN++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 215 YSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y HD R +++ E L ++Q HG + A L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHERK- 134
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI-TDGSQNKNNLKLSGTLGYVAPE 323
VIHRD+K N+L+ K K++DFG ++ + + + GTL Y+ PE
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLDYLPPE 182
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 35/203 (17%), Positives = 67/203 (33%), Gaps = 43/203 (21%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE----------------------- 193
+LG+ +A + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 194 -----FENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVYELMENRSLD----IQLHGPS 242
F DL+ + ++ + +RF +Y M++ + H +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302
H S L H R+++ L R L LH + ++H L+ +I+LD + L+ F +
Sbjct: 200 HKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 303 DGSQNKNNLKLSGTLGYVAPEYL 325
DG+ + S + G+ PE
Sbjct: 256 DGA----RVVSSVSRGFEPPELE 274
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + ++GEG +G V K + D VA+KK + D RE + LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQ 80
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ H N+V LL ++V+E +++ I + L + + K G+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH---TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ H H +IHRD+K NIL+ KL DFG A T + + T Y APE
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 324 YLL 326
L+
Sbjct: 195 LLV 197
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 22/201 (10%), Positives = 44/201 (21%), Gaps = 39/201 (19%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC---ATQDAGREFENEVDLLSNIHHPNVVCLL 213
L G V+ + ++ A+K ++ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 214 GY-----------------------SAHDDTRFIVYELMENRSLDIQLHG------PSHG 244
D LM S+D++L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
+ R L ++H N+ + L D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 305 SQNKNNLKLSGTLGYVAPEYL 325
++ S + Y E+L
Sbjct: 246 TRGPA---SSVPVTYAPREFL 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 30/193 (15%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDL 200
D + S LG G G V A VA++ + D E E+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 201 LSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIAL 257
L ++HP ++ + + D +IV ELME L + + L
Sbjct: 194 LKKLNHPCIIKI--KNFFDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFY 246
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLK 312
++YLHE+ +IHRDLK N+LL S+ K++DFG + + + S +
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---T 300
Query: 313 LSGTLGYVAPEYL 325
L GT Y+APE L
Sbjct: 301 LCGTPTYLAPEVL 313
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 29/191 (15%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
D + LGEG +G VYKA N VA+K++ ++ G RE V LL
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKE 89
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N++ L H+ +++E EN + +D ++ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSFLYQLI 142
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-----KLSDFGLAITDGSQNKNNLKLSG 315
G+ + H +HRDLK N+LL + K+ DFGLA G +
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 316 TLGYVAPEYLL 326
TL Y PE LL
Sbjct: 200 TLWYRPPEILL 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 22/194 (11%)
Query: 145 LLEKATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVK---KLDCATQDAGREFEN 196
++ +T F + +LG+G FG V K AVK K +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 197 EVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
EV LL + HPN++ L + ++V E+ L +I + +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-----FSEVDAAR 130
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNL 311
I G+ Y+H++ ++HRDLK N+LL+SK N ++ DFGL+ +K
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMK 186
Query: 312 KLSGTLGYVAPEYL 325
GT Y+APE L
Sbjct: 187 DKIGTAYYIAPEVL 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-24
Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHP 207
F ++G G +G VYK + + A+K +D + E + E+++L HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHR 81
Query: 208 NVVCLLG------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
N+ G DD ++V E S+ L + G+ L I + R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
GL +LH+H VIHRD+K N+LL KL DFG++ + +N GT +
Sbjct: 141 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYW 195
Query: 320 VAPE 323
+APE
Sbjct: 196 MAPE 199
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
++G+G F V + + AVK K + + + + E + + HP++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 212 LLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
LL + D ++V+E M+ L +I G + + L Y H++
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 270 CNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
+IHRD+K +LL SK N+ KL FG+AI G GT ++APE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENE 197
+ D + S LG G G V A VA+K + D E E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
+++L ++HP ++ + + D +IV ELME L + + ++
Sbjct: 66 IEILKKLNHPCIIKI--KNFFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEA 114
Query: 255 IALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGS 305
++YLHE+ +IHRDLK N+LL S+ K++DFG + + + S
Sbjct: 115 TCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 306 QNKNNLKLSGTLGYVAPEYL 325
+ L GT Y+APE L
Sbjct: 172 LMR---TLCGTPTYLAPEVL 188
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + +G+G FG V+KA+ VA+KK+ + G RE + +L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQL 72
Query: 204 IHHPNVVCLLG--------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
+ H NVV L+ Y+ + ++V++ E+ D+ + T ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRV 129
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT-DGSQNKNNLKLS 314
GL Y+H + ++HRD+K++N+L+ KL+DFGLA ++N + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 315 G---TLGYVAPEYLL 326
TL Y PE LL
Sbjct: 187 NRVVTLWYRPPELLL 201
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 36/172 (20%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFEN-EVDLLSNIH 205
E+ ++ ++G G FG V++AKL ++ VA+KK+ QD F+N E+ ++ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV---LQDK--RFKNRELQIMRIVK 90
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
HPNVV L YS D +V E + ++ A + ++K +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVY-----RASRHYAKLKQTMPM 140
Query: 260 A----------RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLA 300
R L Y+H + HRD+K N+LLD KL DFG A
Sbjct: 141 LLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 44/221 (19%)
Query: 99 SFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNI 158
SF S K + + + +S +V+ G S+ ++ +
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR-------PQEVSYTDTKV 61
Query: 159 LGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN-EVDLLSNIHHPNVVCLLG-- 214
+G G FG VY+AKL D VA+KK+ QD F+N E+ ++ + H N+V L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV---LQDK--RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 215 YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD----------TA 260
YS+ + +V + + ++ + R K L
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP---ET--VY-----RVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLA 300
R L Y+H + HRD+K N+LLD KL DFG A
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 49/301 (16%), Positives = 97/301 (32%), Gaps = 60/301 (19%)
Query: 60 HHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLS 119
HHHH L ++I L + + + + + +V +
Sbjct: 4 HHHHSSGRENLYFQGFRGTDPGDVVIEELF-----NRIPQANVRTTSEYMQSAADSLVST 58
Query: 120 SFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHV 178
S R+ S+ G + L + +LG+ +A +
Sbjct: 59 SLWNTGQPFRVESELGE-----RPRTLVRG-------TVLGQEDPYAYLEATDQETGESF 106
Query: 179 AVK---KLDCATQDAGREFENEV-------------------------DLLSNIHHPNVV 210
V + +A ++ + EV DL+ + ++
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 211 CLLGYSAHDD--TRFIVYELMENRSLD----IQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ +RF +Y M++ + H +H S L H R+++ L R L
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIRLLA 225
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
LH + ++H L+ +I+LD + L+ F + DG+ + G+ PE
Sbjct: 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIGRGFAPPET 278
Query: 325 L 325
Sbjct: 279 T 279
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 8e-24
Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 27/200 (13%)
Query: 147 EKATDSFH-ESNILGEGGFGCVYKAKLDDNL---HVAVKKLDCATQDAGREFEN--EVDL 200
E+ D F E +G G +G VYKAK D A+K++ + G E+ L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIAL 71
Query: 201 LSNIHHPNVVCLLG--YSAHDDTRFIVYELMEN---RSLDIQLHGPSH--GSALTWHMRM 253
L + HPNV+ L S D +++++ E+ + ++ L M
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQNKN 309
+ G+ YLH + V+HRDLK +NIL+ + K++D G A S K
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 310 NLKLSG---TLGYVAPEYLL 326
L T Y APE LL
Sbjct: 189 LADLDPVVVTFWYRAPELLL 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 8e-24
Identities = 47/243 (19%), Positives = 73/243 (30%), Gaps = 52/243 (21%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDC 185
G + + L + +H +G+G +G V A A+K K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 186 ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSH 243
+ EV L+ +HHPN+ L + +V EL L + +
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 244 GSALTWHMRMKIALDTAR-----------------------------------GLEYLHE 268
+ L YLH
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 269 HCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAP 322
+ HRD+K N L + + KL DFGL+ N ++ GT +VAP
Sbjct: 187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 323 EYL 325
E L
Sbjct: 244 EVL 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 11/196 (5%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDA 190
S K + I + + + +G G G V+K + +AVK++ +
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 191 GRE-FENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
+ ++D +L + P +V G + FI ELM + ++ +
Sbjct: 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR---MQGPIP 122
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQN 307
+ K+ + + L YL E VIHRD+K SNILLD + KL DFG+ +
Sbjct: 123 ERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 308 KNNLKLSGTLGYVAPE 323
K+ +G Y+APE
Sbjct: 181 KDR--SAGCAAYMAPE 194
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 11/200 (5%)
Query: 130 MVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQ 188
M + + + + + + +G G +G V K +AVK++
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60
Query: 189 DAGRE-FENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI-QLHGPSHGS 245
+ ++ ++D ++ + P +V G + +I ELM +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITD 303
+ + KI L T + L +L E+ +IHRD+K SNILLD N KL DFG++ + D
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 304 GSQNKNNLKLSGTLGYVAPE 323
+ G Y+APE
Sbjct: 179 SIAKTRDA---GCRPYMAPE 195
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 60/199 (30%), Positives = 83/199 (41%), Gaps = 32/199 (16%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-----EVDLL 201
AT + +G G +G VYKA+ VA+K + G EV LL
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 202 ---SNIHHPNVVCLL----GYSAHDDTR-FIVYELMEN---RSLDIQLHGPSHGSALTWH 250
HPNVV L+ + + +V+E ++ LD +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310
MR RGL++LH +C ++HRDLK NIL+ S KL+DFGLA
Sbjct: 126 MRQ-----FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----Q 173
Query: 311 LKLSG---TLGYVAPEYLL 326
+ L+ TL Y APE LL
Sbjct: 174 MALTPVVVTLWYRAPEVLL 192
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 24/180 (13%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G F V + + A ++ + ++ E E + + HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHE 268
+ + +++++L+ L DI + A + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128
Query: 269 HCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
V+HR+LK N+LL SK KL+DFGLAI + + +GT GY++PE L
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 8/182 (4%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVD-LLS 202
+E D LG G +G V K + + +AVK++ ++ ++D +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+ P V G + +I ELM+ G + + KIA+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSGTLGYVA 321
LE+LH + VIHRD+K SN+L+++ K+ DFG+ K+ +G Y+A
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDAGCKPYMA 177
Query: 322 PE 323
PE
Sbjct: 178 PE 179
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 26/195 (13%)
Query: 144 KLLEKATDSFHE----SNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEV 198
+ L + + F + +G G + + N+ AVK +D + +D E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
LL HPN++ L +DD + ++V ELM+ L I +
Sbjct: 69 -LLRYGQHPNIITL--KDVYDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASA 120
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQNKNN 310
+ + +EYLH V+HRDLK SNIL + ++ DFG A ++N
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 311 LKLSGTLGYVAPEYL 325
+ T +VAPE L
Sbjct: 178 MTPCYTANFVAPEVL 192
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 49/198 (24%), Positives = 74/198 (37%), Gaps = 30/198 (15%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH 205
K D F + G+G FG V K + VA+KK+ + RE + + L+ +H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 206 HPNVVCLL------GYSAHDDTRF-IVYELME---NRSLDIQLHGPSHGSALTWHMRMKI 255
HPN+V L G D +V E + +R + A +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR---NYYRRQVAPPPILIKVF 134
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLS 314
R + LH V HRD+K N+L++ + KL DFG A N
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----- 188
Query: 315 GTLGYV------APEYLL 326
+ Y+ APE +
Sbjct: 189 --VAYICSRYYRAPELIF 204
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 39/237 (16%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
K K K ++ K+ + K+GS + Y +LE+ LG
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEE----------LG 60
Query: 161 EGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219
G FG V++ K ++ +NE+ +++ +HHP ++ L + A +
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL--HDAFE 118
Query: 220 DTRFI--VYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
D + + E + +R ++ + GL+++HEH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAA-------EDYKMSEAEVINYMRQACEGLKHMHEH--- 168
Query: 273 AVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
+++H D+K NI+ ++K + K+ DFGLA + K T + APE +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-23
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 129 RMVSKKGSAISFIEYKLLEKATDSFHES----NILGEGGFGCVYKA-KLDDNLHVAVK-- 181
M S G + + A+ F ++ LG+G F V + L A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 182 -KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQL 238
+ +D ++ E E + + HPN+V L + ++V++L+ L DI
Sbjct: 63 NTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 239 HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLS 295
+ + Y H + ++HR+LK N+LL SK KL+
Sbjct: 122 RE-----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
DFGLAI + +GT GY++PE L
Sbjct: 174 DFGLAIEVNDSEAWH-GFAGTPGYLSPEVL 202
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 8e-23
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 21/193 (10%)
Query: 145 LLEKATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENE 197
+ E LG G +G V + ++ A+K + + + + E
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE 86
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
V +L + HPN++ L + ++V E + L +I I
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVI 141
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLK 312
G+ YLH+H ++HRDLK N+LL+SK K+ DFGL+ +Q K +
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK-E 197
Query: 313 LSGTLGYVAPEYL 325
GT Y+APE L
Sbjct: 198 RLGTAYYIAPEVL 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 38/201 (18%)
Query: 148 KATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVKKLD---------CATQDAGRE 193
+T F+E ILG G V + AVK +D Q+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 194 FENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWH 250
EVD+L + HPN++ L + F+V++LM+ L +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------T 120
Query: 251 MRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDG 304
+ K R + LH+ ++HRDLK NILLD N KL+DFG + + G
Sbjct: 121 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 305 SQNKNNLKLSGTLGYVAPEYL 325
+ + + GT Y+APE +
Sbjct: 178 EKLRE---VCGTPSYLAPEII 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+ ++ ILG G FG V+K + L +A K + E +NE+ +++ + H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 211 CLLGYSAHDDTRFI--VYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
L Y A + I V E ++ +R +D LT + G+
Sbjct: 150 QL--YDAFESKNDIVLVMEYVDGGELFDRIID-------ESYNLTELDTILFMKQICEGI 200
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
++H+ ++H DLK NIL ++ K+ DFGLA + K N GT +
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEF 254
Query: 320 VAPEYL 325
+APE +
Sbjct: 255 LAPEVV 260
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 49/191 (25%), Positives = 71/191 (37%), Gaps = 49/191 (25%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDLLSNIHHPNV 209
LG G FG V+ A + N V VK + + E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA------LTWHMRMKIALDTAR-- 261
+ + ++ EN+ QL HGS + H R+ A
Sbjct: 92 IKV-------------LDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDE--PLASYI 135
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ YL +IHRD+K NI++ F KL DFG A + G
Sbjct: 136 FRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYT 188
Query: 314 S-GTLGYVAPE 323
GT+ Y APE
Sbjct: 189 FCGTIEYCAPE 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 21/186 (11%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHH 206
+D++ LG+G F V + L A K ++ + ++ E E + + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN+V L + ++V++L+ L DI + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIA 119
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
Y H + ++HR+LK N+LL SK KL+DFGLA + D +GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 173
Query: 320 VAPEYL 325
++PE L
Sbjct: 174 LSPEVL 179
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+LG G F V+ K A+K + + ENE+ +L I H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 217 AHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
++V +L+ L I G T + ++YLHE+ +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN---GI 127
Query: 275 IHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
+HRDLK N+L + ++DFGL+ + + + GT GYVAPE L
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS--TACGTPGYVAPEVL 179
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 45/201 (22%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVK--KLDCAT-QDAGREFENE 197
Y+L E LG GG V+ A+ D H VAVK + D A F E
Sbjct: 14 YELGEI----------LGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 198 VDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHM 251
+ ++HP +V + + +IV E ++ +L + GP +T
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKR 117
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---------IT 302
+++ D + L + H++ +IHRD+K +NI++ + K+ DFG+A +T
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 303 DGSQNKNNLKLSGTLGYVAPE 323
+ + GT Y++PE
Sbjct: 175 QTAA------VIGTAQYLSPE 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 61/201 (30%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQDAG------REFENEVD 199
+A + +GEG +G V+KA+ + VA+K++ T + G RE V
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VA 63
Query: 200 LLSNIH---HPNVVCLL----GYSAHDDTR-FIVYELMEN---RSLDIQLHGPSHGSALT 248
+L ++ HPNVV L +T+ +V+E ++ LD +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
M RGL++LH H V+HRDLK NIL+ S KL+DFGLA
Sbjct: 124 DMMFQ-----LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 172
Query: 309 NNLKLSG---TLGYVAPEYLL 326
+ L+ TL Y APE LL
Sbjct: 173 -QMALTSVVVTLWYRAPEVLL 192
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHH 206
+ ++ +LG+G FG V K K AVK ++ A EV+LL + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN++ L + +IV EL L +I + H +I G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGIT 135
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
Y+H+H ++HRDLK NILL+SK + K+ DFGL+ K GT Y+A
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-DRIGTAYYIA 191
Query: 322 PEYL 325
PE L
Sbjct: 192 PEVL 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 51/234 (21%), Positives = 86/234 (36%), Gaps = 32/234 (13%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
+ K S N + K + V K + Y + E+ LG
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEE----------LG 166
Query: 161 EGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219
G FG V++ + A K + + E+ +S + HP +V L + A +
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL--HDAFE 224
Query: 220 DTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + +YE M L + + ++ ++ +GL ++HE+ +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 276 HRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
H DLK NI+ +K + KL DFGL + K GT + APE
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 33/189 (17%), Positives = 67/189 (35%), Gaps = 24/189 (12%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH 205
++ + + + LG G FG V++ K + D + E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59
Query: 206 HPNVVCLLGYSAHDDTRFIVYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
H N++ L + +++E + R L +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINT-------SAFELNEREIVSYVHQVC 112
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGT 316
L++LH H + H D++ NI+ ++ ++ K+ +FG A + G +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TA 166
Query: 317 LGYVAPEYL 325
Y APE
Sbjct: 167 PEYYAPEVH 175
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHH 206
+ ++ +LG+G FG V K K AVK ++ A EV+LL + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN++ L + +IV EL L +I + H +I G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGIT 135
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
Y+H+H ++HRDLK NILL+SK + K+ DFGL+ K GT Y+A
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-DRIGTAYYIA 191
Query: 322 PEYL 325
PE L
Sbjct: 192 PEVL 195
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 33/192 (17%)
Query: 151 DSFHESNILGEGGFGCVYKA-KLDDNLHVAVK---KLDCATQDAGREFENEVDLLSNIHH 206
D F +G+G FG V K D A+K K C ++ R E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMR--MKIALDTAR-- 261
P +V L YS D+ F+V +L+ G L +H++ + +T +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLL-------------GGDLRYHLQQNVHFKEETVKLF 120
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
L+YL +IHRD+K NILLD + ++DF +A + ++G
Sbjct: 121 ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMAG 176
Query: 316 TLGYVAPEYLLD 327
T Y+APE
Sbjct: 177 TKPYMAPEMFSS 188
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 53/179 (29%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G V A VAVK +D D + E+ + ++H NVV G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 217 AHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYL 266
+ +++ E L D I+ M A+ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI-----------GMPE--PDAQRFFHQLMAGVVYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLGYVAPE 323
H + HRD+K N+LLD + N K+SDFGL + + + L GTL YVAPE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 53/198 (26%), Positives = 79/198 (39%), Gaps = 28/198 (14%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-------------CATQDAGR 192
K +S+ + LG G +G V K + + A+K + +
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 193 EFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWH 250
E NE+ LL ++ HPN++ L ++V E E L I
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-----FDEC 146
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQN 307
I G+ YLH+H ++HRD+K NILL++K N K+ DFGL+
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 308 KNNLKLSGTLGYVAPEYL 325
K GT Y+APE L
Sbjct: 204 KLR-DRLGTAYYIAPEVL 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 43/185 (23%), Positives = 68/185 (36%), Gaps = 36/185 (19%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD----CATQDAGREFENEVDLLSNIHHPNVVCLL 213
LGEG +G V + + AVK L + + E+ LL + H NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 214 G--YSAHDDTRFIVYELMENRS---LDIQLHGPSHGSALTWHMRMKIALDTAR------- 261
Y+ ++V E LD R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPV--CQAHGYFCQLI 119
Query: 262 -GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLG 318
GLEYLH ++H+D+K N+LL + K+S G+ + + S G+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 319 YVAPE 323
+ PE
Sbjct: 177 FQPPE 181
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 36/185 (19%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE--FENEVDLLSNIHHPNVVCLLGY 215
+G+G F V A+ + VA+K +D + EV ++ ++HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 216 SAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEY 265
+ T +++ E + D + HG RMK AR ++Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-----------RMKE--KEARSKFRQIVSAVQY 129
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVAP 322
H+ ++HRDLK+ N+LLD+ N K++DFG + T G + L G Y AP
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----LDAFCGAPPYAAP 182
Query: 323 EYLLD 327
E
Sbjct: 183 ELFQG 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 27/163 (16%), Positives = 45/163 (27%), Gaps = 24/163 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVKKLD---CATQDAGREFENE 197
Y+LL G ++A D L VA+ +D D +E +
Sbjct: 33 YRLLIF----------HGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSR 81
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
LS I P V +L +V E + SL + ++
Sbjct: 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQ 136
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
A + H V S + + + L+
Sbjct: 137 SLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 26/191 (13%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHH 206
+ + +GEG +G V A + + VA+KK+ R E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 207 PNVVCLLG-YSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRMKIALD 258
N++ + A + IV +LME + L Q H + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------- 137
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
RGL+Y+H N V+HRDLK SN+LL++ + K+ DFGLA + + L+
Sbjct: 138 -LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 316 TLGYVAPEYLL 326
T Y APE +L
Sbjct: 194 TRWYRAPEIML 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 37/188 (19%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDLLSNIH-HP 207
++G G V + AVK ++ ++ E +L + HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 208 NVVCLLGYSAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR-- 261
+++ L +++ + F+V++LM L + + K R
Sbjct: 161 HIITL--IDSYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSL 209
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+ +LH + ++HRDLK NILLD +LSDFG + + G + + +L GT
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTP 263
Query: 318 GYVAPEYL 325
GY+APE L
Sbjct: 264 GYLAPEIL 271
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 44/180 (24%), Positives = 69/180 (38%), Gaps = 27/180 (15%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G +G V A + A KK+ + F+ E++++ ++ HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 217 AHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHEHC 270
+ ++V EL L + R A + + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKL- 125
Query: 271 NPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
V HRDLK N L + KL DFGLA G + GT YV+P+ L
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVL 180
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 16/185 (8%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHP 207
D F LG G FG V+ + L +K ++ +Q + E E+++L ++ HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
N++ + +IV E E L I + L+ ++ L Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNALAY 139
Query: 266 LHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
H V+H+DLK NIL K+ DFGLA + N GT Y+
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYM 193
Query: 321 APEYL 325
APE
Sbjct: 194 APEVF 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 64/208 (30%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGREFEN---------------- 196
+G+G +G V A +DN + A+K KL R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 197 -----EVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSL-DIQLHGPSHGSA 246
E+ +L + HPNVV L ++D ++V+EL+ + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132
Query: 247 LTWHMRMKIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
+ D AR G+EYLH +IHRD+K SN+L+ + K++DFG
Sbjct: 133 -----PLSE--DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 299 LAITDGSQNKNNLKLS---GTLGYVAPE 323
++ ++ LS GT ++APE
Sbjct: 183 VS---NEFKGSDALLSNTVGTPAFMAPE 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 49/168 (29%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD---------LLSNIHHP 207
++G G +G V +A + VA+KK+ R FE+ +D +L+ ++H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHD 112
Query: 208 NVVCLL-----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA-- 260
+VV +L D ++V E+ + D R + L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKK---------LFRTPVYLTELHI 158
Query: 261 --------RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
G++Y+H ++HRDLK +N L++ + K+ DFGLA
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 46/197 (23%), Positives = 71/197 (36%), Gaps = 47/197 (23%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVD---------LLSNIHH 206
+ G +G V + + VA+K++ D + LL++ HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 207 PNVVCLLG-YSAHDDTRF----IVYELMEN------RSLDIQLHGPSHGSALTWHMRMKI 255
PN++ L + ++ +V ELM I + P H +H+
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYFMYHI---- 143
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
GL LHE V+HRDL NILL + + DF LA D +
Sbjct: 144 ----LLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN------- 189
Query: 316 TLGYV------APEYLL 326
YV APE ++
Sbjct: 190 KTHYVTHRWYRAPELVM 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 53/179 (29%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G V A VAVK +D D + E+ + ++H NVV G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 217 AHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYL 266
+ +++ E L D I+ M A+ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI-----------GMPE--PDAQRFFHQLMAGVVYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLGYVAPE 323
H + HRD+K N+LLD + N K+SDFGL + + + L GTL YVAPE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-21
Identities = 47/177 (26%), Positives = 66/177 (37%), Gaps = 22/177 (12%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY 215
LGEG F K N AVK + + + E+ L HPN+V L +
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN---TQKEITALKLCEGHPNIVKL--H 72
Query: 216 SAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
D F+V EL+ L I+ + I + ++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 272 PAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
V+HRDLK N+L + K+ DFG A N+ TL Y APE L
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 39/210 (18%)
Query: 140 FIEYKLLEKAT---DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE 195
F+++K LE D F + +LG GGFG V+ ++ + A KKL+ + ++
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 196 ---NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHM 251
E +L+ +H +V L Y+ T +V +M +G + +H+
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIM-------------NGGDIRYHI 276
Query: 252 RM------KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
A GLE+LH+ +I+RDLK N+LLD N ++SD
Sbjct: 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333
Query: 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
GLA+ + +GT G++APE LL
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-21
Identities = 51/191 (26%), Positives = 73/191 (38%), Gaps = 45/191 (23%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD------CATQDAGREFENEVDLLSNIHH--PNV 209
LG GGFG VY + DNL VA+K ++ G EV LL + V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 210 VCLLGYSAHDDTRFIVYELMENRS--LD-IQLHGPSHGSALTWHMRMKIALDTAR----- 261
+ LL + D+ ++ E E D I G ++ + AR
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----------ALQ--EELARSFFWQ 157
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLA--ITDGSQNKNNLKLS- 314
+ + H V+HRD+K NIL+D + KL DFG + D
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFD 209
Query: 315 GTLGYVAPEYL 325
GT Y PE++
Sbjct: 210 GTRVYSPPEWI 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 22/232 (9%)
Query: 104 NKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHE----SNIL 159
+ + S + G + + +SV + G+A +Y + D+ + + L
Sbjct: 3 HHHHHSSGVDLGT-ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 160 GEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
G G VY+ K A+K L + E+ +L + HPN++ L
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 219 DDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+V EL+ L I G + + YLHE+ ++H
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVH 171
Query: 277 RDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
RDLK N+L + K++DFGL+ Q + GT GY APE L
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-TVCGTPGYCAPEIL 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 42/210 (20%)
Query: 140 FIEYKLLEKAT---DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE 195
F+++K LE+ ++F + +LG+GGFG V ++ + A KKL+ +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA 229
Query: 196 ---NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHM 251
NE +L ++ VV L Y+ +V LM +G L +H+
Sbjct: 230 MALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLM-------------NGGDLKFHI 275
Query: 252 ----RMKIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+ A GLE LH +++RDLK NILLD + ++SD GL
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 300 A--ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
A + +G K GT+GY+APE + +
Sbjct: 333 AVHVPEGQTIKG---RVGTVGYMAPEVVKN 359
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 49/195 (25%), Positives = 71/195 (36%), Gaps = 49/195 (25%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD------CATQDAGREFENEVDLLSNIH----HP 207
LG+GGFG V+ L D L VA+K + + EV LL + HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSAL----TWHMRMKIALDTAR-- 261
V+ LL + + +V E P L T + +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYITEKGPLG--EGPSRCF 144
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLA--ITDGSQNKNNLK 312
+++ H V+HRD+K NIL+D + KL DFG + D
Sbjct: 145 FGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYT 196
Query: 313 LS-GTLGYVAPEYLL 326
GT Y PE++
Sbjct: 197 DFDGTRVYSPPEWIS 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-21
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 133 KKGSAISFIEYKLLEKATDSFHE-----SNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA 186
S + L ++ ++F+ S LG G F V + A K L
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65
Query: 187 --TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI--VYELME-----NRSLDI 236
QD E +E+ +L P V+ L + +++T I + E + L
Sbjct: 66 RRGQDCRAEILHEIAVLELAKSCPRVINL--HEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAK 293
S + +K L+ G+ YLH++ ++H DLK NILL S + + K
Sbjct: 124 LAEMVSENDVIRL---IKQILE---GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174
Query: 294 LSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
+ DFG++ I + + + GT Y+APE L
Sbjct: 175 IVDFGMSRKIGHACELREIM---GTPEYLAPEIL 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 49/200 (24%), Positives = 76/200 (38%), Gaps = 31/200 (15%)
Query: 149 ATDSFHES---------NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV 198
+TDSF ++LGEG V L + AVK ++ EV
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 199 DLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
++L H NV+ L+ + +D ++V+E M S+ I +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVV 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAI----TDGSQNK 308
D A L++LH + HRDLK NIL + K+ DF L
Sbjct: 117 VQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 309 NNLKLS---GTLGYVAPEYL 325
+ +L G+ Y+APE +
Sbjct: 174 STPELLTPCGSAEYMAPEVV 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 37/182 (20%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + VAVK L+ + D + + E+ L HP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 215 YSAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ F+V E + L D I HG R++ AR ++
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEE--MEARRLFQQILSAVD 125
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVA 321
Y H H V+HRDLK N+LLD+ NAK++DFGL+ ++DG L+ S G+ Y A
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAA 178
Query: 322 PE 323
PE
Sbjct: 179 PE 180
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 130 MVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KL 183
M + K + Y + E+ LG G F V K + L A K +
Sbjct: 2 METFKQQKVE-DFYDIGEE----------LGSGQFAIVKKCREKSTGLEYAAKFIKKRQS 50
Query: 184 DCATQDAGRE-FENEVDLLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQL 238
+ + RE E EV +L + HPN++ L + +++ + + EL+ L +
Sbjct: 51 RASRRGVCREEIEREVSILRQVLHPNIITL--HDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 239 HGPSHGSALTWHMRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK----F 290
+ + A + G+ YLH + H DLK NI+L K
Sbjct: 109 KE---------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156
Query: 291 NAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
+ KL DFGLA I DG + KN GT +VAPE +
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPEIV 190
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 51/194 (26%), Positives = 77/194 (39%), Gaps = 34/194 (17%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE---NEVDLLSNIHH 206
+ F ILGEG F V A+ A+K L+ + E D++S + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR-- 261
P V L ++ DD + + + L ++R R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAK-------------NGELLKYIRKIGSFDETCTRFY 135
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
LEYLH +IHRDLK NILL+ + +++DFG A ++ S+
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 314 SGTLGYVAPEYLLD 327
GT YV+PE L +
Sbjct: 193 VGTAQYVSPELLTE 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 31/189 (16%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL- 213
+LGEG +G V A VA+KK++ A R E+ +L + H N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 214 -----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALDTARGLEYLH 267
+ ++ +I+ ELM+ D LH L+ H++ T R ++ LH
Sbjct: 77 IQRPDSFENFNEV-YIIQELMQT---D--LHRVISTQMLSDDHIQY-FIYQTLRAVKVLH 129
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG----YV--- 320
N VIHRDLK SN+L++S + K+ DFGLA +N + +G +V
Sbjct: 130 G-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 321 ---APEYLL 326
APE +L
Sbjct: 187 WYRAPEVML 195
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 55/200 (27%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVD 199
+K D + LG G F V K + L A K + + + RE E EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
+L + H NV+ L + +++ + + EL+ L + + +
Sbjct: 68 ILRQVLHHNVITL--HDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEE 116
Query: 256 ALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLA--ITDGS 305
A + G+ YLH + H DLK NI+L K + KL DFGLA I DG
Sbjct: 117 ATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 306 QNKNNLKLSGTLGYVAPEYL 325
+ KN GT +VAPE +
Sbjct: 174 EFKNIF---GTPEFVAPEIV 190
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 56/182 (30%), Positives = 80/182 (43%), Gaps = 37/182 (20%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
LG G FG V K VAVK L+ + E+ L HP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 215 YSAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ F+V E + L D I +G R+ +R G++
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDE--KESRRLFQQILSGVD 130
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVA 321
Y H H V+HRDLK N+LLD+ NAK++DFGL+ ++DG L+ S G+ Y A
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAA 183
Query: 322 PE 323
PE
Sbjct: 184 PE 185
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 51/203 (25%), Positives = 75/203 (36%), Gaps = 33/203 (16%)
Query: 141 IEYKLLEKATDSFHE-----SNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREF 194
+ ++ E + + +LG G G V + A+K L + A +E
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV 72
Query: 195 ENEVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSL--DIQLHGPSHGSALT 248
++ P++VC+L I+ E ME L IQ G T
Sbjct: 73 DH---HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FT 126
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAITDGS 305
+I D +++LH H + HRD+K N+L SK KL+DFG A
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 306 QNKNNLKLS---GTLGYVAPEYL 325
L T YVAPE L
Sbjct: 184 N-----ALQTPCYTPYYVAPEVL 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 57/241 (23%), Positives = 89/241 (36%), Gaps = 43/241 (17%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
+ ++ +F + K +AI +YK+ + +LG
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI-IDDYKVTSQ---------VLG 71
Query: 161 EGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218
G G V + A+K L A RE V+L P++V + +
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRI--VDVY 124
Query: 219 DDTR------FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
++ IV E ++ L IQ G T +I ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSI- 180
Query: 271 NPAVIHRDLKSSNILLDSKF-NA--KLSDFGLAITDGSQNKNNLKLS---GTLGYVAPEY 324
+ HRD+K N+L SK NA KL+DFG A + ++ L+ T YVAPE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFA----KETTSHNSLTTPCYTPYYVAPEV 234
Query: 325 L 325
L
Sbjct: 235 L 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 130 MVSKKGSAISFIEYKLLEKA---TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC 185
M S+ +F ++ + + +G G G V A +VA+KKL
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 186 A---TQDAGREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRF----IVYELME---NRS 233
A R + E+ L+ ++H N++ LL F IV ELM+ +
Sbjct: 61 PFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+ ++L S L + M G+++LH + +IHRDLK SNI++ S K
Sbjct: 120 IQMELD-HERMSYLLYQM--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 294 LSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLL 326
+ DFGLA T G+ ++ T Y APE +L
Sbjct: 168 ILDFGLARTAGTSF----MMTPYVVTRYYRAPEVIL 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 8e-20
Identities = 52/188 (27%), Positives = 77/188 (40%), Gaps = 38/188 (20%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVDLLSNIHHPNVVC 211
LG G F V K + A K +L + + RE E EV++L I HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 212 LLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GL 263
L + ++ + + EL+ L + + A + G+
Sbjct: 73 L--HDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGV 121
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLA--ITDGSQNKNNLKLSGTL 317
YLH + H DLK NI+L K KL DFG+A I G++ KN GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTP 175
Query: 318 GYVAPEYL 325
+VAPE +
Sbjct: 176 EFVAPEIV 183
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 35/193 (18%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
++ +G G +G V A VA+KKL A R + E+ LL ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRMKIA 256
H NV+ LL A F +V M+ + + ++ L + M
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF-SEEKIQYLVYQM----- 135
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
+GL+Y+H + V+HRDLK N+ ++ K+ DFGLA ++ ++G
Sbjct: 136 ---LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGY 183
Query: 316 --TLGYVAPEYLL 326
T Y APE +L
Sbjct: 184 VVTRWYRAPEVIL 196
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 49/200 (24%), Positives = 77/200 (38%), Gaps = 35/200 (17%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVV 210
+ + LG GG G V+ A D + VA+KK+ E+ ++ + H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 211 CLL----------GYSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRM 253
+ T IV E ME L+ H + +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL-- 129
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNKNNLK 312
RGL+Y+H + V+HRDLK +N+ ++++ K+ DFGLA +
Sbjct: 130 ------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 313 LSG---TLGYVAPEYLLDGM 329
LS T Y +P LL
Sbjct: 181 LSEGLVTKWYRSPRLLLSPN 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 37/216 (17%)
Query: 130 MVSKKGSAISFIEYKLLEKA---TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC 185
M S + F ++ + A + + +G G +G V A VA+KKL
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 186 A---TQDAGREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRF----IVYELME---NRS 233
A R + E+ LL ++ H NV+ LL F +V M +
Sbjct: 61 PFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL 119
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+ + G L + M +GL Y+H +IHRDLK N+ ++ K
Sbjct: 120 MKHEKLGEDRIQFLVYQM--------LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 168
Query: 294 LSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLL 326
+ DFGLA S+ ++G T Y APE +L
Sbjct: 169 ILDFGLARQADSE------MTGYVVTRWYRAPEVIL 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 53/191 (27%), Positives = 76/191 (39%), Gaps = 56/191 (29%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
LGEG FG V A VA+K + E+ L + HP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-----------HGPSHGSALTWHMRMKIALDTAR-- 261
Y+++ + DI + + RM D R
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKK-------RMTE--DEGRRF 113
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+EY H H ++HRDLK N+LLD N K++DFGL+ +TDG+ LK
Sbjct: 114 FQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKT 166
Query: 314 S-GTLGYVAPE 323
S G+ Y APE
Sbjct: 167 SCGSPNYAAPE 177
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVD 199
E D + LG G F V K + L A K + + + RE E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
+L I HPNV+ L + +++ + + EL+ L + + +
Sbjct: 67 ILKEIQHPNVITL--HEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEE 115
Query: 256 ALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLA--ITDGS 305
A + + G+ YLH + H DLK NI+L + K+ DFGLA I G+
Sbjct: 116 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 306 QNKNNLKLSGTLGYVAPEYL 325
+ KN GT +VAPE +
Sbjct: 173 EFKNIF---GTPEFVAPEIV 189
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 34/253 (13%)
Query: 91 LWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKA- 149
+ L+ L Y + + G + +SK F ++ +
Sbjct: 1 MSLHFLYYCSEPTLD--VKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTF 58
Query: 150 --TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSN 203
+ +G G G V A + +VA+KKL A R + E+ L+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117
Query: 204 IHHPNVVCLL-------GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIA 256
++H N++ LL D ++V ELM D L M +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDV-YLVMELM-----DANLCQVIQMELDHERMSY-LL 170
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
G+++LH + +IHRDLK SNI++ S K+ DFGLA T G+ ++
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY 223
Query: 316 --TLGYVAPEYLL 326
T Y APE +L
Sbjct: 224 VVTRYYRAPEVIL 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 140 FIEYKLLEKAT----DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREF 194
F ++K +E + F I+G GGFG VY + D + A+K LD +
Sbjct: 174 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 195 E---NEVDLLSNIH---HPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSAL 247
NE +LS + P +VC+ Y+ H + + +LM G L
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMN-------------GGDL 279
Query: 248 TWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
+H+ + R GLE++H V++RDLK +NILLD + ++SD
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL 336
Query: 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
GLA D S+ K + GT GY+APE L G
Sbjct: 337 GLAC-DFSKKKPH-ASVGTHGYMAPEVLQKG 365
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 30/194 (15%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
+ + + +G G +G V A L VAVKKL A R + E+ LL ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALD 258
H NV+ LL A F +V LM D L+ LT H++ +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQF-LIYQ 140
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
RGL+Y+H + +IHRDLK SN+ ++ K+ DFGLA + ++G
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVA 191
Query: 316 TLGYVAPEYLLDGM 329
T Y APE +L+ M
Sbjct: 192 TRWYRAPEIMLNWM 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 54/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
D F LG G FG V K + H A+K LD ++ E NE +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P +V L +S D++ +Y +ME + G + H+R + + AR
Sbjct: 101 PFLVKLE-FSFKDNSN--LYMVMEYVA----------GGEMFSHLRRIGRFSEPHARFYA 147
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
EYLH +I+RDLK N+L+D + +++DFG A + L GT
Sbjct: 148 AQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGT 201
Query: 317 LGYVAPEYLLD 327
+APE +L
Sbjct: 202 PEALAPEIILS 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 39/199 (19%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVC 211
LG+G +G V+K+ VAVKK+ A + DA R F E+ +L+ + H N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 212 LLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALDTARGLEYLHE 268
LL + +D ++V++ ME D LH + L H + + + ++YLH
Sbjct: 74 LLNVLRADNDRDVYLVFDYMET---D--LHAVIRANILEPVHKQY-VVYQLIKVIKYLHS 127
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL----------- 317
++HRD+K SNILL+++ + K++DFGL+ + + + + ++
Sbjct: 128 -GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 318 ----GYV------APEYLL 326
YV APE LL
Sbjct: 185 PILTDYVATRWYRAPEILL 203
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 51/210 (24%), Positives = 81/210 (38%), Gaps = 59/210 (28%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLL 213
++G G +G VY A + +VA+KK++ D R E+ +L+ + ++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLY 91
Query: 214 G-YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA-------- 260
D +F IV E+ ++ D L L + I L
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS---D--LK------KL---FKTPIFLTEEHIKTILYN 137
Query: 261 --RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL- 317
G ++HE +IHRDLK +N LL+ + K+ DFGLA T S+ N+
Sbjct: 138 LLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 318 ---------------GYV------APEYLL 326
+V APE +L
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-18
Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 23/155 (14%)
Query: 187 TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL----DIQLHGPS 242
+ ++ + N V L S+ +I +L +L + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302
+ H+ ++IA +E+LH ++HRDLK SNI K+ DFGL
Sbjct: 161 REHGVCLHIFIQIAE----AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 303 DGSQNKNNLKLS------------GTLGYVAPEYL 325
+ L+ GT Y++PE +
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 47/181 (25%), Positives = 64/181 (35%), Gaps = 37/181 (20%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G G FG + VAVK ++ + E+ ++ HPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 218 HDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYLH 267
I+ E L + I G R D AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAG-----------RFSE--DEARFFFQQLLSGVSYCH 133
Query: 268 EHCNPAVIHRDLKSSNILLDSKF--NAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVAP 322
+ HRDLK N LLD K+ DFG + SQ K + GT Y+AP
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAP 186
Query: 323 E 323
E
Sbjct: 187 E 187
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 46/227 (20%), Positives = 85/227 (37%), Gaps = 60/227 (26%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI 204
LE ++ + LG G FG V + ++ A+KK+ QD + E+D++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKNR-ELDIMKVL 57
Query: 205 HHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-------------- 248
H N++ L+ Y+ D+ ++ L + +G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 249 --------------WHMRMKIALD--------TARGLEYLHEHCNPAVIHRDLKSSNILL 286
I ++ R + ++H + HRD+K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174
Query: 287 DSKFNA-KLSDFGLAITDGSQNKNNLKLSGTLGYV------APEYLL 326
+SK N KL DFG A K + ++ Y+ APE +L
Sbjct: 175 NSKDNTLKLCDFGSA-------KKLIPSEPSVAYICSRFYRAPELML 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 50/192 (26%), Positives = 79/192 (41%), Gaps = 35/192 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
F LG G FG V+ + + + A+K L ++ E +E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR-- 261
P ++ + + D + F++ + +E G L +R + A+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIE-------------GGELFSLLRKSQRFPNPVAKFY 111
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
LEYLH +I+RDLK NILLD + K++DFG A L G
Sbjct: 112 AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCG 165
Query: 316 TLGYVAPEYLLD 327
T Y+APE +
Sbjct: 166 TPDYIAPEVVST 177
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
+ + ++G G FG V + V A+K L + + F E D+++ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----- 261
P VV L Y+ DD +Y +ME + G G + + AR
Sbjct: 129 PWVVQLF-YAFQDDRY--LYMVME------YMPG---GDLVNLMSNYDVPEKWARFYTAE 176
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSG 315
L+ +H IHRD+K N+LLD + KL+DFG +G + G
Sbjct: 177 VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVG 231
Query: 316 TLGYVAPEYLLD 327
T Y++PE L
Sbjct: 232 TPDYISPEVLKS 243
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 32/193 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G F V K+ V A+K + D + F E D+L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR---MKIALDTAR-- 261
+ L ++ D+ +Y +ME G L + +I + AR
Sbjct: 121 RWITQLH-FAFQDENY--LYLVMEYYV----------GGDLLTLLSKFGERIPAEMARFY 167
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS- 314
++ +H +HRD+K NILLD + +L+DFG + + ++
Sbjct: 168 LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 315 GTLGYVAPEYLLD 327
GT Y++PE L
Sbjct: 225 GTPDYLSPEILQA 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 49/195 (25%), Positives = 80/195 (41%), Gaps = 36/195 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGRE---FENEVDLLSNIHH 206
+ F ++G G FG V KL + V A+K L+ E F E D+L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR---MKIALDTAR-- 261
+ L Y+ DD +Y +M+ G L + ++ + AR
Sbjct: 134 KWITTLH-YAFQDDNN--LYLVMDYYV----------GGDLLTLLSKFEDRLPEEMARFY 180
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLK 312
++ +H+ +HRD+K NIL+D + +L+DFG + DG+ +
Sbjct: 181 LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-- 235
Query: 313 LSGTLGYVAPEYLLD 327
GT Y++PE L
Sbjct: 236 AVGTPDYISPEILQA 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 45/197 (22%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y+L+ K LG G + V++A + +N V VK L ++ + E+ +L
Sbjct: 38 YQLVRK----------LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKIL 84
Query: 202 SNI-HHPNVVCLLGYSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALT-WHMR--M 253
N+ PN++ L D + + D + + LT + +R M
Sbjct: 85 ENLRGGPNIITLADI-VKDPVSRTPALVFEHVNNT---DFKQLYQT----LTDYDIRFYM 136
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLK 312
L + L+Y H ++HRD+K N+++D + +L D+GLA + N++
Sbjct: 137 YEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 313 LSGTLGYVAPEYLLDGM 329
++ + + PE L+D
Sbjct: 191 VA-SRYFKGPELLVDYQ 206
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 37/181 (20%)
Query: 133 KKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG 191
KK + I +YK+ + +LG G G V + A+K L A
Sbjct: 11 KKNAIID--DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR 58
Query: 192 REFENEVDLLSNI-HHPNVVCLLGYSAHDDTR------FIVYELMENRSL--DIQLHGPS 242
RE V+L P++V + +++ IV E ++ L IQ G
Sbjct: 59 RE----VELHWRASQCPHIVRI--VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NA--KLSDFGL 299
T +I ++YLH + HRD+K N+L SK NA KL+DFG
Sbjct: 113 A---FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 300 A 300
A
Sbjct: 167 A 167
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 56/191 (29%), Positives = 79/191 (41%), Gaps = 29/191 (15%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHH 206
+ F +LG+G FG V K + A+K L A E + E +L N H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P + L YS R + +ME + G L +H+ + D AR
Sbjct: 208 PFLTALK-YSFQTHDR--LCFVMEYAN----------GGELFFHLSRERVFSEDRARFYG 254
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
L+YLH N V++RDLK N++LD + K++DFGL GT
Sbjct: 255 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 317 LGYVAPEYLLD 327
Y+APE L D
Sbjct: 313 PEYLAPEVLED 323
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHH 206
+ F +LG+G FG V + + A+K L A E + E +L N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P + L Y+ R + +ME + G L +H+ + AR
Sbjct: 65 PFLTALK-YAFQTHDR--LCFVMEYAN----------GGELFFHLSRERVFTEERARFYG 111
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKL 313
LEYLH V++RD+K N++LD + K++DFGL I+DG+ K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---F 165
Query: 314 SGTLGYVAPEYLLD 327
GT Y+APE L D
Sbjct: 166 CGTPEYLAPEVLED 179
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 8e-13
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 147 EKAT-DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKL--DCATQDAGREFENEVD 199
EKA F +LG+G FG V+ K D A+K L + E D
Sbjct: 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
+L ++HP +V L Y+ + + +Y +++ G L +
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGK--LYLILDFLR----------GGDLFTRLSKEVMFTE 125
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ + L++LH +I+RDLK NILLD + + KL+DFGL+ K
Sbjct: 126 EDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 310 NLKLSGTLGYVAPEYLLD 327
GT+ Y+APE +
Sbjct: 183 AYSFCGTVEYMAPEVVNR 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 57/205 (27%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
FH ++G+G FG V A+ + + AVK L + E
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK------KEEKHIMSERNV 91
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
LL N+ HP +V L +S + +Y +++ + G L +H++
Sbjct: 92 LLKNVKHPFLVGLH-FSFQTADK--LYFVLDYIN----------GGELFYHLQRERCFLE 138
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
AR L YLH +++RDLK NILLDS+ + L+DFGL K
Sbjct: 139 PRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC-------KE 188
Query: 310 NLKLS-------GTLGYVAPEYLLD 327
N++ + GT Y+APE L
Sbjct: 189 NIEHNSTTSTFCGTPEYLAPEVLHK 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 51/202 (25%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
+ F +LG+G FG V+ A+ N A+K L D D ++V+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD------DDVECTMVEKRV 70
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
L HP + + + F V E + G L +H++ K
Sbjct: 71 LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLN-------------GGDLMYHIQSCHKFD 116
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
L A GL++LH +++RDLK NILLD + K++DFG+ + +
Sbjct: 117 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 306 QNKNNLKLSGTLGYVAPEYLLD 327
+ GT Y+APE LL
Sbjct: 174 KTNT---FCGTPDYIAPEILLG 192
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 51/202 (25%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F ++G G + V +L + A+K + + D ++D
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD------EDIDWVQTEKHV 62
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
+HP +V L ++R F V E + G L +HM+ K+
Sbjct: 63 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVN-------------GGDLMFHMQRQRKLP 108
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
+ AR L YLHE +I+RDLK N+LLDS+ + KL+D+G+ + G
Sbjct: 109 EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 306 QNKNNLKLSGTLGYVAPEYLLD 327
GT Y+APE L
Sbjct: 166 TTST---FCGTPNYIAPEILRG 184
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 49/201 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F+ +LG+G FG V ++ + AVK L D QD ++V+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD------DDVECTMVEKRV 394
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
L P + L R +Y +ME + G L +H++ +
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDR--LYFVMEYVN----------GGDLMYHIQQVGRFKE 441
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
A GL +L +I+RDLK N++LDS+ + K++DFG+ I DG
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 307 NKNNLKLSGTLGYVAPEYLLD 327
K GT Y+APE +
Sbjct: 499 TKT---FCGTPDYIAPEIIAY 516
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 42/199 (21%)
Query: 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKL--DCATQDAGREFEN---EVDLL 201
+ F +LG+GG+G V++ + + A+K L ++A ++ + E ++L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA-KDTAHTKAERNIL 75
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDT 259
+ HP +V L+ Y+ + +Y ++E S G L + DT
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGK--LYLILEYLS----------GGELFMQLEREGIFMEDT 122
Query: 260 AR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNK 308
A L +LH+ +I+RDLK NI+L+ + + KL+DFGL I DG+
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 309 NNLKLSGTLGYVAPEYLLD 327
GT+ Y+APE L+
Sbjct: 180 T---FCGTIEYMAPEILMR 195
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 49/201 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F ++G G + V +L + A++ + + D ++D
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD------EDIDWVQTEKHV 105
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
+HP +V L ++R ++ ++E + G L +HM+ K+
Sbjct: 106 FEQASNHPFLVGLH-SCFQTESR--LFFVIEYVN----------GGDLMFHMQRQRKLPE 152
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
+ AR L YLHE +I+RDLK N+LLDS+ + KL+D+G+ + G
Sbjct: 153 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 307 NKNNLKLSGTLGYVAPEYLLD 327
GT Y+APE L
Sbjct: 210 TST---FCGTPNYIAPEILRG 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 6e-12
Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 51/202 (25%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
D+F +LG+G FG V A++ + AVK L D QD ++V+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD------DDVECTMTEKRI 76
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
L +HP + L R F V E + G L +H++ +
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVN-------------GGDLMFHIQKSRRFD 122
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
AR L +LH+ +I+RDLK N+LLD + + KL+DFG+ I +G
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 306 QNKNNLKLSGTLGYVAPEYLLD 327
GT Y+APE L +
Sbjct: 180 TTAT---FCGTPDYIAPEILQE 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 54/250 (21%), Positives = 99/250 (39%), Gaps = 45/250 (18%)
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKAT-DSFHESNILGE 161
+ + + S G +S G ++++ K + EK ++F +LG
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64
Query: 162 GGFGCVYKAKL----DDNLHVAVK---KLDCATQDAGRE---FENEVDLLSNIHHPNVVC 211
G +G V+ + D A+K K + E E +V L P +V
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVT 123
Query: 212 LLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR------- 261
L Y+ +T+ ++ + + G L H+ + +
Sbjct: 124 LH-YAFQTETKLHLILDYIN-------------GGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 262 -GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTL 317
LE+LH+ +I+RD+K NILLDS + L+DFGL+ + D ++ + GT+
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTI 224
Query: 318 GYVAPEYLLD 327
Y+AP+ +
Sbjct: 225 EYMAPDIVRG 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 49/201 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
F+ +LG+G FG V ++ + AVK L D QD ++V+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD------DDVECTMVEKRV 73
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
L P + L R +Y +ME + G L +H++ +
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDR--LYFVMEYVN----------GGDLMYHIQQVGRFKE 120
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
A GL +L +I+RDLK N++LDS+ + K++DFG+ I DG
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 307 NKNNLKLSGTLGYVAPEYLLD 327
K GT Y+APE +
Sbjct: 178 TKT---FCGTPDYIAPEIIAY 195
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 34/193 (17%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIH--------- 205
LG G F V+ AK + +N HVA+K + D +A + E+ LL ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 206 --HPNVVCLLGYSAHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
+++ LL + H +V+E++ L + G L +++ +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI-YVK-QISKQL 140
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLD------SKFNAKLSDFGLAITDGSQNKNNLKL 313
GL+Y+H C +IH D+K N+L++ + K++D G A N+++
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 314 SGTLGYVAPEYLL 326
T Y +PE LL
Sbjct: 198 --TREYRSPEVLL 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 39/158 (24%), Positives = 56/158 (35%), Gaps = 19/158 (12%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSN 203
D LG G FG V +A VAVK L + AT R +E+ +L +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 204 I-HHPNVVCLLGY-SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
I HH NVV LLG + ++ E + +L L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKTK 131
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
G + I DLK + S ++ S F
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 9/144 (6%)
Query: 191 GREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
G F D + I + + S + V E + + + + LT
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
+ + A+G+E+L IHRDL + NILL K K+ DFGLA D ++
Sbjct: 192 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDP 247
Query: 309 NNLKLSGTLGYV---APEYLLDGM 329
+ ++ + APE + D +
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV 271
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 34/177 (19%), Positives = 67/177 (37%), Gaps = 32/177 (18%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
++ L +K +G GGFG +Y A + A + Q+ G F +E+
Sbjct: 38 QWVLGKK----------IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKF 86
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFI---------VYELMENRSLDIQLHGPSHGSALTWHM 251
+ + + D I ++ R + ++ G +
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG 146
Query: 252 RM------KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK--LSDFGLA 300
++ + LEY+HE+ +H D+K++N+LL K + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 33/181 (18%), Positives = 65/181 (35%), Gaps = 37/181 (20%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK---------LDDNLHVAVK----------K 182
++KL G +Y+A ++K +
Sbjct: 43 QWKLKSF----------QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNE 92
Query: 183 LDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-RFIVYELMENRSLDIQLHGP 241
+ + A N+ L + + +G+ H D RF+V + RSL
Sbjct: 93 QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDV 150
Query: 242 SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK--LSDFGL 299
S L+ +++A LE+LHE+ +H ++ + NI +D + ++ L+ +G
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 300 A 300
A
Sbjct: 208 A 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 37/173 (21%), Positives = 61/173 (35%), Gaps = 41/173 (23%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV--D 199
+++ +K +G G FG + K L N +VA+K ++ E
Sbjct: 11 FRVGKK----------IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
L S P V + +V ++L GPS +
Sbjct: 61 LGSGDGIPQV---YYFGPCGKYNAMV----------LELLGPSLEDLFDLCDRTFSLKTV 107
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK-----LSDFGLA 300
+ IA+ +EY+H +I+RD+K N L+ N + DF LA
Sbjct: 108 LMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 8e-10
Identities = 33/201 (16%), Positives = 50/201 (24%), Gaps = 54/201 (26%)
Query: 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL--------DCATQDAGREFENEVDL 200
T+ +GEG FG V++ D+ VA+K + + + Q E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 201 LSNIH---------HPNVVCLLG------------------------------YSAHDDT 221
+ + L DD
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281
FIV E Q+ + I L HRDL
Sbjct: 137 LFIVLEFEFGGIDLEQM----RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 282 SNILLDSKFNAKLSDFGLAIT 302
N+LL KL +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKS 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 35/180 (19%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKK---LDCATQDAGREFENEV 198
+K+ +G+GGFGC+Y A ++ + V + D G F E+
Sbjct: 36 AWKVGLP----------IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF-TEL 84
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFI---------VYELMENRSLDIQLHGPSHGSALTW 249
P + + + R + + G
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 250 HMR-------MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK--LSDFGLA 300
+ + ++++L LEY+HEH +H D+K+SN+LL+ K + L D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 39/171 (22%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV-DL 200
Y+L K +G G FG +Y + VA+K T+ E+++ +
Sbjct: 11 YRLGRK----------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM 60
Query: 201 LSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
+ P + A D +V ++L GPS +
Sbjct: 61 MQGGVGIPTI---RWCGAEGDYNVMV----------MELLGPSLEDLFNFCSRKFSLKTV 107
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK---LSDFGLA 300
+ +A +EY+H IHRD+K N L+ + DFGLA
Sbjct: 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 44/196 (22%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV-DL 200
++L K +G G FG +Y + N VA+K + T+ +E+++ +
Sbjct: 9 FRLGRK----------IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI 58
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMRM 253
L + + + D +V + L GPS L+ +
Sbjct: 59 LQGGTG--IPNVRWFGVEGDYNVLV----------MDLLGPSLEDLFNFCSRKLSLKTVL 106
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK---LSDFGLAI--TDGSQN- 307
+A +E++H +HRD+K N L+ A + DFGLA D S +
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 308 ----KNNLKLSGTLGY 319
+ N L+GT Y
Sbjct: 164 HIPYRENKNLTGTARY 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 37/197 (18%), Positives = 63/197 (31%), Gaps = 44/197 (22%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
YK+ + +GEG FG +++ L +N VA+K + E
Sbjct: 12 YKVGRR----------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YK 60
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMRMK 254
+ + + +V I L GPS G +
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLV----------IDLLGPSLEDLLDLCGRKFSVKTVAM 110
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK-----LSDFGLAI--TDGSQN 307
A ++ +HE +++RD+K N L+ + + DFG+ D
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
Query: 308 K-----NNLKLSGTLGY 319
+ LSGT Y
Sbjct: 168 QHIPYREKKNLSGTARY 184
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 39/143 (27%), Positives = 60/143 (41%), Gaps = 22/143 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI-----HHPN-- 208
LG G F V+ + + VA+K K + +E+ LL ++ + PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101
Query: 209 -VVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
VV LL + +V+E++ + L + G L KI +GL
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGL 159
Query: 264 EYLHEHCNPAVIHRDLKSSNILL 286
+YLH C +IH D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILL 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI--HHP---- 207
+++G+G FG V KA + VA+K K A + + EV LL + H
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKY 116
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V L + + +V+E++ D+ + G +L R K A L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN-LTR-KFAQQMCTALLFLA 174
Query: 268 EHCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDG 304
++IH DLK NILL + K+ DFG + G
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI------HHPN 208
++G+G FG V KA + HVA+K + + E E+ +L ++ + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMN 160
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
V+ +L + + +EL+ ++ G +L +R K A + L+ LH+
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP-LVR-KFAHSILQCLDALHK 218
Query: 269 HCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDG 304
+ +IH DLK NILL + K+ DFG + +
Sbjct: 219 N---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 36/166 (21%), Positives = 63/166 (37%), Gaps = 18/166 (10%)
Query: 158 ILGEGGFGCVYKA--KLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHP------ 207
LGEG FG V + VA+K + ++A R E+++L I
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V + + I +EL+ + + L H+R +A L +LH
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP-HVR-HMAYQLCHALRFLH 140
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
E+ + H DLK NIL + L + + + S ++++
Sbjct: 141 ENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 41/167 (24%), Positives = 67/167 (40%), Gaps = 20/167 (11%)
Query: 158 ILGEGGFGCVYKAK--LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHP------ 207
LGEG FG V + HVAVK K +A R E+ +L +++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
V +L + H IV+EL+ S D L H+R K+A + + +L
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLG-LSTYDFIKENGFLPFRLD-HIR-KMAYQICKSVNFL 134
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
H + + H DLK NIL + + + + + ++K+
Sbjct: 135 HSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 22/170 (12%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI-----HHPNV 209
+G+G FG V + +D+ + AVK + + + E D+L I ++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V G + D +++E + +I +G + ++ ++ + L YL +
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIE-DIK-LYCIEILKALNYLRKM 156
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ------NKNNLKL 313
+ H DLK NILLD + K +TDG + +KL
Sbjct: 157 S---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.98 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.98 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.98 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.98 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.11 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.94 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.43 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.45 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.21 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.8 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 81.5 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=324.77 Aligned_cols=178 Identities=27% Similarity=0.407 Sum_probs=149.0
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|...+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999987777777899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 225 VYELMENRSLDIQLHGPS------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
|||||++|+|.++++... ...+++|.++++|+.|||+||+|||++ +|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997532 124699999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 293 KLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||+++....... ......||+.|||||++.++.||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 9999999976543322 22345799999999999998876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=324.41 Aligned_cols=179 Identities=28% Similarity=0.441 Sum_probs=154.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|...+.||+|+||+||+|++. ++..||||+++..+.+..++|.+|+++|++++|||||+++|+|.+++..|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356778899999999999999864 47789999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 224 IVYELMENRSLDIQLHGP----------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
||||||++|+|.++|+.. .....++|.++++|+.|||+||+|||++ +|+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 999999999999999642 2235799999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 294 LSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 294 l~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+|||+|+....... ......||+.|||||++.++.||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 208 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 208 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC
Confidence 999999976543322 12234689999999999998886
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=323.77 Aligned_cols=174 Identities=29% Similarity=0.361 Sum_probs=157.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888899999999999999875 68999999997666666677999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999863 3599999999999999999999999 9999999999999999999999999999877655554
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....+||+.|||||++.+..|+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~ 248 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYG 248 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC
T ss_pred ccccccCcCcCCHHHHCCCCCC
Confidence 5567899999999999988775
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=325.51 Aligned_cols=177 Identities=25% Similarity=0.374 Sum_probs=150.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999874 6899999999654 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
||++|+|.+++.. .....+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999964 2345689999999999999999999999 99999999999999999999999999997765433
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+||+.|||||++.+..|+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~ 203 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN 203 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred ccccccCCCccccCHHHHCCCCCC
Confidence 333456799999999999988875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=320.03 Aligned_cols=178 Identities=32% Similarity=0.427 Sum_probs=150.8
Q ss_pred cCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999863 46789999996543 344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 224 IVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
||||||++|+|.++|+.... ...++|.++++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999965321 24699999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||+++...... .......||++|||||++.++.||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 99999999997643322 122345799999999999999886
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=325.67 Aligned_cols=175 Identities=29% Similarity=0.358 Sum_probs=158.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999875 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
|++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.......
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999853 3599999999999999999999999 999999999999999999999999999987765555
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+||+.|||||++.++.|+
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~ 325 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYG 325 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBC
T ss_pred cccccccCcCcCCHHHHCCCCCC
Confidence 45567899999999999988775
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=315.65 Aligned_cols=175 Identities=27% Similarity=0.370 Sum_probs=154.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|+++|++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999864 6899999999643 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999963 34699999999999999999999999 9999999999999999999999999999876432
Q ss_pred --CcccceeccccCCccccccccCCCC
Q 020072 307 --NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 --~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.......+||+.|||||++.++.|+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~ 212 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSAC 212 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCC
Confidence 2233456899999999999888775
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=315.98 Aligned_cols=172 Identities=34% Similarity=0.531 Sum_probs=144.1
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
...+++...+.||+|+||+||+|++++ .||||+++.. +.+..++|.+|++++++++|||||+++|+|.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345677888999999999999998754 5999998643 34456789999999999999999999999865 568999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||||++|+|.++|+. ....++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999974 335699999999999999999999999 999999999999999999999999999976543
Q ss_pred C--CcccceeccccCCcccccccc
Q 020072 306 Q--NKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~--~~~~~~~~gt~~y~aPE~l~~ 327 (331)
. .......+||+.|||||++.+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp ---------CCCCTTSCCHHHHHC
T ss_pred CCcceeecccccCCCccCHHHhhc
Confidence 2 222334579999999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.43 Aligned_cols=178 Identities=27% Similarity=0.432 Sum_probs=144.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC--------
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-------- 220 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-------- 220 (331)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999875 689999999975443 34567999999999999999999999987544
Q ss_pred ----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 221 ----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
..|+||||+++|+|.+++.........++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 3699999999999999998654445567788899999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCc------------ccceeccccCCccccccccCCCC
Q 020072 297 FGLAITDGSQNK------------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 297 fgla~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|+....... .....+||+.|||||++.++.||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 208 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC
Confidence 999976543221 11234799999999999988875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.05 Aligned_cols=175 Identities=29% Similarity=0.356 Sum_probs=146.1
Q ss_pred cCCcccceeeecCceEEEEEEEC----CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999752 46789999986432 2234568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999963 34699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........+||+.|||||++.++.|+
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~ 204 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHT 204 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred CCCccccccccCcccCCHHHhccCCCC
Confidence 444444456899999999999988775
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.54 Aligned_cols=172 Identities=27% Similarity=0.401 Sum_probs=138.5
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999864 68999999996432 334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 5899988853 35699999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ....+||+.|||||++.+..|
T Consensus 166 ~~-~~~~~GT~~Y~APE~~~~~~y 188 (275)
T 3hyh_A 166 NF-LKTSCGSPNYAAPEVISGKLY 188 (275)
T ss_dssp ----------CTTSCHHHHSSSSC
T ss_pred Cc-cCCeeECcccCChhhhcCCCC
Confidence 22 234689999999999988765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.67 Aligned_cols=171 Identities=27% Similarity=0.417 Sum_probs=143.9
Q ss_pred cccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVY 226 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 226 (331)
+..+.||+|+||+||+|... ++..||+|++... .....+.|.+|++++++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45667999999999999875 5889999998643 33455779999999999999999999999865 34689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~ 305 (331)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999963 35699999999999999999999998 22399999999999998 489999999999976443
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. .....+||+.|||||++.+ .||
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~ 207 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYD 207 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCC
T ss_pred C--ccCCcccCccccCHHHcCC-CCC
Confidence 2 2335689999999998864 464
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=309.50 Aligned_cols=170 Identities=27% Similarity=0.327 Sum_probs=146.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+.|...+.||+|+||.||+|+.. +|+.||||+++... ...+|+.++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46777889999999999999875 68999999996432 2247999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeCCCCCc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 308 (331)
++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.......
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999963 34699999999999999999999999 999999999999999987 599999999987543221
Q ss_pred -----ccceeccccCCccccccccCCCC
Q 020072 309 -----NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 -----~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....+||+.|||||++.++.||
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCC
T ss_pred ccceecCCccccCccccCHHHHCCCCCC
Confidence 12235799999999999998875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=313.00 Aligned_cols=187 Identities=29% Similarity=0.374 Sum_probs=157.9
Q ss_pred cHHHHHHHhcCCcccceeeecCceEEEEEEECC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCC-Ccceeee
Q 020072 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHH-PNVVCLL 213 (331)
Q Consensus 142 ~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H-~niv~l~ 213 (331)
+..++|...++|+..+.||+|+||+||+|++.. ++.||||++.... ....++|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345677788999999999999999999998642 3679999997543 3445789999999999965 8999999
Q ss_pred eeEEcC-CeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCC
Q 020072 214 GYSAHD-DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL 279 (331)
Q Consensus 214 g~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdl 279 (331)
|+|.+. +..|+|||||++|+|.++|+... ....+++.+++.++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 57899999999999999996421 134589999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 280 KSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 280 k~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||+++++.+||+|||+|+....... ......||+.|||||++.++.||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 99999999999999999999986543322 23345789999999999998886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=301.21 Aligned_cols=172 Identities=31% Similarity=0.410 Sum_probs=139.8
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----eEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 226 (331)
.+|...+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3566788999999999999998 588999999964322 2223445666778899999999999998754 579999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
|||++|+|.++|+. ..++|+.+++++.|+++||+|||++ ..++|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999964 3589999999999999999999976 24589999999999999999999999999997
Q ss_pred eCCCCCc----ccceeccccCCccccccccC
Q 020072 302 TDGSQNK----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~ 328 (331)
....... .....+||+.|||||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred cccCCCCceeeecccccccccccCHHHhccc
Confidence 6543221 12235799999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.46 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=146.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEc------CCe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH------DDT 221 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~ 221 (331)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999875 68999999996543 3345678899999999999999999998764 357
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|||||||+ |+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 779988853 45799999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCC----CcccceeccccCCccccccccCC
Q 020072 302 TDGSQ----NKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 302 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
..... .......+||+.|||||++.+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCC
Confidence 65322 12233468999999999988754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.80 Aligned_cols=176 Identities=24% Similarity=0.354 Sum_probs=157.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999875 6899999999776666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC--CcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfgla~~~~~~ 306 (331)
|++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999863 335699999999999999999999999 99999999999999864 89999999999887544
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ....+||+.|||||++.+..|+
T Consensus 311 ~~-~~~~~GT~~y~APEv~~~~~y~ 334 (573)
T 3uto_A 311 QS-VKVTTGTAEFAAPEVAEGKPVG 334 (573)
T ss_dssp SE-EEEECSSGGGCCHHHHTTCCBC
T ss_pred Cc-eeeeEECccccCHHHhCCCCCC
Confidence 33 2356899999999999988774
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=302.85 Aligned_cols=173 Identities=30% Similarity=0.404 Sum_probs=147.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHH---HHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGR---EFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|+..++||+|+||.||+|+.. +|+.||+|++.... ..... ....++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 68999999996431 11222 2334567788899999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.++|.. ...+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999963 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccceeccccCCccccccccC-CCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDG-MVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~t 331 (331)
..... ...+||+.|||||++.++ .|+
T Consensus 343 ~~~~~--~t~~GTp~YmAPEvl~~~~~y~ 369 (689)
T 3v5w_A 343 SKKKP--HASVGTHGYMAPEVLQKGVAYD 369 (689)
T ss_dssp SSCCC--CSCCSCGGGCCHHHHSTTCCCC
T ss_pred CCCCC--CCccCCcCccCHHHHhCCCCCC
Confidence 54332 346899999999999765 453
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.56 Aligned_cols=171 Identities=26% Similarity=0.353 Sum_probs=145.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC----CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
...++|+..+.||+|+||+||+|+.+ +++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35688999999999999999999753 46789999986433 345688999999998 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCce
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAI 301 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~ 301 (331)
|+||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999883 389999999999999999999999 99999999999999877 799999999997
Q ss_pred eCCCCCc----------------------------ccceeccccCCccccccccCC
Q 020072 302 TDGSQNK----------------------------NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 302 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~ 329 (331)
....... .....+||+.|||||++.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 5433211 112346999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=262.95 Aligned_cols=176 Identities=27% Similarity=0.433 Sum_probs=153.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57788999999999999999875 58899999987766777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++.. ....+++.+++.++.|+++||+|||++ +++||||||+|||+++++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999974 245699999999999999999999999 9999999999999999999999999999765432221
Q ss_pred c--------------ceeccccCCccccccccCCCC
Q 020072 310 N--------------LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~--------------~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....||+.|+|||++.++.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCC
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCC
Confidence 1 134689999999999887664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=261.20 Aligned_cols=176 Identities=26% Similarity=0.378 Sum_probs=157.1
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
..++|...+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999986 4689999999976666666789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ..+++.++..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999864 2589999999999999999999999 99999999999999999999999999997766554
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.......||+.|+|||++.++.++
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~ 194 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYG 194 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBC
T ss_pred cccCCccCCcCccChhhhcCCCCC
Confidence 444456799999999999887764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=267.20 Aligned_cols=176 Identities=28% Similarity=0.335 Sum_probs=154.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. +|+.||+|.+... .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999875 6899999999643 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998863 34689999999999999999999999 999999999999999999999999999976444
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........+||+.|+|||++.++.|+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 183 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBC
T ss_pred CCCcccccccChhhCChhhhcCCCCC
Confidence 33344456899999999999887664
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.58 Aligned_cols=184 Identities=27% Similarity=0.339 Sum_probs=160.0
Q ss_pred ccHHHHHHHhcC----------CcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc
Q 020072 141 IEYKLLEKATDS----------FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209 (331)
Q Consensus 141 ~~~~~l~~~~~~----------~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni 209 (331)
++.++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 445556555543 566779999999999999986 689999999976666667789999999999999999
Q ss_pred eeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC
Q 020072 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (331)
Q Consensus 210 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 289 (331)
+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+|||++.+
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999998853 3599999999999999999999999 99999999999999999
Q ss_pred CcEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 290 FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 290 ~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+.+||+|||++..............||+.|+|||++.++.++
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCC
Confidence 999999999997765444333455799999999999887664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=265.43 Aligned_cols=194 Identities=41% Similarity=0.696 Sum_probs=165.9
Q ss_pred cccccHHHHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeE
Q 020072 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYS 216 (331)
Q Consensus 138 ~~~~~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~ 216 (331)
...++..+++...++|...+.||+|+||.||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 455677889999999999999999999999999988899999999865432 2334789999999999999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEE
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 295 (331)
.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++.++++||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997633 33459999999999999999999999877799999999999999999999999
Q ss_pred eccCceeCCCCCc-ccceeccccCCccccccccCCCC
Q 020072 296 DFGLAITDGSQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 296 Dfgla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|||++........ ......||+.|+|||++.++.++
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCC
Confidence 9999976543322 22334589999999998776553
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=261.59 Aligned_cols=183 Identities=39% Similarity=0.717 Sum_probs=159.8
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++..+++|...+.||+|+||.||+|+.++++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34567899999999999999999999888999999998776666778899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999986532 223699999999999999999999999 99999999999999999999999999997643
Q ss_pred CCC--cccceeccccCCccccccccCCCC
Q 020072 305 SQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... .......||+.|+|||++.++.++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCC
T ss_pred cccccccccccCCCccccCHHHhcCCCCC
Confidence 222 122234689999999999877654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=275.09 Aligned_cols=179 Identities=24% Similarity=0.313 Sum_probs=153.8
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEc
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 218 (331)
.++++...++|+..++||+|+||+||+|+..+ ++.||+|++.... ......+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445567899999999999999999999864 7889999986432 2233458999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999974 235699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCc-ccceeccccCCccccccc
Q 020072 299 LAITDGSQNK-NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 299 la~~~~~~~~-~~~~~~gt~~y~aPE~l~ 326 (331)
+++....... .....+||+.|+|||++.
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHh
Confidence 9976544332 223357999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.46 Aligned_cols=180 Identities=25% Similarity=0.395 Sum_probs=150.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3457888999999999999999986 78999999996543 345678999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEecCCCChhhhhcCCCCCCCCCH
Q 020072 221 ---------------------------------------------------TRFIVYELMENRSLDIQLHGPSHGSALTW 249 (331)
Q Consensus 221 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 249 (331)
..++||||+++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987555556788
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc------------ccceecccc
Q 020072 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK------------NNLKLSGTL 317 (331)
Q Consensus 250 ~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------------~~~~~~gt~ 317 (331)
..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999976554321 112346899
Q ss_pred CCccccccccCCCC
Q 020072 318 GYVAPEYLLDGMVN 331 (331)
Q Consensus 318 ~y~aPE~l~~~~~t 331 (331)
.|+|||++.++.++
T Consensus 241 ~y~aPE~~~~~~~~ 254 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS 254 (332)
T ss_dssp GGSCHHHHHCCCCC
T ss_pred CccChHHhcCCCCc
Confidence 99999999887664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=263.87 Aligned_cols=174 Identities=24% Similarity=0.348 Sum_probs=152.8
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++|...+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46789999999999999999987 57899999998654 3345567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999853 24599999999999999999999999 9999999999999999999999999999655433
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. ....+||+.|+|||++.+..+
T Consensus 168 ~~-~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 168 GK-LDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp CG-GGTTSSSGGGCCHHHHHTCCC
T ss_pred Cc-cccccCCcceeCcccccCCCc
Confidence 22 234579999999999987765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=268.10 Aligned_cols=177 Identities=28% Similarity=0.378 Sum_probs=148.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
..++|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999875 5889999999643 233456688999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999863 34699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..........+||+.|+|||++.+..|+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 202 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYG 202 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCT
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcC
Confidence 4444444456899999999998776553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=262.33 Aligned_cols=181 Identities=33% Similarity=0.487 Sum_probs=146.0
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+...++|...+.||+|+||.||+|+. +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34457888899999999999999987 57889999986543 3445679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--eEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
||||+++|+|.+++........+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999997533233499999999999999999999998 7 99999999999999999999999999976
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
............||+.|+|||++.++.++
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCC
T ss_pred ccccccccccCCCCccccChhhhcCCCCC
Confidence 54443333445799999999999887653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=270.06 Aligned_cols=176 Identities=24% Similarity=0.352 Sum_probs=151.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (331)
.++|+..++||+|+||.||+|+.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467889999999999999999876 5788999999654 223345688999999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998863 34699999999999999999999999 99999999999999999999999999997644
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........+||+.|+|||++.+..|+
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~ 231 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYG 231 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBC
T ss_pred cCCCccccccCCcccCCchhhcCCCCC
Confidence 443444456899999999999887764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.96 Aligned_cols=176 Identities=24% Similarity=0.353 Sum_probs=153.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999876 5789999999654 233456788999999988 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999998863 24699999999999999999999999 99999999999999999999999999997644
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........+||+.|+|||++.+..|+
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~ 188 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYG 188 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred CCCCcccccCCCccccCccccCCCCCC
Confidence 333334456899999999999887664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.12 Aligned_cols=178 Identities=28% Similarity=0.399 Sum_probs=153.3
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (331)
...++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999875 58899999996432 23456678899999876 999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999863 24689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...........+||+.|+|||++.++.|+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYN 196 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCC
Confidence 54333334456899999999999887664
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=256.24 Aligned_cols=174 Identities=31% Similarity=0.463 Sum_probs=148.5
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..++|+..+.||+|+||+||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457888999999999999999999889999999986443 233467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++ +|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99984 77777763 335699999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcccceeccccCCccccccccC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
........||+.|+|||++.+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~ 194 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGS 194 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTC
T ss_pred cccccCCcccCCcCCHHHhcCC
Confidence 4433445789999999998763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=259.61 Aligned_cols=176 Identities=28% Similarity=0.352 Sum_probs=153.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch------hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
..+.|...+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567899999999999999999875 5889999998654322 34679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEec
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDF 297 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Df 297 (331)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999953 35699999999999999999999999 999999999999998877 7999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++........ .....||+.|+|||++.++.|+
T Consensus 164 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 164 GLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp SSCEECCTTCC-CCCCCSCGGGCCHHHHTTCCCC
T ss_pred CCceEcCCCCc-cccCCCCccEECchHHcCCCCC
Confidence 99977654322 2345799999999999887664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.32 Aligned_cols=178 Identities=24% Similarity=0.305 Sum_probs=153.6
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
++.+...++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|..++.+++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344456789999999999999999999875 68999999996432 22345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
+..|+||||+++|+|.+++.. .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999963 234699999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCCc-ccceeccccCCccccccc
Q 020072 300 AITDGSQNK-NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 300 a~~~~~~~~-~~~~~~gt~~y~aPE~l~ 326 (331)
++....... .....+||+.|+|||++.
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHh
Confidence 977654332 223457999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=260.87 Aligned_cols=176 Identities=26% Similarity=0.402 Sum_probs=142.4
Q ss_pred hcCCcccceeeecCceEEEEEEE----CCCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
.++|+..+.||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999987 478999999996542 2344568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999863 34589999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCCcccceeccccCCccccccccCCCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.............||+.|+|||++.++.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 199 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCC
Confidence 543333333345799999999999877654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=263.53 Aligned_cols=179 Identities=28% Similarity=0.429 Sum_probs=151.6
Q ss_pred hcCCcccceeeecCceEEEEEEE--------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL--------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
.++|...+.||+|+||.||+|+. .++..||+|++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788899999999999999975 235679999997543 34457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE
Q 020072 220 DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill 286 (331)
+..|+||||+++|+|.+++.... ....+++.+++.++.||++||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999987432 124589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 287 DSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 287 ~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+.++.+||+|||+++....... ......+|+.|+|||++.++.|+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 283 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence 9999999999999976543322 12233567899999999887764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=257.75 Aligned_cols=173 Identities=28% Similarity=0.368 Sum_probs=151.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999875 68999999986432 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999863 34689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ...+||+.|+|||++.++.++
T Consensus 159 ~~---~~~~gt~~y~aPE~~~~~~~~ 181 (318)
T 1fot_A 159 VT---YTLCGTPDYIAPEVVSTKPYN 181 (318)
T ss_dssp CB---CCCCSCTTTCCHHHHTTCCBC
T ss_pred cc---ccccCCccccCHhHhcCCCCC
Confidence 22 245799999999999887664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=262.19 Aligned_cols=177 Identities=25% Similarity=0.283 Sum_probs=153.3
Q ss_pred HhcCCcccceeeecCceEEEEEEECC-CceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
..++|...+.||+|+||.||+|+... ++.||+|++... .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999998864 788999998643 223456788999999988 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999863 24599999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..........+||+.|+|||++.++.|+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 199 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYG 199 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBS
T ss_pred ccCCcccccccCCccccChhhhcCCCcC
Confidence 4333334456899999999999887664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=261.39 Aligned_cols=179 Identities=26% Similarity=0.395 Sum_probs=152.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457889999999999999999875 68999999985321 224577999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEeccC
Q 020072 224 IVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGL 299 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgl 299 (331)
+||||+++|+|.+++... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777532 2334689999999999999999999999 9999999999999987655 99999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++.............||+.|+|||++.++.|+
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 211 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCC
Confidence 98766544433445799999999999887664
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=257.67 Aligned_cols=177 Identities=29% Similarity=0.449 Sum_probs=148.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC----CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|...+.||+|+||.||+|++. .+..||||.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999874 3456999999754 34455789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999964 335699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcc---cceeccccCCccccccccCCCC
Q 020072 305 SQNKN---NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~---~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... .....+|+.|+|||++.++.++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 232 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEEC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCC
Confidence 33221 1122457789999999776553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.49 Aligned_cols=173 Identities=27% Similarity=0.396 Sum_probs=148.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999875 58899999986443 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 44444432 235699999999999999999999999 99999999999999999999999999998765444
Q ss_pred cccceeccccCCccccccccCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.......||+.|+|||++.++.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~ 177 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCS
T ss_pred ccccCCccccCCcChHHHcCCC
Confidence 4344457899999999997765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=253.31 Aligned_cols=176 Identities=27% Similarity=0.450 Sum_probs=147.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999865 6889999998543 233456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999863 34699999999999999999999999 999999999999999999999999999965543
Q ss_pred CC-cccceeccccCCccccccccCCCC
Q 020072 306 QN-KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~-~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .......||+.|+|||.+.++.++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCC
T ss_pred ccccccCccccCccccCHhHhcCCCCC
Confidence 22 222235689999999999877653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=253.71 Aligned_cols=174 Identities=18% Similarity=0.253 Sum_probs=152.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468889999999999999999876 5789999998644 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC--CCcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999863 334699999999999999999999999 9999999999999997 789999999999776543
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. .....||+.|+|||++.++.+
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~ 180 (321)
T 1tki_A 158 DN-FRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp CE-EEEEESCGGGSCHHHHTTCEE
T ss_pred Cc-cccccCChhhcCcHHhcCCCC
Confidence 32 234568999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=267.99 Aligned_cols=178 Identities=24% Similarity=0.300 Sum_probs=152.9
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
.++...++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445688999999999999999999876 5789999998642 1223346889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999863 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCc-ccceeccccCCccccccccCC
Q 020072 301 ITDGSQNK-NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 301 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~ 329 (331)
+....... .....+||+.|+|||++.+..
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccC
Confidence 77654332 223457999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=251.23 Aligned_cols=173 Identities=27% Similarity=0.388 Sum_probs=145.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--------------------------hhHHHHHHHHHHHh
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------------------------DAGREFENEVDLLS 202 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 202 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467889999999999999999875 688999999864321 12356899999999
Q ss_pred cCCCCcceeeeeeEEc--CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCC
Q 020072 203 NIHHPNVVCLLGYSAH--DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (331)
Q Consensus 203 ~l~H~niv~l~g~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk 280 (331)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++.++..++.|+++||+|||++ +++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 568999999999999987653 34699999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCccccccccCC
Q 020072 281 SSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 281 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
|+|||++.++.+||+|||+++.............||+.|+|||++.++.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence 9999999999999999999977654443333457999999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=262.83 Aligned_cols=177 Identities=29% Similarity=0.460 Sum_probs=141.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC----CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|...+.||+|+||.||+|+.. ++..||||++... .....++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457888999999999999999864 5678999999754 33455689999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.++++. ....+++.+++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999974 345699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcc---cceeccccCCccccccccCCCC
Q 020072 305 SQNKN---NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~---~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... .....++..|+|||++.++.++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC
Confidence 32211 1122357789999999877664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=258.66 Aligned_cols=176 Identities=21% Similarity=0.323 Sum_probs=154.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|...+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999875 6889999999766655667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC--CCcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999863 334699999999999999999999999 9999999999999974 577999999999876544
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ....||+.|+|||++.++.++
T Consensus 205 ~~~-~~~~gt~~y~aPE~~~~~~~~ 228 (387)
T 1kob_A 205 EIV-KVTTATAEFAAPEIVDREPVG 228 (387)
T ss_dssp SCE-EEECSSGGGCCHHHHTTCCBC
T ss_pred cce-eeeccCCCccCchhccCCCCC
Confidence 322 234799999999999877654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=261.64 Aligned_cols=177 Identities=20% Similarity=0.238 Sum_probs=149.2
Q ss_pred HhcCCcccceeeecCceEEEEEE------ECCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcC
Q 020072 149 ATDSFHESNILGEGGFGCVYKAK------LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHD 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~ 219 (331)
..++|...+.||+|+||.||+|. ..+++.||+|++... ...++.+|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678889999999999999994 456889999999644 3456778888888886 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---------
Q 020072 220 DTRFIVYELMENRSLDIQLHGP--SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--------- 288 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~--------- 288 (331)
+..++||||+++|+|.+++... .....+++..++.++.|+++||+|||++ +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999998631 1345699999999999999999999999 9999999999999998
Q ss_pred --CCcEEEEeccCceeCC--CCCcccceeccccCCccccccccCCCC
Q 020072 289 --KFNAKLSDFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 289 --~~~~kl~Dfgla~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++.+||+|||+++... ..........||+.|+|||++.++.|+
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 263 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC
Confidence 8999999999997543 222223345799999999999888764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=272.01 Aligned_cols=176 Identities=27% Similarity=0.326 Sum_probs=142.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999865 6889999998643 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998853 3468999999999999999999998 7 99999999999999999999999999997644
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..........||+.|+|||++.++.|+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCC
T ss_pred CCCcccccccCCccccCHhhcCCCCCC
Confidence 333333456799999999999887764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=249.70 Aligned_cols=186 Identities=42% Similarity=0.681 Sum_probs=160.5
Q ss_pred cccccHHHHHHHhcCCccc------ceeeecCceEEEEEEECCCceEEEEEeccc----CchhHHHHHHHHHHHhcCCCC
Q 020072 138 ISFIEYKLLEKATDSFHES------NILGEGGFGCVYKAKLDDNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHHP 207 (331)
Q Consensus 138 ~~~~~~~~l~~~~~~~~~~------~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H~ 207 (331)
...+...+++.++++|... +.||+|+||.||+|+. +++.||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4566788899999999877 8999999999999987 5789999998643 234467899999999999999
Q ss_pred cceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC
Q 020072 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (331)
Q Consensus 208 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~ 287 (331)
||+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||++ +++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999987544456799999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeccCceeCCCCCc--ccceeccccCCcccccccc
Q 020072 288 SKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 288 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 327 (331)
+++.+||+|||++........ ......|++.|+|||.+.+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 999999999999976543222 1223468999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.80 Aligned_cols=172 Identities=28% Similarity=0.329 Sum_probs=151.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 68999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999864 24589999999999999999999999 9999999999999999999999999999776433
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ...+||+.|+|||++.++.++
T Consensus 195 ~---~~~~gt~~y~aPE~~~~~~~~ 216 (350)
T 1rdq_E 195 T---WTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp B---CCCEECGGGCCHHHHTTCCBC
T ss_pred c---ccccCCccccCHHHhcCCCCC
Confidence 2 245799999999999887664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.17 Aligned_cols=175 Identities=30% Similarity=0.395 Sum_probs=149.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468899999999999999999876 68899999986443 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999853 34699999999999999999999999 99999999999999999999999999997543221
Q ss_pred --cccceeccccCCccccccccCCC
Q 020072 308 --KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 --~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......||+.|+|||++.++.+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred cccccCCCccCcCccCcHHhccCCC
Confidence 12224579999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=265.99 Aligned_cols=178 Identities=22% Similarity=0.349 Sum_probs=152.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
...++|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34568999999999999999999864 68899999986543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC---CCCcEEEEeccCce
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAI 301 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgla~ 301 (331)
||||+++|+|.+.+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999988864 34699999999999999999999999 999999999999998 46789999999997
Q ss_pred eCCCCCcccceeccccCCccccccccCCCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.............||+.|+|||++.++.|+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCC
Confidence 765544444456799999999999887664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.34 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=145.2
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|...+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47888999999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 88888864 235689999999999999999999999 999999999999999999999999999966543333
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......||+.|+|||++.+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGS 175 (288)
T ss_dssp ------CCCTTCCHHHHTTC
T ss_pred ccccccccccccCchheeCC
Confidence 33344689999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=252.75 Aligned_cols=175 Identities=29% Similarity=0.371 Sum_probs=151.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch------hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999875 5889999998644321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 298 (331)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999853 35699999999999999999999999 999999999999999887 79999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++....... .....||+.|+|||++.++.++
T Consensus 164 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 195 (326)
T 2y0a_A 164 LAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLG 195 (326)
T ss_dssp TCEECCTTSC-CCCCCSCTTTCCHHHHTTCCCC
T ss_pred CCeECCCCCc-cccccCCcCcCCceeecCCCCC
Confidence 9977643322 2234699999999999877664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=257.55 Aligned_cols=176 Identities=26% Similarity=0.412 Sum_probs=152.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999875 58899999996543 34456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC---cEEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgla~~ 302 (331)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998853 35689999999999999999999999 999999999999998654 599999999976
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... .....||+.|+|||++.++.|+
T Consensus 181 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 208 (362)
T 2bdw_A 181 VNDSEA-WHGFAGTPGYLSPEVLKKDPYS 208 (362)
T ss_dssp CTTCCS-CCCSCSCTTTCCHHHHTTCCCC
T ss_pred ecCCcc-cccCCCCccccCHHHHccCCCC
Confidence 553322 2245799999999999887664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=269.42 Aligned_cols=178 Identities=27% Similarity=0.399 Sum_probs=155.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...++||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999885 68999999996432 233467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987532 234699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........+||+.|+|||++.++.|+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~ 367 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYD 367 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBC
T ss_pred CCcccccccCCccccChhhhcCCCCC
Confidence 44433445899999999999887764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.13 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=150.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999875 5788999998643 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999964 35699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccceeccccCCcccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.. .....+||+.|+|||++.+
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTCC
T ss_pred CC-ceeccCCCccccCCeeecc
Confidence 32 2234579999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=262.77 Aligned_cols=176 Identities=30% Similarity=0.412 Sum_probs=143.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHH-HhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDL-LSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999876 57889999996543 2334556777776 577899999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999863 34689999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........+||+.|+|||++.++.|+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYD 217 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCC
T ss_pred cCCCccccccCCccccCHHHhCCCCCC
Confidence 333334456899999999999887664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=263.79 Aligned_cols=178 Identities=30% Similarity=0.433 Sum_probs=151.4
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
...++|...+.||+|+||.||+|++. +++.||||.+.... .+..++|.+|++++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888999999999999999986 68899999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. .+..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999863 334689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccc--ceeccccCCccccccccCCC
Q 020072 306 QNKNN--LKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~--~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... ....++..|+|||.+.++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 292 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRY 292 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCC
Confidence 22111 11235778999999987655
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.42 Aligned_cols=176 Identities=24% Similarity=0.354 Sum_probs=151.6
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|...+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357888999999999999999998889999999975433 3467999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999964 335689999999999999999999999 999999999999999999999999999965433221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+++.|+|||.+.++.++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~ 185 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS 185 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC
T ss_pred cccCcccccccCCHHHhcCCCCC
Confidence 11223467789999999877654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=253.73 Aligned_cols=177 Identities=27% Similarity=0.390 Sum_probs=148.0
Q ss_pred hcCCcccceeeecCceEEEEEEE-----CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (331)
.++|+..+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788899999999999999984 36789999999877766778899999999999999999999998654 468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998642 34599999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCc---ccceeccccCCccccccccCCCC
Q 020072 303 DGSQNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... ......++..|+|||++.++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCC
Confidence 543221 11223467789999999877664
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=260.79 Aligned_cols=186 Identities=30% Similarity=0.394 Sum_probs=154.5
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeee
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLG 214 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g 214 (331)
...++...++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 455667788999999999999999999974 245789999997543 34456799999999999 7999999999
Q ss_pred eEEcCC-eEEEEEEecCCCChhhhhcCCCC--------------------------------------------------
Q 020072 215 YSAHDD-TRFIVYELMENRSLDIQLHGPSH-------------------------------------------------- 243 (331)
Q Consensus 215 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------- 243 (331)
++.+.+ ..++||||+++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998765 48999999999999999875322
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC--c
Q 020072 244 -------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--K 308 (331)
Q Consensus 244 -------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~ 308 (331)
...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++....... .
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 12289999999999999999999999 99999999999999999999999999997553322 2
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......||+.|+|||++.++.++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~ 273 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYT 273 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCC
T ss_pred hccccCCCceeEChhhhcCCCCC
Confidence 22334688999999999877664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=268.84 Aligned_cols=177 Identities=28% Similarity=0.384 Sum_probs=153.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...++||+|+||.||+|+.. +|+.||+|++... .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999875 6899999999643 223446688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998753 234599999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ....+||+.|+|||++.++.|+
T Consensus 339 ~~~-~~~~~GT~~Y~APEvl~~~~~~ 363 (576)
T 2acx_A 339 GQT-IKGRVGTVGYMAPEVVKNERYT 363 (576)
T ss_dssp TCC-EECCCSCGGGCCHHHHTTCEES
T ss_pred Ccc-ccccCCCccccCHHHHcCCCCC
Confidence 332 2234799999999999887653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=250.41 Aligned_cols=173 Identities=24% Similarity=0.361 Sum_probs=149.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC--eEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999876 48899999997543 334567889999999999999999999998765 78999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE----CCCCcEEEEeccCce
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAI 301 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgla~ 301 (331)
|||+++|+|.+++........+++.+++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998654445599999999999999999999999 99999999999999 788889999999997
Q ss_pred eCCCCCcccceeccccCCccccccc
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
........ ....||+.|+|||++.
T Consensus 165 ~~~~~~~~-~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 165 ELEDDEQF-VSLYGTEEYLHPDMYE 188 (319)
T ss_dssp ECCTTCCB-CCCCSCGGGCCHHHHH
T ss_pred ecCCCCce-eecccCCCccCHHHhh
Confidence 76544332 2346899999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=249.90 Aligned_cols=175 Identities=26% Similarity=0.426 Sum_probs=136.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999865 58899999986543 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|++ |+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6898887532 2224589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccceeccccCCccccccccC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..........||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTC
T ss_pred CCcccCCCCcccccccCchHhhCC
Confidence 433333345789999999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=257.30 Aligned_cols=171 Identities=26% Similarity=0.349 Sum_probs=144.2
Q ss_pred ccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 155 ESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
..+.||+|+||.||+|+.. +|+.||+|++........+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999874 689999999987666667889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE--CCCCcEEEEeccCceeCCCCCcccc
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDGSQNKNNL 311 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~ 311 (331)
|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-~ 246 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-K 246 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-C
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-c
Confidence 9988863 234689999999999999999999999 99999999999999 66789999999999876544332 2
Q ss_pred eeccccCCccccccccCCCC
Q 020072 312 KLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 312 ~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~ 266 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVS 266 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCC
T ss_pred cccCCCcEeChhhccCCCCC
Confidence 34699999999999877654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=254.58 Aligned_cols=173 Identities=27% Similarity=0.370 Sum_probs=149.1
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|.. .+++.||+|++.... .+....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999987 568899999986432 22345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+ +|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6888888753 24699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
... ....+||+.|+|||++.+..+
T Consensus 161 ~~~-~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 161 GNF-LKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp SBT-TCCCTTSTTTSCGGGSCCSGG
T ss_pred Ccc-cccccCCcCcCCHHHHcCCCC
Confidence 322 234579999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=262.28 Aligned_cols=173 Identities=29% Similarity=0.408 Sum_probs=148.0
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-eEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e 227 (331)
..++|...+.||+|+||.||+|+.. ++.||||.++... ..+.|.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888899999999999999986 7799999997543 4578999999999999999999999987765 7999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++... ....+++..++.++.|+++||+|||++ +++||||||+|||+++++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999742 223479999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ...++..|+|||++.++.++
T Consensus 344 ~---~~~~~~~y~aPE~~~~~~~~ 364 (450)
T 1k9a_A 344 D---TGKLPVKWTAPEALREKKFS 364 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCC
T ss_pred c---CCCCCcceeCHHHhcCCCCC
Confidence 2 22578899999999887764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=245.53 Aligned_cols=176 Identities=29% Similarity=0.510 Sum_probs=134.7
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999987 478999999986432 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999874 335799999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.........|++.|+|||.+.++.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAH 189 (278)
T ss_dssp -------------------------
T ss_pred CCCcceeccCCCCcCCcchhcCCCC
Confidence 3333334578999999999877654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=246.28 Aligned_cols=175 Identities=27% Similarity=0.393 Sum_probs=150.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|...+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999999888999999975433 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999864 234599999999999999999999999 999999999999999999999999999976544332
Q ss_pred ccceeccccCCccccccccCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+++.|+|||.+.++.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~ 182 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKY 182 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEE
T ss_pred cccCCCcCcccCCHHHHhccCC
Confidence 1222345678999999876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=255.39 Aligned_cols=183 Identities=29% Similarity=0.427 Sum_probs=153.0
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEc
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 218 (331)
++...++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999874 34789999997543 3445789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEec
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSH---------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHr 277 (331)
.+..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +++||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9999999999999999999864211 25699999999999999999999999 99999
Q ss_pred CCCCCCEEECCCCcEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 278 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||||+|||+++++.+||+|||+++...... .......+|+.|+|||++.++.++
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 254 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 254 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC
Confidence 999999999999999999999986543221 112234578899999999877654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=262.31 Aligned_cols=174 Identities=28% Similarity=0.402 Sum_probs=152.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +|+.||||++.... .+....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999876 68999999996432 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999853 35699999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
... ....+||+.|+|||++.++.+
T Consensus 169 ~~~-~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 169 GEF-LRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp TCC-BCCCCSCSTTCCHHHHTTCCB
T ss_pred ccc-ccccCCCcCeEChhhccCCCC
Confidence 322 224579999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=256.75 Aligned_cols=182 Identities=29% Similarity=0.407 Sum_probs=153.1
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYS 216 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~ 216 (331)
+...++|...+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578889999999999999999852 33579999997543 34457899999999999 999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
.+.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999865321 24599999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+++++.+||+|||+++...... .......+|+.|+|||++.++.++
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 999999999999999997654322 122234578899999999887664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=251.00 Aligned_cols=167 Identities=27% Similarity=0.325 Sum_probs=128.3
Q ss_pred cceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.+++.++ ||||+++++++.+.+..|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999875 5889999998632 4467789999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC---cEEEEeccCceeCCCCCccc
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLSDFGLAITDGSQNKNN 310 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~ 310 (331)
|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.........
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9999864 35699999999999999999999999 999999999999998765 89999999998765544444
Q ss_pred ceeccccCCccccccccCCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~t 331 (331)
....||+.|+|||++.++.|+
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp -----------------CCCC
T ss_pred cccCCCcCccCHHHhcCCCCC
Confidence 455789999999999887664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=247.13 Aligned_cols=171 Identities=26% Similarity=0.381 Sum_probs=143.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999875 589999999864432 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988753 34689999999999999999999999 99999999999999999999999999997765443
Q ss_pred cccceeccccCCcccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~ 327 (331)
.......||..|+|||++.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp ---------GGGCCHHHHHT
T ss_pred cccCCCcCCccccChHHHhc
Confidence 33334578999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=258.87 Aligned_cols=166 Identities=20% Similarity=0.200 Sum_probs=137.3
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--------chhHHHHHHHHHHHhcCC---------CCcceee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIH---------HPNVVCL 212 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~l 212 (331)
.++|...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45678899999999999999998 68999999996542 223477889999988886 6666666
Q ss_pred eee-----------------EEc-------------CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 020072 213 LGY-----------------SAH-------------DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262 (331)
Q Consensus 213 ~g~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 262 (331)
.++ +.+ .+..|+||||+++|++.+.+.. ..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 332 6789999999999977666632 458999999999999999
Q ss_pred HHHHh-hCCCCceEecCCCCCCEEECCCC--------------------cEEEEeccCceeCCCCCcccceeccccCCcc
Q 020072 263 LEYLH-EHCNPAVIHRDLKSSNILLDSKF--------------------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321 (331)
Q Consensus 263 l~yLH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~a 321 (331)
|+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999765432 3479999999
Q ss_pred ccccccC
Q 020072 322 PEYLLDG 328 (331)
Q Consensus 322 PE~l~~~ 328 (331)
||++.+.
T Consensus 246 PE~~~g~ 252 (336)
T 2vuw_A 246 EDLFTGD 252 (336)
T ss_dssp SGGGCCC
T ss_pred hhhhcCC
Confidence 9999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.60 Aligned_cols=177 Identities=26% Similarity=0.417 Sum_probs=143.7
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe---
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT--- 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--- 221 (331)
..++|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356889999999999999999986 568899999996542 2345678999999999999999999999876543
Q ss_pred -EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 222 -RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
.|+||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999863 34699999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCC---cccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQN---KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+...... .......||+.|+|||++.++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 197 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCC
Confidence 6543322 122234689999999999887664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=252.90 Aligned_cols=174 Identities=26% Similarity=0.351 Sum_probs=136.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
..++|...+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567889999999999999999986 57889999986432 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla~~~~ 304 (331)
|+++|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999853 34689999999999999999999999 9999999999999975 8899999999997654
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... .....||+.|+|||++.++.++
T Consensus 203 ~~~~-~~~~~gt~~y~aPE~~~~~~~~ 228 (349)
T 2w4o_A 203 HQVL-MKTVCGTPGYCAPEILRGCAYG 228 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCC
T ss_pred cccc-cccccCCCCccCHHHhcCCCCC
Confidence 3222 2234689999999999887664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=254.95 Aligned_cols=174 Identities=18% Similarity=0.239 Sum_probs=149.1
Q ss_pred hcCCcccceeeec--CceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 150 TDSFHESNILGEG--GFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
.++|+..+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999986 68999999996543 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998652 235699999999999999999999999 99999999999999999999999999985432
Q ss_pred CCC-------cccceeccccCCcccccccc
Q 020072 305 SQN-------KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 305 ~~~-------~~~~~~~gt~~y~aPE~l~~ 327 (331)
... .......||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred cccccccccccccccccccccccCHHHHhc
Confidence 111 11122368899999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=248.35 Aligned_cols=172 Identities=28% Similarity=0.350 Sum_probs=142.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (331)
..++|+..+.||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +|+||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999886 68999999986432 23334556666666555 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 6788888764 235699999999999999999999999 99999999999999999999999999997765
Q ss_pred CCCcccceeccccCCcccccccc
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... .....||+.|+|||++.+
T Consensus 209 ~~~~-~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 209 TAGA-GEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT
T ss_pred cCCC-CcccCCCccccCHhHhcC
Confidence 4332 223468999999998875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=247.47 Aligned_cols=177 Identities=25% Similarity=0.354 Sum_probs=149.3
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..++|...+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4567888999999999999999999888999999975433 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999974 234699999999999999999999999 999999999999999999999999999965433221
Q ss_pred -ccceeccccCCccccccccCCCC
Q 020072 309 -NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 -~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+|+.|+|||++.++.++
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~ 199 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFS 199 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCS
T ss_pred ccccCCccCcccCCHHHhccCCCC
Confidence 11223467789999999877654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=243.99 Aligned_cols=176 Identities=28% Similarity=0.392 Sum_probs=152.5
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888999999999999999876 4788999998643 234456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988753 34689999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........|++.|+|||.+.++.++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 193 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHS 193 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBC
T ss_pred CccccccccCCCCcCCcchhccCCCC
Confidence 33333345789999999999876553
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=265.96 Aligned_cols=180 Identities=26% Similarity=0.386 Sum_probs=152.7
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++...++|...+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345567888899999999999999999888999999997543 34678999999999999999999999987 5678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999742 223588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcc-cceeccccCCccccccccCCCC
Q 020072 306 QNKN-NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~-~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... .....++..|+|||++..+.++
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 363 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFT 363 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCC
T ss_pred CceeccCCCcccccccCHHHhccCCCC
Confidence 2211 1123467889999999877764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.45 Aligned_cols=176 Identities=28% Similarity=0.392 Sum_probs=152.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999876 4788999998643 234556789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998753 34689999999999999999999999 999999999999999999999999999977654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........|+..|+|||++.+..++
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHS 219 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBC
T ss_pred CcccccccCCCccccCHHHhccCCCC
Confidence 33333445789999999999876553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=273.58 Aligned_cols=177 Identities=25% Similarity=0.283 Sum_probs=153.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (331)
..++|+..++||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +|+||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467889999999999999999875 5788999998643 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999864 24699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..........+||+.|+|||++.++.|+
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCC
Confidence 4444444456899999999999887764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=254.95 Aligned_cols=173 Identities=24% Similarity=0.310 Sum_probs=142.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|...+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999876 688999999964332 346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc--EEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998853 34599999999999999999999999 9999999999999988766 999999999643322
Q ss_pred CcccceeccccCCccccccccCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. .....||+.|+|||++.++.+
T Consensus 172 ~~-~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 172 SQ-PKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp ----------CTTSCHHHHHCSSC
T ss_pred CC-CCCCcCCCCcCChhhhcCCCC
Confidence 22 223469999999999987765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=241.39 Aligned_cols=172 Identities=26% Similarity=0.345 Sum_probs=151.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
..++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467888999999999999999876 467899999976666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~~ 304 (331)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988853 34589999999999999999999999 99999999999999 788999999999997655
Q ss_pred CCCcccceeccccCCcccccccc
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
..... ....||+.|+|||++.+
T Consensus 161 ~~~~~-~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 161 PGKMM-RTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp TTSCB-CCCCSCTTTCCHHHHTT
T ss_pred Cccch-hccCCCCCccChHHhcc
Confidence 43322 23468999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=242.86 Aligned_cols=174 Identities=26% Similarity=0.385 Sum_probs=147.2
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
+|....+||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4455669999999999999864 678999999977666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEeccCceeCCCCCcc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+++|.+++........+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999987544445678999999999999999999999 9999999999999987 899999999999776543333
Q ss_pred cceeccccCCccccccccC
Q 020072 310 NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~ 328 (331)
.....|++.|+|||++.++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHG
T ss_pred ccccCCCccccChhhhcCC
Confidence 3345789999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=251.12 Aligned_cols=174 Identities=21% Similarity=0.263 Sum_probs=149.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+++++++ +|+||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 45788899999999999999986 578999999986432 234688999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc-----EEEEeccCcee
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-----AKLSDFGLAIT 302 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfgla~~ 302 (331)
|+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 89999998742 35799999999999999999999999 9999999999999999887 99999999976
Q ss_pred CCCCCcc-------cceeccccCCccccccccCCCC
Q 020072 303 DGSQNKN-------NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....... .....||+.|+|||++.++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS 195 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCC
Confidence 5432221 2345799999999999887764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=267.11 Aligned_cols=180 Identities=27% Similarity=0.382 Sum_probs=153.0
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+...++|...+.||+|+||.||+|++.. +..||||.+..... ..++|.+|++++++++||||++++++|.+.+..++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3345677888999999999999999864 78999999975433 457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999742 235689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCc-ccceeccccCCccccccccCCCC
Q 020072 306 QNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......++..|+|||++.++.++
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCC
Confidence 322 11223457789999999876653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=247.07 Aligned_cols=169 Identities=25% Similarity=0.387 Sum_probs=147.8
Q ss_pred hcCCcccceeeecCceEEEEEEECC-C-------ceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-N-------LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
.++|...+.||+|+||.||+|+... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578889999999999999997643 3 4699999977666677889999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc--------EE
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--------AK 293 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~k 293 (331)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999974 234489999999999999999999999 9999999999999998887 99
Q ss_pred EEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
|+|||++...... ....++..|+|||++.+
T Consensus 162 l~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 162 LSDPGISITVLPK----DILQERIPWVPPECIEN 191 (289)
T ss_dssp ECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC
T ss_pred eccCcccccccCc----cccCCcCcccCHHHhCC
Confidence 9999998554322 23458899999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=251.12 Aligned_cols=182 Identities=26% Similarity=0.405 Sum_probs=150.0
Q ss_pred HHHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 218 (331)
+...++|...+.||+|+||.||+|+. .++..||+|.+... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 44567899999999999999999986 24568999999644 334457899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecC
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSH--------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrd 278 (331)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +++|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 9999999999999999999975322 13489999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 279 LKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 279 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|||+|||++.++.+||+|||++........ ......+|+.|+|||.+.++.++
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence 999999999999999999999965433222 12234578899999999877664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=246.98 Aligned_cols=180 Identities=29% Similarity=0.393 Sum_probs=151.5
Q ss_pred HHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
...++|...+.||+|+||.||+|+. .++..||+|.+... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456788899999999999999976 34578999999754 3345578999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCC
Q 020072 221 TRFIVYELMENRSLDIQLHGPSH---------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL 279 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdl 279 (331)
..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +++||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999875322 13489999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCC
Q 020072 280 KSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 280 k~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+||++++++.+||+|||+++....... ......+++.|+|||.+.++.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 99999999999999999999976543322 1223356788999999877654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=248.97 Aligned_cols=173 Identities=34% Similarity=0.514 Sum_probs=145.3
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----eEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888999999999999999886 7899999996443 23345677999999999999999999998754 47999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-------NPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ +++++||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999964 34899999999999999999999752 3489999999999999999999999999
Q ss_pred CceeCCCCCc--ccceeccccCCccccccccC
Q 020072 299 LAITDGSQNK--NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~--~~~~~~gt~~y~aPE~l~~~ 328 (331)
+++....... ......||+.|+|||++.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred cccccccccCccccccCccCccccCHhhcccc
Confidence 9976543322 22234689999999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=251.29 Aligned_cols=181 Identities=28% Similarity=0.423 Sum_probs=151.1
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYS 216 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~ 216 (331)
+...++|...+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 334578889999999999999999863 46789999997543 34557799999999999 899999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
.+.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +++||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999975321 23489999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||++.++.+||+|||+++....... ......+++.|+|||++.++.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 236 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc
Confidence 9999999999999999976654322 1222356788999999877654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=261.16 Aligned_cols=174 Identities=25% Similarity=0.356 Sum_probs=134.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-----CCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-----DDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~ 221 (331)
.++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999865 6889999998643 33455779999999999999999999999843 357
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 789888863 35699999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCCc---------------------------ccceeccccCCccccccc-cCCC
Q 020072 302 TDGSQNK---------------------------NNLKLSGTLGYVAPEYLL-DGMV 330 (331)
Q Consensus 302 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~l~-~~~~ 330 (331)
....... .....+||+.|+|||++. ++.|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 261 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCC
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCC
Confidence 6532211 122346899999999874 3334
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=251.48 Aligned_cols=180 Identities=26% Similarity=0.303 Sum_probs=153.1
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-----CCcceeeeeeE
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----HPNVVCLLGYS 216 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~g~~ 216 (331)
.+..+...++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+..|++++++++ ||||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3333455788999999999999999999874 688999999863 2344567788999999986 99999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC--------
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-------- 288 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-------- 288 (331)
...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 9999999999999 89999998753 234599999999999999999999999 9999999999999975
Q ss_pred -----------------CCcEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 289 -----------------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 289 -----------------~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++.+||+|||++........ ...||+.|+|||++.++.++
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG---SIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC---SCCSCGGGCCHHHHTTCCCC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCCc---CccCcccccCcHHHcCCCCC
Confidence 78999999999976543322 34689999999999887764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=246.06 Aligned_cols=175 Identities=26% Similarity=0.422 Sum_probs=146.4
Q ss_pred cCCcccceeeecCceEEEEEEE-----CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (331)
+.|+..+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999984 36889999999744 334457899999999999999999999999877 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999853 234699999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCc---ccceeccccCCccccccccCCC
Q 020072 303 DGSQNK---NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
...... ......+|..|+|||++.++.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 206 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKF 206 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEE
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCC
Confidence 654332 1223457888999999877654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=245.80 Aligned_cols=175 Identities=28% Similarity=0.339 Sum_probs=152.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch------hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457888999999999999999875 5889999998644321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 298 (331)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||++++++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999964 34689999999999999999999999 999999999999999988 79999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++........ .....||+.|+|||++.++.++
T Consensus 165 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 196 (321)
T 2a2a_A 165 LAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLG 196 (321)
T ss_dssp TCEECCTTCC-CCCCCSCGGGCCHHHHTTCCCC
T ss_pred cceecCcccc-ccccCCCCCccCcccccCCCCC
Confidence 9976654322 2234689999999999877654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=249.05 Aligned_cols=180 Identities=27% Similarity=0.428 Sum_probs=136.4
Q ss_pred HhcCCcccceeeecCceEEEEEEECCC----ceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDN----LHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
..++|...+.||+|+||.||+|+.... ..||+|.+... .....+++.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456899999999999999999986543 27999998654 345567899999999999999999999999887655
Q ss_pred ------EEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 223 ------FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 223 ------~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
++||||+++|+|.+++... .....+++.+++.++.|+++||+|||++ +++||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 9999999999999888542 1223699999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 294 LSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 294 l~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+|||+++....... ......+++.|+|||.+.++.++
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT 217 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC
Confidence 999999966533221 12223467889999999877654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=250.84 Aligned_cols=167 Identities=32% Similarity=0.452 Sum_probs=144.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588889999999999999986 578999999986443 23346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||++ |+|.+++.. ....+++.++..++.|+++||+|||++ +++||||||+|||+++++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677777642 235699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccceeccccCCccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~ 326 (331)
. ....||+.|+|||++.
T Consensus 207 ~----~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp B----CCCCSCGGGCCHHHHH
T ss_pred C----CcccCCcceeCHhhhc
Confidence 2 2346899999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=243.39 Aligned_cols=169 Identities=27% Similarity=0.402 Sum_probs=140.8
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCcceeeeeeEEcC----CeE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHD----DTR 222 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~----~~~ 222 (331)
..++|...+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.+. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356888999999999999999988 6889999998643 33455666666665 8999999999986543 468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--------EHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +++||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999953 36999999999999999999999 77 9999999999999999999999
Q ss_pred EeccCceeCCCCCcc----cceeccccCCccccccccC
Q 020072 295 SDFGLAITDGSQNKN----NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~ 328 (331)
+|||+++........ .....||+.|+|||++.++
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 999999654332221 1223689999999999775
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=250.75 Aligned_cols=175 Identities=26% Similarity=0.333 Sum_probs=151.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
..++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 688999999865421 1344678899999999999999999999999
Q ss_pred CeEEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 220 DTRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 220 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 99999864 34699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
++........ .....||+.|+|||++.+..+
T Consensus 176 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 176 SAAYLERGKL-FYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp TCEECCTTCC-BCEECSCGGGCCHHHHTTCCB
T ss_pred cceECCCCCc-eeccCCCccccChhhhcCCCC
Confidence 9977654332 234579999999999987765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=241.23 Aligned_cols=175 Identities=28% Similarity=0.401 Sum_probs=153.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.+.|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999999999999864 68899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999853 4689999999999999999999999 99999999999999999999999999997765444
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.......|++.|+|||++.++.++
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~ 197 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYD 197 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred cccCccCCCcCccCHHHHhcCCCC
Confidence 333445789999999999877654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=250.16 Aligned_cols=172 Identities=31% Similarity=0.481 Sum_probs=139.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|...+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999876 6889999998644322 223566899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 588888763 345699999999999999999999999 999999999999999999999999999976554433
Q ss_pred ccceeccccCCccccccccC
Q 020072 309 NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~ 328 (331)
......||+.|+|||++.++
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~ 175 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGS 175 (324)
T ss_dssp -------CGGGCCHHHHTTC
T ss_pred ccccccCcccccChhhhcCC
Confidence 33345689999999998763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-33 Score=262.76 Aligned_cols=179 Identities=28% Similarity=0.406 Sum_probs=147.6
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+...++|...+.||+|+||.||+|+++++..||||++..... ..++|.+|++++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 445667888999999999999999998888899999975443 34679999999999999999999999876 6789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++... .+..+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999998631 234589999999999999999999999 9999999999999999999999999999765432
Q ss_pred Cc-ccceeccccCCccccccccCCCC
Q 020072 307 NK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ......++..|+|||++.++.++
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 359 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFT 359 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCC
T ss_pred ceecccCCcccccccCHhHHhcCCCC
Confidence 21 11223467899999999887764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.72 Aligned_cols=175 Identities=28% Similarity=0.397 Sum_probs=150.3
Q ss_pred cCCcccceeeecCceEEEEEEE-----CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEE--cCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA--HDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~ 223 (331)
++|+..+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 367899999998776667788999999999999999999999987 456789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999863 224589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc---ccceeccccCCccccccccCCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
..... ......++..|+|||++.++.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 207 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF 207 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC
Confidence 43322 1122357888999999876654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=255.73 Aligned_cols=171 Identities=29% Similarity=0.401 Sum_probs=143.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-----Ce
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (331)
.++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 5788999999653 334557899999999999999999999998776 57
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999997 699998864 35699999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCCc----------------------ccceeccccCCcccccccc
Q 020072 302 TDGSQNK----------------------NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~----------------------~~~~~~gt~~y~aPE~l~~ 327 (331)
....... .....+||+.|+|||++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 6543221 1234578999999998743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-33 Score=256.23 Aligned_cols=179 Identities=30% Similarity=0.421 Sum_probs=148.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC------CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|...+.||+|+||.||+|++. ++..||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999853 4678999999644 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC---cEEEE
Q 020072 223 FIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLS 295 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~kl~ 295 (331)
++||||+++|+|.+++.... ....+++.+++.++.|+++||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986421 224599999999999999999999999 999999999999999554 59999
Q ss_pred eccCceeCCC--CCcccceeccccCCccccccccCCCC
Q 020072 296 DFGLAITDGS--QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 296 Dfgla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|||+++.... .........+|+.|+|||++.++.++
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCC
Confidence 9999964321 11122234578999999999887664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-32 Score=239.63 Aligned_cols=176 Identities=26% Similarity=0.417 Sum_probs=151.7
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 5889999998644 334457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla~~ 302 (331)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888753 34689999999999999999999999 9999999999999987655 99999999976
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....... ....|++.|+|||++.++.++
T Consensus 158 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 185 (284)
T 3kk8_A 158 VNDSEAW-HGFAGTPGYLSPEVLKKDPYS 185 (284)
T ss_dssp CCSSCBC-CCSCSCGGGCCHHHHTTCCBC
T ss_pred cccCccc-cCCCCCcCCcCchhhcCCCCC
Confidence 6543322 234689999999999887654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=239.50 Aligned_cols=170 Identities=25% Similarity=0.312 Sum_probs=147.3
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999985 7889999987543 34456799999999999999999999999887 788999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--eEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
|||+++|+|.+++... ....+++.+++.++.|++.||+|||++ + ++||||||+||++++++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999752 234699999999999999999999998 7 999999999999999999999999987543
Q ss_pred CCCCcccceeccccCCccccccccCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
... ...||+.|+|||.+.++.
T Consensus 164 ~~~-----~~~~t~~y~aPE~~~~~~ 184 (271)
T 3kmu_A 164 QSP-----GRMYAPAWVAPEALQKKP 184 (271)
T ss_dssp SCT-----TCBSCGGGSCHHHHHSCG
T ss_pred ccc-----CccCCccccChhhhccCC
Confidence 222 236899999999997654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=245.82 Aligned_cols=181 Identities=27% Similarity=0.362 Sum_probs=152.4
Q ss_pred HHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQ-DAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
...++|...+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456888899999999999999985 3568899999975433 3457799999999999 999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSH---------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999875321 22589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeccCceeCCCCCcc--cceeccccCCccccccccCCCC
Q 020072 285 LLDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++++++.+||+|||++......... .....+++.|+|||++.++.++
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 225 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC
Confidence 9999999999999999765433221 1223567899999998877654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=249.64 Aligned_cols=179 Identities=26% Similarity=0.334 Sum_probs=145.7
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
+....++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456778999999999999999999874 6788999998543 334567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 020072 220 DTRFIVYELMENRSLDIQLHGPS-------------------------------------HGSALTWHMRMKIALDTARG 262 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 262 (331)
+..++||||+++|+|.+++.... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885200 01124677788999999999
Q ss_pred HHHHhhCCCCceEecCCCCCCEEECCCC--cEEEEeccCceeCCCCC----cccceeccccCCcccccccc
Q 020072 263 LEYLHEHCNPAVIHRDLKSSNILLDSKF--NAKLSDFGLAITDGSQN----KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 263 l~yLH~~~~~~ivHrdlk~~Nill~~~~--~~kl~Dfgla~~~~~~~----~~~~~~~gt~~y~aPE~l~~ 327 (331)
|+|||++ +++||||||+|||++.++ .+||+|||++....... .......||+.|+|||++.+
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999 999999999999998776 89999999997543211 11234568999999999965
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=245.85 Aligned_cols=173 Identities=32% Similarity=0.455 Sum_probs=140.6
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|+..+.||+|+||.||+|+.. ++.||+|++.. ....+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999985 67899999863 3355789999999999999999999998874 4799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc-EEEEeccCceeCCCCCcc
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~~ 309 (331)
+|+|.+++........+++..++.++.|+++||+|||+....+++||||||+|||++.++. +||+|||++........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~- 161 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT- 161 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc-
Confidence 9999999986444446889999999999999999999932228999999999999998886 79999999965443221
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...||+.|+|||++.++.++
T Consensus 162 --~~~gt~~y~aPE~~~~~~~~ 181 (307)
T 2eva_A 162 --NNKGSAAWMAPEVFEGSNYS 181 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCC
T ss_pred --cCCCCCceEChhhhCCCCCC
Confidence 23689999999999887664
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=250.72 Aligned_cols=171 Identities=26% Similarity=0.384 Sum_probs=145.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..++|+..+.||+|+||.||+|... +++.||+|.+..... ...+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567899999999999999999875 588999999965432 345688888887 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC----CcEEEEeccCcee
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAIT 302 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgla~~ 302 (331)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999864 34699999999999999999999999 99999999999998543 3599999999977
Q ss_pred CCCCCcccceeccccCCccccccccCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
...........+||+.|+|||++.++.
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~ 196 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQG 196 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHH
T ss_pred CcCCCCceeccCCCccccCHHHhcCCC
Confidence 654433334557899999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=258.19 Aligned_cols=172 Identities=29% Similarity=0.371 Sum_probs=141.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------C
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------D 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~ 220 (331)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999865 5889999999654 344567789999999999999999999999654 3
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..|+||||++++ |...+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999865 555553 2389999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+....... .....||+.|+|||++.+..|+
T Consensus 212 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 241 (464)
T 3ttj_A 212 RTAGTSFM-MTPYVVTRYYRAPEVILGMGYK 241 (464)
T ss_dssp -----CCC-C----CCCTTCCHHHHTTCCCC
T ss_pred eecCCCcc-cCCCcccccccCHHHHcCCCCC
Confidence 76554322 2345799999999999988764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=253.78 Aligned_cols=173 Identities=30% Similarity=0.434 Sum_probs=138.5
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--------chhHHHHHHHHHHHhcCCCCcceeeeeeEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
....++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999875 57899999986431 122345889999999999999999999976
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEE
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKL 294 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl 294 (331)
. +..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4 568999999999999998853 35699999999999999999999999 99999999999999754 45999
Q ss_pred EeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+|||+++....... .....||+.|+|||++.+
T Consensus 284 ~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 284 TDFGHSKILGETSL-MRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp CCSSTTTSCC------------CTTCCTTTTC-
T ss_pred eecccceecCCCcc-ccccCCCCCccCceeeec
Confidence 99999976544322 234579999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=248.07 Aligned_cols=176 Identities=27% Similarity=0.443 Sum_probs=141.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCc----eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|...+.||+|+||.||+|++. +++ .||+|.+... .....+++.+|+.++++++||||++++++|.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888999999999999999864 343 3688887543 3345578999999999999999999999998764 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999874 335699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc--ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......+|..|+|||++.++.++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCC
Confidence 43322 12223467899999999887764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=248.92 Aligned_cols=174 Identities=37% Similarity=0.545 Sum_probs=143.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-----hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-----DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
..++|...+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999875 588999999864322 1235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++ +|..++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 88887753 335688999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccceeccccCCccccccccC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
............||+.|+|||++.++
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 187 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGA 187 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTC
T ss_pred ccCCcccCCcccccccccCchHhhCC
Confidence 65443333345789999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=252.24 Aligned_cols=182 Identities=27% Similarity=0.383 Sum_probs=151.2
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECC------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEc
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 218 (331)
+...++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4456789999999999999999998643 2479999997543 34557799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPS-----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~ 287 (331)
.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 999999999999999999886321 134689999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 288 SKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 288 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++.+||+|||++........ ......+++.|+|||++.++.++
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 244 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC
Confidence 999999999999965432221 12233568899999998877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-32 Score=251.53 Aligned_cols=171 Identities=27% Similarity=0.313 Sum_probs=136.7
Q ss_pred cCCccc-ceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHh-cCCCCcceeeeeeEEc----CCeEE
Q 020072 151 DSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLS-NIHHPNVVCLLGYSAH----DDTRF 223 (331)
Q Consensus 151 ~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~----~~~~~ 223 (331)
++|... ++||+|+||+||+|... +++.||||++.. ...+.+|++++. ..+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999875 588999999852 245678888874 4589999999999875 56789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccCc
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLA 300 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla 300 (331)
+||||+++|+|.+++... ....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999752 234699999999999999999999999 9999999999999998 789999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+....... ....+||+.|+|||++.++.|+
T Consensus 212 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 241 (400)
T 1nxk_A 212 KETTSHNS-LTTPCYTPYYVAPEVLGPEKYD 241 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSS
T ss_pred cccCCCCc-cccCCCCCCccCHhhcCCCCCC
Confidence 76543322 2345789999999999887764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=243.33 Aligned_cols=179 Identities=28% Similarity=0.382 Sum_probs=141.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788899999999999999986 46899999998643 334556789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|||+++|+|.+++... .....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999888531 1245689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..........|++.|+|||++.++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYN 214 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCC
T ss_pred CCCccccccCCCeeEeChHHhCCCCCC
Confidence 433333345689999999999877654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-32 Score=242.38 Aligned_cols=178 Identities=33% Similarity=0.433 Sum_probs=144.8
Q ss_pred HHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC-----chhHHHHHHHHHHHhcCC---CCcceeeeeeEEc
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIH---HPNVVCLLGYSAH 218 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~ 218 (331)
...++|+..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999986 468899999986432 122346677877777664 9999999999987
Q ss_pred CC-----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 219 DD-----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 219 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
.. ..++||||++ |+|.+++... ....+++.++..++.|++.||+|||++ +++||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 65 5799999997 6999998753 234499999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+|||+++....... .....||+.|+|||++.++.++
T Consensus 161 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 197 (308)
T 3g33_A 161 LADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQSTYA 197 (308)
T ss_dssp ECSCSCTTTSTTCCC-SGGGGCCCSSCCHHHHHTSCCC
T ss_pred EeeCccccccCCCcc-cCCccccccccCchHHcCCCCC
Confidence 999999976543322 2345789999999999887764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=248.45 Aligned_cols=175 Identities=23% Similarity=0.359 Sum_probs=143.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCce----EEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLH----VAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|...+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999864 3443 7888875332 334467889999999999999999999986 456899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999874 234689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc--ccceeccccCCccccccccCCCC
Q 020072 305 SQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......++..|+|||++.++.++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT 195 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCC
Confidence 3322 22334578899999999877764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=240.63 Aligned_cols=176 Identities=24% Similarity=0.341 Sum_probs=150.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|...+.||+|+||.||+|+..++..||+|.+..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888899999999999999998888999999975443 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999864 235689999999999999999999999 999999999999999999999999999865433211
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++.++.++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~ 183 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS 183 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC
T ss_pred ccccccccccccChhhhcCCCcc
Confidence 11123467889999999876653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-33 Score=251.92 Aligned_cols=184 Identities=27% Similarity=0.403 Sum_probs=153.0
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEE
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
+++...++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456678999999999999999999754 36789999997543 334567999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGP-------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
+.+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 999999999999999999988641 1124579999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||+++....... ......+++.|+|||++.++.++
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC
Confidence 999999999865433221 11223568899999999877654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=248.77 Aligned_cols=175 Identities=28% Similarity=0.406 Sum_probs=139.3
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
...++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999865 688999999964432 234567899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE-----CCCCcEEEEeccC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL-----DSKFNAKLSDFGL 299 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill-----~~~~~~kl~Dfgl 299 (331)
||||++ |+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 599888863 34599999999999999999999999 99999999999999 4556699999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
++.............||+.|+|||++.+..
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCC
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCC
Confidence 976544333333456899999999997743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=241.14 Aligned_cols=175 Identities=30% Similarity=0.472 Sum_probs=147.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567888999999999999999876 46789999985432 2234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998853 24589999999999999999999999 99999999999999999999999999985543
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... .....|++.|+|||.+.++.++
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~ 185 (279)
T 3fdn_A 161 SSR--RTDLCGTLDYLPPEMIEGRMHD 185 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCC
T ss_pred ccc--ccccCCCCCccCHhHhccCCCC
Confidence 322 2234689999999999876653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=241.80 Aligned_cols=177 Identities=25% Similarity=0.334 Sum_probs=138.8
Q ss_pred HhcCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
..++|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45678889999999999999998743 4579999986543 344567999999999999999999999985 46789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999864 234689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc-ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......+++.|+|||++.++.++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFT 195 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS
T ss_pred CcccccccccCCCcccccChhhcccCCCC
Confidence 43322 12233467899999999876653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-32 Score=247.60 Aligned_cols=179 Identities=25% Similarity=0.377 Sum_probs=144.6
Q ss_pred cHHHHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCc-----------hhHHHHHHHHHHHhcCCCCcce
Q 020072 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-----------DAGREFENEVDLLSNIHHPNVV 210 (331)
Q Consensus 142 ~~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv 210 (331)
...+++...++|...+.||+|+||.||+|...++..||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667888999999999999999999999988899999999854321 1236799999999999999999
Q ss_pred eeeeeEEc-----CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEE
Q 020072 211 CLLGYSAH-----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (331)
Q Consensus 211 ~l~g~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nil 285 (331)
++++++.. ....++||||++ |+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99999854 336899999998 688777763 345799999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 286 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
++.++.+||+|||++........ .....||+.|+|||++.+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTT
T ss_pred EcCCCCEEEEecCcccccccccc-cceecccceecCcHHhcC
Confidence 99999999999999965433322 223468999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=238.74 Aligned_cols=175 Identities=31% Similarity=0.470 Sum_probs=138.1
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCc----hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ----DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888999999999999999975 78999999864322 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC--------CCcEEEEec
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--------KFNAKLSDF 297 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~--------~~~~kl~Df 297 (331)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++...+++||||||+|||+++ ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999998852 46899999999999999999999982122999999999999986 778999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++......... ...|++.|+|||.+.++.++
T Consensus 161 g~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~ 192 (271)
T 3dtc_A 161 GLAREWHRTTKM--SAAGAYAWMAPEVIRASMFS 192 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCS
T ss_pred Cccccccccccc--CCCCccceeCHHHhccCCCC
Confidence 999765433222 34689999999999877654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=251.69 Aligned_cols=174 Identities=24% Similarity=0.359 Sum_probs=149.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC--eEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457888999999999999999876 48999999997543 334567889999999999999999999998765 78999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE----CCCCcEEEEeccCce
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAI 301 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgla~ 301 (331)
|||+++|+|.+++........+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997644444599999999999999999999999 99999999999999 788889999999997
Q ss_pred eCCCCCcccceeccccCCcccccccc
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
........ ....||+.|+|||++.+
T Consensus 165 ~~~~~~~~-~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDEQF-VSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGGGS-SCSSSCCTTCCHHHHHH
T ss_pred EccCCCcc-ccccCCccccCHHHhhc
Confidence 76543322 23469999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=243.05 Aligned_cols=175 Identities=26% Similarity=0.381 Sum_probs=149.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
..++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457888999999999999999875 688999999976555455678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~~ 304 (331)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999988853 24689999999999999999999999 99999999999999 788999999999986544
Q ss_pred CCCcccceeccccCCccccccccCCCC
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... .....|++.|+|||++.++.++
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~ 185 (304)
T 2jam_A 161 NGI--MSTACGTPGYVAPEVLAQKPYS 185 (304)
T ss_dssp CBT--THHHHSCCCBCCTTTBSSCSCC
T ss_pred CCc--cccccCCCCccChHHhccCCCC
Confidence 322 2234689999999999887664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=236.22 Aligned_cols=175 Identities=30% Similarity=0.395 Sum_probs=151.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999876 68899999986443 3455789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999853 34689999999999999999999999 99999999999999999999999999996543221
Q ss_pred --cccceeccccCCccccccccCCC
Q 020072 308 --KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 --~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......|++.|+|||.+.++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred chhcccCCccccCccChHHHhcCCC
Confidence 11223468999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=240.50 Aligned_cols=174 Identities=29% Similarity=0.485 Sum_probs=148.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc---------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--------- 218 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------- 218 (331)
..++|...+.||+|+||.||+|+.. +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567889999999999999999986 78999999986443 356789999999999999999998864
Q ss_pred -------CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc
Q 020072 219 -------DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (331)
Q Consensus 219 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 291 (331)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 34589999999999999998642 235699999999999999999999999 9999999999999999999
Q ss_pred EEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+||+|||++......... ....|++.|+|||++.++.++
T Consensus 161 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 199 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYG 199 (284)
T ss_dssp EEECCCTTCEESSCCSCC-CCCCSCCTTSCHHHHHCSCCC
T ss_pred EEECcchhheeccccccc-cccCCcccccChhhhccCCCc
Confidence 999999999776543322 234689999999999877653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-32 Score=238.23 Aligned_cols=175 Identities=29% Similarity=0.366 Sum_probs=148.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888999999999999999886 689999999864322 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 298 (331)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+||++++++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999853 34689999999999999999999999 999999999999999877 89999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++........ .....|++.|+|||++.++.++
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 189 (283)
T 3bhy_A 158 IAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLG 189 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCC
T ss_pred cceeccCCCc-ccccCCCcCccCcceecCCCCC
Confidence 9976543322 2234689999999999877653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=246.42 Aligned_cols=173 Identities=28% Similarity=0.415 Sum_probs=144.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457888999999999999999876 488999999854432 33566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887653 34599999999999999999999999 9999999999999999999999999999765443
Q ss_pred CcccceeccccCCccccccccC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
........|+..|+|||++.++
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp ------CCCCCTTCCHHHHTTC
T ss_pred ccccCCCcCCccccCcccccCC
Confidence 3333345689999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=239.73 Aligned_cols=177 Identities=29% Similarity=0.439 Sum_probs=149.3
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
...++|...+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3456788899999999999999999888899999986543 245679999999999999999999999874 56899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999998531 123689999999999999999999999 99999999999999999999999999997654332
Q ss_pred cc-cceeccccCCccccccccCCC
Q 020072 308 KN-NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~-~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.. .....++..|+|||.+.++.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~ 187 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTF 187 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEE
T ss_pred cccccCCCCccCccChhhhccCCC
Confidence 21 122346788999999876654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=238.89 Aligned_cols=173 Identities=27% Similarity=0.329 Sum_probs=148.0
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567889999999999999999876 6899999998653 334557788999999999 99999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC--------------
Q 020072 225 VYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-------------- 289 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-------------- 289 (331)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999986421 125689999999999999999999999 99999999999999844
Q ss_pred -----CcEEEEeccCceeCCCCCcccceeccccCCccccccccC
Q 020072 290 -----FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 290 -----~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..+||+|||++........ ..||+.|+|||++.++
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV----EEGDSRFLANEVLQEN 205 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC----CCCCGGGCCHHHHTTC
T ss_pred ccCCceEEEEcccccccccCCccc----cCCCccccChhHhcCC
Confidence 4799999999977654332 3589999999999765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=242.17 Aligned_cols=178 Identities=31% Similarity=0.399 Sum_probs=148.1
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
+...++|...+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345678999999999999999999876 58899999986432 346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998852 235689999999999999999999999 999999999999999999999999999976654
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........|++.|+|||.+.++.++
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYN 203 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred hccccCccCCCCCccChhhcCCCCCC
Confidence 43333345689999999999877653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-33 Score=266.36 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=149.2
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..++|...+.||+|+||.||+|+++++..||||++..... ..++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3456677889999999999999998888899999975443 34679999999999999999999999876 678999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999631 234589999999999999999999999 999999999999999999999999999976543211
Q ss_pred -ccceeccccCCccccccccCCCC
Q 020072 309 -NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 -~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......++..|+|||++.++.++
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~ 442 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFT 442 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCC
T ss_pred ecccCCcCcccccCHHHhccCCCC
Confidence 11123467889999999887764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=250.03 Aligned_cols=177 Identities=23% Similarity=0.340 Sum_probs=143.3
Q ss_pred HhcCCcccceeeecCceEEEEEEECC------CceEEEEEecccCchh-----------HHHHHHHHHHHhcCCCCccee
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCATQDA-----------GREFENEVDLLSNIHHPNVVC 211 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~H~niv~ 211 (331)
..++|...+.||+|+||.||+|.+.+ ++.||+|.+....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45688899999999999999998764 4789999986543221 122445667788899999999
Q ss_pred eeeeEEcC----CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC
Q 020072 212 LLGYSAHD----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (331)
Q Consensus 212 l~g~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~ 287 (331)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998765 4589999999 9999999864 345799999999999999999999999 999999999999999
Q ss_pred --CCCcEEEEeccCceeCCCCCc-------ccceeccccCCccccccccCCCC
Q 020072 288 --SKFNAKLSDFGLAITDGSQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 288 --~~~~~kl~Dfgla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.++.+||+|||+++....... ......||+.|+|||++.+..++
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 239 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS 239 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC
Confidence 889999999999976532211 11234599999999999887664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=249.71 Aligned_cols=175 Identities=28% Similarity=0.403 Sum_probs=138.5
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCC--e
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDD--T 221 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~ 221 (331)
...++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999864 6899999998543 3345567889999999997 999999999997554 7
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||++ |+|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 688888853 3689999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCC---------------------CcccceeccccCCcccccccc-CCC
Q 020072 302 TDGSQ---------------------NKNNLKLSGTLGYVAPEYLLD-GMV 330 (331)
Q Consensus 302 ~~~~~---------------------~~~~~~~~gt~~y~aPE~l~~-~~~ 330 (331)
..... .......+||+.|+|||++.+ ..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence 64321 111223479999999999976 444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=251.15 Aligned_cols=175 Identities=29% Similarity=0.468 Sum_probs=137.6
Q ss_pred CCcccceeeecCceEEEEEEEC--CC--ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD--DN--LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv 225 (331)
.|...+.||+|+||.||+|++. ++ ..||+|.+... .....+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999863 22 46899998643 34556789999999999999999999999765 4578999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ....+++.+++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999974 345689999999999999999999999 999999999999999999999999999975433
Q ss_pred CCc----ccceeccccCCccccccccCCCC
Q 020072 306 QNK----NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~----~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......+++.|+|||++.++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 274 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFT 274 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCC
Confidence 221 11223567889999999887764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=246.22 Aligned_cols=172 Identities=26% Similarity=0.387 Sum_probs=149.7
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCch-----------------hHHHHHHHHHHHhcCCCCcceee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-----------------AGREFENEVDLLSNIHHPNVVCL 212 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~H~niv~l 212 (331)
.++|...+.||+|+||.||+|+. +++.||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999998 8999999998643211 11789999999999999999999
Q ss_pred eeeEEcCCeEEEEEEecCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEE
Q 020072 213 LGYSAHDDTRFIVYELMENRSLDIQ------LHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNIL 285 (331)
Q Consensus 213 ~g~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nil 285 (331)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ + +++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999988 542 225679999999999999999999999 8 9999999999999
Q ss_pred ECCCCcEEEEeccCceeCCCCCcccceeccccCCccccccccC
Q 020072 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 286 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
++.++.+||+|||++...... ......|+..|+|||++.++
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSC
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCC
Confidence 999999999999999765433 22234689999999999876
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=238.89 Aligned_cols=174 Identities=27% Similarity=0.466 Sum_probs=150.5
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999876 57789999985432 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999998863 24589999999999999999999999 999999999999999999999999999866543
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ....|++.|+|||++.++.++
T Consensus 167 ~~~--~~~~~~~~y~aPE~~~~~~~~ 190 (284)
T 2vgo_A 167 LRR--RTMCGTLDYLPPEMIEGKTHD 190 (284)
T ss_dssp SCB--CCCCSCGGGCCHHHHTTCCBC
T ss_pred ccc--ccccCCCCcCCHHHhccCCCC
Confidence 222 234689999999999877653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=242.08 Aligned_cols=177 Identities=24% Similarity=0.335 Sum_probs=143.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 68899999986542 2334779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999863 24689999999999999999999999 99999999999999999999999999986554
Q ss_pred CCC-cccceeccccCCccccccccCCCC
Q 020072 305 SQN-KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~-~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... .......|++.|+|||++.++.++
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 213 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHAT 213 (309)
T ss_dssp -----------CCGGGCCGGGTCC----
T ss_pred ccccccccccCCCcCccCHHHHcCCCCC
Confidence 322 122234689999999999876553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=237.67 Aligned_cols=167 Identities=34% Similarity=0.562 Sum_probs=142.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchh-------HHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA-------GREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999874 68899999985432211 267899999999999999999999987665
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--eEecCCCCCCEEECCCCc-----EEE
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFN-----AKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~-----~kl 294 (331)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ + ++||||||+|||++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 699999999999988864 345799999999999999999999998 7 999999999999988776 999
Q ss_pred EeccCceeCCCCCcccceeccccCCccccccc
Q 020072 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 295 ~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
+|||+++..... .....||+.|+|||++.
T Consensus 171 ~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 171 ADFGLSQQSVHS---VSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CCCTTCBCCSSC---EECCCCCCTTSCGGGSS
T ss_pred CCCCcccccccc---ccccCCCccccCchhhc
Confidence 999999754332 22346899999999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=241.52 Aligned_cols=179 Identities=28% Similarity=0.399 Sum_probs=148.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEE--cCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSA--HDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~~~l 224 (331)
.++|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999875 6889999998644 3345567999999999999999999999875 4568999
Q ss_pred EEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc-----eEecCCCCCCEEECCCCcEEEEecc
Q 020072 225 VYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPA-----VIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
||||+++++|.+++... .....+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999988642 1234599999999999999999999998 7 9999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++..............|++.|+|||.+.++.++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 194 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCC
Confidence 987654433322334689999999999877654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=251.11 Aligned_cols=173 Identities=27% Similarity=0.377 Sum_probs=148.9
Q ss_pred hcCCcccceeeecCceEEEEEEE----CCCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCC
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 220 (331)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999987 468999999986432 23445678899999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999864 24689999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCC-cccceeccccCCccccccccC
Q 020072 301 ITDGSQN-KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 301 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+...... .......||+.|+|||++.++
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGG 235 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCC
Confidence 7654322 222345799999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=244.75 Aligned_cols=177 Identities=27% Similarity=0.409 Sum_probs=143.4
Q ss_pred hcCCcccceeeecCceEEEEEEECC-----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|...+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999997642 2459999997543 334567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999864 335699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc---ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......++..|+|||++.++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCC
Confidence 43221 11122457789999999877654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=240.67 Aligned_cols=171 Identities=27% Similarity=0.355 Sum_probs=145.2
Q ss_pred CcccceeeecCceEEEEEEEC-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC--CeEEE
Q 020072 153 FHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFI 224 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 224 (331)
|+..+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999998653 67899999997543 34467799999999999999999999999874 57899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999864 2489999999999999999999999 99999999999999999999999999997765
Q ss_pred CCCc---ccceeccccCCccccccccCCC
Q 020072 305 SQNK---NNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 305 ~~~~---~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.... ......++..|+|||++.+..+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 214 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKF 214 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEE
T ss_pred ccccccccccCCCCCceeeChHHhcCCCC
Confidence 4322 1223457888999999877654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.32 Aligned_cols=177 Identities=30% Similarity=0.470 Sum_probs=145.5
Q ss_pred hcCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~ 223 (331)
..+|...+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467788999999999999998642 2358999987543 3455789999999999999999999998654 55789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999974 345689999999999999999999999 9999999999999999999999999999755
Q ss_pred CCCCc----ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK----NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~----~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......+|+.|+|||.+.++.++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCC
Confidence 43221 12233577899999999877654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=244.94 Aligned_cols=173 Identities=27% Similarity=0.444 Sum_probs=144.2
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
..++|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568889999999999999999986 588999999976666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999988763 234689999999999999999999999 99999999999999999999999999874322111
Q ss_pred cccceeccccCCccccccc
Q 020072 308 KNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~ 326 (331)
.......|+..|+|||++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HC-----CCGGGCCHHHHH
T ss_pred cccccccCChhhcCCeeec
Confidence 1122346899999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=242.19 Aligned_cols=182 Identities=24% Similarity=0.302 Sum_probs=150.6
Q ss_pred HHHHHhcCCccc-ceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcC
Q 020072 145 LLEKATDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (331)
Q Consensus 145 ~l~~~~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 219 (331)
..+...+.|... +.||+|+||.||+|... +++.||+|.+... .......+.+|+.++.++ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345556677776 89999999999999876 5899999998643 233457899999999999 469999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEe
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSD 296 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 296 (331)
+..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||++ +++||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999998864 2345799999999999999999999999 9999999999999998 78999999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+++....... .....||+.|+|||++.++.++
T Consensus 178 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 211 (327)
T 3lm5_A 178 FGMSRKIGHACE-LREIMGTPEYLAPEILNYDPIT 211 (327)
T ss_dssp GGGCEEC----------CCCGGGCCHHHHTTCCCC
T ss_pred CccccccCCccc-cccccCCcCccCCeeecCCCCC
Confidence 999977654322 2234699999999999887664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=264.17 Aligned_cols=168 Identities=26% Similarity=0.415 Sum_probs=140.0
Q ss_pred eeeecCceEEEEEEEC---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCCCC
Q 020072 158 ILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 158 ~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 45679999997543 3456789999999999999999999999986 56899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc---cc
Q 020072 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK---NN 310 (331)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~---~~ 310 (331)
|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999964 345699999999999999999999999 999999999999999999999999999976543221 11
Q ss_pred ceeccccCCccccccccCCCC
Q 020072 311 LKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 311 ~~~~gt~~y~aPE~l~~~~~t 331 (331)
....+++.|+|||++.++.++
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~ 517 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFS 517 (613)
T ss_dssp -----CCTTSCHHHHHHCCCC
T ss_pred cCCCCccceeCHhhhcCCCCC
Confidence 122356899999999887764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=244.07 Aligned_cols=176 Identities=27% Similarity=0.406 Sum_probs=149.6
Q ss_pred hcCCcccceeeecCceEEEEEEE-----CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC--eE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~ 222 (331)
.++|+..+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368899999998776677788999999999999999999999987654 78
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999874 234689999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCCcc---cceeccccCCccccccccCCC
Q 020072 303 DGSQNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
....... .....++..|+|||.+.++.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 225 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKF 225 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEE
T ss_pred ccccccccccccCCCCceeEECchhhcCCCC
Confidence 6443221 112346778999999876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=239.33 Aligned_cols=174 Identities=28% Similarity=0.410 Sum_probs=144.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457888999999999999999875 58899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeC
Q 020072 228 LMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITD 303 (331)
Q Consensus 228 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~ 303 (331)
|+++|+|.+++... .....+++..++.++.|+++||+|||++ +++||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999887532 1235699999999999999999999999 99999999999999 45688999999999654
Q ss_pred CCCCcccceeccccCCcccccccc
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
..... .....|++.|+|||++.+
T Consensus 178 ~~~~~-~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 178 KSDEH-STNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ----------CTTGGGCCHHHHTT
T ss_pred CCccc-CcCcccccCcCChHHhcc
Confidence 43322 224468999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=241.76 Aligned_cols=179 Identities=27% Similarity=0.374 Sum_probs=153.6
Q ss_pred HHhcCCcccceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
...++|...+.||+|+||.||+|.... +..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 356778889999999999999998764 788999998743 335578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998652 335699999999999999999999999 9999999999999999999999999999765433
Q ss_pred Cc-ccceeccccCCccccccccCCCC
Q 020072 307 NK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ......+++.|+|||.+.++.++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFS 190 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred ccccccCCccccCcCChhhhccCCCC
Confidence 32 22234567899999999877654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=236.96 Aligned_cols=174 Identities=19% Similarity=0.260 Sum_probs=149.0
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+|+. .+++.||+|.+... ...+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999986 57899999998533 2335688999999999 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc-----EEEEeccCcee
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-----AKLSDFGLAIT 302 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfgla~~ 302 (331)
|+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999974 234699999999999999999999999 9999999999999988776 99999999976
Q ss_pred CCCCCc-------ccceeccccCCccccccccCCCC
Q 020072 303 DGSQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... ......||+.|+|||++.++.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 196 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCC
Confidence 543321 12345699999999999887664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=237.15 Aligned_cols=174 Identities=26% Similarity=0.418 Sum_probs=145.9
Q ss_pred cCCcccc-eeeecCceEEEEEEEC---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESN-ILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|...+ .||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 57789999997643 34567899999999999999999999999 45678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999863 345699999999999999999999999 999999999999999999999999999976643
Q ss_pred CCcc---cceeccccCCccccccccCCC
Q 020072 306 QNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.... .....+|+.|+|||++.++.+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKF 190 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred CcceeeccccccccccccCHHHhccCCC
Confidence 3221 112346789999999876654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=237.97 Aligned_cols=175 Identities=27% Similarity=0.409 Sum_probs=145.8
Q ss_pred CCcccceeeecCceEEEEEEEC-CC---ceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE-EEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DN---LHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR-FIV 225 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~-~lv 225 (331)
.|...+.||+|+||.||+|+.. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455689999999999999753 22 3699999875433 4557899999999999999999999999876655 999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
+||+.+|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999974 345789999999999999999999999 999999999999999999999999999965433
Q ss_pred CC----cccceeccccCCccccccccCCCC
Q 020072 306 QN----KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~----~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .......+++.|+|||.+.+..++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 206 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFT 206 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCC
Confidence 21 112234578899999999887664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=243.09 Aligned_cols=172 Identities=26% Similarity=0.371 Sum_probs=143.0
Q ss_pred hcCCcc-cceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHE-SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~-~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.+.|.. .+.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 456766 478999999999999864 6889999999766656677899999999985 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEeccCceeC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITD 303 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla~~~ 303 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999864 24689999999999999999999999 9999999999999998776 999999998654
Q ss_pred CCCC-------cccceeccccCCcccccccc
Q 020072 304 GSQN-------KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~~~-------~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... .......||+.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp -----------------CCSGGGCCHHHHHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhc
Confidence 3211 11123458999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=246.63 Aligned_cols=170 Identities=22% Similarity=0.345 Sum_probs=142.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCC--CcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998644 33445779999999999986 9999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|| +.+++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 567899999864 35689999999999999999999999 999999999999997 67899999999976543
Q ss_pred CCc--ccceeccccCCcccccccc
Q 020072 306 QNK--NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~~~--~~~~~~gt~~y~aPE~l~~ 327 (331)
... ......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ----------CCCCSSCCHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhh
Confidence 322 1224579999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=253.89 Aligned_cols=171 Identities=20% Similarity=0.284 Sum_probs=139.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEeccc---CchhHHHHHHHH---HHHhcCCCCcceeee-------ee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEV---DLLSNIHHPNVVCLL-------GY 215 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~H~niv~l~-------g~ 215 (331)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 46899999998632 344567899999 556666899999998 66
Q ss_pred EEcCC-----------------eEEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCce
Q 020072 216 SAHDD-----------------TRFIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (331)
Q Consensus 216 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 274 (331)
+.+.+ ..|+||||+ +|+|.+++.... ....+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 279999999 589999886421 112345688899999999999999999 99
Q ss_pred EecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCccccccccC
Q 020072 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 275 vHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++.++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhccc
Confidence 99999999999999999999999999864432 223467 999999999765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=235.71 Aligned_cols=174 Identities=26% Similarity=0.369 Sum_probs=143.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... .+..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999886 68999999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999853 24589999999999999999999999 999999999999999999999999999866543
Q ss_pred CCcccceeccccCCccccccccCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
... .....+++.|+|||.+.+..+
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~~~~ 187 (276)
T 2h6d_A 164 GEF-LRTSCGSPNYAAPEVISGRLY 187 (276)
T ss_dssp --------------CCTGGGTTSCC
T ss_pred Ccc-eecccCCccccCHHHHcCCCC
Confidence 322 223468999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=243.62 Aligned_cols=186 Identities=30% Similarity=0.396 Sum_probs=153.6
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCcceeeee
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQ-DAGREFENEVDLLSNI-HHPNVVCLLG 214 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g 214 (331)
...++...++|...+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344555678899999999999999999974 3568899999975433 3456799999999999 7999999999
Q ss_pred eEEcCC-eEEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCC
Q 020072 215 YSAHDD-TRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (331)
Q Consensus 215 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk 280 (331)
++...+ ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +++|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 988755 58999999999999999975322 12389999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 281 SSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 281 ~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+||+++.++.+||+|||+++....... ......+|+.|+|||++.++.++
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence 9999999999999999999976543222 22234578899999999877654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=241.04 Aligned_cols=176 Identities=26% Similarity=0.388 Sum_probs=143.2
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC--CCCcceeeeeeEEcC----C
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI--HHPNVVCLLGYSAHD----D 220 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~g~~~~~----~ 220 (331)
....++|+..+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++.+. +
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 445678999999999999999999986 889999998533 233445566665554 899999999999887 7
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCceEecCCCCCCEEECCCCcEEEE
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-----NPAVIHRDLKSSNILLDSKFNAKLS 295 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivHrdlk~~Nill~~~~~~kl~ 295 (331)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ .++++||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999963 35899999999999999999999752 3489999999999999999999999
Q ss_pred eccCceeCCCCCcc----cceeccccCCccccccccCCC
Q 020072 296 DFGLAITDGSQNKN----NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 296 Dfgla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~ 330 (331)
|||+++........ .....||+.|+|||++.++.+
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 223 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCC
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccC
Confidence 99999765433221 113468999999999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=238.69 Aligned_cols=174 Identities=32% Similarity=0.410 Sum_probs=142.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc---------
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--------- 218 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--------- 218 (331)
..++|+..+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467888999999999999999875 6899999998642 3455778999999999999999999998865
Q ss_pred ----CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEE
Q 020072 219 ----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (331)
Q Consensus 219 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl 294 (331)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3568999999999999999974 334678899999999999999999999 9999999999999999999999
Q ss_pred EeccCceeCCCC--------------CcccceeccccCCccccccccC
Q 020072 295 SDFGLAITDGSQ--------------NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 295 ~Dfgla~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+|||++...... ........|++.|+|||++.+.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 999998654321 1112234689999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=238.36 Aligned_cols=171 Identities=36% Similarity=0.556 Sum_probs=136.0
Q ss_pred HHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
...++|...+.||+|+||.||+|+..+ .||+|++.... ....+.+.+|++++++++|+||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345788999999999999999998643 59999986543 34457799999999999999999999965 45678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999864 345699999999999999999999999 999999999999999999999999999865432
Q ss_pred C--CcccceeccccCCccccccc
Q 020072 306 Q--NKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 306 ~--~~~~~~~~gt~~y~aPE~l~ 326 (331)
. ........||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -----------CCCTTCCHHHHC
T ss_pred ccccccccccCCCccccCchhhc
Confidence 1 11222346899999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=248.97 Aligned_cols=175 Identities=29% Similarity=0.401 Sum_probs=149.5
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999876 6889999998754 33445779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.. +++||||||+|||++.++.+||+|||++.......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999864 245899999999999999999999831 79999999999999999999999999985432211
Q ss_pred cccceeccccCCccccccccCCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....||+.|+|||++.++.++
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~ 208 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYS 208 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCS
T ss_pred --ccCCCCCCCeECHHHHcCCCCC
Confidence 1234689999999999887664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=241.07 Aligned_cols=176 Identities=27% Similarity=0.373 Sum_probs=147.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEE----cCCeEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA----HDDTRFI 224 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----~~~~~~l 224 (331)
.++|...+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788999999999999999987 578999999997666667788999999999999999999999987 3347899
Q ss_pred EEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 225 VYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
||||+++|+|.+++... .....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999888641 2346799999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcc---------cceeccccCCccccccccC
Q 020072 304 GSQNKN---------NLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~~~---------~~~~~gt~~y~aPE~l~~~ 328 (331)
...... .....||+.|+|||++.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC
T ss_pred ccccccccccccccccccccCCcccCCHhHhccC
Confidence 321110 1123468999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=245.29 Aligned_cols=178 Identities=26% Similarity=0.430 Sum_probs=152.6
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc--------hhHHHHHHHHHHHhcC-CCCcceee
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------DAGREFENEVDLLSNI-HHPNVVCL 212 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l 212 (331)
........++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556678999999999999999999985 689999999864431 1245688999999999 79999999
Q ss_pred eeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 213 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999863 34699999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
||+|||++........ .....||+.|+|||++.+
T Consensus 240 kl~DfG~~~~~~~~~~-~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKC 273 (365)
T ss_dssp EECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHH
T ss_pred EEEecCcccccCCCcc-cccCCCCCCccChhhccc
Confidence 9999999976654332 224579999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=255.25 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=143.6
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|...+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457888999999999999999876 67899999986542 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla~~ 302 (331)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988853 24689999999999999999999999 9999999999999976 45599999999976
Q ss_pred CCCCCcccceeccccCCcccccccc
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
...... .....||+.|+|||++.+
T Consensus 189 ~~~~~~-~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 189 FENQKK-MKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp CBTTBC-BCCCCSCTTTCCHHHHTT
T ss_pred CCCCcc-ccccCCCcCeeCHHHHcc
Confidence 554322 234579999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=253.71 Aligned_cols=172 Identities=30% Similarity=0.421 Sum_probs=146.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc-------------hhHHHHHHHHHHHhcCCCCcceeeee
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-------------DAGREFENEVDLLSNIHHPNVVCLLG 214 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~g 214 (331)
..++|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 578999999864321 23567899999999999999999999
Q ss_pred eEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC---c
Q 020072 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---N 291 (331)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~ 291 (331)
++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988853 34699999999999999999999999 999999999999999876 6
Q ss_pred EEEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+||+|||++........ .....||+.|+|||++.+
T Consensus 188 ~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp EEECCCTTCEECCTTSC-BCCCCSCTTTCCHHHHTT
T ss_pred EEEEECCCCEEcCCCCc-cccccCCcCCCCHHHhcc
Confidence 99999999977654332 234579999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=255.67 Aligned_cols=172 Identities=27% Similarity=0.420 Sum_probs=149.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457888999999999999999876 68999999985432 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCce
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAI 301 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~ 301 (331)
||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998864 34699999999999999999999999 99999999999999 567899999999997
Q ss_pred eCCCCCcccceeccccCCcccccccc
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
....... .....||+.|+|||++.+
T Consensus 178 ~~~~~~~-~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 178 HFEASKK-MKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp HBCCCCS-HHHHTTGGGTCCHHHHHT
T ss_pred Ecccccc-cccCCCCccccCceeecC
Confidence 6544332 223469999999999865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=246.49 Aligned_cols=170 Identities=28% Similarity=0.394 Sum_probs=140.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999874 6899999998543 2334567899999999999999999999998663
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..|+||||+ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899988863 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCcccccccc-CCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GMV 330 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~ 330 (331)
+...... ....+|..|+|||++.+ ..+
T Consensus 176 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~ 203 (367)
T 1cm8_A 176 RQADSEM---TGYVVTRWYRAPEVILNWMRY 203 (367)
T ss_dssp EECCSSC---CSSCSCGGGCCTHHHHTTTCC
T ss_pred ccccccc---CcCcCCCCcCCHHHHhCCCCC
Confidence 8754332 23468999999999876 444
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.82 Aligned_cols=173 Identities=27% Similarity=0.389 Sum_probs=143.7
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEc--------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH-------- 218 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-------- 218 (331)
.++|...+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788899999999999999987 468999999985443 2334578899999999999999999999887
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
.+..++||||+++ +|.+.+.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999985 67666653 334699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCC----cccceeccccCCccccccccC
Q 020072 299 LAITDGSQN----KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~----~~~~~~~gt~~y~aPE~l~~~ 328 (331)
+++...... .......||+.|+|||++.+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCC
Confidence 997654221 122234689999999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=254.76 Aligned_cols=172 Identities=31% Similarity=0.454 Sum_probs=146.9
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|...+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567889999999999999999875 6889999998533 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC---CCCcEEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgla~~ 302 (331)
|||+++|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988853 24699999999999999999999999 999999999999995 466799999999965
Q ss_pred CCCCCcccceeccccCCcccccccc
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
...... .....||+.|+|||++.+
T Consensus 174 ~~~~~~-~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 174 FQQNTK-MKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp BCCC-----CCTTGGGGCCGGGGGS
T ss_pred CCCCCc-cCCCcCCCCCCCHHHhCC
Confidence 543322 223469999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.24 Aligned_cols=176 Identities=27% Similarity=0.446 Sum_probs=140.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCce----EEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLH----VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|+..+.||+|+||.||+|+.. +++. ||+|.+... .....+++.+|+.++++++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999864 4443 577777533 3445678999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+++||+.+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999864 235699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc--ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......+|+.|+|||++.++.++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCC
Confidence 43222 12223467789999999887664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.81 Aligned_cols=169 Identities=22% Similarity=0.343 Sum_probs=143.0
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCC--CCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH--HPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|...+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ |+||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998644 3345678999999999996 599999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
| +.+++|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 567899999864 24689999999999999999999999 999999999999995 579999999999765432
Q ss_pred Cc--ccceeccccCCcccccccc
Q 020072 307 NK--NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~~--~~~~~~gt~~y~aPE~l~~ 327 (331)
.. ......||+.|+|||++.+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhh
Confidence 21 1223469999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=239.52 Aligned_cols=181 Identities=28% Similarity=0.407 Sum_probs=140.5
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC----CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC-
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD- 220 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~- 220 (331)
...++|...+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999764 3458999998644 3344577999999999999999999999998765
Q ss_pred ----eEEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEE
Q 020072 221 ----TRFIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (331)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 293 (331)
..++||||+++|+|.+++... .....+++..++.++.|+++||.|||++ +++||||||+||++++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 359999999999999988421 2345699999999999999999999999 999999999999999999999
Q ss_pred EEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 294 LSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 294 l~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+|||++........ ......+++.|+|||.+.++.++
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 227 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCcc
Confidence 999999965433221 12233568899999999877654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=245.51 Aligned_cols=174 Identities=22% Similarity=0.343 Sum_probs=140.1
Q ss_pred HHHhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 219 (331)
+...++|...+.||+|+||.||+|+. .+|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45677899999999999999999986 4789999999864322 234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 020072 220 --------------------------------DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYL 266 (331)
Q Consensus 220 --------------------------------~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yL 266 (331)
...++||||++ |+|.+.+.. ......+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 577666542 12345799999999999999999999
Q ss_pred hhCCCCceEecCCCCCCEEEC-CCCcEEEEeccCceeCCCCCcccceeccccCCccccccccCC
Q 020072 267 HEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 267 H~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
|++ +|+||||||+|||++ +++.+||+|||+++........ ....+|..|+|||++.+..
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGAT 217 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-CCCCCCSSCCCHHHHTTCS
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-cCcccCCCccCHHHhcCCC
Confidence 999 999999999999998 6899999999999765443322 2346899999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=242.64 Aligned_cols=173 Identities=28% Similarity=0.390 Sum_probs=133.3
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEE--------c
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSA--------H 218 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~--------~ 218 (331)
...+|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457888999999999999999875 68899999997666666778999999999996 999999999984 3
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--eEecCCCCCCEEECCCCcEEEEe
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~kl~D 296 (331)
....+++|||++ |+|.+++........+++.+++.++.|++.||+|||++ + ++||||||+|||+++++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 345899999996 78888876433445699999999999999999999998 7 99999999999999999999999
Q ss_pred ccCceeCCCCCcc------------cceeccccCCcccccc
Q 020072 297 FGLAITDGSQNKN------------NLKLSGTLGYVAPEYL 325 (331)
Q Consensus 297 fgla~~~~~~~~~------------~~~~~gt~~y~aPE~l 325 (331)
||++......... .....||+.|+|||++
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CTTCBCCSSCC------------------------------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999765432211 1134589999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.01 Aligned_cols=176 Identities=31% Similarity=0.516 Sum_probs=144.2
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCce--EEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLH--VAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 225 (331)
++|...+.||+|+||.||+|+.. ++.. ||+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999864 4554 489988643 334556799999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
|||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987532 234699999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+|||+++....... .....+++.|+|||++.++.+
T Consensus 182 kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 218 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVY 218 (327)
T ss_dssp EECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEE
T ss_pred EEcccCcCcccccccc-ccCCCCCccccChhhhccccC
Confidence 9999999864332211 122356889999999876654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=240.10 Aligned_cols=175 Identities=29% Similarity=0.464 Sum_probs=144.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc------
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH------ 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~------ 218 (331)
....++|...+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 345678999999999999999999874 68899999986443 3456789999999999 89999999999987
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46889999999999999998642 235689999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCccccccc
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
++..............|++.|+|||++.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC
T ss_pred CceecCcCccccccccCCccccChhhhc
Confidence 9876543333333456899999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=233.54 Aligned_cols=168 Identities=27% Similarity=0.408 Sum_probs=142.9
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~l 224 (331)
.|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999875 5788999998643 34456779999999999999999999999875 356899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCc--eEecCCCCCCEEEC-CCCcEEEEeccCce
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLD-SKFNAKLSDFGLAI 301 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~Dfgla~ 301 (331)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ + ++||||||+|||++ +++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999863 24689999999999999999999998 7 99999999999998 78999999999996
Q ss_pred eCCCCCcccceeccccCCcccccccc
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
....... ....|++.|+|||++.+
T Consensus 181 ~~~~~~~--~~~~~t~~y~aPE~~~~ 204 (290)
T 1t4h_A 181 LKRASFA--KAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp GCCTTSB--EESCSSCCCCCGGGGGT
T ss_pred ccccccc--ccccCCcCcCCHHHHhc
Confidence 5443322 23468999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=242.80 Aligned_cols=172 Identities=30% Similarity=0.366 Sum_probs=138.2
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467889999999999999999865 6889999998643 3344567899999999999999999999998665
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++||||++ |+|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999998 47777775 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+....... .....||+.|+|||++.++.++
T Consensus 175 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 204 (371)
T 2xrw_A 175 RTAGTSFM-MTPYVVTRYYRAPEVILGMGYK 204 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCC
T ss_pred cccccccc-cCCceecCCccCHHHhcCCCCC
Confidence 76543322 2234789999999999887664
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=234.22 Aligned_cols=172 Identities=30% Similarity=0.406 Sum_probs=148.7
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---------chhHHHHHHHHHHHhcCC-CCcceeeeeeE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---------QDAGREFENEVDLLSNIH-HPNVVCLLGYS 216 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-H~niv~l~g~~ 216 (331)
...++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999875 67899999986442 123456889999999995 99999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999863 34689999999999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccc
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
||++........ .....+++.|+|||++.
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 168 FGFSCQLDPGEK-LREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CTTCEECCTTCC-BCCCCSCGGGCCHHHHH
T ss_pred ccchhhcCCCcc-cccccCCccccCHHHhc
Confidence 999976544322 22346899999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=238.58 Aligned_cols=170 Identities=32% Similarity=0.451 Sum_probs=141.8
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--------chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 219 (331)
..++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567899999999999999999875 57899999986432 12334688999999999999999999998766
Q ss_pred CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEe
Q 020072 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSD 296 (331)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~D 296 (331)
+ .++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999998853 35699999999999999999999999 9999999999999987664 99999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccc
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
||++........ .....||+.|+|||++.
T Consensus 161 fg~~~~~~~~~~-~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 161 FGHSKILGETSL-MRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CTTCEECCCCHH-HHHHHSCCTTCCHHHHH
T ss_pred Cccceecccccc-cccccCCcCccCchhhc
Confidence 999977654322 22346899999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.40 Aligned_cols=168 Identities=26% Similarity=0.377 Sum_probs=139.0
Q ss_pred ceeeecCceEEEEEEEC---CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 45789999997543 3345789999999999999999999999975 568999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc---
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--- 308 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--- 308 (331)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999963 35699999999999999999999999 999999999999999999999999999976543221
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......+|+.|+|||++.++.++
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~ 550 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS 550 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC
T ss_pred cccCCCCceeeeChhhhcCCCCC
Confidence 11223467889999999887764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=236.05 Aligned_cols=177 Identities=27% Similarity=0.396 Sum_probs=145.2
Q ss_pred HhcCCcccceeeecCceEEEEEEECC----CceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
..++|...+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678889999999999999998642 346999998754 33456789999999999999999999999875 4568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCCc-ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......+++.|+|||++.++.++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCC
Confidence 43322 12233568899999999776653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=237.27 Aligned_cols=172 Identities=31% Similarity=0.437 Sum_probs=147.1
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCcceeeeeeEEcCC---
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHDD--- 220 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~g~~~~~~--- 220 (331)
-+...++|...+.||+|+||.||+|+. +++.||+|.+... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 355667899999999999999999998 4889999998633 34567888888887 79999999999998876
Q ss_pred -eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCceEecCCCCCCEEECCCCc
Q 020072 221 -TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--------EHCNPAVIHRDLKSSNILLDSKFN 291 (331)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivHrdlk~~Nill~~~~~ 291 (331)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +. +++||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 78999999999999999963 35899999999999999999999 77 9999999999999999999
Q ss_pred EEEEeccCceeCCCCCc----ccceeccccCCccccccccC
Q 020072 292 AKLSDFGLAITDGSQNK----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~ 328 (331)
+||+|||++........ ......||+.|+|||++.++
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 99999999966543322 12234689999999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=243.58 Aligned_cols=175 Identities=19% Similarity=0.267 Sum_probs=140.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC----CCceEEEEEecccCch-----------hHHHHHHHHHHHhcCCCCcceeeee
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQD-----------AGREFENEVDLLSNIHHPNVVCLLG 214 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~g 214 (331)
.++|...+.||+|+||.||+|+.. ++..||+|+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457888999999999999999875 5688999998654322 1234678889999999999999999
Q ss_pred eEEc----CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 215 YSAH----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 215 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
++.. .+..++||||+ +++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998642 3799999999999999999999999 999999999999999887
Q ss_pred --cEEEEeccCceeCCCCC-------cccceeccccCCccccccccCCCC
Q 020072 291 --NAKLSDFGLAITDGSQN-------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 --~~kl~Dfgla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||+++...... .......||+.|+|||++.++.++
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC
Confidence 99999999997653221 111334689999999999887654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=246.48 Aligned_cols=171 Identities=26% Similarity=0.367 Sum_probs=139.0
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------eEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~~ 223 (331)
..+|...+.||+|+||.||+|+..++..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346888999999999999999998777799998854322 2236999999999999999999986543 378
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEEEEeccCcee
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAIT 302 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~ 302 (331)
+||||++++.+............+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998765544332212345799999999999999999999999 999999999999999 799999999999977
Q ss_pred CCCCCcccceeccccCCccccccccC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
....... ....+|+.|+|||++.+.
T Consensus 192 ~~~~~~~-~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 192 LIAGEPN-VSYICSRYYRAPELIFGA 216 (394)
T ss_dssp CCTTCCC-CSSCSCGGGCCHHHHTTC
T ss_pred ccCCCCC-cccccCcCccCHHHHcCC
Confidence 5433322 234689999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=235.54 Aligned_cols=164 Identities=25% Similarity=0.392 Sum_probs=143.1
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEc--CCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAH--DDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5788899999999999999986 46889999998633 3467899999999997 9999999999988 56789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~ 305 (331)
||+++++|.+++. .+++.++..++.|++.||+|||++ +++||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998874 388999999999999999999999 999999999999999776 899999999976544
Q ss_pred CCcccceeccccCCcccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... ....++..|+|||++.+
T Consensus 184 ~~~~-~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 184 GQEY-NVRVASRYFKGPELLVD 204 (330)
T ss_dssp TCCC-CSCCSCGGGCCHHHHTT
T ss_pred CCcc-ccccccccccChhhhcC
Confidence 3322 23468999999999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.18 Aligned_cols=174 Identities=25% Similarity=0.332 Sum_probs=147.3
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcC------CCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI------HHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~g~~~~~~~ 221 (331)
..++|+..+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567899999999999999999875 5789999999643 33446677888888776 57799999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc--EEEEeccC
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGL 299 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgl 299 (331)
.++||||++ ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6888888652 234599999999999999999999999 9999999999999999987 99999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... ...||+.|+|||++.++.|+
T Consensus 249 a~~~~~~~~---~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 249 SCYEHQRVY---TYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp CEETTCCCC---SSCSCGGGCCHHHHHTBCCC
T ss_pred ceecCCccc---ccCCCCCccChHHHhCCCCC
Confidence 976543322 34789999999999887764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=234.68 Aligned_cols=174 Identities=25% Similarity=0.359 Sum_probs=143.2
Q ss_pred hcCCcccc-eeeecCceEEEEEEE---CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 150 TDSFHESN-ILGEGGFGCVYKAKL---DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 150 ~~~~~~~~-~ig~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
.++|...+ .||+|+||.||+|.+ .+++.||+|.+.... ....+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 246789999986543 33467899999999999999999999999 567789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999964 34589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcc---cceeccccCCccccccccCCC
Q 020072 304 GSQNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
...... .....+++.|+|||.+.++.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 197 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKF 197 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCC
Confidence 443221 112245688999999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=232.58 Aligned_cols=175 Identities=22% Similarity=0.300 Sum_probs=143.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCcceeeeeeEE--cCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNVVCLLGYSA--HDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~--~~~~ 221 (331)
..++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999875 67899999986432 334578999999999999999999999984 4458
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++||||++++ |.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999977 65655432 345699999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCC--cccceeccccCCccccccccC
Q 020072 302 TDGSQN--KNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 328 (331)
...... .......|++.|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCc
Confidence 654321 222234689999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=236.69 Aligned_cols=172 Identities=29% Similarity=0.408 Sum_probs=139.3
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-CeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+.+ ++.||+|.+... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467888999999999999999875 789999998643 2456789999999999999999999997654 478999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 9999999998632 112378999999999999999999999 999999999999999999999999999865443222
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...++..|+|||.+.++.++
T Consensus 173 ---~~~~~~~y~aPE~~~~~~~~ 192 (278)
T 1byg_A 173 ---TGKLPVKWTAPEALREKKFS 192 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCC
T ss_pred ---CCCccccccCHHHhCCCCCC
Confidence 23578899999999876653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=235.08 Aligned_cols=170 Identities=27% Similarity=0.380 Sum_probs=138.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEE-----------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA----------- 217 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~----------- 217 (331)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467888999999999999999886 48999999998766667788999999999999999999999874
Q ss_pred ---cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEE
Q 020072 218 ---HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAK 293 (331)
Q Consensus 218 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~k 293 (331)
+.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 4468899999998 699998853 4689999999999999999999999 999999999999997 577999
Q ss_pred EEeccCceeCCCCC---cccceeccccCCcccccccc
Q 020072 294 LSDFGLAITDGSQN---KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 294 l~Dfgla~~~~~~~---~~~~~~~gt~~y~aPE~l~~ 327 (331)
|+|||+++...... .......++..|+|||.+.+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 99999997653221 11123357899999998865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=240.00 Aligned_cols=172 Identities=29% Similarity=0.427 Sum_probs=145.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-----CeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~ 222 (331)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999875 67889999997543 33457799999999999999999999998765 368
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||++ |+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 589888853 3599999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCc---ccceeccccCCccccccccCC
Q 020072 303 DGSQNK---NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~ 329 (331)
...... ......||+.|+|||++.++.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 207 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCC
Confidence 543221 122347899999999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=242.91 Aligned_cols=167 Identities=31% Similarity=0.439 Sum_probs=128.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------C
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------D 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~ 220 (331)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468889999999999999999864 6889999998643 334556788999999999999999999998754 5
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6889888753 4699999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCcccccccc
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+..... .....||..|+|||++.+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp --------------CCCTTCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcC
Confidence 765432 223478999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=239.32 Aligned_cols=178 Identities=26% Similarity=0.397 Sum_probs=131.8
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
....++|...+.||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 445678999999999999999999864 67899999986443 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccC
Q 020072 225 VYELMENRSLDIQLHG-----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 299 (331)
||||+++++|.+++.. ......+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999988853 11345699999999999999999999999 999999999999999999999999999
Q ss_pred ceeCCCCC-----cccceeccccCCcccccccc
Q 020072 300 AITDGSQN-----KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 300 a~~~~~~~-----~~~~~~~gt~~y~aPE~l~~ 327 (331)
+....... .......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 86543221 11223468999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=239.79 Aligned_cols=180 Identities=30% Similarity=0.426 Sum_probs=145.7
Q ss_pred HhcCCcccceeeecCceEEEEEEE------CCCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 221 (331)
..++|...+.||+|+||.||+|++ .++..||+|.+... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456888999999999999999984 35678999999644 34455679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEE
Q 020072 222 RFIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKL 294 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl 294 (331)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999987532 124589999999999999999999999 9999999999999994 456999
Q ss_pred EeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 295 SDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 295 ~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|||++....... .......+++.|+|||++.++.++
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 223 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCC
Confidence 9999986432211 112233578899999999877654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=243.46 Aligned_cols=172 Identities=20% Similarity=0.313 Sum_probs=143.7
Q ss_pred hcCCcccceeeecCceEEEEEEECC---------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCccee---------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDD---------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC--------- 211 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------- 211 (331)
.++|...+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678889999999999999998764 789999998643 46889999999999999998
Q ss_pred ------eeeeEEc-CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 212 ------LLGYSAH-DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 212 ------l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
+++++.. ++..++||||+ +++|.+++... ....+++.+++.++.|++.||+|||++ +++||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5677765 67899999999 99999999742 235699999999999999999999999 999999999999
Q ss_pred EECCCC--cEEEEeccCceeCCCCCc-------ccceeccccCCccccccccCCCC
Q 020072 285 LLDSKF--NAKLSDFGLAITDGSQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 285 ll~~~~--~~kl~Dfgla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++.++ .+||+|||+++....... ......||+.|+|||++.++.++
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 246 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS 246 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC
Confidence 999998 999999999965432211 11233689999999999887664
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=245.92 Aligned_cols=169 Identities=27% Similarity=0.369 Sum_probs=135.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC----C--eEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD----D--TRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~----~--~~~ 223 (331)
.+|...+.||+|+||.||+|+.. +++.||||++.... +...+|++++++++|+||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999985 58999999986432 2334799999999999999999988542 2 367
Q ss_pred EEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-CcEEEEeccCce
Q 020072 224 IVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAI 301 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~ 301 (331)
+||||+++ +|.+.+.. ......+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55444321 12345799999999999999999999999 99999999999999965 678999999998
Q ss_pred eCCCCCcccceeccccCCccccccccC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
....... .....||+.|+|||++.+.
T Consensus 206 ~~~~~~~-~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 206 QLVRGEP-NVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp ECCTTCC-CCSCCSCTTSCCHHHHTTC
T ss_pred hcccCCC-ceeeeeCCCcCCHHHHcCC
Confidence 6543322 2234689999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=235.38 Aligned_cols=177 Identities=32% Similarity=0.450 Sum_probs=145.7
Q ss_pred HhcCCcccceeeecCceEEEEEEE--CCCceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCcceeeeeeEE----
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL--DDNLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSA---- 217 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~---- 217 (331)
..++|...+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 4678999999864322 2234566777777666 8999999999987
Q ss_pred -cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 218 -HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 6999888642 234589999999999999999999999 999999999999999999999999
Q ss_pred ccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 297 fgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||++....... ......|+..|+|||++.++.++
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 197 (326)
T 1blx_A 164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYA 197 (326)
T ss_dssp CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCC
T ss_pred CcccccccCCC-CccccccccceeCHHHHhcCCCC
Confidence 99997654322 22234689999999999877654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=258.42 Aligned_cols=161 Identities=19% Similarity=0.212 Sum_probs=124.7
Q ss_pred eeecCceEEEEEE-ECCCceEEEEEecccC----------chhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEE
Q 020072 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT----------QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 159 ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.+.|++|.+..++ ...|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455566555443 2357889999985431 22346799999999999 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||++|++|.+.|.. ..+++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999964 3456654 5889999999999999 9999999999999999999999999999876555
Q ss_pred CcccceeccccCCccccccccC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
.......+||++|||||++.+.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC---
T ss_pred CccccCceechhhccHHHhCCC
Confidence 4444556899999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=236.91 Aligned_cols=171 Identities=29% Similarity=0.438 Sum_probs=143.5
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-----Ce
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (331)
..++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568889999999999999999876 68899999996443 33456788999999999999999999988754 67
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 689888753 3589999999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCCcc----------cceeccccCCcccccccc
Q 020072 302 TDGSQNKN----------NLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 302 ~~~~~~~~----------~~~~~gt~~y~aPE~l~~ 327 (331)
........ .....||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHS
T ss_pred ccccccccccCccccccchhhccccccccCCeeecc
Confidence 65432111 112468999999998865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-31 Score=237.74 Aligned_cols=170 Identities=32% Similarity=0.497 Sum_probs=135.7
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHH--HHhcCCCCcceeeeeeEEc-----CCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVD--LLSNIHHPNVVCLLGYSAH-----DDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~H~niv~l~g~~~~-----~~~~ 222 (331)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.+ .+..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46888899999999999999987 57899999986432 233444444 4556899999999986542 2367
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCceEecCCCCCCEEECCCCcEEEEe
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC------NPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
++||||+++|+|.+++.. ...++..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999864 23589999999999999999999863 33899999999999999999999999
Q ss_pred ccCceeCCCCC--------cccceeccccCCcccccccc
Q 020072 297 FGLAITDGSQN--------KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 297 fgla~~~~~~~--------~~~~~~~gt~~y~aPE~l~~ 327 (331)
||+++...... .......||+.|+|||++.+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99997654221 11123468999999999876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=238.84 Aligned_cols=166 Identities=27% Similarity=0.398 Sum_probs=140.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE----
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR---- 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~---- 222 (331)
.++|...+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468888999999999999999865 68999999996542 33457789999999999999999999999887654
Q ss_pred --EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 223 --FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 223 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68877763 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCcccccccc
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+...... ....||+.|+|||++.+
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 192 RHADAEM---TGYVVTRWYRAPEVILS 215 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSC
T ss_pred cccccCc---CCcccCccccCHHHhcC
Confidence 7654322 23468999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=258.74 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=142.5
Q ss_pred hcCCcccceeeecCceEEEEEEEC--CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe-----
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----- 221 (331)
.++|...+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 5889999998643 33455678999999999999999999999987665
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887642 699999999999999999999999 99999999999999986 89999999997
Q ss_pred eCCCCCcccceeccccCCccccccccC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
..... ....||+.|+|||++.++
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHC
T ss_pred hcccC----CccCCCccccCHHHHcCC
Confidence 76543 234699999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=230.72 Aligned_cols=175 Identities=22% Similarity=0.291 Sum_probs=142.3
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeE-EcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lv~ 226 (331)
..++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+|++++++++|+|++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 578899999865332 234688999999999988877776665 5677889999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITD 303 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~ 303 (331)
||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999863 234699999999999999999999999 99999999999999 78999999999999765
Q ss_pred CCCCc-------ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......||+.|+|||.+.++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCC
Confidence 43322 12245689999999999887664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=228.76 Aligned_cols=174 Identities=22% Similarity=0.293 Sum_probs=145.4
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeE-EcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+|+. .+++.||+|++.... ..+++.+|+.++++++|+|++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56889999999999999999986 578999999986433 234688999999999998877666655 56678899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~~ 304 (331)
|+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||+ ++++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999999863 234699999999999999999999999 99999999999999 488999999999997654
Q ss_pred CCCc-------ccceeccccCCccccccccCCCC
Q 020072 305 SQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......||+.|+|||.+.++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCC
Confidence 3322 12345689999999999887664
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=233.76 Aligned_cols=173 Identities=27% Similarity=0.352 Sum_probs=147.1
Q ss_pred hcCCcccceeeecCceEEEEEEE--CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc------ceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL--DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN------VVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~ 221 (331)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+++++.++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999986 36789999998643 334567889999999887654 9999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-------------
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS------------- 288 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~------------- 288 (331)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999888642 234689999999999999999999999 9999999999999987
Q ss_pred ------CCcEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 289 ------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 289 ------~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++.+||+|||++....... ....||+.|+|||++.++.++
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~ 212 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWS 212 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC---CSSCSCGGGCCHHHHTTSCCC
T ss_pred ccccccCCCceEeeCcccccCcccc---ccccCCccccChHHhhCCCCC
Confidence 6689999999997754332 234689999999999887664
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.59 Aligned_cols=180 Identities=25% Similarity=0.270 Sum_probs=133.9
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe--
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-- 221 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-- 221 (331)
......++|...+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999875 68899999985432 233456788888999999999999999875433
Q ss_pred -----EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCceEecCCCCCCEEECC-CCcEE
Q 020072 222 -----RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--EHCNPAVIHRDLKSSNILLDS-KFNAK 293 (331)
Q Consensus 222 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~ivHrdlk~~Nill~~-~~~~k 293 (331)
.++||||++++.+............+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986533322211134457899999999999999999999 77 9999999999999997 89999
Q ss_pred EEeccCceeCCCCCcccceeccccCCccccccccCC
Q 020072 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 294 l~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
|+|||+++........ ....||+.|+|||++.+..
T Consensus 173 l~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~ 207 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPN-VAYICSRYYRAPELIFGNQ 207 (360)
T ss_dssp ECCCTTCBCCCTTSCC-CSTTSCGGGCCHHHHTTCS
T ss_pred EeeCCCceecCCCCCc-ccccCCcceeCHHHHcCCC
Confidence 9999999765543322 2346899999999986543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=234.72 Aligned_cols=175 Identities=28% Similarity=0.378 Sum_probs=137.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC--CCc--eEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD--DNL--HVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++|+..+.||+|+||.||+|++. ++. .||+|.+... ..+..+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 233 6899988643 3345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++|+||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999998863 234689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcc---cceeccccCCccccccccCCC
Q 020072 303 DGSQNKN---NLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 303 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 330 (331)
....... .....++..|+|||++.++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCC
Confidence 5443221 122356788999999876544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=242.19 Aligned_cols=167 Identities=12% Similarity=0.108 Sum_probs=125.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHH---HHHhcCCCCcceeee-------eeE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEV---DLLSNIHHPNVVCLL-------GYS 216 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~H~niv~l~-------g~~ 216 (331)
.+|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+ ..|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45778899999999999999875 789999999976442 3445677884 55555 799987754 444
Q ss_pred EcC-----------------CeEEEEEEecCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCc
Q 020072 217 AHD-----------------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMR------MKIALDTARGLEYLHEHCNPA 273 (331)
Q Consensus 217 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~ 273 (331)
... +..|+||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 332 33799999999 8999998642 223455556 78889999999999999 9
Q ss_pred eEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 274 ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
|+||||||+|||++.++.+||+|||+++..+.... ...+++.|+|||++.+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNA 265 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccC
Confidence 99999999999999999999999999987653321 2356799999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=257.22 Aligned_cols=180 Identities=24% Similarity=0.328 Sum_probs=147.4
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
.+...++|...+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34456788889999999999999998742 4579999986543 334577999999999999999999999985 45
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 68999999999999999874 234689999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCc-ccceeccccCCccccccccCCCC
Q 020072 301 ITDGSQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 301 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+....... ......+++.|+|||++.++.++
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 570 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCC
Confidence 76543322 12233567899999999877654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=241.88 Aligned_cols=173 Identities=29% Similarity=0.406 Sum_probs=128.3
Q ss_pred cCCcc-cceeeecCceEEEEEEEC---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEEE
Q 020072 151 DSFHE-SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFI 224 (331)
Q Consensus 151 ~~~~~-~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~l 224 (331)
+.|.. .++||+|+||.||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 568999999999999865 57899999996432 23568899999999999999999999954 678999
Q ss_pred EEEecCCCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE----CCCCcEEE
Q 020072 225 VYELMENRSLDIQLHG------PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKL 294 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~kl 294 (331)
||||++ |+|.+++.. ......+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 477666542 11223599999999999999999999999 99999999999999 77899999
Q ss_pred EeccCceeCCCCC---cccceeccccCCccccccccCC
Q 020072 295 SDFGLAITDGSQN---KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 295 ~Dfgla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
+|||+++...... .......||+.|+|||++.+..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 211 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence 9999997654321 1222357899999999998743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=229.05 Aligned_cols=174 Identities=32% Similarity=0.457 Sum_probs=148.4
Q ss_pred HHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
....++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999876 6889999998643 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC---CcEEEEeccCc
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA 300 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgla 300 (331)
+|+||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999888753 24689999999999999999999999 99999999999999764 46999999998
Q ss_pred eeCCCCCcccceeccccCCcccccccc
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
......... ....+++.|+|||.+.+
T Consensus 172 ~~~~~~~~~-~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 172 TCFQQNTKM-KDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp GTBCCCSSC-SCHHHHHTTCCHHHHTT
T ss_pred eeecCCCcc-ccccCcccccChHHhcC
Confidence 655433221 23358999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=236.05 Aligned_cols=178 Identities=26% Similarity=0.339 Sum_probs=140.4
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc------hhHHHHHHHHHHHhcC----CCCcceeee
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNI----HHPNVVCLL 213 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~H~niv~l~ 213 (331)
..+...++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556788999999999999999999864 678999999964432 2234567799999888 899999999
Q ss_pred eeEEcCCeEEEEEEe-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCc
Q 020072 214 GYSAHDDTRFIVYEL-MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFN 291 (331)
Q Consensus 214 g~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~ 291 (331)
+++.+.+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999864 34689999999999999999999999 999999999999999 8999
Q ss_pred EEEEeccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 292 ~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
+||+|||++........ ....|+..|+|||++.++.+
T Consensus 179 ~kl~dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPY--TDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp EEECCCSSCEECCSSCB--CCCCSCTTTSCHHHHHHSCB
T ss_pred EEEEEcchhhhcccCcc--cccCCcccccCceeeecCCC
Confidence 99999999977654332 23468999999999876554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-30 Score=234.75 Aligned_cols=166 Identities=27% Similarity=0.394 Sum_probs=139.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCe-----
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----- 221 (331)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 457888999999999999999875 68999999996542 3345678999999999999999999999987654
Q ss_pred -EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 222 -RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
.++||||++ ++|.+++. ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 68877763 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCcccccccc
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
...... .....+|+.|+|||++.+
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSC
T ss_pred cCCCCC---ccccccCcCcCCHHHHhC
Confidence 654332 223468999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=238.43 Aligned_cols=174 Identities=27% Similarity=0.312 Sum_probs=143.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC--------CCcceeeeeeEE---
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH--------HPNVVCLLGYSA--- 217 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~g~~~--- 217 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999864 6789999998633 334567899999999986 788999999987
Q ss_pred -cCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC------
Q 020072 218 -HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF------ 290 (331)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~------ 290 (331)
+....++||||+. ++|.+++.. .....+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 5568999999995 555555543 23356999999999999999999999864 799999999999999775
Q ss_pred -------------------------------------------cEEEEeccCceeCCCCCcccceeccccCCcccccccc
Q 020072 291 -------------------------------------------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 291 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
.+||+|||+++...... ....||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---CSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---ccCCCCCcccCChhhcC
Confidence 79999999997764332 23468999999999988
Q ss_pred CCCC
Q 020072 328 GMVN 331 (331)
Q Consensus 328 ~~~t 331 (331)
+.++
T Consensus 268 ~~~~ 271 (397)
T 1wak_A 268 SGYN 271 (397)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 7664
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=229.78 Aligned_cols=173 Identities=27% Similarity=0.365 Sum_probs=132.3
Q ss_pred HhcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCc-h-hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQ-D-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
..++|+..+.||+|+||.||+|+. .+++.||+|++..... . ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356788999999999999999987 4688999999965422 2 233445555568888999999999999999999999
Q ss_pred EEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 226 YELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
|||++ |+|.+++.. ......+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 577766542 123457999999999999999999999842 89999999999999999999999999997654
Q ss_pred CCCcccceeccccCCcccccc
Q 020072 305 SQNKNNLKLSGTLGYVAPEYL 325 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l 325 (331)
..... ....||+.|+|||++
T Consensus 162 ~~~~~-~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 162 DDVAK-DIDAGCKPYMAPERI 181 (290)
T ss_dssp ---------CCCCCCSCHHHH
T ss_pred ccccc-cccCCCccccChhhc
Confidence 33222 233689999999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=240.86 Aligned_cols=174 Identities=22% Similarity=0.328 Sum_probs=145.3
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCC-CcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46889999999999999999986 4689999998764332 3458899999999987 556666667778889999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---CCCCcEEEEeccCceeCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfgla~~~~ 304 (331)
|+ +++|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 8999999863 234699999999999999999999999 99999999999999 688999999999997654
Q ss_pred CCCc-------ccceeccccCCccccccccCCCC
Q 020072 305 SQNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......||..|+|||++.+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 191 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC
Confidence 3322 11245799999999999887764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=231.23 Aligned_cols=172 Identities=27% Similarity=0.329 Sum_probs=122.6
Q ss_pred HhcCCccc-ceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeE
Q 020072 149 ATDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTR 222 (331)
Q Consensus 149 ~~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~ 222 (331)
..++|... ++||+|+||.||+|+.. +++.||+|++... . .........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45678774 57999999999999876 6899999998642 1 112222334566799999999999876 4468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccC
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl 299 (331)
++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +++||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999753 235699999999999999999999999 9999999999999986 45599999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
+........ ....+|+.|+|||++.++.+
T Consensus 178 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~ 206 (336)
T 3fhr_A 178 AKETTQNAL--QTPCYTPYYVAPEVLGPEKY 206 (336)
T ss_dssp CEEC------------------------CHH
T ss_pred ceecccccc--ccCCCCcCccChhhhCCCCC
Confidence 976543322 23468999999999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=234.92 Aligned_cols=179 Identities=28% Similarity=0.372 Sum_probs=149.2
Q ss_pred HHHHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch------hHHHHHHHHHHHhcCC--CCcceeeee
Q 020072 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD------AGREFENEVDLLSNIH--HPNVVCLLG 214 (331)
Q Consensus 144 ~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--H~niv~l~g 214 (331)
++.+...++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 334556778999999999999999999864 6889999998644221 2356778999999996 599999999
Q ss_pred eEEcCCeEEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcE
Q 020072 215 YSAHDDTRFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNA 292 (331)
Q Consensus 215 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ 292 (331)
++.+.+..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+|||++ +++.+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence 99999999999999986 899998863 34689999999999999999999999 999999999999999 78999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCccccccccCCC
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
||+|||++........ ....||+.|+|||++.++.+
T Consensus 190 kL~Dfg~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~ 225 (320)
T 3a99_A 190 KLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 225 (320)
T ss_dssp EECCCTTCEECCSSCB--CCCCSCGGGSCHHHHHHSCB
T ss_pred EEeeCccccccccccc--cCCCCCccCCChHHhccCCC
Confidence 9999999977654322 23468999999999876654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=233.16 Aligned_cols=177 Identities=26% Similarity=0.317 Sum_probs=146.4
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CC-----cceeeeeeEEcCC
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HP-----NVVCLLGYSAHDD 220 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~g~~~~~~ 220 (331)
...++|...+.||+|+||+||+|+.. +++.||||++... .....++.+|+.++..++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999875 5789999999633 334567788998888885 55 4999999999999
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC--CCCcEEEEecc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFG 298 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg 298 (331)
..++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 5999888653 234589999999999999999999952 22899999999999995 47889999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+++....... ...||+.|+|||++.++.++
T Consensus 207 ~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~ 236 (382)
T 2vx3_A 207 SSCQLGQRIY---QYIQSRFYRSPEVLLGMPYD 236 (382)
T ss_dssp TCEETTCCCC---SSCSCGGGCCHHHHTTCCCC
T ss_pred Cceecccccc---cccCCccccChHHHcCCCCC
Confidence 9987654322 34689999999999887764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=251.68 Aligned_cols=178 Identities=28% Similarity=0.384 Sum_probs=149.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc------CCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH------DDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~ 221 (331)
.++|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999874 6889999998654 34456779999999999999999999998765 667
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCc---EEEEecc
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFG 298 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg 298 (331)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. +++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998655555799999999999999999999999 9999999999999997665 9999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++......... ....||+.|+|||++.++.++
T Consensus 170 ~a~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s 201 (676)
T 3qa8_A 170 YAKELDQGELC-TEFVGTLQYLAPELLEQKKYT 201 (676)
T ss_dssp CCCBTTSCCCC-CCCCSCCTTCSSCSSCCSCCS
T ss_pred ccccccccccc-ccccCCcccCChHHhccCCCC
Confidence 99765443322 245789999999999887764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=239.89 Aligned_cols=170 Identities=29% Similarity=0.329 Sum_probs=131.5
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345557889999999998777778999999998643 345678999999876 8999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC-------------CcE
Q 020072 230 ENRSLDIQLHGPSHGS----ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-------------FNA 292 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~-------------~~~ 292 (331)
+ |+|.+++....... ..++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999987532211 113334678999999999999999 99999999999999754 489
Q ss_pred EEEeccCceeCCCCCc----ccceeccccCCcccccccc
Q 020072 293 KLSDFGLAITDGSQNK----NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~----~~~~~~gt~~y~aPE~l~~ 327 (331)
||+|||+++....... ......||+.|+|||++.+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 9999999976544321 1123469999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=229.16 Aligned_cols=171 Identities=22% Similarity=0.340 Sum_probs=142.0
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCC--CCcceeeeeeEEcCCeEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH--HPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~l 224 (331)
..++|...+.||+|+||.||+++..+++.||+|.+... .....+.+.+|++++.+++ |+||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 45678889999999999999999888999999998643 3345578999999999997 5999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||| +.+++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+|||+++ +.+||+|||++....
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 567899999864 34689999999999999999999999 9999999999999964 899999999996654
Q ss_pred CCCc--ccceeccccCCcccccccc
Q 020072 305 SQNK--NNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~l~~ 327 (331)
.... ......|++.|+|||.+.+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp ------------CCGGGCCHHHHTT
T ss_pred CccccccccCCCCCCCcCCHHHHhh
Confidence 3221 1223468999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=238.76 Aligned_cols=169 Identities=31% Similarity=0.405 Sum_probs=134.4
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
..+|...++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+.+..|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34678889999999999766556678999999986432 23467899999999 799999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-----CCcEEEEeccCceeC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-----KFNAKLSDFGLAITD 303 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfgla~~~ 303 (331)
++ |+|.+++.... ..+.+..++.++.||+.||+|||++ +|+||||||+|||++. +..+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 69999987532 3345556779999999999999999 9999999999999953 346889999999765
Q ss_pred CCCC---cccceeccccCCcccccccc
Q 020072 304 GSQN---KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~l~~ 327 (331)
.... .......||+.|+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ------------CCSCTTSCCGGGTSC
T ss_pred cCCCcceeeccccCCCcCccChhhhhc
Confidence 4322 12234569999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=232.45 Aligned_cols=175 Identities=26% Similarity=0.429 Sum_probs=143.8
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.++...++|...+.||+|+||.||+|+..+ .||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334456789999999999999999998754 59999986432 33446688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999864 334689999999999999999999999 999999999999998 67999999999854
Q ss_pred CCC-----CCcccceeccccCCcccccccc
Q 020072 303 DGS-----QNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 303 ~~~-----~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
... .........|++.|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccccCCCcccccChHHhhh
Confidence 321 1112223458999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=228.60 Aligned_cols=173 Identities=23% Similarity=0.317 Sum_probs=144.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CC-ceEEEEEecccCchhHHHHHHHHHHHhcCCCCc------ceeeeeeEEcCCe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DN-LHVAVKKLDCATQDAGREFENEVDLLSNIHHPN------VVCLLGYSAHDDT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~g~~~~~~~ 221 (331)
.++|...+.||+|+||.||+|... ++ ..||+|++... ....+.+.+|+.++++++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999875 34 68999998643 334567889999999998766 8999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEE---------------
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL--------------- 286 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill--------------- 286 (331)
.++||||+ +++|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5666666643 2234699999999999999999999999 99999999999999
Q ss_pred ----CCCCcEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 287 ----DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 287 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+.++.+||+|||+++...... ....||+.|+|||++.++.++
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~ 217 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWA 217 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHHHTTCCCC
T ss_pred cccccCCCcEEEeecCccccccccc---cCCcCCCcccCCeeeecCCCC
Confidence 567899999999997654332 234689999999999887664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=227.42 Aligned_cols=173 Identities=27% Similarity=0.396 Sum_probs=126.0
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHH-HHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++|...+.||+|+||.||+|... +++.||+|++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999885 68899999996543 233455666666 777889999999999999999999999
Q ss_pred EecCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 227 ELMENRSLDIQLHG--PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 227 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 77666542 112456899999999999999999999842 79999999999999999999999999996654
Q ss_pred CCCcccceeccccCCccccccc
Q 020072 305 SQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
..... ....||+.|+|||++.
T Consensus 178 ~~~~~-~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 178 DSIAK-TRDAGCRPYMAPERID 198 (327)
T ss_dssp ----------------------
T ss_pred ccccc-ccCCCCccccCceeec
Confidence 33222 2336899999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=231.46 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=144.7
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCC-----------CCcceeeeeeEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----------HPNVVCLLGYSA 217 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~ 217 (331)
.++|...+.||+|+||.||+|+. .+++.||+|.+... ......+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999987 46889999998632 334567889999999886 899999999988
Q ss_pred cCC----eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC------
Q 020072 218 HDD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD------ 287 (331)
Q Consensus 218 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~------ 287 (331)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999888642 2345899999999999999999999853 899999999999994
Q ss_pred CCCcEEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 288 SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 288 ~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.++.+||+|||++........ ...||+.|+|||++.++.++
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~ 213 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYT---NSIQTREYRSPEVLLGAPWG 213 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCC---SCCSCGGGCCHHHHHTCCCC
T ss_pred CcceEEEcccccccccCCCCC---CCCCCccccCcHHHhCCCCC
Confidence 445899999999977653322 33689999999999887664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=224.09 Aligned_cols=170 Identities=27% Similarity=0.382 Sum_probs=126.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCch-h-HHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-A-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
.++|...+.||+|+||.||+|+.. +++.||+|++...... . .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999885 6899999999654332 2 234445556788889999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+ ++.+...... ....+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455444431 23568999999999999999999998 5 899999999999999999999999999865443
Q ss_pred CCcccceeccccCCccccccc
Q 020072 306 QNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~ 326 (331)
... .....+++.|+|||++.
T Consensus 178 ~~~-~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 178 DKA-KDRSAGCAAYMAPERID 197 (318)
T ss_dssp ----------CCTTCCHHHHC
T ss_pred Ccc-ccccCCCccccChhhcc
Confidence 222 22346899999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-29 Score=238.29 Aligned_cols=157 Identities=17% Similarity=0.199 Sum_probs=123.6
Q ss_pred cccceeeecCceEEEEEEECCCceEEEEEecccCc--------hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
...++||+|+||.||+|+. .+..+++|+...... ...+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 567889988643211 1234589999999999999999777777777888999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 568999999999999999 9999999999999999 999999999987755
Q ss_pred CCcc-------cceeccccCCcccccccc
Q 020072 306 QNKN-------NLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 306 ~~~~-------~~~~~gt~~y~aPE~l~~ 327 (331)
.... .....||+.|||||++..
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 3221 124579999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=210.01 Aligned_cols=143 Identities=16% Similarity=0.030 Sum_probs=127.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... .+..+.+.+|+..+++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357888999999999999999886 48999999997543 23447899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
|||+++++|.+++.. . ....++.+++.|++.||+|||++ +|+||||||+|||+++++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999843 1 35567889999999999999999 9999999999999999999999987754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=207.76 Aligned_cols=147 Identities=25% Similarity=0.337 Sum_probs=127.0
Q ss_pred hcCCccc-ceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHH-hcCCCCcceeeeeeEEc----CCeE
Q 020072 150 TDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLL-SNIHHPNVVCLLGYSAH----DDTR 222 (331)
Q Consensus 150 ~~~~~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~----~~~~ 222 (331)
.++|... ++||+|+||.||+|... +++.||+|.+.. ...+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456665 78999999999999874 688999999853 24567888888 66699999999999886 6678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccC
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl 299 (331)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998752 334699999999999999999999999 9999999999999998 78999999999
Q ss_pred ceeCCC
Q 020072 300 AITDGS 305 (331)
Q Consensus 300 a~~~~~ 305 (331)
+.....
T Consensus 167 a~~~~~ 172 (299)
T 3m2w_A 167 AKETTG 172 (299)
T ss_dssp CEECTT
T ss_pred cccccc
Confidence 976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=223.47 Aligned_cols=168 Identities=21% Similarity=0.268 Sum_probs=127.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCc---hhHHHHHHHHHHHhcCCC-Ccceeee-----------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQ---DAGREFENEVDLLSNIHH-PNVVCLL----------- 213 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H-~niv~l~----------- 213 (331)
..+|...++||+|+||.||+|++ .+|+.||||++..... ...+.+.+|+.+++.++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34566788999999999999985 4689999999873322 235779999999999987 3221111
Q ss_pred ----------eeEEc-----CCeEEEEEEecCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCce
Q 020072 214 ----------GYSAH-----DDTRFIVYELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (331)
Q Consensus 214 ----------g~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 274 (331)
.+... ....+++|+++ +++|.+++.. ......+++..++.++.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12356777765 5889888741 12345688999999999999999999999 99
Q ss_pred EecCCCCCCEEECCCCcEEEEeccCceeCCCCCcccceeccccCCcccccc
Q 020072 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325 (331)
Q Consensus 275 vHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l 325 (331)
+||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETT 279 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhh
Confidence 99999999999999999999999999775543 223467 999999999
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=203.52 Aligned_cols=150 Identities=17% Similarity=0.147 Sum_probs=120.5
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCc------------------hhHHHHHHHHHHHhcCCCC
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ------------------DAGREFENEVDLLSNIHHP 207 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~ 207 (331)
+......|...+.||+|+||.||+|...+|+.||+|.+..... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444556677799999999999999997799999999864321 13456899999999999
Q ss_pred cceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC
Q 020072 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (331)
Q Consensus 208 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~ 287 (331)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||++ +|+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 5 677776544 56699999999999987 421 12457999999999999999 999999999999999
Q ss_pred CCCcEEEEeccCceeCCCCCcccceeccccCCccccccc
Q 020072 288 SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 288 ~~~~~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~ 326 (331)
++.+||+|||+++. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99999999999854 33467777764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=176.08 Aligned_cols=137 Identities=21% Similarity=0.146 Sum_probs=106.2
Q ss_pred CcccceeeecCceEEEEEEE-CCCce--EEEEEecccCch------------------------hHHHHHHHHHHHhcCC
Q 020072 153 FHESNILGEGGFGCVYKAKL-DDNLH--VAVKKLDCATQD------------------------AGREFENEVDLLSNIH 205 (331)
Q Consensus 153 ~~~~~~ig~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 205 (331)
|...+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999987 67888 999987532111 1136889999999998
Q ss_pred CCcc--eeeeeeEEcCCeEEEEEEecCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCceEec
Q 020072 206 HPNV--VCLLGYSAHDDTRFIVYELMEN-R----SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVIHR 277 (331)
Q Consensus 206 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivHr 277 (331)
|+|+ ...+++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8764 333332 356899999953 4 56555421 234457899999999999999 88 99999
Q ss_pred CCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 278 DLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 278 dlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+|||+++ .++|+|||++....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=164.87 Aligned_cols=140 Identities=13% Similarity=0.128 Sum_probs=98.8
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCc--------------hhHHHH--------HHHHHHHhcCCCCc
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------------DAGREF--------ENEVDLLSNIHHPN 208 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~e~~~l~~l~H~n 208 (331)
.-|.+.+.||+|++|.||+|...+|+.||||.++.... ...... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999998999999998753210 001112 23445555553333
Q ss_pred ceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC
Q 020072 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (331)
Q Consensus 209 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~ 288 (331)
+....-+.. ...+|||||+++++|..... . .....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 221111111 12379999999988865432 1 12357889999999999998 9999999999999988
Q ss_pred CC----------cEEEEeccCceeCC
Q 020072 289 KF----------NAKLSDFGLAITDG 304 (331)
Q Consensus 289 ~~----------~~kl~Dfgla~~~~ 304 (331)
++ .+.|+||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 77 38999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8.5e-14 Score=121.38 Aligned_cols=146 Identities=18% Similarity=0.128 Sum_probs=114.2
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv 225 (331)
....+.|.....++.|+.+.||+.... +..+++|............+.+|+++++.+. +.++.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334467877778888888999999754 6789999986432233456889999999884 67788899999988999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC----------------------------------- 270 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------- 270 (331)
|||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999765321 1123478899999999999810
Q ss_pred ---------------------CCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 271 ---------------------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 271 ---------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999877667899999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=115.09 Aligned_cols=137 Identities=15% Similarity=0.100 Sum_probs=101.9
Q ss_pred CCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--ceeeeeeEEcCCeEEEEEEec
Q 020072 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~ 229 (331)
++....+.+.|..+.||+....+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333455569999998777888999987543 2356788999999886544 456888888888899999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC--------------------------------------- 270 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------- 270 (331)
++.+|. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 211 11 2367788888899998742
Q ss_pred ----------------CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 271 ----------------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 271 ----------------~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
...++|+|++|.||+++++..+.|.||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998877778999999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.7e-11 Score=110.44 Aligned_cols=142 Identities=13% Similarity=0.157 Sum_probs=106.7
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEec--ccC-chhHHHHHHHHHHHhcCC--CCcceeeeeeEEcC---CeEEEEE
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLD--CAT-QDAGREFENEVDLLSNIH--HPNVVCLLGYSAHD---DTRFIVY 226 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~ 226 (331)
..+.++.|.++.+|+....+ ..+++|+.. ... ......+.+|..+++.+. +.++.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678899999999998765 577788765 222 123457889999999987 45678888888776 4589999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC------------------------------------ 270 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------ 270 (331)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988775321 124778888999999999999999731
Q ss_pred -------------------CCceEecCCCCCCEEECCCCc--EEEEeccCcee
Q 020072 271 -------------------NPAVIHRDLKSSNILLDSKFN--AKLSDFGLAIT 302 (331)
Q Consensus 271 -------------------~~~ivHrdlk~~Nill~~~~~--~kl~Dfgla~~ 302 (331)
.+.++|||+++.|||+++++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=2e-08 Score=89.22 Aligned_cols=137 Identities=26% Similarity=0.295 Sum_probs=99.7
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCc--ceeeeeeEEcCC---eEEEEEEec
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPN--VVCLLGYSAHDD---TRFIVYELM 229 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~~ 229 (331)
.+.++.|....||+.. ..+++|.... ......+.+|.++++.+. +.. +.+.++.....+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 4688887542 234567899999998873 333 334444443333 348899999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH---------------------------------------- 269 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------- 269 (331)
++.++.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864332 2367778888899999999998861
Q ss_pred ---------------CCCceEecCCCCCCEEECC--CCcEEEEeccCceeC
Q 020072 270 ---------------CNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITD 303 (331)
Q Consensus 270 ---------------~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~~ 303 (331)
..+.++|+|+++.||++++ +..+.|.||+.+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1135899999999999998 566889999988543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.4e-07 Score=82.35 Aligned_cols=137 Identities=22% Similarity=0.251 Sum_probs=96.8
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC---cceeeeeeEE-cCCeEEEEEEecCC
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP---NVVCLLGYSA-HDDTRFIVYELMEN 231 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~ 231 (331)
.+.++.|....||+. +..+++|.-. .......+.+|.++|..+.+. .+.+.+.++. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 4678888742 233456789999999999653 3556666664 44567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH------------------------------------------ 269 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------ 269 (331)
.++..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1245555666666666666666642
Q ss_pred ---------------CCCceEecCCCCCCEEECC---CCc-EEEEeccCceeC
Q 020072 270 ---------------CNPAVIHRDLKSSNILLDS---KFN-AKLSDFGLAITD 303 (331)
Q Consensus 270 ---------------~~~~ivHrdlk~~Nill~~---~~~-~kl~Dfgla~~~ 303 (331)
..+.++|+|+++.||++++ ++. +.|.||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235699999999999998 455 589999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.4e-07 Score=80.52 Aligned_cols=135 Identities=15% Similarity=0.098 Sum_probs=95.6
Q ss_pred eeeecCce-EEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEEEEEEecCCCCh
Q 020072 158 ILGEGGFG-CVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (331)
Q Consensus 158 ~ig~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g~L 234 (331)
.+..|..| .||+.... ++..+.+|+-.. ....++.+|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 78987765 456788887642 24567888999998874 33466788999999999999999998887
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------
Q 020072 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-------------------------------------------- 270 (331)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------------- 270 (331)
.+.... .......++.+++..|.-||+..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654321 11223355666666666666421
Q ss_pred -----------CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 271 -----------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 271 -----------~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.1e-07 Score=84.39 Aligned_cols=80 Identities=8% Similarity=0.003 Sum_probs=54.4
Q ss_pred ccee-eecCceEEEEEEEC-------CCceEEEEEecccC---chhHHHHHHHHHHHhcCC-C--CcceeeeeeEEcC--
Q 020072 156 SNIL-GEGGFGCVYKAKLD-------DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIH-H--PNVVCLLGYSAHD-- 219 (331)
Q Consensus 156 ~~~i-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~-- 219 (331)
.+.| +.|....+|+.... ++..+++|...... ......+.+|..+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3456 77888999988764 25678888764322 111246788888888874 3 3466778877665
Q ss_pred -CeEEEEEEecCCCChh
Q 020072 220 -DTRFIVYELMENRSLD 235 (331)
Q Consensus 220 -~~~~lv~e~~~~g~L~ 235 (331)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.8e-06 Score=73.60 Aligned_cols=141 Identities=19% Similarity=0.290 Sum_probs=80.1
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-----CCcceeee-e--eEEcCCeEEEEEEe
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----HPNVVCLL-G--YSAHDDTRFIVYEL 228 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~e~ 228 (331)
+.|+.|..+.||+...++| .+++|..... ..++..|..++..|. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455567889999987665 4888888642 123334445444442 34444311 1 22346678999999
Q ss_pred cCCCChh--------------hhhcC--CCC--C-------CCCCHHHHH------------------------------
Q 020072 229 MENRSLD--------------IQLHG--PSH--G-------SALTWHMRM------------------------------ 253 (331)
Q Consensus 229 ~~~g~L~--------------~~l~~--~~~--~-------~~l~~~~~~------------------------------ 253 (331)
+++..+. ..+|. ... . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221 000 0 011232211
Q ss_pred -HHHHHHHHHHHHHhh----------CCCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 254 -KIALDTARGLEYLHE----------HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 254 -~i~~~ia~~l~yLH~----------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.+..++..++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446667763 1235899999999999998888999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.25 E-value=4.2e-06 Score=73.47 Aligned_cols=80 Identities=19% Similarity=0.182 Sum_probs=58.3
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC---cceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP---NVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e 227 (331)
......+.+|.|..+.||+.+..+|+.+.+|+...........|..|...|+.|.-. -+.+.+++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 345556779999999999999999999999987654444456788999998887422 234444442 2378999
Q ss_pred ecCCCCh
Q 020072 228 LMENRSL 234 (331)
Q Consensus 228 ~~~~g~L 234 (331)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.9e-06 Score=77.21 Aligned_cols=75 Identities=13% Similarity=0.111 Sum_probs=49.0
Q ss_pred cceeeecCceEEEEEEEC-CCceEEEEEecccCc-------hhHHHHHHHHHHHhcCCC--Cc-ceeeeeeEEcCCeEEE
Q 020072 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-------DAGREFENEVDLLSNIHH--PN-VVCLLGYSAHDDTRFI 224 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 224 (331)
.+.+|.|..+.||+++.. ++..+++|....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899997643211 123456788888887732 33 3355544 3445689
Q ss_pred EEEecCCC
Q 020072 225 VYELMENR 232 (331)
Q Consensus 225 v~e~~~~g 232 (331)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.14 E-value=2e-05 Score=70.08 Aligned_cols=139 Identities=17% Similarity=0.188 Sum_probs=92.4
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
..+.|+.|....+|+.... +..+++|..... ....+..|.+.|+.|. ...+.+.++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3466888999999998864 567888886532 3567889998888884 35678888888888899999999998
Q ss_pred CChhh-----------hhcCCCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 020072 232 RSLDI-----------QLHGPSH-G------------------SALTWHMRM---KIAL----------------DTARG 262 (331)
Q Consensus 232 g~L~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~~ 262 (331)
..+.. .||.... . -.-+|.... ++.. ++...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 2332111 0 012454322 1111 11111
Q ss_pred -HHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 263 -LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 263 -l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2356899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=7.6e-05 Score=69.11 Aligned_cols=74 Identities=12% Similarity=0.102 Sum_probs=44.8
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEeccc----Cch-----hHHHHHHHHHHHh-cCCCCcceeeeeeEEcCCeEEE
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA----TQD-----AGREFENEVDLLS-NIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~-----~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~l 224 (331)
..+.+|.|..+.||+... ++..++||..... ... ....++.|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356788899999999964 4678999943211 111 2233444443332 12234556666665 466799
Q ss_pred EEEec-CC
Q 020072 225 VYELM-EN 231 (331)
Q Consensus 225 v~e~~-~~ 231 (331)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00021 Score=63.36 Aligned_cols=157 Identities=15% Similarity=0.169 Sum_probs=86.2
Q ss_pred HHHHHHHhcCCcc-----cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--ceeeeee
Q 020072 143 YKLLEKATDSFHE-----SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGY 215 (331)
Q Consensus 143 ~~~l~~~~~~~~~-----~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~ 215 (331)
.+++......|.. .+.|+.|....+|+....+| .+++|..... ....++..|..++..+...+ +.+++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 4445555555644 23455677789999987666 6788887642 12234556777766653212 2233321
Q ss_pred ------EEcCCeEEEEEEecCCCChhh--------------hhcCC--C--CC--CCC---CHHHHHH------------
Q 020072 216 ------SAHDDTRFIVYELMENRSLDI--------------QLHGP--S--HG--SAL---TWHMRMK------------ 254 (331)
Q Consensus 216 ------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~--~~l---~~~~~~~------------ 254 (331)
....+..++++||+++..+.. .+|.. . .. ... .|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 223456789999999765421 12210 0 00 001 1322111
Q ss_pred HHHHHHHHHHHHhhC----CCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 255 IALDTARGLEYLHEH----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 255 i~~~ia~~l~yLH~~----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
+...+...++++.+. ....++|+|+.+.|||++++..+.|.||+.+..
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666532 234799999999999999876678999998743
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00027 Score=62.19 Aligned_cols=138 Identities=17% Similarity=0.092 Sum_probs=74.3
Q ss_pred cceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEEEec-CCCC
Q 020072 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELM-ENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~g~ 233 (331)
.+.|+.|....+|+. ..+++|........ ..+..+|...++.+...++ .++++++ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567888999999998 46888877543221 1233567777766643233 3455443 33457899999 5544
Q ss_pred hhh------------------hhcCCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HHhh-CCCCc
Q 020072 234 LDI------------------QLHGPSH--GSALTW-HMRMKIAL--------------DTARGLE----YLHE-HCNPA 273 (331)
Q Consensus 234 L~~------------------~l~~~~~--~~~l~~-~~~~~i~~--------------~ia~~l~----yLH~-~~~~~ 273 (331)
+.. .+|.... ...... .....+.. .+...+. .+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 1222110 000111 11111110 0111111 1111 22346
Q ss_pred eEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 274 VIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 274 ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
++|+|+.+.||+ .+++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0016 Score=57.69 Aligned_cols=142 Identities=17% Similarity=0.191 Sum_probs=80.8
Q ss_pred ceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC--cceeeeee-----EEcCCeEEEEEEec
Q 020072 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLLGY-----SAHDDTRFIVYELM 229 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~~ 229 (331)
..++ |....||+....+|+.+++|...... .....+..|..++..+... .+.+++.. ....+..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77789999887777789999985321 1234566777777766422 23444432 22345678899999
Q ss_pred CCCChhh--------------hhcC---CC---CCCCCCHHHH----HHH---------------HHHHHHHHHHHhhC-
Q 020072 230 ENRSLDI--------------QLHG---PS---HGSALTWHMR----MKI---------------ALDTARGLEYLHEH- 269 (331)
Q Consensus 230 ~~g~L~~--------------~l~~---~~---~~~~l~~~~~----~~i---------------~~~ia~~l~yLH~~- 269 (331)
++..+.. .+|. .. .....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754320 0111 00 0111222211 000 11111223333221
Q ss_pred ---CCCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 270 ---CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 270 ---~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 5 899999987743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00067 Score=60.47 Aligned_cols=32 Identities=25% Similarity=0.341 Sum_probs=27.7
Q ss_pred CCceEecCCCCCCEEECCC----CcEEEEeccCcee
Q 020072 271 NPAVIHRDLKSSNILLDSK----FNAKLSDFGLAIT 302 (331)
Q Consensus 271 ~~~ivHrdlk~~Nill~~~----~~~kl~Dfgla~~ 302 (331)
...++|||+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3489999999999999875 6899999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00091 Score=62.55 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=47.2
Q ss_pred cceeeecCceEEEEEEECC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEEEecCCCC
Q 020072 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELMENRS 233 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~g~ 233 (331)
.+.|+.|-...+|+....+ +..+.+|+....... .-+..+|..++..|...++ .++++++. +. +|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 3467778888999998765 467888877433221 1123678888888865555 45676663 22 5999998755
Q ss_pred h
Q 020072 234 L 234 (331)
Q Consensus 234 L 234 (331)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00026 Score=65.79 Aligned_cols=73 Identities=12% Similarity=0.118 Sum_probs=48.4
Q ss_pred cceeeecCceEEEEEEECC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 226 (331)
.+.|+.|....+|+....+ +..+.+|+..... ....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567778889999998753 4678888874321 11455678888888753333 556665542 2899
Q ss_pred EecCCCCh
Q 020072 227 ELMENRSL 234 (331)
Q Consensus 227 e~~~~g~L 234 (331)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00088 Score=61.04 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=82.0
Q ss_pred ceeeecCceEEEEEEEC--------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeEEcCCeEEEEEE
Q 020072 157 NILGEGGFGCVYKAKLD--------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e 227 (331)
+.+..|-...+|+.... ++..+.+|+..... .....+.+|..+++.|.-.+ ..++++++.+ . +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence 45666777788998764 24678888864322 23456678998888874222 3456666543 2 8999
Q ss_pred ecCCCChhh-----------------hhcCCC--CCCCC--CHHHHHHHHHHHHH-------------------HHHHHh
Q 020072 228 LMENRSLDI-----------------QLHGPS--HGSAL--TWHMRMKIALDTAR-------------------GLEYLH 267 (331)
Q Consensus 228 ~~~~g~L~~-----------------~l~~~~--~~~~l--~~~~~~~i~~~ia~-------------------~l~yLH 267 (331)
|+++.+|.. .||... .+... -|.+..++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865531 122211 11122 24455555544322 233332
Q ss_pred ----hC-CCCceEecCCCCCCEEECCC----CcEEEEeccCce
Q 020072 268 ----EH-CNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAI 301 (331)
Q Consensus 268 ----~~-~~~~ivHrdlk~~Nill~~~----~~~kl~Dfgla~ 301 (331)
.. ....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23478999999999999876 789999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0009 Score=60.61 Aligned_cols=73 Identities=11% Similarity=0.066 Sum_probs=42.7
Q ss_pred ceeeecCceEEEEEEECC---------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEE
Q 020072 157 NILGEGGFGCVYKAKLDD---------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 226 (331)
+.++.|....+|+....+ +..+++|....... ...+...|.++++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 456677778999988754 25788887643222 22234678888877743333 3565543 2 26899
Q ss_pred EecCCCCh
Q 020072 227 ELMENRSL 234 (331)
Q Consensus 227 e~~~~g~L 234 (331)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0072 Score=54.05 Aligned_cols=31 Identities=16% Similarity=0.326 Sum_probs=27.7
Q ss_pred CceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 272 ~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987744
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.023 Score=52.36 Aligned_cols=140 Identities=14% Similarity=0.185 Sum_probs=82.3
Q ss_pred cceeeecCceEEEEEEECC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-ceeeeeeEEcCCeEEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~ 226 (331)
.+.+..|-...+|+....+ +..+.+|+..... ...-+..+|..+++.+.-.+ ..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3456667778999988753 5778888864332 22223467888887774323 34455433 2 27899
Q ss_pred EecCCCChhh-----------------hhcC--------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 020072 227 ELMENRSLDI-----------------QLHG--------PS--HGSALTWHMRMKIALDT-------------------A 260 (331)
Q Consensus 227 e~~~~g~L~~-----------------~l~~--------~~--~~~~l~~~~~~~i~~~i-------------------a 260 (331)
||+++.+|.. .||. +. ...+.-|.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999866421 0111 00 11122344444443222 2
Q ss_pred HHHHHHhhC---------------------CCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 261 RGLEYLHEH---------------------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 261 ~~l~yLH~~---------------------~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
..+++|.+. ....++|+|+.+.||+ ++++.+.++||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 233343311 1236899999999999 888899999999884
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0071 Score=36.23 Aligned_cols=25 Identities=24% Similarity=0.153 Sum_probs=11.7
Q ss_pred EEehhHHHHHHHHHHHHHHHHhhhh
Q 020072 72 IALIIACSALCLIILALLCLWLYHL 96 (331)
Q Consensus 72 i~~~v~~~~~~~l~~~~~~~~~~~~ 96 (331)
|+..++++++++++++++.++++|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 5555555555544444443333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.0098 Score=35.55 Aligned_cols=24 Identities=21% Similarity=0.170 Sum_probs=10.5
Q ss_pred EEehhHHHHHHHHHHHHHHHHhhh
Q 020072 72 IALIIACSALCLIILALLCLWLYH 95 (331)
Q Consensus 72 i~~~v~~~~~~~l~~~~~~~~~~~ 95 (331)
|+..++++++++++++++.++++|
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~R 35 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVR 35 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHHHHHHHHhh
Confidence 444554444444444433333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.45 E-value=0.031 Score=33.33 Aligned_cols=7 Identities=14% Similarity=0.074 Sum_probs=2.9
Q ss_pred EEehhHH
Q 020072 72 IALIIAC 78 (331)
Q Consensus 72 i~~~v~~ 78 (331)
|+.++++
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 3444444
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.35 E-value=0.019 Score=33.22 Aligned_cols=25 Identities=16% Similarity=0.064 Sum_probs=12.5
Q ss_pred EEehhHHHHHHHHHHHHHHHHhhhh
Q 020072 72 IALIIACSALCLIILALLCLWLYHL 96 (331)
Q Consensus 72 i~~~v~~~~~~~l~~~~~~~~~~~~ 96 (331)
|+.+++++++.+++++.+.++++||
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeeehHHHHHHHHHHHHHHHHeec
Confidence 4445555555555555555555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.21 E-value=0.35 Score=44.00 Aligned_cols=29 Identities=34% Similarity=0.442 Sum_probs=24.8
Q ss_pred ceEecCCCCCCEEE------CCCCcEEEEeccCce
Q 020072 273 AVIHRDLKSSNILL------DSKFNAKLSDFGLAI 301 (331)
Q Consensus 273 ~ivHrdlk~~Nill------~~~~~~kl~Dfgla~ 301 (331)
-++|+|+.+.|||+ +++..++++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456779999999884
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.97 E-value=0.27 Score=40.51 Aligned_cols=84 Identities=14% Similarity=0.131 Sum_probs=63.9
Q ss_pred CCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 205 ~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
.||+++.. .+-.+.+...+.|+.-+++.-...+ ..++...+++++..|+...++++.. +|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 68888876 5666777777777665544322333 2478899999999999988766644 6778999999
Q ss_pred EECCCCcEEEEeccCc
Q 020072 285 LLDSKFNAKLSDFGLA 300 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla 300 (331)
+++.++.+++.=.|+-
T Consensus 111 ~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp EECTTSCEEESCCEET
T ss_pred EEcCCCCEEEEEccCc
Confidence 9999999999988864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.80 E-value=0.43 Score=39.46 Aligned_cols=83 Identities=10% Similarity=0.095 Sum_probs=62.4
Q ss_pred CCCcceeeeeeEEcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCceEecCCCCCC
Q 020072 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE-YLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 205 ~H~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~ivHrdlk~~N 283 (331)
.||++ -...-.+++...+.++.-+++.-...+. .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57877 3344567778888887765554444443 4788899999999888766 5553 4777899999
Q ss_pred EEECCCCcEEEEeccCc
Q 020072 284 ILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla 300 (331)
+++|.++.+++.=.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999988864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.95 E-value=0.037 Score=51.72 Aligned_cols=59 Identities=8% Similarity=0.108 Sum_probs=16.9
Q ss_pred cceeeecCceEEEEEEECC-CceEEE------EEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEE
Q 020072 156 SNILGEGGFGCVYKAKLDD-NLHVAV------KKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
.+.+| ||.||+|.+.. ..+||| |..... ..+....|.+|..+++.++|+|+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34565 99999998864 367888 766432 2334457888999999999999999988754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=81.50 E-value=0.087 Score=49.41 Aligned_cols=31 Identities=6% Similarity=-0.113 Sum_probs=26.0
Q ss_pred hHHHHHHHHHHHhcCCCCcceeeeeeEEcCC
Q 020072 190 AGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (331)
Q Consensus 190 ~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 220 (331)
..++|..|++.+.+++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 3568999999999999999999999998653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 331 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-50
Identities = 58/180 (32%), Positives = 86/180 (47%), Gaps = 8/180 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+G G FG VYK K ++ V + + T + F+NEV +L H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
+GYS IV + E SL LH + + IA TA+G++YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+IHRDLKS+NI L K+ DFGLA + S + +LSG++ ++APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-49
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 9/188 (4%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
+E D F + + LG G G V+K L +A K + + A R E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ P +V G D I E M+ SLD L + + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
YL E ++HRD+K SNIL++S+ KL DFG++ N+ GT Y++PE
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPE 173
Query: 324 YLLDGMVN 331
L +
Sbjct: 174 RLQGTHYS 181
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-48
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENE 197
+ KL+E+ LG G FG V+ + + VAVK L + F E
Sbjct: 10 VPRETLKLVER----------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAE 58
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
+L+ + H +V L + +I+ E MEN SL L P G LT + + +A
Sbjct: 59 ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAA 116
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGT 316
A G+ ++ E IHRDL+++NIL+ + K++DFGLA + + ++
Sbjct: 117 QIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 317 LGYVAPEYLLDG 328
+ + APE + G
Sbjct: 174 IKWTAPEAINYG 185
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-47
Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 6/183 (3%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
D + LG+G FG VYKA+ + ++ A K +D +++ ++ E+D+L++ HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V LL +++ +I+ E ++D + LT + T L YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+ +IHRDLK+ NIL + KL+DFG++ + + GT ++APE ++
Sbjct: 129 NK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 329 MVN 331
Sbjct: 186 TSK 188
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 8e-47
Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
F + +G G FG VY A+ + ++ VA+KK+ + + + ++ EV L +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HPN + G + T ++V E + D+ H L + +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH H +IHRD+K+ NILL KL DFG A N GT ++APE +
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPEVI 183
Query: 326 L 326
L
Sbjct: 184 L 184
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-45
Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 7/182 (3%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LG G FG V K VA+K + + EF E ++ N+ H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G FI+ E M N L L H +++ D +EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
+HRDL + N L++ + K+SDFGL+ + +++ + + PE L+
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 330 VN 331
+
Sbjct: 178 FS 179
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-44
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 7/182 (3%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+G G FG V+ + VA+K + +F E +++ + HP +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G +V+E ME+ L + + + + LD G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
VIHRDL + N L+ K+SDFG+ Q ++ + + +PE
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 330 VN 331
+
Sbjct: 179 YS 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-44
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 138 ISFIE-YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA-TQDAGREF 194
+ F+E + L++ LGEG +G V A VAVK +D D
Sbjct: 1 VPFVEDWDLVQT----------LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI 50
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ E+ + ++H NVV G+ + +++ E L ++ + +
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQR 107
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
G+ YLH + HRD+K N+LLD + N K+SDFGLA ++ + K
Sbjct: 108 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 313 LSGTLGYVAPEYLLDG 328
+ GTL YVAPE L
Sbjct: 165 MCGTLPYVAPELLKRR 180
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-44
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 12/185 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
+ F LG+G FG VY A+ +A+K L + EV++ S++ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
PN++ L GY +++ E ++ +L S + A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H VIHRD+K N+LL S K++DFG ++ S + L GTL Y+ PE +
Sbjct: 123 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC--GTLDYLPPEMIE 177
Query: 327 DGMVN 331
M +
Sbjct: 178 GRMHD 182
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-43
Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 8/189 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +G G +G K + D + K+LD + + +EV+LL + HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 208 NVVCLLGY--SAHDDTRFIVYELMENRSLDIQLH-GPSHGSALTWHMRMKIALDTARGLE 264
N+V + T +IV E E L + G L +++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHEH--CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
H V+HRDLK +N+ LD K N KL DFGLA GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 323 EYLLDGMVN 331
E + N
Sbjct: 184 EQMNRMSYN 192
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 3e-43
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 24/208 (11%)
Query: 143 YKLLEKATDSFHES---------NILGEGGFGCVYKAKL----DDNLHVAVKKLD-CATQ 188
++ +A F + ++G G FG V L + VA+K L T+
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 189 DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
R+F +E ++ HPNV+ L G I+ E MEN SLD L + T
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFT 126
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
+ + A G++YL + +HRDL + NIL++S K+SDFGL+
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 309 NNLKLS-----GTLGYVAPEYLLDGMVN 331
+ S + + APE +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFT 211
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-43
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G+G FG V++ K VAVK + ++ E E+ + H N++ +
Sbjct: 11 IGKGRFGEVWRGKWRGEE-VAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 219 DD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC---- 270
D+ ++V + E+ SL L+ + +T +K+AL TA GL +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 271 -NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS----GTLGYVAPEYL 325
PA+ HRDLKS NIL+ ++D GLA+ S GT Y+APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 326 LDGM 329
D +
Sbjct: 185 DDSI 188
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-43
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 7/182 (3%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG+G FG V+ + VA+K L T F E ++ + H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + + +IV E M SL L G + + +A A G+ Y+
Sbjct: 76 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN 133
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
+HRDL+++NIL+ K++DFGLA + + ++ + + APE L G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 330 VN 331
Sbjct: 191 FT 192
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-43
Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G A++ E KLL+ +G+G FG V N VAVK + + F
Sbjct: 1 GWALNMKELKLLQT----------IGKGEFGDVMLGDYRGNK-VAVKCIK--NDATAQAF 47
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
E +++ + H N+V LLG + +IV E M SL L S L +
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLL 106
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
K +LD +EYL + +HRDL + N+L+ AK+SDFGL S
Sbjct: 107 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---G 160
Query: 314 SGTLGYVAPEYLLDGMVN 331
+ + APE L + +
Sbjct: 161 KLPVKWTAPEALREKKFS 178
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 2e-42
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLD-CATQDAGREFENEV 198
LE ++ +GEG FG V++A+ L VAVK L A+ D +F+ E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS------------- 245
L++ +PN+V LLG A +++E M L+ L S +
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 246 --------ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
L+ ++ IA A G+ YL E +HRDL + N L+ K++DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 184
Query: 298 GLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331
GL+ I K + + + ++ PE +
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 3e-42
Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 7/192 (3%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDL 200
Y E + LG G +G VY+ +L VAVK L T + EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ I HPN+V LLG + +I+ E M +L L + ++ + + +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGY 319
+EYL + IHRDL + N L+ K++DFGL+ + G + + +
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 320 VAPEYLLDGMVN 331
APE L +
Sbjct: 183 TAPESLAYNKFS 194
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 14/177 (7%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL 213
+G G F VYK + + VA +L T+ + F+ E ++L + HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 214 GY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+V ELM + +L L + + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 270 CNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
P +IHRDLK NI + + K+ D GLA + + GT ++APE
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEMY 185
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-42
Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 18/190 (9%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y EK +G+G G VY A + VA+++++ Q NE+ ++
Sbjct: 22 YTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+PN+V L D ++V E + SL + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQ 127
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
LE+LH + VIHRD+KS NILL + KL+DFG + + GT ++A
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 322 PEYLLDGMVN 331
PE +
Sbjct: 185 PEVVTRKAYG 194
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-41
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 21/197 (10%)
Query: 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCATQDAG--REF 194
+++ KLL E LG G FG V K VAVK L D E
Sbjct: 2 YLDRKLL------TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
E +++ + +P +V ++G ++ +V E+ E L+ L H + ++
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIE 111
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNL 311
+ + G++YL E +HRDL + N+LL ++ AK+SDFGL+ D + K
Sbjct: 112 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 312 KLSGTLGYVAPEYLLDG 328
+ + APE +
Sbjct: 169 HGKWPVKWYAPECINYY 185
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-41
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 33/211 (15%)
Query: 151 DSFHESNILGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
++ +LG G FG V A K ++ VAVK L + RE +E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 204 I-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSH------------------- 243
+ H N+V LLG ++++E L L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 244 -GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-- 300
+ LT+ + A A+G+E+L +HRDL + N+L+ K+ DFGLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331
I S + ++APE L +G+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-41
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDN---LHVAVKKLD-CATQDAGREFENEVDLLSNI-H 205
+ +++GEG FG V KA++ + + A+K++ A++D R+F E+++L + H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG-------------PSHGSALTWHMR 252
HPN++ LLG H ++ E + +L L S S L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
+ A D ARG++YL + IHRDL + NIL+ + AK++DFGL+ K +
Sbjct: 130 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185
Query: 313 LSGTLGYVAPEYLLDG 328
+ ++A E L
Sbjct: 186 GRLPVRWMAIESLNYS 201
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 14/191 (7%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLD-CATQDAGREFENEVDL 200
E ++G G FG VYK L + + VA+K L T+ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N++ L G + I+ E MEN + + + + + A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTL 317
G++YL +HRDL + NIL++S K+SDFGL+ D +
Sbjct: 121 AGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 318 GYVAPEYLLDG 328
+ APE +
Sbjct: 178 RWTAPEAISYR 188
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (359), Expect = 2e-40
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 9/184 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
D + LG G FG V++ + A K + + E+ +S + HP +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V L D+ ++YE M L ++ + ++ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 270 CNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+H DLK NI+ +K + KL DFGL + +GT + APE
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEVAEG 199
Query: 328 GMVN 331
V
Sbjct: 200 KPVG 203
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-40
Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 14/193 (7%)
Query: 144 KLLEKATDSFHESNI-LGEGGFGCVYKAKL---DDNLHVAVKKLDCATQDAGRE-FENEV 198
K L D+ ++I LG G FG V + + VA+K L T+ A E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
++ + +P +V L+G + +V E+ L L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---G 315
+ G++YL E +HRDL + N+LL ++ AK+SDFGL+ G+ + S
Sbjct: 118 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 316 TLGYVAPEYLLDG 328
L + APE +
Sbjct: 175 PLKWYAPECINFR 187
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (355), Expect = 9e-40
Identities = 40/192 (20%), Positives = 77/192 (40%), Gaps = 19/192 (9%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y +LE+ LG G FG V++ K ++ +NE+ ++
Sbjct: 31 YDILEE----------LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+ +HHP ++ L ++ E + L ++ + ++ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACE 138
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLAITDGSQNKNNLKLSGTLGY 319
GL+++HEH ++H D+K NI+ ++K + K+ DFGLA + T +
Sbjct: 139 GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTTATAEF 194
Query: 320 VAPEYLLDGMVN 331
APE + V
Sbjct: 195 AAPEIVDREPVG 206
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-40
Identities = 46/192 (23%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 148 KATDSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKL-DCATQDAGREFENEVDLL 201
K T+ F + +LG G FG VYK + VA+K+L + + A +E +E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+++ +P+V LLG + I + LD + H + + + A+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD---YVREHKDNIGSQYLLNWCVQIAK 122
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
G+ YL + ++HRDL + N+L+ + + K++DFGLA + + + + +
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 320 VAPEYLLDGMVN 331
+A E +L +
Sbjct: 180 MALESILHRIYT 191
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-39
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 12/191 (6%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLS 202
+K + F ILGEG F V A+ L + A+K L+ ++ E D++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+ HP V L D+ + +N L + + +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLGYV 320
LEYLH +IHRDLK NILL+ + +++DFG A ++K GT YV
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 321 APEYLLDGMVN 331
+PE L +
Sbjct: 178 SPELLTEKSAC 188
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 6e-39
Identities = 52/206 (25%), Positives = 78/206 (37%), Gaps = 28/206 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
+ LG G FG V +A D + VAVK L + RE +E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 204 I-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG---------------PSHGSAL 247
+ +H N+V LLG ++ E L L AL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 248 TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ + A+G+ +L IHRDL + NILL K+ DFGLA I + S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331
+ ++APE + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYT 225
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 15/185 (8%)
Query: 154 HESNILGEGGFGCVYKAKLDDN----LHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
H + ++G G FGCVY L DN +H AVK L+ +F E ++ + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 209 VVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V+ LLG + +V M++ L + T + L A+G+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLGYVAPE 323
+ +HRDL + N +LD KF K++DFGLA + N + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 324 YLLDG 328
L
Sbjct: 205 SLQTQ 209
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 3e-38
Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 15/186 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCAT------QDAGREFENEVDLLSN 203
+ F I+G GGFG VY + D A+K LD + + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
P +VC+ D + +LM L L + A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
E++H V++RDLK +NILLD + ++SD GLA + + GT GY+APE
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 324 YLLDGM 329
L G+
Sbjct: 176 VLQKGV 181
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 19/197 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLD-CATQDAGREFENEVDLLSN 203
+ S LG+G FG VY+ + VA+K ++ A+ EF NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA-------LTWHMRMKIA 256
+ +VV LLG + ++ ELM L L A + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQNKNNLKLS 314
+ A G+ YL+ + +HRDL + N ++ F K+ DFG+ I + + K
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 315 GTLGYVAPEYLLDGMVN 331
+ +++PE L DG+
Sbjct: 197 LPVRWMSPESLKDGVFT 213
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-38
Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 26/204 (12%)
Query: 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLD---CATQDA 190
I + +LLEK LG+G FG V + + D + VAVK L + +A
Sbjct: 5 IGEKDLRLLEK----------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 54
Query: 191 GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH 250
+F EV+ + ++ H N++ L G +V EL SL H
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLL--DRLRKHQGHFLLG 111
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQN 307
+ A+ A G+ YL IHRDL + N+LL ++ K+ DFGL +
Sbjct: 112 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 308 KNNLKLSGTLGYVAPEYLLDGMVN 331
+ APE L +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFS 192
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 65/179 (36%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDC-----ATQDAGREFENEVDLLSNIHHPNVV 210
+ LGEG F VYKA+ + N VA+KK+ A R E+ LL + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LL H +V++ ME I + LT L T +GLEYLH+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329
++HRDLK +N+LLD KL+DFGLA + GS N+ T Y APE L
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-37
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIH 205
+ +GEG FG V++ + L VA+K T D+ RE F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HP++V L+G ++ +I+ EL L +L + A + L Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEY 324
L +HRD+ + N+L+ S KL DFGL+ + S K + ++APE
Sbjct: 124 LESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 325 LLDG 328
+
Sbjct: 181 INFR 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-35
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 8/181 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHP 207
++F + +GEG +G VYKA+ VA+KK+ D T+ E+ LL ++HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LL ++ ++V+E + G + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
H V+HRDLK N+L++++ KL+DFGLA G + TL Y APE LL
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 328 G 328
Sbjct: 177 C 177
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 8e-35
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 12/191 (6%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC-ATQDAGREFENEVDL 200
+K E D + ++LG G F V A+ VA+K + A + ENE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
L I HPN+V L +++ +L+ L ++ T ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
++YLH+ ++HRDLK N+L D +SDFGL+ + + + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTP 173
Query: 318 GYVAPEYLLDG 328
GYVAPE L
Sbjct: 174 GYVAPEVLAQK 184
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (316), Expect = 9e-35
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 17/193 (8%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIH 205
+D + ILG GG V+ A+ L + VAVK L F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 206 HPNVVCLLGYSAHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
HP +V + + +IV E ++ +L +H +T +++ D +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTLG 318
L + H++ +IHRD+K +NI++ + K+ DFG+A + + + GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 319 YVAPEYLLDGMVN 331
Y++PE V+
Sbjct: 180 YLSPEQARGDSVD 192
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (318), Expect = 1e-34
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 23/194 (11%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENE 197
++++L LG G FG V+ + + + A+K L +E
Sbjct: 5 DFQILRT----------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
+LS + HP ++ + G F++ + +E L L + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAA 111
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+ LEYLH +I+RDLK NILLD + K++DFG A L GT
Sbjct: 112 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCGTP 165
Query: 318 GYVAPEYLLDGMVN 331
Y+APE + N
Sbjct: 166 DYIAPEVVSTKPYN 179
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 58/205 (28%), Positives = 79/205 (38%), Gaps = 27/205 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLD-CATQDAGREFENEVDLLSN 203
D LG G FG V +A VAVK L AT R +E+ +L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 204 I-HHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHG-------------PSHGSALT 248
I HH NVV LLG ++ E + +L L + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ 306
+ + A+G+E+L IHRDL + NILL K K+ DFGLA I
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331
L ++APE + D +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYT 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 11/186 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLS-NIH 205
+ F +LG+G FG V+ A+ N A+K L D E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HP + + + F V E + L + A + GL++
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH +++RDLK NILLD + K++DFG+ + + GT Y+APE L
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 326 LDGMVN 331
L N
Sbjct: 176 LGQKYN 181
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-34
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 8/185 (4%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHP 207
+ + +GEG +G V A + + VA+KK+ Q + E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N++ + + + + L+ L+ RGL+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEY 324
V+HRDLK SN+LL++ + K+ DFGLA D + T Y APE
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 325 LLDGM 329
+L+
Sbjct: 184 MLNSK 188
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (310), Expect = 7e-34
Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 18/192 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---------QDAGREFENEVDL 200
+++ ILG G V + AVK +D Q+ EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 201 LSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
L + HPN++ L + F+V++LM+ L L L+ KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+ LH+ ++HRDLK NILLD N KL+DFG + K ++ GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-EVCGTPSY 175
Query: 320 VAPEYLLDGMVN 331
+APE + M +
Sbjct: 176 LAPEIIECSMND 187
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-34
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 16/187 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
S+ ++ ++G G FG VY+AKL D VA+KK+ R E+ ++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 210 VCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
V L + + +V + + + H L R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
Y+H + HRD+K N+LLD KL DFG A + + N+ + Y AP
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-KQLVRGEPNVSYICSRYYRAP 191
Query: 323 EYLLDGM 329
E +
Sbjct: 192 ELIFGAT 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 1e-33
Identities = 36/192 (18%), Positives = 71/192 (36%), Gaps = 20/192 (10%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y + E LG G FG V++ K + D + E+ +L
Sbjct: 7 YMIAED----------LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISIL 55
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+ H N++ L + +++E + + +++ + L +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCE 113
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLAITDGSQNKNNLKLSGTLGY 319
L++LH H + H D++ NI+ ++ ++ K+ +FG A N L Y
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA-RQLKPGDNFRLLFTAPEY 169
Query: 320 VAPEYLLDGMVN 331
APE +V+
Sbjct: 170 YAPEVHQHDVVS 181
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (306), Expect = 3e-33
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 8/181 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPN 208
+ +H +GEG +G VYKA+ + A+KK+ +D G E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V L +V+E ++ + L L G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
V+HRDLK N+L++ + K++DFGLA G + TL Y AP+ L+
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 329 M 329
Sbjct: 176 K 176
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 9e-33
Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKL--------DDNLHVAVKKLD-CATQDAGREFENEVDLL 201
D LGEG FG V A+ + VAVK L AT+ + +E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 202 SNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-------------GPSHGSAL 247
I H N++ LLG D +++ E +L L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 248 TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ + A ARG+EYL IHRDL + N+L+ K++DFGLA I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331
K + ++APE L D +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYT 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 49/185 (26%), Positives = 68/185 (36%), Gaps = 10/185 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
+ F +LG+G FG V + + A+K L +D E +L N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P + L D V E L L T + LEYL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H V++RD+K N++LD + K++DFGL S GT Y+APE L
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 327 DGMVN 331
D
Sbjct: 179 DNDYG 183
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 51/192 (26%), Positives = 74/192 (38%), Gaps = 18/192 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR------EFENEVDLLSN 203
D + LG G F V K + L A K + + R + E EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
I HPNV+ L + ++ EL+ L + +LT + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGV 126
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
YLH + H DLK NI+L K K+ DFGLA N+ + GT +
Sbjct: 127 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEF 182
Query: 320 VAPEYLLDGMVN 331
VAPE + +
Sbjct: 183 VAPEIVNYEPLG 194
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-31
Identities = 48/184 (26%), Positives = 71/184 (38%), Gaps = 17/184 (9%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKL------DCATQDAGREFENEVDLLSNIH--HPN 208
+LG GGFG VY + DNL VA+K + D G EV LL +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
V+ LL + D+ ++ E E + AL + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 269 HCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
V+HRD+K NIL+D ++ KL DFG + GT Y PE++
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRY 183
Query: 328 GMVN 331
+
Sbjct: 184 HRYH 187
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 9e-31
Identities = 51/196 (26%), Positives = 76/196 (38%), Gaps = 30/196 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L+ +G G +G V A VA+KKL Q + E+
Sbjct: 20 YRDLQP----------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
LL ++ H NV+ LL D+T ++V M + H L
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQ 124
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ +GL Y+H HRDLK N+ ++ K+ DFGLA S+ +
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-- 179
Query: 314 SGTLGYVAPEYLLDGM 329
T Y APE +L+ M
Sbjct: 180 -VTRWYRAPEVILNWM 194
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 9e-31
Identities = 48/199 (24%), Positives = 73/199 (36%), Gaps = 28/199 (14%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
+YK+ + +LG G G V + A+K L + EV+L
Sbjct: 12 DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVEL 57
Query: 201 LSNI-HHPNVVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
P++V ++ A IV E ++ L ++ + T +I
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEI 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITDGSQNKNNLK 312
++YLH + HRD+K N+L SK KL+DFG A S N
Sbjct: 117 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-T 172
Query: 313 LSGTLGYVAPEYLLDGMVN 331
T YVAPE L +
Sbjct: 173 PCYTPYYVAPEVLGPEKYD 191
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 58/196 (29%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQDAG--REFENEVDLLSN 203
+A + +GEG +G V+KA+ + VA+K++ T + G EV +L +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 204 I---HHPNVVCLLGY-----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
+ HPNVV L + + +V+E ++ P G + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDM 121
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
RGL++LH H V+HRDLK NIL+ S KL+DFGLA Q +
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVV 177
Query: 316 TLGYVAPEYLLDGMVN 331
TL Y APE LL
Sbjct: 178 TLWYRAPEVLLQSSYA 193
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 19/189 (10%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ LEK +GEG +G V+KAK + + VA+K++ D G E+
Sbjct: 4 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
LL + H N+V L D +V+E + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQL 110
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+GL + H V+HRDLK N+L++ KL++FGLA G + TL Y
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 320 VAPEYLLDG 328
P+ L
Sbjct: 168 RPPDVLFGA 176
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 31/202 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L K +G+G FG V+KA+ VA+KK+ + G E+
Sbjct: 12 YEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 200 LLSNIHHPNVVCLLG--------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251
+L + H NVV L+ Y+ + ++V++ E+ + + T
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSE 118
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQN 307
++ GL Y+H + ++HRD+K++N+L+ KL+DFGLA + SQ
Sbjct: 119 IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 308 KNNLKLSGTLGYVAPEYLLDGM 329
TL Y PE LL
Sbjct: 176 NRYTNRVVTLWYRPPELLLGER 197
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (279), Expect = 8e-29
Identities = 48/185 (25%), Positives = 71/185 (38%), Gaps = 13/185 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
D F LG G FG V K + H A+K LD NE +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P +V L + ++V E + + L + A EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +I+RDLK N+L+D + +++DFG A + L GT +APE +L
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEALAPEIIL 211
Query: 327 DGMVN 331
N
Sbjct: 212 SKGYN 216
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-27
Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 30/201 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y+L K +G G FG +Y + VA+K T+ + E +
Sbjct: 9 YRLGRK----------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIY 56
Query: 202 SNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ + + A D +V EL+ D+ + + +A
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMI 113
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA-------ITDGSQNKNN 310
+EY+H IHRD+K N L+ + DFGLA + N
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 311 LKLSGTLGYVAPEYLLDGMVN 331
L+GT Y + L +
Sbjct: 171 KNLTGTARYASINTHLGIEQS 191
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (266), Expect = 2e-27
Identities = 34/203 (16%), Positives = 68/203 (33%), Gaps = 32/203 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
YK+ + +GEG FG +++ L +N VA+K + + +E
Sbjct: 7 YKVGRR----------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY 54
Query: 202 SNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ + + + +V +L+ D+ G + A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQML 111
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKF-----NAKLSDFGLA-------ITDGSQNK 308
++ +HE +++RD+K N L+ + DFG+ +
Sbjct: 112 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 309 NNLKLSGTLGYVAPEYLLDGMVN 331
LSGT Y++ L +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQS 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (266), Expect = 3e-27
Identities = 39/179 (21%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPN 208
D + LG G + V++A + +N V VK L + ++ + E+ +L N+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 209 VVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
++ L +R +V+E + N LT + + + L+Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYC 145
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
H ++HRD+K N+++D + +L D+GLA + + + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPEL 200
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 20/189 (10%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHH 206
+ + + +G G +G V A L VAVKKL Q + E+ LL ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 207 PNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
NV+ LL + ++V LM +I LT +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQIL 131
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
RGL+Y+H HRDLK SN+ ++ K+ DFGLA + + T Y
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA---TRWYR 185
Query: 321 APEYLLDGM 329
APE +L+ M
Sbjct: 186 APEIMLNWM 194
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-25
Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 16/188 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLS 202
++F +LG G +G V+ + D A+K L AT E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 203 NI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+I P +V L + ++ + + L L + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT-DGSQNKNNLKLSGTLGYV 320
+ L +I+RD+K NILLDS + L+DFGL+ + + GT+ Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 321 APEYLLDG 328
AP+ + G
Sbjct: 198 APDIVRGG 205
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 8e-25
Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 29/194 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L+ +G G G V A + +VA+KKL Q+ + E+
Sbjct: 19 YQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
L+ ++H N++ LL T ++V ELM+ +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMS 122
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ G+++LH IHRDLK SNI++ S K+ DFGLA T G+
Sbjct: 123 YLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-PY 178
Query: 314 SGTLGYVAPEYLLD 327
T Y APE +L
Sbjct: 179 VVTRYYRAPEVILG 192
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.6 bits (213), Expect = 8e-20
Identities = 42/203 (20%), Positives = 72/203 (35%), Gaps = 30/203 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y L+ K LG G F V+ AK + +N HVA+K + E+E+ LL
Sbjct: 15 YILVRK----------LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLL 63
Query: 202 SNIHHPNVVCLLGYSA-------------HDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
++ + A + +V + L +
Sbjct: 64 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 123
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGS-- 305
+I+ GL+Y+H C +IH D+K N+L++ L +A +
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 306 QNKNNLKLSGTLGYVAPEYLLDG 328
+++ T Y +PE LL
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGA 204
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 2e-19
Identities = 21/161 (13%), Positives = 47/161 (29%), Gaps = 20/161 (12%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVK----------KLDCATQDAGREFENEVDLLSNIHH 206
++GEG V+ + VK K+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+ L G + Y N ++ ++L + ++ +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307
+ ++H DL N+L+ + + DF ++ G +
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.54 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-42 Score=303.02 Aligned_cols=174 Identities=26% Similarity=0.377 Sum_probs=156.8
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999864 68999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988753 3599999999999999999999999 9999999999999999999999999999876555444
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
....+||+.|+|||++.++.|+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~ 194 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYG 194 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC
T ss_pred ccccccCCCccChhhhcCCCCC
Confidence 4556799999999999988775
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=300.00 Aligned_cols=175 Identities=30% Similarity=0.395 Sum_probs=150.7
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... .+..+++.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 457889999999999999999875 68999999986543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999863 35699999999999999999999999 99999999999999999999999999997653222
Q ss_pred --cccceeccccCCccccccccCCC
Q 020072 308 --KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 --~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
......+||+.|||||++.++.+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred ccccccceeeCcCccCHhHhcCCCC
Confidence 22334579999999999988765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=299.25 Aligned_cols=175 Identities=24% Similarity=0.352 Sum_probs=145.7
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888899999997543 345689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-c
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~ 309 (331)
+|+|.+++.. ....+++..++.++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999874 345689999999999999999999999 999999999999999999999999999976543322 2
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....||+.|+|||++.++.||
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC
T ss_pred ecceecCcccCChHHhcCCCCC
Confidence 2234689999999999998876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=302.25 Aligned_cols=172 Identities=30% Similarity=0.461 Sum_probs=152.8
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.+.|+..+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 356888999999999999999875 6889999999877777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 91 CAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 999999998753 235699999999999999999999999 999999999999999999999999999976543333
Q ss_pred ccceeccccCCccccccc
Q 020072 309 NNLKLSGTLGYVAPEYLL 326 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~ 326 (331)
......||+.|+|||++.
T Consensus 166 ~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHTCCCSCCTTCCHHHHT
T ss_pred cccccccccccCCHHHHh
Confidence 333457999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=300.81 Aligned_cols=179 Identities=29% Similarity=0.440 Sum_probs=153.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
|...++|+..+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 34456888899999999999999999988999999997543 345679999999999999999999998865 5679999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++... ....+++.++++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999887642 234599999999999999999999999 9999999999999999999999999999876543
Q ss_pred Cc-ccceeccccCCccccccccCCCC
Q 020072 307 NK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ......||+.|||||++.++.||
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~ 188 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFT 188 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred ccccccccCCcccccChHHHhCCCCC
Confidence 32 22234689999999999887765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=294.10 Aligned_cols=173 Identities=30% Similarity=0.475 Sum_probs=152.7
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999875 6889999998643 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999863 34699999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. .....||+.|||||++.++.|+
T Consensus 160 ~--~~~~~Gt~~Y~APE~~~~~~~~ 182 (263)
T d2j4za1 160 R--RTTLCGTLDYLPPEMIEGRMHD 182 (263)
T ss_dssp C--CEETTEEGGGCCHHHHTTCCCC
T ss_pred c--ccccCCCCcccCHHHHcCCCCC
Confidence 2 2345799999999999988775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-42 Score=304.40 Aligned_cols=181 Identities=28% Similarity=0.380 Sum_probs=156.8
Q ss_pred HHHHhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 146 l~~~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+|...++|+..+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 4445678888999999999999999876 58899999987543 345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+++|+|.+++.. .....+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999999864 2345799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc-ccceeccccCCccccccccCCCC
Q 020072 305 SQNK-NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~-~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......|++.|+|||++.++.||
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred CCCceeeccccccccccChHHHcCCCCC
Confidence 4322 22234588999999999988875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=298.48 Aligned_cols=181 Identities=27% Similarity=0.390 Sum_probs=141.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEc--CCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv 225 (331)
++|+..+.||+|+||+||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999875 68899999986543 3445679999999999999999999999865 4568999
Q ss_pred EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHC--NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
|||+++|+|.+++... .....+++..++.++.|++.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988532 23457999999999999999999999861 12499999999999999999999999999977
Q ss_pred CCCCCcccceeccccCCccccccccCCCC
Q 020072 303 DGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
............||+.|||||++.++.||
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCC
Confidence 65444434456799999999999988775
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=297.28 Aligned_cols=171 Identities=36% Similarity=0.544 Sum_probs=143.7
Q ss_pred HhcCCcccceeeecCceEEEEEEECCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..++|...+.||+|+||+||+|++++ .||||+++.. .....++|++|++++++++|||||+++|++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 45688889999999999999998653 5999998644 34556789999999999999999999999865 5689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.++++. ....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999974 335699999999999999999999999 9999999999999999999999999999665432
Q ss_pred C--cccceeccccCCcccccccc
Q 020072 307 N--KNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~--~~~~~~~gt~~y~aPE~l~~ 327 (331)
. .......||+.|||||++.+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp --------CCCCGGGCCHHHHTT
T ss_pred CCcccccccccCcccCCHHHHhc
Confidence 2 22234579999999999964
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-41 Score=296.86 Aligned_cols=176 Identities=30% Similarity=0.453 Sum_probs=141.0
Q ss_pred cCCcccceeeecCceEEEEEEECC-C---ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..++||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456677899999999999998752 2 35899988654 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998874 345699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcc-----cceeccccCCccccccccCCCC
Q 020072 306 QNKN-----NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~-----~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... .....||+.|||||++.++.||
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 211 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC
Confidence 2211 1123578999999999988875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=298.79 Aligned_cols=176 Identities=28% Similarity=0.335 Sum_probs=156.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++.. .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357899999999999999999874 6899999999643 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999863 34689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........+||+.|+|||++.++.|+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~ 183 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBC
T ss_pred CCcccccceeCHHHhhhhhccCCCCC
Confidence 44444567899999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=306.30 Aligned_cols=175 Identities=29% Similarity=0.413 Sum_probs=152.4
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..++|+..+.||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999875 6899999998654 3344567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999863 3469999999999999999999997 5 799999999999999999999999999975432
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ....+||+.|+|||++.++.||
T Consensus 158 ~~--~~~~~GT~~Y~APEvl~~~~y~ 181 (322)
T d1s9ja_ 158 SM--ANSFVGTRSYMSPERLQGTHYS 181 (322)
T ss_dssp HT--C---CCSSCCCCHHHHHCSCCC
T ss_pred Cc--cccccCCccccCchHHcCCCCC
Confidence 21 2245899999999999998875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-40 Score=297.91 Aligned_cols=176 Identities=24% Similarity=0.348 Sum_probs=156.4
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999874 6899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC--CCcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999863 335699999999999999999999999 9999999999999964 678999999999876544
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....||+.|||||++.++.|+
T Consensus 180 ~~-~~~~~gT~~Y~aPEv~~~~~~~ 203 (350)
T d1koaa2 180 QS-VKVTTGTAEFAAPEVAEGKPVG 203 (350)
T ss_dssp SC-EEEECSCTTTCCHHHHHTCCBC
T ss_pred cc-cceecCcccccCHHHHcCCCCC
Confidence 33 2345799999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=294.85 Aligned_cols=175 Identities=27% Similarity=0.371 Sum_probs=151.1
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57889999999999999999874 6899999998643 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998853 34699999999999999999999999 9999999999999999999999999999876433
Q ss_pred C--cccceeccccCCccccccccCCCC
Q 020072 307 N--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ......+||+.|||||++.++.||
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~ 188 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSAC 188 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCC
T ss_pred CcccccccccCCccccCceeeccCCCC
Confidence 2 222345799999999999988775
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=287.66 Aligned_cols=175 Identities=25% Similarity=0.358 Sum_probs=154.5
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecC
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 230 (331)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999999889999999975443 44689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-c
Q 020072 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (331)
Q Consensus 231 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~ 309 (331)
+|+|..++.. ....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999988764 345689999999999999999999999 999999999999999999999999999976543322 2
Q ss_pred cceeccccCCccccccccCCCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....||+.|+|||.+.++.||
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCC
Confidence 2234689999999999988775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=290.38 Aligned_cols=175 Identities=26% Similarity=0.423 Sum_probs=147.9
Q ss_pred cCCcccce-eeecCceEEEEEEEC---CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNI-LGEGGFGCVYKAKLD---DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~-ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|...++ ||+|+||.||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999764 3557999999754 34456789999999999999999999999975 568999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ....+++.++.+++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998853 345799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc---ccceeccccCCccccccccCCCC
Q 020072 306 QNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......||+.|+|||++.++.||
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFS 190 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred cccccccccccccCccccChHHHhCCCCC
Confidence 332 12234588999999999887764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=290.84 Aligned_cols=176 Identities=27% Similarity=0.419 Sum_probs=144.6
Q ss_pred cCCcccceeeecCceEEEEEEECCC-----ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
+.|+..++||+|+||.||+|+++++ ..||||++... ......+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999987532 46999999654 33445679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
||||+.+|++.+.+.. ....+++.++++++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887753 345799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc---ccceeccccCCccccccccCCCC
Q 020072 305 SQNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... ......||+.|||||++.++.|+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFT 191 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCC
Confidence 3221 22234589999999999988875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-39 Score=293.98 Aligned_cols=176 Identities=21% Similarity=0.321 Sum_probs=155.9
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357899999999999999999874 6899999999766666667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC--CCCcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|......
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887753 345699999999999999999999999 999999999999998 6789999999999876654
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....||+.|+|||++.++.|+
T Consensus 183 ~~-~~~~~gt~~y~aPE~~~~~~~~ 206 (352)
T d1koba_ 183 EI-VKVTTATAEFAAPEIVDREPVG 206 (352)
T ss_dssp SC-EEEECSSGGGCCHHHHTTCCBC
T ss_pred Cc-eeeccCcccccCHHHHcCCCCC
Confidence 33 2345799999999999888764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-40 Score=292.63 Aligned_cols=167 Identities=31% Similarity=0.442 Sum_probs=146.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999864 688999999865432 34467999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|..++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999999776642 35699999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcccceeccccCCcccccccc
Q 020072 307 NKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~ 327 (331)
....||+.|||||++.+
T Consensus 169 ----~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTT
T ss_pred ----CccccCccccCHHHHhc
Confidence 23479999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-39 Score=291.10 Aligned_cols=172 Identities=28% Similarity=0.369 Sum_probs=152.5
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57889999999999999999874 6899999998643 2334577999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988853 45688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. ..+||+.|||||++.++.|+
T Consensus 158 ~~---~~~Gt~~Y~APE~l~~~~y~ 179 (316)
T d1fota_ 158 TY---TLCGTPDYIAPEVVSTKPYN 179 (316)
T ss_dssp BC---CCCSCTTTCCHHHHTTCCBC
T ss_pred cc---cccCcccccCHHHHcCCCCC
Confidence 32 45799999999999888775
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=283.47 Aligned_cols=171 Identities=27% Similarity=0.417 Sum_probs=143.0
Q ss_pred cccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc----CCeEEEEE
Q 020072 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVY 226 (331)
Q Consensus 154 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 226 (331)
+..+.||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++||||+++++++.+ ++..|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999875 5789999998644 34455679999999999999999999999875 34689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC-CCCcEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~ 305 (331)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999863 35699999999999999999999998 12399999999999996 578999999999976443
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....||+.|||||++.+ .||
T Consensus 168 ~~--~~~~~GT~~Y~aPE~~~~-~~~ 190 (270)
T d1t4ha_ 168 SF--AKAVIGTPEFMAPEMYEE-KYD 190 (270)
T ss_dssp TS--BEESCSSCCCCCGGGGGT-CCC
T ss_pred Cc--cCCcccCccccCHHHhCC-CCC
Confidence 32 234579999999998864 454
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-40 Score=292.90 Aligned_cols=176 Identities=27% Similarity=0.397 Sum_probs=138.1
Q ss_pred HhcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
..+.|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|++++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999875 68899999986543 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEEC---CCCcEEEEeccCceeC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAITD 303 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgla~~~ 303 (331)
||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999964 35699999999999999999999999 999999999999994 5789999999999765
Q ss_pred CCCCcccceeccccCCccccccccCCCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ....+||+.|||||++.++.|+
T Consensus 161 ~~~~~-~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 161 DPGSV-LSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp -------------CTTSCHHHHTTCCCC
T ss_pred cCCCe-eeeeeeCccccCcHHHcCCCCC
Confidence 43322 2345799999999999988775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=290.01 Aligned_cols=176 Identities=28% Similarity=0.405 Sum_probs=146.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++|+..+.||+|+||.||+|+++++..||||++.... ...++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46788999999999999999999988899999996543 345679999999999999999999999854 5689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++|+|..++... ....++|.+++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999887642 234699999999999999999999999 999999999999999999999999999976543322
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......||+.|+|||++.++.+|
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~ 192 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFT 192 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCC
T ss_pred eeccccccccccChHHHhCCCCC
Confidence 22234689999999999988875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=294.92 Aligned_cols=182 Identities=26% Similarity=0.405 Sum_probs=150.3
Q ss_pred HHHhcCCcccceeeecCceEEEEEEECC------CceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 218 (331)
|...++|+..+.||+|+||+||+|+... ...||+|++... .......+.+|+.++.++ +|||||+++|++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3445788899999999999999998642 236999998643 334556799999999998 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecC
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSH--------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrd 278 (331)
.+..++||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975321 23589999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 279 LKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 279 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|||+|||++.++.+||+|||+|+....... ......||+.|||||++.++.||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 999999999999999999999976443322 22245689999999999988875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=284.97 Aligned_cols=168 Identities=26% Similarity=0.374 Sum_probs=140.6
Q ss_pred ceeeecCceEEEEEEECC---CceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEecCC
Q 020072 157 NILGEGGFGCVYKAKLDD---NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (331)
Q Consensus 157 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 231 (331)
+.||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999998643 33445789999999999999999999999965 467899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc--
Q 020072 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-- 309 (331)
Q Consensus 232 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 309 (331)
|+|.++++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999863 35699999999999999999999999 9999999999999999999999999999865433221
Q ss_pred -cceeccccCCccccccccCCCC
Q 020072 310 -NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 310 -~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.....||+.|||||++.++.||
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~ 188 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFS 188 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEE
T ss_pred cccccCCCceecCchhhcCCCCC
Confidence 2234689999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-39 Score=283.65 Aligned_cols=175 Identities=29% Similarity=0.362 Sum_probs=152.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 222 (331)
.+.|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999874 68999999985432 12356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC----cEEEEecc
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg 298 (331)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999863 34699999999999999999999999 999999999999998876 49999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++........ .....||+.|+|||++.++.|+
T Consensus 163 ~a~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 163 LAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp TCEECTTSCB-CSCCCCCGGGCCHHHHTTCCBC
T ss_pred hhhhcCCCcc-ccccCCCCcccCHHHHcCCCCC
Confidence 9977654332 2345789999999999887764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-38 Score=288.33 Aligned_cols=172 Identities=28% Similarity=0.329 Sum_probs=152.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 226 (331)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999875 6899999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 306 (331)
||+.+|+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999998853 34699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
. ....||+.|||||++.++.|+
T Consensus 195 ~---~~~~Gt~~Y~APE~~~~~~~~ 216 (350)
T d1rdqe_ 195 T---WTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp B---CCCEECGGGCCHHHHTTCCBC
T ss_pred c---ccccCccccCCHHHHcCCCCC
Confidence 2 245799999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-39 Score=285.67 Aligned_cols=186 Identities=28% Similarity=0.412 Sum_probs=156.2
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCcceeeeee
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGY 215 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~ 215 (331)
..++|...++|+..+.||+|+||+||+|+.. +++.||||+++.... +..++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445667889999999999999999999863 457899999975433 345679999999999999999999999
Q ss_pred EEcCCeEEEEEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCce
Q 020072 216 SAHDDTRFIVYELMENRSLDIQLHGPS---------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (331)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 274 (331)
|.+.+..+++|||+++|+|.++++... ....+++..++.|+.|++.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999886321 123589999999999999999999999 99
Q ss_pred EecCCCCCCEEECCCCcEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 275 vHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+||||||+|||++.++.+||+|||+++...... .......|++.|+|||.+.++.||
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t 220 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC
Confidence 999999999999999999999999996543222 222245688999999999988876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=284.16 Aligned_cols=175 Identities=28% Similarity=0.413 Sum_probs=152.4
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc---CchhHHHHHHHHHHHh-cCCCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLS-NIHHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999875 6899999999643 2334456677777665 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCC
Q 020072 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 305 (331)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999863 34689999999999999999999999 999999999999999999999999999976655
Q ss_pred CCcccceeccccCCccccccccCCCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.........||+.|+|||++.++.|+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 181 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYN 181 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred ccccccccCCCCCcCCHHHHcCCCCC
Confidence 44444456799999999999998875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=282.09 Aligned_cols=175 Identities=27% Similarity=0.449 Sum_probs=144.3
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCc----eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (331)
++|+..++||+|+||+||+|++. +|+ .||+|++... .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 343 5899988643 344567899999999999999999999999875 5678
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 304 (331)
++||+.+|+|.+++.. ....+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888763 346799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcc--cceeccccCCccccccccCCCC
Q 020072 305 SQNKN--NLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 305 ~~~~~--~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... .....||+.|+|||++.++.||
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 191 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYT 191 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCC
Confidence 33222 2234589999999999998875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-38 Score=275.45 Aligned_cols=171 Identities=30% Similarity=0.399 Sum_probs=149.9
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCc---------hhHHHHHHHHHHHhcCC-CCcceeeeeeEEc
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQ---------DAGREFENEVDLLSNIH-HPNVVCLLGYSAH 218 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~ 218 (331)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999987 4789999999864321 12346889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
++..|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999963 34699999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCcccceeccccCCcccccccc
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~ 327 (331)
+++....... .....||+.|+|||.+.+
T Consensus 156 ~a~~~~~~~~-~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 156 FSCQLDPGEK-LREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp TCEECCTTCC-BCCCCSCGGGCCHHHHHH
T ss_pred heeEccCCCc-eeeeeccCCCCCHHHhhc
Confidence 9987655333 234579999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.9e-38 Score=284.70 Aligned_cols=171 Identities=30% Similarity=0.407 Sum_probs=146.0
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEecccC---chhHHHH---HHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREF---ENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|+..++||+|+||.||+|+.. +|+.||||++.... ......+ .+|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 68999999985321 1122233 34577888889999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999863 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccceeccccCCccccccccCC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
..... ....||+.|+|||++.++.
T Consensus 158 ~~~~~--~~~~GT~~y~APE~~~~~~ 181 (364)
T d1omwa3 158 SKKKP--HASVGTHGYMAPEVLQKGV 181 (364)
T ss_dssp SSSCC--CSCCSCGGGCCHHHHSTTC
T ss_pred CCCcc--cccccccccchhHHhhcCC
Confidence 54332 2347999999999997653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=277.31 Aligned_cols=175 Identities=18% Similarity=0.258 Sum_probs=152.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
.++|...+.||+|+||+||+|... +++.||||.++.... ....+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999875 688999999975433 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCC--CcEEEEeccCceeCCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLAITDGSQ 306 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfgla~~~~~~ 306 (331)
+++|+|.+++.. .+..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999963 334699999999999999999999999 99999999999999854 58999999999876544
Q ss_pred CcccceeccccCCccccccccCCCC
Q 020072 307 NKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.. .....+++.|+|||.+.++.|+
T Consensus 158 ~~-~~~~~~t~~y~ape~~~~~~~~ 181 (321)
T d1tkia_ 158 DN-FRLLFTAPEYYAPEVHQHDVVS 181 (321)
T ss_dssp CE-EEEEESCGGGSCHHHHTTCEEC
T ss_pred Cc-ccccccccccccchhccCCCCC
Confidence 33 2345789999999999887664
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=276.79 Aligned_cols=172 Identities=29% Similarity=0.404 Sum_probs=140.9
Q ss_pred hcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEEEEEEe
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIVYEL 228 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~ 228 (331)
.++|+..+.||+|+||.||+|+++ |..||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356778899999999999999985 778999999643 345779999999999999999999999865 4568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+++|+|.+++... ....+++..+++++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 9999999998642 223589999999999999999999999 999999999999999999999999999976543322
Q ss_pred ccceeccccCCccccccccCCCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...++..|+|||++.++.||
T Consensus 159 ---~~~~~~~y~aPE~l~~~~~t 178 (262)
T d1byga_ 159 ---TGKLPVKWTAPEALREKKFS 178 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCC
T ss_pred ---cccccccCCChHHHhCCCCC
Confidence 33678999999999988875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-38 Score=278.04 Aligned_cols=168 Identities=38% Similarity=0.510 Sum_probs=142.5
Q ss_pred cceeeecCceEEEEEEEC-CCceEEEEEecccCch-----hHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEec
Q 020072 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 229 (331)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999874 6899999998644221 2356899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCcc
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 309 (331)
+++++..... ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9888776653 345689999999999999999999999 9999999999999999999999999999776554444
Q ss_pred cceeccccCCccccccccCC
Q 020072 310 NLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 310 ~~~~~gt~~y~aPE~l~~~~ 329 (331)
.....||+.|+|||++.++.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~ 176 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGAR 176 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCS
T ss_pred ccceecChhhccHHHHccCC
Confidence 44557999999999987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=278.03 Aligned_cols=177 Identities=25% Similarity=0.334 Sum_probs=140.2
Q ss_pred HhcCCcccceeeecCceEEEEEEECC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 149 ATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 149 ~~~~~~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
..++|+..+.||+|+||.||+|++.. +..||||+++... ....+.|.+|++++++++||||++++|++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35688889999999999999998643 3568999986543 334567999999999999999999999996 46789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|+|.+++.. ....+++..++.++.||++||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999988753 345689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC-cccceeccccCCccccccccCCCC
Q 020072 304 GSQN-KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.... .......||+.|+|||++.++.|+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS
T ss_pred cCCcceeccceecCcccchhhHhccCCCC
Confidence 4332 223345689999999999988775
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-37 Score=273.82 Aligned_cols=176 Identities=26% Similarity=0.403 Sum_probs=144.5
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----e
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----T 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~ 221 (331)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... .+....+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 478999999996542 334567999999999999999999999987654 4
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 7999999999999988853 34699999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCC---cccceeccccCCccccccccCCCC
Q 020072 302 TDGSQN---KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 302 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
...... .......||+.|+|||++.++.|+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 192 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCC
Confidence 543222 223345799999999999988775
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=276.23 Aligned_cols=175 Identities=31% Similarity=0.462 Sum_probs=148.5
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 468999999996443 2335689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
|+.++.+..... .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998665544333 2345699999999999999999999999 99999999999999999999999999997665544
Q ss_pred cccceeccccCCccccccccCCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
.......||+.|+|||.+....+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSS
T ss_pred ccceeecccceeeehhhhccccC
Confidence 44445679999999999877654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-38 Score=279.25 Aligned_cols=186 Identities=31% Similarity=0.384 Sum_probs=145.5
Q ss_pred HHHHHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeee
Q 020072 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLG 214 (331)
Q Consensus 143 ~~~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g 214 (331)
...++...++|+..+.||+|+||.||+|++. +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3445556688999999999999999999853 3468999998654 334556788888888887 6899999999
Q ss_pred eEEcC-CeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCC
Q 020072 215 YSAHD-DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (331)
Q Consensus 215 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk 280 (331)
++.+. +..++||||+++|+|.++++... ....+++.+++.++.||++||+|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98765 46899999999999999986422 134589999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 281 SSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 281 ~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+||||++++.+||+|||+|+...... .......||+.|+|||++.++.||
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 999999999999999999997644322 223345799999999999988775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=278.09 Aligned_cols=177 Identities=31% Similarity=0.510 Sum_probs=147.5
Q ss_pred cCCcccceeeecCceEEEEEEECC-Cc--eEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCcceeeeeeEEcCCeEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDD-NL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 225 (331)
++|+..++||+|+||.||+|++.+ +. .||||++... ..+..++|.+|+++|+++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999998753 33 5788887543 344567899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcE
Q 020072 226 YELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (331)
Q Consensus 226 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 292 (331)
|||+++|+|.++++.. .....+++..+++++.||++||.|||++ +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998753 2346799999999999999999999999 99999999999999999999
Q ss_pred EEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 293 kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||+|||+++........ ....||..|+|||.+.++.||
T Consensus 167 kl~DfG~a~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK-TMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp EECCTTCEESSCEECCC-----CCTTTCCHHHHHHCEEC
T ss_pred EEccccccccccccccc-cceecCCcccchHHhccCCCC
Confidence 99999999765433222 234689999999999888775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-37 Score=273.05 Aligned_cols=171 Identities=30% Similarity=0.484 Sum_probs=145.0
Q ss_pred cceeeecCceEEEEEEECCC----ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc-CCeEEEEEEec
Q 020072 156 SNILGEGGFGCVYKAKLDDN----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIVYELM 229 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 229 (331)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999987532 35899999643 44556789999999999999999999999876 45899999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc-
Q 020072 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (331)
Q Consensus 230 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 308 (331)
++|+|.++++. ....+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998874 345688999999999999999999999 999999999999999999999999999976533221
Q ss_pred ---ccceeccccCCccccccccCCCC
Q 020072 309 ---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 309 ---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
......||..|+|||.+.++.+|
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 212 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFT 212 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCC
T ss_pred cceecccccccccccChHHHhcCCCC
Confidence 22234689999999999988775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-38 Score=279.24 Aligned_cols=184 Identities=27% Similarity=0.403 Sum_probs=154.6
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEEC------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEE
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 217 (331)
+++...++|...+.||+|+||.||+|.+. ++..||||+++... ......|.+|++++++++||||++++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34555678888999999999999999763 35789999997543 344467999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGP-------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 290 (331)
..+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 999999999999999999887531 2234579999999999999999999999 999999999999999999
Q ss_pred cEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 291 NAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 291 ~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
.+||+|||+++....... ......||+.|+|||.+.++.++
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~ 213 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC
Confidence 999999999976543322 22233589999999999988775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-37 Score=275.94 Aligned_cols=172 Identities=27% Similarity=0.312 Sum_probs=144.9
Q ss_pred hcCCccc-ceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCcceeeeeeEEc----CCeE
Q 020072 150 TDSFHES-NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH----DDTR 222 (331)
Q Consensus 150 ~~~~~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~~ 222 (331)
.++|.+. ++||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++ +||||+++++++++ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4678765 5799999999999987 4689999999853 34577899987654 89999999999875 3578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccC
Q 020072 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (331)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgl 299 (331)
|+|||||++|+|.+++... ....+++.++..++.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999999742 235799999999999999999999999 9999999999999986 56799999999
Q ss_pred ceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 300 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
++....... .....||+.|||||++.+..|+
T Consensus 161 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 161 AKETTSHNS-LTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp CEECCCCCC-CCCCSCCCSSCCCCCCCGGGGS
T ss_pred eeeccCCCc-cccccCCcccCCcHHHcCCCCC
Confidence 987654333 2345799999999999887764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-37 Score=270.86 Aligned_cols=173 Identities=27% Similarity=0.404 Sum_probs=147.6
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCCc
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 308 (331)
+.++.+..+.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 99887776664 346799999999999999999999999 999999999999999999999999999976554444
Q ss_pred ccceeccccCCccccccccCC
Q 020072 309 NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 309 ~~~~~~gt~~y~aPE~l~~~~ 329 (331)
......+++.|+|||.+.+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~ 176 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSK 176 (286)
T ss_dssp ------CCCTTCCHHHHTTCC
T ss_pred ccceecccchhhhHHHHhCCC
Confidence 444456899999999997654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=272.54 Aligned_cols=175 Identities=28% Similarity=0.383 Sum_probs=138.3
Q ss_pred cCCcccceeeecCceEEEEEEEC--CC--ceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD--DN--LHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (331)
++|+..+.||+|+||.||+|+.+ ++ ..||||++... ..+..++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888899999999999999863 22 47899998643 33455789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
+||||+++|++.+++.. ....+++..+++++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988763 335699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc---ccceeccccCCccccccccCCCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... ......|+..|+|||++.++.+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 192 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCC
Confidence 44332 12234578899999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=270.46 Aligned_cols=172 Identities=31% Similarity=0.410 Sum_probs=138.2
Q ss_pred cCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----eEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 226 (331)
++|...+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+.+++||||++++|+|.+.+ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999997 578999999864322 2222344555667889999999999998654 689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
||+++|+|.++++. ..++|.++++++.|++.||+|||+. ..++|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999974 3589999999999999999999963 13499999999999999999999999999997
Q ss_pred eCCCCCc----ccceeccccCCccccccccC
Q 020072 302 TDGSQNK----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 302 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~ 328 (331)
....... ......||++|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred cccCCCcceeccccceecccCcCChhhcccc
Confidence 5533221 22245799999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=272.62 Aligned_cols=182 Identities=27% Similarity=0.360 Sum_probs=154.5
Q ss_pred HHHhcCCcccceeeecCceEEEEEEE------CCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCcceeeeeeEEc
Q 020072 147 EKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (331)
Q Consensus 147 ~~~~~~~~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 218 (331)
+...++|+..+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 44557888899999999999999975 345789999997543 34556799999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCC
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPS---------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~N 283 (331)
.+..++||||+++|+|.++++... ....+++..+.+++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999986432 223689999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeccCceeCCCCCc--ccceeccccCCccccccccCCCC
Q 020072 284 ILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 284 ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
||++.++.+|++|||+++....... ......||+.|+|||++.++.+|
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC
Confidence 9999999999999999976543322 22235689999999999988765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=269.90 Aligned_cols=181 Identities=29% Similarity=0.400 Sum_probs=148.2
Q ss_pred HHhcCCcccceeeecCceEEEEEEEC--------CCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCcceeeeeeEE
Q 020072 148 KATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNI-HHPNVVCLLGYSA 217 (331)
Q Consensus 148 ~~~~~~~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 217 (331)
...++|+..+.||+|+||.||+|+.. ++..||||+++.... ....++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34578888999999999999999753 235799999975543 4457889999999888 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCE
Q 020072 218 HDDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (331)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Ni 284 (331)
+++..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999997532 124689999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeccCceeCCCCC--cccceeccccCCccccccccCCCC
Q 020072 285 LLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 285 ll~~~~~~kl~Dfgla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|++.++.+||+|||+++...... .......+++.|+|||.+.++.||
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 99999999999999997553322 222334689999999999998876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=267.18 Aligned_cols=173 Identities=28% Similarity=0.376 Sum_probs=146.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCC--CCcceeeeeeEEcCC
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIH--HPNVVCLLGYSAHDD 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~ 220 (331)
.++|+..++||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999874 689999999864321 12245778999999996 899999999999999
Q ss_pred eEEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-CCcEEEEecc
Q 020072 221 TRFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFG 298 (331)
Q Consensus 221 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg 298 (331)
..++||||+.+ +++.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777743 35699999999999999999999999 9999999999999985 4799999999
Q ss_pred CceeCCCCCcccceeccccCCccccccccCCC
Q 020072 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGMV 330 (331)
Q Consensus 299 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 330 (331)
+++....... ....||+.|+|||++.++.+
T Consensus 157 ~a~~~~~~~~--~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 157 SGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp TCEECCSSCB--CCCCSCGGGSCHHHHHHSCB
T ss_pred cceecccccc--cccccCCCcCCHHHHcCCCC
Confidence 9976544322 34579999999999987664
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=261.99 Aligned_cols=176 Identities=31% Similarity=0.412 Sum_probs=143.6
Q ss_pred hcCCcccceeeecCceEEEEEEEC-C-CceEEEEEecccC--chhHHHHHHHHHHHhcC---CCCcceeeeeeEEc----
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-D-NLHVAVKKLDCAT--QDAGREFENEVDLLSNI---HHPNVVCLLGYSAH---- 218 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~---- 218 (331)
.++|+..+.||+|+||+||+|+.. + ++.||||++.... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999873 4 5679999986432 22334566777776655 89999999999853
Q ss_pred -CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEec
Q 020072 219 -DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (331)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 297 (331)
....+++|||++++++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 346899999999887765544 3345689999999999999999999999 9999999999999999999999999
Q ss_pred cCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 298 gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
|+++....... .....||+.|+|||++.++.||
T Consensus 161 g~~~~~~~~~~-~~~~~gT~~Y~APE~~~~~~y~ 193 (305)
T d1blxa_ 161 GLARIYSFQMA-LTSVVVTLWYRAPEVLLQSSYA 193 (305)
T ss_dssp CSCCCCCGGGG-GCCCCCCCTTCCHHHHTTCCCC
T ss_pred hhhhhhccccc-CCCcccChhhcCcchhcCCCCC
Confidence 99876543322 2345799999999999988875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-35 Score=264.95 Aligned_cols=169 Identities=27% Similarity=0.367 Sum_probs=138.8
Q ss_pred CCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceeeeeeEEcC------CeEEE
Q 020072 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------DTRFI 224 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~l 224 (331)
+|...++||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777899999999999999975 689999999965432 234799999999999999999998543 35789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeC
Q 020072 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (331)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~ 303 (331)
||||++++.+....+.......+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998775544433223445799999999999999999999999 999999999999999775 8999999999776
Q ss_pred CCCCcccceeccccCCccccccccC
Q 020072 304 GSQNKNNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~l~~~ 328 (331)
...... ....|+..|+|||.+.++
T Consensus 174 ~~~~~~-~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 174 VRGEPN-VSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CTTSCC-CSCCSCTTSCCHHHHTTC
T ss_pred cCCccc-ccccccccccChHHhhcc
Confidence 543332 245799999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=254.16 Aligned_cols=173 Identities=26% Similarity=0.365 Sum_probs=151.9
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCCeEEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 227 (331)
++|+..+.||+|+||+||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999874 6889999998644 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeCCCCC
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 307 (331)
++.+++|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999887753 45689999999999999999999999 99999999999999999999999999998766554
Q ss_pred cccceeccccCCccccccccCC
Q 020072 308 KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 308 ~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.......++..|+|||.+.+..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~ 177 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCS
T ss_pred ccceeeccccchhhhhHhccCC
Confidence 4444456788999999987664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-34 Score=257.81 Aligned_cols=166 Identities=25% Similarity=0.373 Sum_probs=142.1
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcC--CeEEEEE
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHD--DTRFIVY 226 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 226 (331)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999987 46899999998643 3467889999999995 99999999998744 5689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCC-cEEEEeccCceeCCC
Q 020072 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGS 305 (331)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~ 305 (331)
||+++++|.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 3589999999999999999999999 999999999999998654 699999999977654
Q ss_pred CCcccceeccccCCccccccccCC
Q 020072 306 QNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
.... ....+|+.|+|||.+.+..
T Consensus 183 ~~~~-~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 183 GQEY-NVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp TCCC-CSCCSCGGGCCHHHHTTCC
T ss_pred CCcc-cccccCccccCcccccCCC
Confidence 3322 3446899999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=256.31 Aligned_cols=173 Identities=26% Similarity=0.377 Sum_probs=142.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc--------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-------- 218 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-------- 218 (331)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367889999999999999999874 7899999998543 33445678999999999999999999998865
Q ss_pred CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEecc
Q 020072 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (331)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 298 (331)
.+..++||||++++++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 345799999999887765553 345689999999999999999999999 99999999999999999999999999
Q ss_pred CceeCCCCCc----ccceeccccCCccccccccC
Q 020072 299 LAITDGSQNK----NNLKLSGTLGYVAPEYLLDG 328 (331)
Q Consensus 299 la~~~~~~~~----~~~~~~gt~~y~aPE~l~~~ 328 (331)
+++....... .....+||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 9976543221 22234699999999998765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=261.72 Aligned_cols=169 Identities=28% Similarity=0.412 Sum_probs=139.1
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC------
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 220 (331)
.++|+..+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999875 6899999999643 3344567899999999999999999999998654
Q ss_pred eEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCc
Q 020072 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (331)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 300 (331)
..|+||||+ +.+|....+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 579999999 4567666542 4699999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCCcccceeccccCCccccccccCC
Q 020072 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
+....... ...||+.|+|||++.+..
T Consensus 169 ~~~~~~~~---~~~~t~~y~aPE~~~~~~ 194 (346)
T d1cm8a_ 169 RQADSEMT---GYVVTRWYRAPEVILNWM 194 (346)
T ss_dssp EECCSSCC---SSCSCGGGCCTHHHHTTT
T ss_pred eccCCccc---cccccccccCHHHHcCCC
Confidence 87654332 346899999999997654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=260.41 Aligned_cols=173 Identities=26% Similarity=0.366 Sum_probs=141.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCcceeeeeeEEcCC----eEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRF 223 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~ 223 (331)
+++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788899999999999999986 478999999997543 344567899999999999999999999987653 234
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCceeC
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 303 (331)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55566778999999853 3599999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCc---ccceeccccCCccccccccCC
Q 020072 304 GSQNK---NNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~l~~~~ 329 (331)
..... ......||+.|+|||++..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 188 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSK 188 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBC
T ss_pred cCCCccceeeccccccceechHHHhhcCC
Confidence 33211 223456899999999986654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.7e-34 Score=251.46 Aligned_cols=174 Identities=19% Similarity=0.262 Sum_probs=146.3
Q ss_pred hcCCcccceeeecCceEEEEEEEC-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC-CcceeeeeeEEcCCeEEEEEE
Q 020072 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYE 227 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 227 (331)
.++|+..+.||+|+||+||+|+.. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357899999999999999999865 68899999885432 33457889999999975 899999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC-----CCcEEEEeccCcee
Q 020072 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-----KFNAKLSDFGLAIT 302 (331)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfgla~~ 302 (331)
|+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 5899888763 345699999999999999999999999 9999999999999974 57899999999976
Q ss_pred CCCCC-------cccceeccccCCccccccccCCCC
Q 020072 303 DGSQN-------KNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 303 ~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
..... .......||+.|||||++.+..+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~ 191 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC
Confidence 53221 122345799999999999988775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-34 Score=255.17 Aligned_cols=173 Identities=27% Similarity=0.369 Sum_probs=148.1
Q ss_pred cCCcccceeeecCceEEEEEEE----CCCceEEEEEeccc----CchhHHHHHHHHHHHhcCCC-CcceeeeeeEEcCCe
Q 020072 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDT 221 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~ 221 (331)
++|+..+.||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999975 24789999998643 22345678899999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.+++|||+.+|+|.+++.. ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999863 34578889999999999999999999 99999999999999999999999999997
Q ss_pred eCCCCC-cccceeccccCCccccccccCC
Q 020072 302 TDGSQN-KNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 302 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
...... .......|++.|+|||.+.++.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~ 206 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGD 206 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC
T ss_pred hhcccccccccccccccccchhHHhhcCC
Confidence 654332 2233457999999999997654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-33 Score=246.35 Aligned_cols=173 Identities=23% Similarity=0.266 Sum_probs=139.1
Q ss_pred cCCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcceee-eeeEEcCCeEEEEEEe
Q 020072 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL-LGYSAHDDTRFIVYEL 228 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l-~g~~~~~~~~~lv~e~ 228 (331)
++|+..+.||+|+||.||+|+. .+|+.||||.+.... ...++.+|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5789999999999999999987 468999999876433 23468899999999987765554 5556777899999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECC---CCcEEEEeccCceeCCC
Q 020072 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITDGS 305 (331)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla~~~~~ 305 (331)
++ +++...+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+....
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 555555442 345699999999999999999999999 9999999999999864 55799999999976543
Q ss_pred CCc-------ccceeccccCCccccccccCCCC
Q 020072 306 QNK-------NNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 306 ~~~-------~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
... ......||+.|||||.+.+..||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCC
Confidence 221 22345799999999999988765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-33 Score=253.57 Aligned_cols=171 Identities=29% Similarity=0.362 Sum_probs=135.6
Q ss_pred cCCcccceeeecCceEEEEEEEC-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCcceeeeeeEEc------CCe
Q 020072 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH------DDT 221 (331)
Q Consensus 151 ~~~~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~ 221 (331)
++|+..+.||+|+||+||+|+.. +|+.||||++... +....+++.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999875 6899999999644 33445678999999999999999999999864 368
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.|+||||+.++.+. .+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 89999999766554 332 3489999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCCcccceeccccCCccccccccCCCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
........ ....+|+.|+|||++.+..++
T Consensus 168 ~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~ 196 (355)
T d2b1pa1 168 TAGTSFMM-TPYVVTRYYRAPEVILGMGYK 196 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCC
T ss_pred cccccccc-ccccccccccChhhhcCCCCC
Confidence 65443322 244689999999999887664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.5e-33 Score=252.46 Aligned_cols=170 Identities=29% Similarity=0.379 Sum_probs=141.2
Q ss_pred hcCCcccceeeecCceEEEEEEE-CCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCcceeeeeeEEcC-----Ce
Q 020072 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (331)
Q Consensus 150 ~~~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (331)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999986 478999999997543 33456789999999999999999999998643 34
Q ss_pred EEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 5677788889999999853 3599999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCCcccceeccccCCccccccccCC
Q 020072 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGM 329 (331)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 329 (331)
..... .....|++.|+|||.+.+..
T Consensus 170 ~~~~~---~~~~~g~~~y~apE~~~~~~ 194 (348)
T d2gfsa1 170 HTDDE---MTGYVATRWYRAPEIMLNWM 194 (348)
T ss_dssp CCTGG---GSSSCHHHHTSCHHHHTTCS
T ss_pred ccCcc---cccccccccccCchhhcCCc
Confidence 54332 22346899999999987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=1.2e-28 Score=224.09 Aligned_cols=173 Identities=24% Similarity=0.278 Sum_probs=137.5
Q ss_pred CCcccceeeecCceEEEEEEE-CCCceEEEEEecccCchhHHHHHHHHHHHhcCC-----------CCcceeeeeeEEc-
Q 020072 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----------HPNVVCLLGYSAH- 218 (331)
Q Consensus 152 ~~~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~- 218 (331)
+|+..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588999999999999999987 478999999997432 23467788999888875 5789999988764
Q ss_pred -CCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCceEecCCCCCCEEECCCCc-----
Q 020072 219 -DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFN----- 291 (331)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~----- 291 (331)
....+++++++..+..............+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 35677777777666543333222445678999999999999999999998 5 8999999999999987653
Q ss_pred -EEEEeccCceeCCCCCcccceeccccCCccccccccCCCC
Q 020072 292 -AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGMVN 331 (331)
Q Consensus 292 -~kl~Dfgla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t 331 (331)
+|++|||.+....... ....||+.|+|||++.++.||
T Consensus 170 ~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp EEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCC
T ss_pred eeeEeeccccccccccc---ccccccccccChhhccccCCC
Confidence 9999999997654332 234799999999999887764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.4e-25 Score=181.53 Aligned_cols=132 Identities=17% Similarity=0.219 Sum_probs=105.5
Q ss_pred ccceeeecCceEEEEEEECCCceEEEEEecccCc------------------hhHHHHHHHHHHHhcCCCCcceeeeeeE
Q 020072 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ------------------DAGREFENEVDLLSNIHHPNVVCLLGYS 216 (331)
Q Consensus 155 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~g~~ 216 (331)
..+.||+|+||+||+|+..+|+.||||.++.... .......+|...+.++.|.|++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4688999999999999998999999998743210 0123356788999999999999887653
Q ss_pred EcCCeEEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCceEecCCCCCCEEECCCCcEEEEe
Q 020072 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (331)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 296 (331)
. .+++|||++++.+.. ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2 379999999766543 23334568999999999999999 99999999999999965 589999
Q ss_pred ccCceeCC
Q 020072 297 FGLAITDG 304 (331)
Q Consensus 297 fgla~~~~ 304 (331)
||+|+...
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99997764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.4e-08 Score=85.94 Aligned_cols=149 Identities=18% Similarity=0.130 Sum_probs=100.8
Q ss_pred HHHHHhcCCcccceeeecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCcceeeeeeEEcCCeEE
Q 020072 145 LLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRF 223 (331)
Q Consensus 145 ~l~~~~~~~~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~ 223 (331)
++....+.|...+..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556665554443344568998875 45567788876554444556788888877663 433567788888888999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 020072 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC--------------------------------- 270 (331)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------- 270 (331)
+|||++++.++.+..... . ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999988886543210 1 12344556666666666421
Q ss_pred -----------------------CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 271 -----------------------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 271 -----------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999887778999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=4.6e-06 Score=69.48 Aligned_cols=130 Identities=16% Similarity=0.110 Sum_probs=85.5
Q ss_pred eeecC-ceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCC--CcceeeeeeEEcCCeEEEEEEecCCCChh
Q 020072 159 LGEGG-FGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (331)
Q Consensus 159 ig~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 235 (331)
+..|. .+.||+...+++..+.+|...... ..++..|...++.+.. -.+.++++++.+++..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 368999988888888888765332 3456778887776643 33566788888888999999999876663
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 020072 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHE----------------------------------------------- 268 (331)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~----------------------------------------------- 268 (331)
+.- ... ...+.+++..|.-||+
T Consensus 95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 210 111 1112233333333332
Q ss_pred ----CC----CCceEecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 269 ----HC----NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 269 ----~~----~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
.. .+.++|+|+.|.|||++++..+-|.||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12479999999999999887788999998744
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=3e-05 Score=68.99 Aligned_cols=76 Identities=13% Similarity=0.071 Sum_probs=47.6
Q ss_pred cceeeecCceEEEEEEECC-CceEEEEEeccc-------CchhHHHHHHHHHHHhcC-CC--CcceeeeeeEEcCCeEEE
Q 020072 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDCA-------TQDAGREFENEVDLLSNI-HH--PNVVCLLGYSAHDDTRFI 224 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~H--~niv~l~g~~~~~~~~~l 224 (331)
.+.||.|....||+....+ ++.+++|.-... ......+...|.+.|+.+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998754 578888865321 111233456677777766 23 345555544 4455689
Q ss_pred EEEecCCCC
Q 020072 225 VYELMENRS 233 (331)
Q Consensus 225 v~e~~~~g~ 233 (331)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.48 E-value=0.00048 Score=59.25 Aligned_cols=135 Identities=16% Similarity=0.198 Sum_probs=77.5
Q ss_pred eEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-----eeee--eeEEcCCeEEEEEEecCCCChhh-
Q 020072 165 GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-----VCLL--GYSAHDDTRFIVYELMENRSLDI- 236 (331)
Q Consensus 165 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l~--g~~~~~~~~~lv~e~~~~g~L~~- 236 (331)
-.||+.+.++|..+++|..+... ...+++..|...+..|...++ +..- ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 58999999999999999976432 234567778888777642222 1111 12345667889999998644310
Q ss_pred -------------hhc----CC--CCCCCCCHH-------------------HHHHHHHHHHHHHHHHhh----CCCCce
Q 020072 237 -------------QLH----GP--SHGSALTWH-------------------MRMKIALDTARGLEYLHE----HCNPAV 274 (331)
Q Consensus 237 -------------~l~----~~--~~~~~l~~~-------------------~~~~i~~~ia~~l~yLH~----~~~~~i 274 (331)
.+| .. .....+++. ....+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 011 00 001111111 111122222333333322 234578
Q ss_pred EecCCCCCCEEECCCCcEEEEeccCcee
Q 020072 275 IHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (331)
Q Consensus 275 vHrdlk~~Nill~~~~~~kl~Dfgla~~ 302 (331)
+|+|+.+.|||++++ ..+.||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.0016 Score=57.48 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=48.0
Q ss_pred cceeeecCceEEEEEEECCC--------ceEEEEEecccCchhHHHHHHHHHHHhcCCCCcc-eeeeeeEEcCCeEEEEE
Q 020072 156 SNILGEGGFGCVYKAKLDDN--------LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (331)
Q Consensus 156 ~~~ig~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 226 (331)
.+.|+.|-.-.+|+....++ ..|.++... ... ...+..+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 34677777889999987543 456666654 222 23456688888888843344 467777643 5889
Q ss_pred EecCCCCh
Q 020072 227 ELMENRSL 234 (331)
Q Consensus 227 e~~~~g~L 234 (331)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.54 E-value=0.063 Score=44.92 Aligned_cols=157 Identities=14% Similarity=0.100 Sum_probs=81.7
Q ss_pred cHHHHHHHhcCCcccceee-----ecCceEEEEEEECCCceEEEEEecccCchhHHHHHHHHHHHhcCCC-----Cccee
Q 020072 142 EYKLLEKATDSFHESNILG-----EGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-----PNVVC 211 (331)
Q Consensus 142 ~~~~l~~~~~~~~~~~~ig-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-----~niv~ 211 (331)
+.++++....+|...++.. .|---+.|+.+.++| .+++|+.... ...+++..|++++..|.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 3567777778887655443 444467899988776 4788887532 122344556666666542 22221
Q ss_pred ee-e--eEEcCCeEEEEEEecCCCChhh--------------hhc--CC----CCCCCCCHH------------------
Q 020072 212 LL-G--YSAHDDTRFIVYELMENRSLDI--------------QLH--GP----SHGSALTWH------------------ 250 (331)
Q Consensus 212 l~-g--~~~~~~~~~lv~e~~~~g~L~~--------------~l~--~~----~~~~~l~~~------------------ 250 (331)
.. | +.........++.+..+..... .++ .. .........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 1223445666777766543311 000 00 000000000
Q ss_pred HHHHHHHHHHHHHHHHh-hCCCCceEecCCCCCCEEECCCCcEEEEeccCce
Q 020072 251 MRMKIALDTARGLEYLH-EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (331)
Q Consensus 251 ~~~~i~~~ia~~l~yLH-~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 301 (331)
.....+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111122222222222 1234489999999999999998888899999874
|